Science.gov

Sample records for nuclear medicine progress

  1. Converting energy to medical progress [nuclear medicine

    SciTech Connect

    2001-04-01

    For over 50 years the Office of Biological and Environmental Research (BER) of the United States Department of Energy (DOE) has been investing to advance environmental and biomedical knowledge connected to energy. The BER Medical Sciences program fosters research to develop beneficial applications of nuclear technologies for medical diagnosis and treatment of many diseases. Today, nuclear medicine helps millions of patients annually in the United States. Nearly every nuclear medicine scan or test used today was made possible by past BER-funded research on radiotracers, radiation detection devices, gamma cameras, PET and SPECT scanners, and computer science. The heart of biological research within BER has always been the pursuit of improved human health. The nuclear medicine of tomorrow will depend greatly on today's BER-supported research, particularly in the discovery of radiopharmaceuticals that seek specific molecular and genetic targets, the design of advanced scanners needed to create meaningful images with these future radiotracers, and the promise of new radiopharmaceutical treatments for cancers and genetic diseases.

  2. Nuclear Medicine

    MedlinePLUS

    ... Parents/Teachers Resource Links for Students Glossary Nuclear Medicine What is nuclear medicine? What are radioactive tracers? ... funded researchers advancing nuclear medicine? What is nuclear medicine? Nuclear medicine is a medical specialty that uses ...

  3. Nuclear Medicine.

    ERIC Educational Resources Information Center

    Badawi, Ramsey D.

    2001-01-01

    Describes the use of nuclear medicine techniques in diagnosis and therapy. Describes instrumentation in diagnostic nuclear medicine and predicts future trends in nuclear medicine imaging technology. (Author/MM)

  4. General Nuclear Medicine

    MedlinePLUS

    ... Resources Professions Site Index A-Z General Nuclear Medicine What is General Nuclear Medicine? What are some ... of General Nuclear Medicine? What is General Nuclear Medicine? Nuclear medicine is a branch of medical imaging ...

  5. Children's (Pediatric) Nuclear Medicine

    MedlinePLUS

    ... Professions Site Index A-Z Children's (Pediatric) Nuclear Medicine Children’s (pediatric) nuclear medicine imaging uses small amounts ... Children's Nuclear Medicine? What is Children's (Pediatric) Nuclear Medicine? Nuclear medicine is a branch of medical imaging ...

  6. Nuclear medicine and imaging research (instrumentation and quantitative methods of evaluation). Progress report, January 15, 1992--January 14, 1993

    SciTech Connect

    Beck, R.N.; Cooper, M.; Chen, C.T.

    1992-07-01

    This document is the annual progress report for project entitled ``Instrumentation and Quantitative Methods of Evaluation.`` Progress is reported in separate sections individually abstracted and indexed for the database. Subject areas reported include theoretical studies of imaging systems and methods, hardware developments, quantitative methods of evaluation, and knowledge transfer: education in quantitative nuclear medicine imaging.

  7. Nuclear medicine

    SciTech Connect

    Wagner, H.N. Jr.

    1986-10-17

    In 1985 and 1986 nuclear medicine became more and more oriented toward in vov chemistry, chiefly as a result of advances in positron emission tomography (PET). The most important trend was the extension of PET technology into the care of patients with brain tumors, epilepsy, and heart disease. A second trend was the increasing use of single-photon emission computed tomography (SPECT).

  8. Nuclear Medicine Program progress report for quarter ending June 30, 1993

    SciTech Connect

    Knapp, F.F. Jr.; Ambrose, K.R.; Beets, A.L.; Callahan, A.P.; Hsieh, B.T.; McPherson, D.W.; Mirzadeh, S.; Lambert, C.R.

    1993-07-01

    The ``IQNP`` agent is an antagonist for the cholinergic-muscarinic receptor. Since the IQNP molecule has two asymmetric centers and either cis or trans isomerism of the vinyl iodide, there are eight possible isomeric combinations. In this report, the systematic synthesis, purification and animal testing of several isomers of radioiodinated ``IQNP`` are reported. A dramatic and unexpected relation between the absolute configuration at the two asymmetric centers and the stereochemistry of the vinyl iodide on receptor specificity was observed. The E-(R)(R) isomer shows specific and significant localization (per cent dose/gram at 6 hours) in receptor-rich cerebral structures (i.e. Cortex = 1.38 + 0.31; Striatum = 1.22 + 0.20) and low uptake in tissues rich in the M{sub 2} subtype (Heart = 0.10; Cerebellum = 0.04). In contrast, the E-(R)(S) isomer shows very low receptor-specific uptake (Cortex = 0.04; Striatum = 0.02), demonstrating the importance of absolute configuration at the acetate center. An unexpected and important observation is that the stereochemistry of the vinyl iodine appears to affect receptor subtype specificity, since the Z-(R,S)(R) isomer shows much higher uptake in the heart (0.56 + 0.12) and cerebellum (0.17 + 0.04). Studies are now in progress to confirm these exciting results in vitro. Progress has also continued during this period with several collaborative programs. The first large-scale clinical tungsten-188/rhenium-188 generator prototype (500 mCi) was fabricated and supplied to the Center for Molecular Medicine and Immunology (CMMI), in Newark, New Jersey, for Phase I clinical trials of rhenium-188-labeled anti CEA antibodies for patient treatment. Collaborative studies are also continuing in conjunction with the Nuclear Medicine Department at the University of Massachusetts where a generator is in use to compare the biological properties of {open_quotes}direct{close_quotes} and {open_quotes}indirect{close_quotes} labeled antibodies.

  9. Nuclear medicine program progress report for quarter ending December 31, 1996

    SciTech Connect

    Knapp, F.F. Jr.; Beets, A.L.; Boll, R.; Luo, H.; McPherson, D.W.; Mirzadeh, S.

    1997-03-20

    In this report the authors describe the use of an effective method for concentration of the rhenium-188 bolus and the results of the first Phase 1 clinical studies for bone pain palliation with rhenium-188 obtained from the tungsten-188/rhenium-188 generator. Initial studies with therapeutic levels of Re-188-HEDP at the Clinic for Nuclear Medicine at the University of Bonn, Germany, have demonstrated the expected good metastatic uptake of Re-188-HEDP in four patients who presented with skeletal metastases from disseminated prostatic cancer with good pain palliation and minimal marrow suppression. In addition, skeletal metastatic targeting of tracer doses of Re-188(V)-DMSA has been evaluated in several patients with metastases from prostatic cancer at the Department of Nuclear Medicine at the Canterbury and Kent Hospital in Canterbury, England. In this report the authors also describe further studies with the E-(R,R)-IQNP ligand developed in the ORNL Nuclear Medicine Program as a potential imaging agent for detection of changes which may occur in the cerebral muscarinic-cholinergic receptors (mAChR) in Alzheimer`s and other diseases.

  10. Nuclear medicine program progress report for quarter ending September 30, 1993

    SciTech Connect

    Knapp, F.F. Jr.; Ambrose, K.R.; Beets, A.L.; Callahan, A.P.; Luo, H.; McPherson, D.W.; Mirzadeh, S.; Lambert, C.R.; Hsieh, B.T.

    1994-01-01

    Processing of enriched tungsten-186 oxide targets after long irradiations (> 2 cycles) in the ORNL High Flux Isotope Reactor (HFIR) has resulted in specific activities significantly lower than the theoretical values, with the concomitant formation of varying amounts of highly radioactive black insoluble material to total tungsten-188 yield, 5% sodium hypochlorite solution has been found to dissolve this black material. Yields for longer irradiation periods (> 2 cycles) have nearly doubled. As an alternative, more simple approach, enriched tungsten-186 metallic targets have also now been irradiated. Following irradiation, these targets were dissolved in hydrogen peroxide/NaOH solution with no evidence of any residual black insoluble material remaining. Yields for a 2-cycle (e.g. 42 days) HFIR irradiation have thus now significantly increased, for example, from 5--6 mCi {sup 188}W/mg of {sup 186}W, to 10 mCi/mg (43 days) and 12.9 mCi/mg (53 days). Large clinical scale (< 1 Ci) generators fabricated from tungsten-188 prepared from such metal targets have exhibited the expected high {sup 188}Re yield and low {sup 188}W breakthrough. Also during this period, a systematic evaluation of the production yields of a number of radioisotopes of current interest in nuclear medicine were evaluated by irradiation of targets in the Hydraulic Tube Facility (HT) of the ORNL High Flux Isotope Reactor (HFIR). Small samples were irradiated for short periods, and the radioactive contents of the sealed sources then analyzed by gamma spectroscopy.

  11. Technologists for Nuclear Medicine

    ERIC Educational Resources Information Center

    Barnett, Huey D.

    1974-01-01

    Physicians need support personnel for work with radioisotopes in diagnosing dangerous diseases. The Nuclear Medicine Technology (NMT) Program at Hillsborough Community College in Tampa, Florida, is described. (MW)

  12. Nuclear Medicine Program progress report for quarter ending September 30, 1991

    SciTech Connect

    Knapp, F.F. Jr.; Ambrose, K.R.; Callahan, A.P.; McPherson, D.W.; Mirzadeh, S.; Srivastava, P.C.; Hasan, A.; Lambert, C.R.; Lambert, S.J.; Rice, D.E.

    1992-02-01

    Rat tissue distribution properties of ``IQNP,`` a new radioiodinated cholinergic-muscarinic receptor antagonist, are described. IQNP is the acronym for 1-azabicyclo[2.2.2]oct-3-yl {alpha}-hydroxy-{alpha}-phenyl-{alpha}(1-iodo-1-propen-3-yl) acetate, which is an analogue of the QNB muscarinic antagonist in which the p-iodophenyl moiety has been replaced with the 1-iodo-1-propen-3-yl moiety. The radioiodinated IQNP analogue is easier to prepare in much higher yields than QNB and is thus a candidate for the evaluation of muscarinic receptors by external imaging techniques. Studies in rats demonstrated that IQNP shows high uptake in those cerebral regions rich in muscarinic receptors QNB-treatment of rats either 1 h before (pre) or 2 h after (post) administration of radioiodinated IQNP resulted in significant displacement or blocking of cerebral specific IQNP uptake (% dose/gm) in the cortex and striatum. These studies demonstrate that IQNP has specificity for the cholinergic-muscarinic receptor and is a good candidate for further studies. Also during this period, several agents developed in the ORNL Nuclear Medicine Program were supplied to Medical Cooperative Programs for collaborative studies including the iodine-125-labeled BMIPP and DMIPP fatty acid analogues and the IPM antibody labeling agent. Tin-117m and gold-199 were produced in the ORNL High Flux Isotope Reactor (HFIR) and supplied to the OHER-supported program in the Medical Department at Brookhaven National Laboratory to aid in their research until the re-start of the High Flux Brookhaven Reactor.

  13. Nuclear Medicine Program progress report for quarter ending September 30, 1991

    SciTech Connect

    Knapp, F.F. Jr.; Ambrose, K.R.; Callahan, A.P.; McPherson, D.W.; Mirzadeh, S.; Srivastava, P.C.; Hasan, A.; Lambert, C.R.; Lambert, S.J.; Rice, D.E.

    1992-02-01

    Rat tissue distribution properties of IQNP,'' a new radioiodinated cholinergic-muscarinic receptor antagonist, are described. IQNP is the acronym for 1-azabicyclo(2.2.2)oct-3-yl {alpha}-hydroxy-{alpha}-phenyl-{alpha}(1-iodo-1-propen-3-yl) acetate, which is an analogue of the QNB muscarinic antagonist in which the p-iodophenyl moiety has been replaced with the 1-iodo-1-propen-3-yl moiety. The radioiodinated IQNP analogue is easier to prepare in much higher yields than QNB and is thus a candidate for the evaluation of muscarinic receptors by external imaging techniques. Studies in rats demonstrated that IQNP shows high uptake in those cerebral regions rich in muscarinic receptors QNB-treatment of rats either 1 h before (pre) or 2 h after (post) administration of radioiodinated IQNP resulted in significant displacement or blocking of cerebral specific IQNP uptake (% dose/gm) in the cortex and striatum. These studies demonstrate that IQNP has specificity for the cholinergic-muscarinic receptor and is a good candidate for further studies. Also during this period, several agents developed in the ORNL Nuclear Medicine Program were supplied to Medical Cooperative Programs for collaborative studies including the iodine-125-labeled BMIPP and DMIPP fatty acid analogues and the IPM antibody labeling agent. Tin-117m and gold-199 were produced in the ORNL High Flux Isotope Reactor (HFIR) and supplied to the OHER-supported program in the Medical Department at Brookhaven National Laboratory to aid in their research until the re-start of the High Flux Brookhaven Reactor.

  14. Nuclear medicine program progress report for quarter ending September 30, 1995

    SciTech Connect

    Knapp, F.F. Jr.; Ambrose, K.R.; Beets, A.L.; Luo, H.; McPherson, D.W.; Mirzadeh, S.

    1995-12-31

    In this report, we describe the results for study of the production of lutetium-177 ({sup 177}Lu) in the High Flux Isotope Reactor (HFIR). Two pathways for production of {sup 177}Lu were studied which involved both direct neutron capture on enriched {sup 176}Lu, {sup 176}Lu (n,{gamma}){sup 177}Lu, reaction and by decay of ytterbium-177 ({sup 177}Yb) produced by the {sup 176}Yb(n,{gamma}){sup 177}Yb ({beta}{sup {minus}} {sup {yields}}) reaction. Although the direct route is more straight forward and does not involve any separation steps, the indirect method via {beta}{sup {minus}}-decay of {sup 177}Yb has the advantage of providing carrier-free {sup 177}Lu, which would be required for antibody radiolabeling and other applications where very high specific activity is required.Substrates required for preparation of tissue-specific agents and several radioisotopes were also provided during this period through several Medical Cooperative Programs. These include the substrate for preparation of the ``BMIPP`` cardiac imaging which was developed in the ORNL Nuclear Medicine Program, which was provided to Dr. A. Giodamo, M.D. and colleagues at the Catholic University Hospital in Rome, Italy. Tungsten-188 produced in the ORNL HFIR was also provided to the Catholic University Hospital for fabrication of a tungsten-188/rhenium-188 generator to provide carrier-free rhenium-188 which will be used for preparation of rhenium-188 labeled methylenediphosphonate (MDP) for initial clinical evaluation for palliative treatment of bone pain (L. Troncone, M.D.). Samples of substrates for preparation of the new ORNL ``IQNP`` agent for imaging of muscarinic-cholinergic receptors were provided to the Karolinska Institute in Stockholm, Sweden, for preparation of radioiodinated IQNP for initial imaging studies with this new agent in monkeys and for tissue binding studies with human brain samples obtained from autopsy (C. Halldin, Ph.D.).

  15. Your Radiologist Explains Nuclear Medicine

    MedlinePLUS Videos and Cool Tools

    ... by: Image/Video Gallery Your Radiologist Explains Nuclear Medicine Transcript Welcome to Radiology Info dot org Hello! ... d like to talk to you about nuclear medicine. Nuclear medicine offers the potential to identify disease ...

  16. Nuclear Medicine Annual, 1989

    SciTech Connect

    Freeman, L.M.; Weissmann, H.S.

    1989-01-01

    Among the highlights of Nuclear Medicine Annual, 1989 are a status report on the thyroid scan in clinical practice, a review of functional and structural brain imaging in dementia, an update on radionuclide renal imaging in children, and an article outlining a quality assurance program for SPECT instrumentation. Also included are discussions on current concepts in osseous sports and stress injury scintigraphy and on correlative magnetic resonance and radionuclide imaging of bone. Other contributors assess the role of nuclear medicine in clinical decision making and examine medicolegal and regulatory aspects of nuclear medicine.

  17. Society of Nuclear Medicine

    Cancer.gov

    June 14, 2008 12:00 AM - June 18, 2008 12:00 AM Ernest N Morial Convention Center, Booth 419 New Orleans, LA + Add to Outlook Calendar 2008 Annual Meeting Print This Page Society of Nuclear Medicine News & Events

  18. Evaluative studies in nuclear medicine research. Progress report, October 1, 1979-June 30, 1980

    SciTech Connect

    Potchen, E.J.

    1980-07-01

    Effort since the last progress report (September 1979) has been directed toward assessing the potential short and long term benefits of continued development and application and medical research of emission computed tomograhy (ECT). This report contains a review of existing ECT technology, including functional descriptions of current and proposed image systems, for both sngle-photon ECT (SPECT) and positron ECT (PECT) approaches. Medical research and clinical topics to which ECT has been, or may be, applied are presented. One such area of investigation involves the effects of stroke. The application of ECT to laboratory research, and to clinical diagnosis and prognosis, of stroke may result in improved management of the disease. An illustration of the potential savings in the cost of management of stroke due to the effects of applied ECT research is included. The results represent a compilation of data collected from conversations with, and conference presentations by, ECT users, researchers and image system designers, and from a review of the literature.

  19. Nuclear Medicine Program progress report for quarter ending September 30, 1992

    SciTech Connect

    Knapp, F.F. Jr.; Ambrose, K.R.; Beets, A.L.; Callahan, A.P.; McPherson, D.W.; Mirzadeh, S.; Hasan, A.; Lambert, C.R.

    1992-12-01

    The radioiodination and in vivo evaluation of p-iodocaramiphen a muscarinic antagonist which binds with high affinity to the M[sub 1] receptor subtype in vitro are described. Biodistribution studies in female Fischer rats demonstrated that [[sup 125]I]-piodocaraminphen had significant cerebral localization, but the uptake did not demonstrate specific uptake in those cerebral regions rich in muscarinic receptors, and radioactivity washed out rapidly from the brain. In addition there was no significant blockage of activity when the rats were preinjected with quinuclidinyl benzilate. These results suggest that p-iodocaramiphen is not a good candidate for the in vivo study of M[sub 1] muscarinic receptor populations by SPECT. Because of the widespread interest and expected importance of the availability of large amounts of tungsten-188 required for the tungsten-188/rhenium-188 generator systems, we have investigated the large-scale production of tungsten-188 in the ORNL HFIR. We have also compared our production data with the theoretical production values and with experimental data available in the literature from other reactors. Tungsten-188 is produced in a fission nuclear reactor by double neutron capture of tungsten-186. The experimental yield of tungsten-188 is approximately 4 mCi/mg of tungsten-186 at the end of bombardment (EOB) in the HFIR operating at 85 MWt power for a one cycle irradiation ([approximately]21 days) at a thermal neutron flux of 2 [times] 10[sup 15] n.s[sup [minus]1]cm[sup [minus]2].

  20. Nuclear Medicine Program progress report for quarter ending September 30, 1992

    SciTech Connect

    Knapp, F.F. Jr.; Ambrose, K.R.; Beets, A.L.; Callahan, A.P.; McPherson, D.W.; Mirzadeh, S.; Hasan, A.; Lambert, C.R.

    1992-12-01

    The radioiodination and in vivo evaluation of p-iodocaramiphen a muscarinic antagonist which binds with high affinity to the M{sub 1} receptor subtype in vitro are described. Biodistribution studies in female Fischer rats demonstrated that [{sup 125}I]-piodocaraminphen had significant cerebral localization, but the uptake did not demonstrate specific uptake in those cerebral regions rich in muscarinic receptors, and radioactivity washed out rapidly from the brain. In addition there was no significant blockage of activity when the rats were preinjected with quinuclidinyl benzilate. These results suggest that p-iodocaramiphen is not a good candidate for the in vivo study of M{sub 1} muscarinic receptor populations by SPECT. Because of the widespread interest and expected importance of the availability of large amounts of tungsten-188 required for the tungsten-188/rhenium-188 generator systems, we have investigated the large-scale production of tungsten-188 in the ORNL HFIR. We have also compared our production data with the theoretical production values and with experimental data available in the literature from other reactors. Tungsten-188 is produced in a fission nuclear reactor by double neutron capture of tungsten-186. The experimental yield of tungsten-188 is approximately 4 mCi/mg of tungsten-186 at the end of bombardment (EOB) in the HFIR operating at 85 MWt power for a one cycle irradiation ({approximately}21 days) at a thermal neutron flux of 2 {times} 10{sup 15} n.s{sup {minus}1}cm{sup {minus}2}.

  1. Pediatric nuclear medicine

    SciTech Connect

    Not Available

    1986-01-01

    This symposium presented the latest techniques and approaches to the proper medical application of radionuclides in pediatrics. An expert faculty, comprised of specialists in the field of pediatric nuclear medicine, discussed the major indications as well as the advantages and potential hazards of nuclear medicine procedures compared to other diagnostic modalities. In recent years, newer radiopharmaceuticals labeled with technetium-99m and other short-lived radionuclides with relatively favorable radiation characteristics have permitted a variety of diagnostic studies that are very useful clinically and carry a substantially lower radiation burden then many comparable X-ray studies. This new battery of nuclear medicine procedures is now widely available for diagnosis and management of pediatric patients. Many recent research studies in children have yielded data concerning the effacacy of these procedures, and current recommendations will be presented by those involved in conducting such studies. Individual papers are processed separately for the Energy Data Base.

  2. Whistleblowers and nuclear medicine.

    PubMed

    Rysavy, C F; Donald, J W

    1999-01-01

    Healthcare facilities that practice nuclear medicine are subject to federal "whistleblower" protection laws when an employee reports a potentially unsafe radiological condition. This article addresses enforcement of the applicable sections of the Atomic Energy Act and the Nuclear Regulatory Commission's regulations in order to help such facilities avoid running afoul of those laws, which can result in fines, generate civil lawsuits by the claimant, and significantly disrupt the operation of a healthcare facility. PMID:10538012

  3. Nuclear medicine case studies

    SciTech Connect

    Wagner, H.N. Jr.

    1986-01-01

    This text presents case studies in nuclear medicine which emphasize the diagnosis of the patient's problem rather than the technical performance of the procedure. The book is arranged by organ systems and each section begins with a description of the technique and findings in a normal study.

  4. Nuclear medicine in oncology

    SciTech Connect

    Murphy, J.

    1996-12-31

    Radioactivity was discovered in the late 1890s, and as early as 1903, Alexander Graham Bell advocated that radioactivity be used to treat tumors. In 1913, the first paper describing therapeutic uses of radium was published; in 1936, {sup 24}Na was administered as a therapy to a leukemia patient. Three years later, uptake of {sup 89}Sr was noted in bone metastases. During the 1940s, there was increasing use of iodine therapy for thyroid diseases, including thyroid cancer. Diagnostic {open_quotes}imaging{close_quotes} with radioisotopes was increasingly employed in the 1930s and 40s using probes and grew in importance and utility with the development of scintillation detectors with photorecording systems. Although coincidence counting to detect positron emissions was developed in 1953, the first medical center cyclotron was not installed until 1961. The 1960s saw the development of {sup 99m}Tc-labeled radiopharmaceuticals, emission reconstruction tomography [giving rise to single photon emission computed tomography (SPECT) and positron emission tomography (PET)], and {sup 64}Ga tumor imaging. Nuclear medicine was recognized as a medical specialty in 1971. Radiolabeled antibodies targeting human tumors in animals was reported in 1973; antibody tumor imaging in humans was reported in 1978. Technology has continued to advance, including the development of SPECT cameras with coincidence detection able to perform FDG/PET imaging. With this overview as as backdrop, this paper focuses on the role of nuclear medicine in oncology from three perspectives: nonspecific tumor imaging agents, specific tumor imaging agents, and radioisotopes for tumor therapy. In summary, while tumor diagnosis and treatment were among the first uses explored for radioactivity, these areas have yet to reach their full potential. Development of new radioisotopes and new radiopharmaceuticals, coupled with improvements in technology, make nuclear oncology an area of growth for nuclear medicine.

  5. Nuclear medicine annual

    SciTech Connect

    Freeman, L.M.

    1988-01-01

    This book features a state-of-the-art report on single photon emission computed tomography (SPECT) in abdominal imaging, which highlights the emergency of /sup 99m/Tc-red cell imaging as the procedure of choice for diagnosing heptatic hemangioma. In addition, the use of captropril scinitigraphy in the study of suspected renovascular hypertension is reviewed. Articles survey research on radiolabeled monoclonal antibodies and assess the clinical experience with bone scanning for osseous metastases from breast carcinoma. An article on the role of nuclear medicine in the management of osteoporosis examines the problems that must be overcome before the bone mineral analysis with dual photon absorptiometry gains widespread clinical acceptance.

  6. Nuclear medicine annual 1990

    SciTech Connect

    Freeman, L.M. )

    1990-01-01

    Two of the major areas of cutting-edge nuclear medicine research, single-photon emission computed tomography (SPECT) functional brain imaging and monoclonal antibody studies receive attention in this volume. Advances in these areas are critical to the continued growth of our specialty. Fortunately, the current outlook in both areas remains quite optimistic. As has been the policy in the first decade of publication, thorough state-of-the-art reviews on existing procedures are interspersed with chapters dealing with research developments. The editor wishes to express a particular note of appreciation to a very supportive British colleague, Dr. Ignac Fogelman, who is becoming a regular contributor. His exhaustive review of the role of nuclear medicine in the evaluation of osteoporotic patients is packed with extremely useful information that will prove to be fruitful to all readers. The author would like to thank the readers and colleagues who have taken the time to offer useful and constructive comments over the past ten years. The author continue to welcome suggestions that will help to further improve this Annual.

  7. Nuclear medicine imaging system

    DOEpatents

    Bennett, Gerald W. (East Moriches, NY); Brill, A. Bertrand (Shoreham, NY); Bizais, Yves J. C. (Upton, NY); Rowe, R. Wanda (Upton, NY); Zubal, I. George (Upton, NY)

    1986-01-01

    A nuclear medicine imaging system having two large field of view scintillation cameras mounted on a rotatable gantry and being movable diametrically toward or away from each other is disclosed. In addition, each camera may be rotated about an axis perpendicular to the diameter of the gantry. The movement of the cameras allows the system to be used for a variety of studies, including positron annihilation, and conventional single photon emission, as well as static orthogonal dual multi-pinhole tomography. In orthogonal dual multi-pinhole tomography, each camera is fitted with a seven pinhole collimator to provide seven views from slightly different perspectives. By using two cameras at an angle to each other, improved sensitivity and depth resolution is achieved. The computer system and interface acquires and stores a broad range of information in list mode, including patient physiological data, energy data over the full range detected by the cameras, and the camera position. The list mode acquisition permits the study of attenuation as a result of Compton scatter, as well as studies involving the isolation and correlation of energy with a range of physiological conditions.

  8. The role of general nuclear medicine in breast cancer

    PubMed Central

    Greene, Lacey R; Wilkinson, Deborah

    2015-01-01

    The rising incidence of breast cancer worldwide has prompted many improvements to current care. Routine nuclear medicine is a major contributor to a full gamut of clinical studies such as early lesion detection and stratification; guiding, monitoring, and predicting response to therapy; and monitoring progression, recurrence or metastases. Developments in instrumentation such as the high-resolution dedicated breast device coupled with the diagnostic versatility of conventional cameras have reinserted nuclear medicine as a valuable tool in the broader clinical setting. This review outlines the role of general nuclear medicine, concluding that targeted radiopharmaceuticals and versatile instrumentation position nuclear medicine as a powerful modality for patients with breast cancer. PMID:26229668

  9. The role of general nuclear medicine in breast cancer

    SciTech Connect

    Greene, Lacey R; Wilkinson, Deborah

    2015-03-15

    The rising incidence of breast cancer worldwide has prompted many improvements to current care. Routine nuclear medicine is a major contributor to a full gamut of clinical studies such as early lesion detection and stratification; guiding, monitoring, and predicting response to therapy; and monitoring progression, recurrence or metastases. Developments in instrumentation such as the high-resolution dedicated breast device coupled with the diagnostic versatility of conventional cameras have reinserted nuclear medicine as a valuable tool in the broader clinical setting. This review outlines the role of general nuclear medicine, concluding that targeted radiopharmaceuticals and versatile instrumentation position nuclear medicine as a powerful modality for patients with breast cancer.

  10. Boron in nuclear medicine: New synthetic approaches to PET and SPECT. Progress report, March 1, 1992--February 28, 1993

    SciTech Connect

    Kabalka, G.W.

    1992-09-01

    This annual progress report describes new methods of incorporation of radioiodine into physiologically active compounds (amphetamines), and the use of organoboranes to labeled radiopharmaceuticals with Oxygen- 15, Nitrogen-13, carbon-11 and fluorine-18. Preclinical studies are also reported on evaluation of butyothiophenones as agents acting at dopaminergic or serotonic synapses.

  11. Nuclear medicine and imaging research (quantitative studies in radiopharmaceutical science). Progress report, January 1, 1992--December 31, 1992

    SciTech Connect

    Cooper, M.; Beck, R.N.

    1992-06-01

    This report describes three studies aimed at using radiolabeled pharmaceuticals to explore brain function and anatomy. The first section describes the chemical preparation of [F18]fluorinated benzamides (dopamine D-2 receptor tracers), [F18]fluorinated benzazepines (dopamine D-1 receptor tracers), and tissue distribution of [F18]-fluoxetine (serotonin reuptake site tracer). The second section relates pharmacological and behavioral studies of amphetamines. The third section reports on progress made with processing of brain images from CT, MRI and PET/SPECT with regards to brain metabolism of glucose during mental tasks.

  12. What Is Nuclear Medicine?

    MedlinePLUS

    ... small dose, just a few drops. Is the radioactivity harmful? Although exposure to radioactivity in very large doses can be harmful, the radioactivity in radiopharmaceuticals is carefully selected by the nuclear ...

  13. Nuclear medicine imaging system

    DOEpatents

    Bennett, G.W.; Brill, A.B.; Bizais, Y.J.C.; Rowe, R.W.; Zubal, I.G.

    1983-03-11

    It is an object of this invention to provide a nuclear imaging system having the versatility to do positron annihilation studies, rotating single or opposed camera gamma emission studies, and orthogonal gamma emission studies. It is a further object of this invention to provide an imaging system having the capability for orthogonal dual multipinhole tomography. It is another object of this invention to provide a nuclear imaging system in which all available energy data, as well as patient physiological data, are acquired simultaneously in list mode.

  14. Data resources for nuclear medicine

    SciTech Connect

    Bhat, M.R.; Lemmel, H.D.

    1995-07-01

    The objective of this article is to list data resources needed for nuclear medicine and provide information on how to access them. This list will include publications of data compilations or evaluations, databases, and data processing codes for both nuclear structure and decay, as well as reaction data. Sources of bibliographic and related information on nuclear data are also be listed. The authors of this article have used their judgement in choosing a representative list of data sources; a more complete listing may be found in the references.

  15. Explore the Latest Progress on Medicines in Development

    MedlinePLUS

    Medicines in Development Explore the Latest Progress on Medicines in Development Each patient battling with a disease ... the hope that tomorrow will bring a new medicine that delivers better health. America’s biopharmaceutical research companies ...

  16. Nuclear chemistry progress report

    SciTech Connect

    Viola, V.E.; Kwiatkowski, K.

    1993-08-01

    This is the annual progress report for the Indiana University nuclear chemistry program for the 1992/1993 year. Accomplishments include the construction, testing, and initial experimental runs of the Indiana Silicon Sphere (ISiS) 4{pi} charged particle detector. ISiS is designed to study energy dissipation and multifragmentation phenomena in light-ion-induced nuclear reactions at medium-to-high energies. Its second test run was to examine 3.6 GeV {sup 3}He beam reactions at Laboratoire National Saturne (LNS) in Saclay. The development and deployment of this system has occupied a great deal of the groups effort this reporting period. Additional work includes: calculations of isotopic IMF yields in the {sup 4}He + {sup 116,124}Sn reaction; cross sections for A = 6 - 30 fragments from the {sup 4}He + {sup 28}Si reaction at 117 and 198 MeV; charging effects of passivated silicon detectors; neck emission of intermediate-mass fragments in the fission of hot heavy nuclei.

  17. Nuclear Medicine Technology: A Suggested Postsecondary Curriculum.

    ERIC Educational Resources Information Center

    Technical Education Research Center, Cambridge, MA.

    The purpose of this curriculum guide is to assist administrators and instructors in establishing nuclear medicine technician programs that will meet the accreditation standards of the American Medical Association (AMA) Council on Medical Education. The guide has been developed to prepare nuclear medicine technicians (NMT's) in two-year…

  18. The Journal of Nuclear Medicine Dear Author,

    E-print Network

    Piana, Michele

    of Publications Society of Nuclear Medicine 1850 Samuel Morse Drive Reston, VA 20190-5316 Fax: (703) 708-9018 Tel of Publications Society of Nuclear Medicine 1850 Samuel Morse Drive Reston, VA 20190-5316 USA Corrections may also: ______________________________________________________________________ State or country: ________________________________________ Postal code: __________ Phone number

  19. Redesigning the nuclear medicine reading room.

    PubMed

    Zemariame, Nigist; Knight, Nancy; Siegel, Eliot L

    2011-11-01

    The process of image review and interpretation has become increasingly complex and challenging for today's nuclear medicine physician from many perspectives, especially with regard to workstation integration and reading room ergonomics. With the recent proliferation of hybrid imaging systems, this complexity has increased rapidly, along with the number of studies performed. At the same time, clinicians throughout the health care enterprise are expecting remote access to nuclear medicine images whereas nuclear medicine physicians require reliable access at the point of care to the electronic medical record and to medical images from radiology and cardiology. The authors discuss the background and challenges related to integration of nuclear medicine into the health care enterprise and provide a series of recommendations for advancing successful integration efforts. Also addressed are unique characteristics of the nuclear medicine environment as well as ergonomic, lighting, and environmental considerations in the design and redesign of the modern reading room. PMID:21978448

  20. About Nuclear Medicine Nuclear Medicine is the medical specialty that utilizes the

    E-print Network

    Kachroo, Pushkin

    and Waste Management Association: www.awma.org/Public/ American Water Works Association: wwwAbout Nuclear Medicine Nuclear Medicine is the medical specialty that utilizes the nuclear/or physiologic conditions of the body and to provide therapy with unsealed radioactive sources. The Nuclear

  1. Patient dosimetry in nuclear medicine.

    PubMed

    Mattsson, Sören

    2015-07-01

    In diagnostic nuclear medicine, the biokinetics of the radiopharmaceutical (actually of the radionuclide) is determined for a number of representative patients. At therapy, it is essential to determine the patient's individual biokinetics of the radiopharmaceutical in order to calculate the absorbed doses to critical normal organs/tissues and to the target volume(s) with high accuracy. For the diagnostic situations, there is still a lack of quantitative determinations of the organ/tissue contents of radiopharmaceuticals and their variation with time. Planar gamma camera imaging using the conjugate view technique combined with a limited number of SPECT/CT images is the main method for such studies. In a similar way, PET/CT is used for 3D image-based internal dosimetry for PET substances. The transition from stylised reference phantoms to voxel phantoms will lead to improved dose estimates for diagnostic procedures. Examples of dose coefficients and effective doses for diagnostic substances are given. For the therapeutic situation, a pre-therapeutic low activity administration is used for quantitative measurements of organ/tissue distribution data by a gamma camera or a SPECT- or PET-unit. Together with CT and/or MR images this will be the base for individual dose calculations using Monte Carlo technique. Treatments based on administered activity should only be used if biological variations between patients are small or if a pre-therapeutic activity administration is impossible. PMID:25821210

  2. Nuclear medicine applications: Summary of Panel 4

    SciTech Connect

    Wolf, A.P.

    1988-01-01

    Nuclear medicine is currently facing a desperate shortage of organic and inorganic chemists and nuclear pharmacists who also have advanced training in nuclear and radiochemistry. Ironically, this shortfall is occurring in the face of rapid growth and technological advances which have made the practice of nuclear medicine an integral part of the modern health care system. This shortage threatens to limit the availability of radiopharmaceuticals required in routine hospital procedures and to impede the development of new diagnostic and therapeutic agents. To redress this need and prevent a similar shortfall in the future, this panel recommends immediate action and a long-term commitment to the following: educating the public on the benefits of nuclear medicine; informing undergraduate and graduate chemistry students about career opportunities in nuclear medicine; offering upper level courses in nuclear and radiochemistry (including laboratory) in universities; establishing training centers and fellowships at the postgraduate level for specialized education in the aspects of nuclear and radiochemistry required by the nuclear medicine profession. 1 tab.

  3. Brief overview of nuclear medicine in China

    SciTech Connect

    Wang, S.C.; Chou, C.E.

    1989-04-01

    The year 1956 witnessed the birth of Nuclear Medicine in China, when the first course, Biomedical Applications of Isotopes, was offered in our country by the Peking Union Medical College (PUMC). This course was preceded by a training course in nuclear instruments in which students learned to construct the radiation detection devices required for performing experiments using radioisotopes. In 1958, several courses in clinical nuclear medicine brought up the first generation of nuclear medicine physicians in China. Historically, some of the chief events include: (1) operation of the first reactor, producing 33 radioactive isotopes in 1958; (2) first linear scanner built in 1960; (3) setting up an organization for the control of radiopharmaceuticals in 1961; (4) distribution of the first batch of cyclotron-produced isotopes in 1963; (5) development and use of the first radioimmunoassay (RIA) procedure in 1963; (6) production of tritium in 1964; (7) production of 99.8% enriched heavy water in 1965; (8) supply of 99mTc and 113mIn generators in 1972; (9) first gamma camera imported in 1972 and first homemade gamma camera installed in 1977; (10) founding of Chinese Society of Nuclear Medicine (CSNM) in 1980; (11) publication of the Chinese Journal of Nuclear Medicine beginning in 1981; (12) first single photon emission computed tomography (SPECT) imported in 1983. At present, there are 556 nuclear medicine departments in China with 4,000 staff.

  4. An overview of nuclear medicine imaging procedures.

    PubMed

    Hogg, Peter; Lawson, Richard

    2015-11-25

    Nuclear medicine imaging is not generally well understood by nurses who work outside this area. Consequently, nurses can find themselves unable to answer patients' questions about nuclear medicine imaging procedures or give them proper information before they attend for a test. This article aims to explain what is involved in some common diagnostic nuclear medicine imaging procedures so that nurses are able to discuss this with patients. It also addresses some common issues about radiation protection that nurses might encounter in their usual working routine. The article includes links to videos showing some typical nuclear medicine imaging procedures from a patient's point of view and links to an e-Learning for Healthcare online resource that provides detailed information for nurses. PMID:26602680

  5. A Training Manual for Nuclear Medicine Technologists.

    ERIC Educational Resources Information Center

    Simmons, Guy H.; Alexander, George W.

    This manual was prepared for a training program in Nuclear Medicine Technology at the University of Cincinnati. Instructional materials for students enrolled in these courses in the training program include: Nuclear Physics and Instrumentation, Radionuclide Measurements, Radiation Protection, and Tracer Methodology and Radiopharmaceuticals. (CS)

  6. Nuclear spectroscopic studies. Progress report

    SciTech Connect

    Bingham, C.R.; Riedinger, L.L.; Sorensen, S.P.

    1996-01-16

    This report describes progress in the experimental nuclear physics program of the University of Tennessee, Knoxville. It presents findings related to properties of high-spin states, low-energy levels of nuclei far from stability, and high-energy heavy-ion physics, as well as a brief description of the Joint Institute of Heavy Ion Research (a collaboration between the University of Tennessee, Vanderbilt University, and Oak Ridge National Laboratory) and its activities (particularly those of the last few years), and a list of publications. 89 refs., 18 figs., 5 tabs.

  7. Computer-assisted cardiac nuclear medicine

    SciTech Connect

    Holman, B.L.; Paker, J.A.

    1981-01-01

    The purpose of this work is to supply an introduction to the use of computers for the non-computer scientist, physician, technologist, or other individual who is involved with clinical cardiovascular nuclear medicine. The book is divided into four sections. The first section (two chapters) deals with applications of numbers and logic to computers. The second section (eight chapters) deals with computer hardware. Software is described in the third section (five chapters) and the discussion leads the reader from programming fundamentals to the application of Basic and Fortran languages. The final section (six chapters) deals with specific computer applications in cardiovascular nuclear medicine, ranging from a brief discussion of the necessary basics for a cardiac nuclear medicine facility to introductory remarks about the application of tomography. (JMT)

  8. Nuclear medicine in clinical urology and nephrology

    SciTech Connect

    Tauxe, W.N.; Dubousky, E.V.

    1985-01-01

    This book presents explanations of current procedures involving the kidney with information of the performance of each test, its rationale, and interpretation. The information covers all currently used radiopharmaceuticals, radiation dosimetry, instrumentation, test protocols, and mathematical principles of pathophysiology as they relate to nuclear medicine studies. Information is provided on which radiopharmaceutical, instrument, or computer application to use, and when.

  9. Mo Supply Chain for Nuclear Medicine Ladimer S. Nagurney

    E-print Network

    Nagurney, Anna

    The 99 Mo Supply Chain for Nuclear Medicine Ladimer S. Nagurney Department of Electrical November 13, 2012 #12;Nuclear Medicine: Meeting Patient Needs with 99 Mo Ladimer S. Nagurney The 99 Mo Supply Chain #12;Background and Motivation Study of Nuclear Medicine Supply Chains is a combination

  10. Progress toward personalized medicine for glaucoma

    PubMed Central

    Moroi, Sayoko E; Raoof, Duna A; Reed, David M; Zöllner, Sebastian; Qin, Zhaohui; Richards, Julia E

    2013-01-01

    How will you respond when a patient asks, “Doctor, what can I do to prevent myself from going blind from glaucoma like mom?”. There is optimism that genetic profiling will help target patients to individualized treatments based on validated disease risk alleles, validated pharmacogenetic markers and behavioral modification. Personalized medicine will become a reality through identification of disease and pharmacogenetic markers, followed by careful study of how to employ this information in order to improve treatment outcomes. With advances in genomic technologies, research has shifted from the simple monogenic disease model to a complex multigenic and environmental disease model to answer these questions. Our challenges lie in developing risk models that incorporate gene–gene interactions, gene copy-number variations, environmental interactions, treatment effects and clinical covariates. PMID:23914252

  11. Radiopharmaceuticals in nuclear medicine practice

    SciTech Connect

    Kowalsky, R.J.; Perry, J.R.

    1987-01-01

    This book discusses the basic principles and clinical applications of radiopharmaceuticals. Topics include atomic physics as applied to radiopharmaceuticals, radionuclide generator function, nuclear pharmacy and safety, and radiopharmaceutical use in evaluating the major organ systems of the body. For each body system the author explains rationale for use, typical procedures, current agents of choice, and interpretation of results. Images, tables, and graphs illustrate normal and abnormal studies.

  12. Potentials for progress in laser medicine

    SciTech Connect

    Parrish, J.A.; Walsh, J.T. Jr.

    1985-11-01

    Lasers could come to occupy a highly important position in the armament of medicine. They are the brightest known sources of light, man-made or natural, and emit light having such properties as coherence and monochromaticity. Furthermore, lasers have the ability to deliver very brief pulses of light which can cause unique alterations in biological materials. The major obstacle to the increased use of lasers in medicine and surgery is not the availability of laser devices, but the dearth of basic information about laser-tissue interactions. We have recently demonstrated that, even in turbid tissue such as the dermis, it is possible simultaneously to induce microscopically selective thermal damage, localized to millions of selectively absorbing targets, while sparing surrounding tissues. These targets may be as small as organelles or as large as blood vessels. Such localized thermal damage is truly unique to pulsed laser exposures. The scope and medical utility of these lesions has yet to be fully understood. Thus, there is much research to be done in describing and characterizing laser-induced injury. There is, however, ample evidence that several laser therapies could be improved by using selectively absorbed, short pulses that lead to the spatial confinement of thermal injury. Treatment of port wine stains, pigmented lesions, atheromatous arterial plaques, and the fragmentation of kidney and gall stones are examples. It should also be possible to use a variety of systems to deliver exogenous laser targets on or within individual types of cells or organelles. Such chromophores may lead to new forms of cancer therapy, for example.

  13. Potentials for progress in laser medicine.

    PubMed Central

    Parrish, J. A.; Walsh, J. T.

    1985-01-01

    Lasers could come to occupy a highly important position in the armament of medicine. They are the brightest known sources of light, man-made or natural, and emit light having such properties as coherence and monochromaticity. Furthermore, lasers have the ability to deliver very brief pulses of light which can cause unique alterations in biological materials. The major obstacle to the increased use of lasers in medicine and surgery is not the availability of laser devices, but the dearth of basic information about laser-tissue interactions. We have recently demonstrated that, even in turbid tissue such as the dermis, it is possible simultaneously to induce microscopically selective thermal damage, localized to millions of selectively absorbing targets, while sparing surrounding tissues. These "targets" may be as small as organelles or as large as blood vessels. Such localized thermal damage is truly unique to pulsed laser exposures. The scope and medical utility of these lesions has yet to be fully understood. Thus, there is much research to be done in describing and characterizing laser-induced injury. There is, however, ample evidence that several laser therapies could be improved by using selectively absorbed, short pulses that lead to the spatial confinement of thermal injury. Treatment of port wine stains, pigmented lesions, atheromatous arterial plaques, and the fragmentation of kidney and gall stones are examples. It should also be possible to use a variety of systems to deliver exogenous laser targets on or within individual types of cells or organelles. Such chromophores may lead to new forms of cancer therapy, for example. PMID:3832665

  14. Nuclear medicine and imaging research (instrumentation and quantitative methods of evaluation)

    SciTech Connect

    Beck, R.N.; Cooper, M.; Chen, C.T.

    1992-07-01

    This document is the annual progress report for project entitled 'Instrumentation and Quantitative Methods of Evaluation.' Progress is reported in separate sections individually abstracted and indexed for the database. Subject areas reported include theoretical studies of imaging systems and methods, hardware developments, quantitative methods of evaluation, and knowledge transfer: education in quantitative nuclear medicine imaging.

  15. Coded-aperture imaging in nuclear medicine

    NASA Technical Reports Server (NTRS)

    Smith, Warren E.; Barrett, Harrison H.; Aarsvold, John N.

    1989-01-01

    Coded-aperture imaging is a technique for imaging sources that emit high-energy radiation. This type of imaging involves shadow casting and not reflection or refraction. High-energy sources exist in x ray and gamma-ray astronomy, nuclear reactor fuel-rod imaging, and nuclear medicine. Of these three areas nuclear medicine is perhaps the most challenging because of the limited amount of radiation available and because a three-dimensional source distribution is to be determined. In nuclear medicine a radioactive pharmaceutical is administered to a patient. The pharmaceutical is designed to be taken up by a particular organ of interest, and its distribution provides clinical information about the function of the organ, or the presence of lesions within the organ. This distribution is determined from spatial measurements of the radiation emitted by the radiopharmaceutical. The principles of imaging radiopharmaceutical distributions with coded apertures are reviewed. Included is a discussion of linear shift-variant projection operators and the associated inverse problem. A system developed at the University of Arizona in Tucson consisting of small modular gamma-ray cameras fitted with coded apertures is described.

  16. Gender Bias in Academic Medicine: Pitfalls, Promise and Progress

    E-print Network

    Sheridan, Jennifer

    Gender Bias in Academic Medicine: Pitfalls, Promise and Progress University of Pittsburgh April 28 of the issues · Introduce some key constructs from social psychology that account for the tenacity of gender the application of gender bias #12;What we believed... · That the lack of women leaders in any field would fix

  17. Solid state detectors in nuclear medicine.

    PubMed

    Darambara, D G; Todd-Pokropek, A

    2002-03-01

    Since Nuclear Medicine diagnostic applications are growing fast, room temperature semiconductor detectors such CdTe and CdZnTe either in the form of single detectors or as segmented monolithic detectors have been investigated aiming to replace the NaI scintillator. These detectors have inherently better energy resolution that scintillators coupled to photodiodes or photomultiplier tubes leading to compact imaging systems with higher spatial resolution and enhanced contrast. Advantages and disadvantages of CdTe and CdZnTe detectors in imaging systems are discussed and efforts to develop semiconductor-based planar and tomographic cameras as well as nuclear probes are presented. PMID:12072840

  18. A nuclear chocolate box: the periodic table of nuclear medicine.

    PubMed

    Blower, Philip J

    2015-03-21

    Radioisotopes of elements from all parts of the periodic table find both clinical and research applications in radionuclide molecular imaging and therapy (nuclear medicine). This article provides an overview of these applications in relation to both the radiological properties of the radionuclides and the chemical properties of the elements, indicating past successes, current applications and future opportunities and challenges for inorganic chemistry. PMID:25406520

  19. Evidence-based medicine and progress in the medical sciences.

    PubMed

    De Vreese, Leen

    2011-10-01

    The question what scientific progress means for a particular domain such as medicine seems importantly different from the question what scientific progress is in general. While the latter question received ample treatment in the philosophical literature, the former question is hardly discussed. I argue that it is nonetheless important to think about this question in view of the methodological choices we make. I raise specific questions that should be tackled regarding scientific progress in the medical sciences and demonstrate their importance by means of an analysis of what evidence-based medicine (EBM) has, and has not, to offer in terms of progress. I show how critically thinking about EBM from the point of view of progress can help us in putting EBM and its favoured methodologies in the right perspective. My conclusion will be that blindly favouring certain methods because of their immediately tangible short-term benefits implies that we parry the important question of how best to advance progress in the long run. This leads us to losing sight of our general goals in doing research in the medical sciences. PMID:21848941

  20. Society of Nuclear Medicine 52nd Annual Meeting Highlights of the Society of Nuclear Medicine 52nd Annual Meeting CME

    E-print Network

    Jadvar, Hossein

    medicine specialists, and select referring physicians (cardiologists, oncologists, pediatric specialists, into their practice to facilitate the early detection and clinical management of cardiac disease, cancer, pediatric to outline the value of these technologies for the radiology, nuclear medicine, oncology, cardiology

  1. Development of Scintillators in Nuclear Medicine.

    PubMed

    Khoshakhlagh, Mohammad; Islamian, Jalil Pirayesh; Abedi, Seyed Mohammad; Mahmoudian, Babak

    2015-01-01

    High-quality image is necessary for accurate diagnosis in nuclear medicine. There are many factors in creating a good image and detector is the most important one. In recent years, several detectors are studied to get a better picture. The aim of this paper is comparison of some type of these detectors such as thallium activated sodium iodide bismuth germinate cesium activated yttrium aluminum garnet (YAG: Ce) YAP: Ce "lutetium aluminum garnet activated by cerium" CRY018 "CRY019" lanthanum bromide and cadmium zinc telluride. We studied different properties of these crystals including density, energy resolution and decay times that are more important factors affecting the image quality. PMID:26420984

  2. Development of Scintillators in Nuclear Medicine

    PubMed Central

    Khoshakhlagh, Mohammad; Islamian, Jalil Pirayesh; Abedi, Seyed Mohammad; Mahmoudian, Babak

    2015-01-01

    High-quality image is necessary for accurate diagnosis in nuclear medicine. There are many factors in creating a good image and detector is the most important one. In recent years, several detectors are studied to get a better picture. The aim of this paper is comparison of some type of these detectors such as thallium activated sodium iodide bismuth germinate cesium activated yttrium aluminum garnet (YAG: Ce) YAP: Ce “lutetium aluminum garnet activated by cerium” CRY018 “CRY019” lanthanum bromide and cadmium zinc telluride. We studied different properties of these crystals including density, energy resolution and decay times that are more important factors affecting the image quality. PMID:26420984

  3. Nuclear medicine training and practice in Poland.

    PubMed

    Teresi?ska, Anna; Birkenfeld, Bo?ena; Królicki, Leszek; Dziuk, Miros?aw

    2014-10-01

    In Poland, nuclear medicine (NM) has been an independent specialty since 1988. At the end of 2013, the syllabus for postgraduate specialization in NM has been modified to be in close accordance with the syllabus approved by the European Union of Medical Specialists and is expected to be enforced before the end of 2014. The National Consultant in Nuclear Medicine is responsible for the specialization program in NM. The Medical Center of Postgraduate Training is the administrative body which accepts the specialization programs, supervises the training, organizes the examinations, and awards the specialist title. Specialization in NM for physicians lasts for five years. It consists of 36 months of training in a native nuclear medicine department, 12 months of internship in radiology, 3 months in cardiology, 3 months in endocrinology, 3 months in oncology, and 3 months in two other departments of NM. If a NM trainee is a specialist of a clinical discipline and/or is after a long residency in NM departments, the specialization in NM can be shortened to three years. During the training, there are obligatory courses to be attended which include the elements of anatomy imaging in USG, CT, and MR. Currently, there are about 170 active NM specialists working for 38.5 million inhabitants in Poland. For other professionals working in NM departments, it is possible to get the title of a medical physics specialist after completing 3.5 years of training (for those with a master's in physics, technical physics or biomedical engineering) or the title of a radiopharmacy specialist after completing 3 years of training (for those with a master's in chemistry or biology). At present, the specialization program in NM for nurses is being developed by the Medical Centre of Postgraduate Education. Continuing education and professional development are obligatory for all physicians and governed by the Polish Medical Chamber. The Polish Society of Nuclear Medicine (PTMN) organizes regular postgraduate training for physicians working in NM. Educational programs are comprehensive, covering both diagnostics and current forms of radioisotope therapy. They are aimed not only at physicians specialized/specializing in NM, but also at other medical professionals employed in radionuclide departments as well as physicians of other specialties. PMID:25091218

  4. IAEA programs in empowering the nuclear medicine profession through online educational resources.

    PubMed

    Pascual, Thomas Nb; Dondi, Maurizio; Paez, Diana; Kashyap, Ravi; Nunez-Miller, Rodolfo

    2013-05-01

    The International Atomic Energy Agency's (IAEA) programme in human health aims to enhance the capabilities in Member States to address needs related to the prevention, diagnosis, and treatment of diseases through the application of nuclear techniques. It has the specific mission of fostering the application of nuclear medicine techniques as part of the clinical management of certain types of diseases. Attuned to the continuous evolution of this specialty as well as to the advancement and diversity of methods in delivering capacity building efforts in this digital age, the section of nuclear medicine of the IAEA has enhanced its program by incorporating online educational resources for nuclear medicine professionals into its repertoire of projects to further its commitment in addressing the needs of its Member States in the field of nuclear medicine. Through online educational resources such as the Human Health Campus website, e-learning modules, and scheduled interactive webinars, a validation of the commitment by the IAEA in addressing the needs of its Member States in the field of nuclear medicine is strengthened while utilizing the advanced internet and communications technology which is progressively becoming available worldwide. The Human Health Campus (www.humanhealth.iaea.org) is the online educational resources initiative of the Division of Human Health of the IAEA geared toward enhancing professional knowledge of health professionals in radiation medicine (nuclear medicine and diagnostic imaging, radiation oncology, and medical radiation physics), and nutrition. E-learning modules provide an interactive learning environment to its users while providing immediate feedback for each task accomplished. Webinars, unlike webcasts, offer the opportunity of enhanced interaction with the learners facilitated through slide shows where the presenter guides and engages the audience using video and live streaming. This paper explores the IAEA's available online educational resources programs geared toward the enhancement of the nuclear medicine profession as delivered by the section of nuclear medicine of the IAEA. PMID:23561452

  5. Display of nuclear medicine imaging studies

    E-print Network

    Singh, B; Samuel, A M

    2002-01-01

    Nuclear medicine imaging studies involve evaluation of a large amount of image data. Digital signal processing techniques have introduced processing algorithms that increase the information content of the display. Nuclear medicine imaging studies require interactive selection of suitable form of display and pre-display processing. Static imaging study requires pre-display processing to detect focal defects. Point operations (histogram modification) along with zoom and capability to display more than one image in one screen is essential. This album mode of display is also applicable to dynamic, MUGA and SPECT data. Isometric display or 3-D graph of the image data is helpful in some cases e.g. point spread function, flood field data. Cine display is used on a sequence of images e.g. dynamic, MUGA and SPECT imaging studies -to assess the spatial movement of tracer with time. Following methods are used at the investigator's discretion for inspection of the 3-D object. 1) Display of orthogonal projections, 2) Disp...

  6. 42 CFR Appendix F to Part 75 - Standards for Licensing Radiographers, Nuclear Medicine Technologists, and Radiation Therapy...

    Code of Federal Regulations, 2012 CFR

    2012-10-01

    ...Nuclear Medicine Technologists, and Radiation Therapy Technologists F Appendix...Nuclear Medicine Technologists, and Radiation Therapy Technologists The following...Nuclear Medicine Technologists, or Radiation Therapy Technologists. 2....

  7. 42 CFR Appendix F to Part 75 - Standards for Licensing Radiographers, Nuclear Medicine Technologists, and Radiation Therapy...

    Code of Federal Regulations, 2013 CFR

    2013-10-01

    ...Nuclear Medicine Technologists, and Radiation Therapy Technologists F Appendix...Nuclear Medicine Technologists, and Radiation Therapy Technologists The following...Nuclear Medicine Technologists, or Radiation Therapy Technologists. 2....

  8. 42 CFR Appendix F to Part 75 - Standards for Licensing Radiographers, Nuclear Medicine Technologists, and Radiation Therapy...

    Code of Federal Regulations, 2014 CFR

    2014-10-01

    ...Nuclear Medicine Technologists, and Radiation Therapy Technologists F Appendix...Nuclear Medicine Technologists, and Radiation Therapy Technologists The following...Nuclear Medicine Technologists, or Radiation Therapy Technologists. 2....

  9. 42 CFR Appendix F to Part 75 - Standards for Licensing Radiographers, Nuclear Medicine Technologists, and Radiation Therapy...

    Code of Federal Regulations, 2011 CFR

    2011-10-01

    ...Nuclear Medicine Technologists, and Radiation Therapy Technologists F Appendix...Nuclear Medicine Technologists, and Radiation Therapy Technologists The following...Nuclear Medicine Technologists, or Radiation Therapy Technologists. 2....

  10. 42 CFR Appendix F to Part 75 - Standards for Licensing Radiographers, Nuclear Medicine Technologists, and Radiation Therapy...

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ...Nuclear Medicine Technologists, and Radiation Therapy Technologists F Appendix...Nuclear Medicine Technologists, and Radiation Therapy Technologists The following...Nuclear Medicine Technologists, or Radiation Therapy Technologists. 2....

  11. Source Book of Educational Materials for Nuclear Medicine.

    ERIC Educational Resources Information Center

    Pijar, Mary Lou, Comp.; Lewis, Jeannine T., Comp.

    The contents of this sourcebook of educational materials are divided into the following sections: Anatomy and Physiology; Medical Terminology; Medical Ethics and Department Management; Patient Care and Medical Decision-Making; Basic Nuclear Medicine; Diagnostic in Vivo; Diagnostic in Vitro; Pediatric Nuclear Medicine; Radiation Detection and…

  12. Common uses of nonradioactive drugs in nuclear medicine

    SciTech Connect

    Ponto, J.A.; Hladik, W.B.

    1984-06-01

    A variety of nonradioactive pharmaceuticals commonly used in patients who receive nuclear medicine diagnostic tests are described. Nonradioactive drugs used in thyroid, brain, hepatobiliary, cardiac, renal, Meckel's diverticulum, gallium, adrenal, and hematological studies are described. Pharmaceutical necessities used as disinfectants, diluents, and anticoagulants are also described. Hospital pharmacists should be familiar with the uses of commonly prescribed nonradioactive drugs in nuclear medicine studies.

  13. Pulmonary nuclear medicine: Techniques in diagnosis of lung disease

    SciTech Connect

    Atkins, H.L.

    1984-01-01

    This book presents papers on the application of nuclear medicine to the diagnosis of lung diseases. Topics considered include lung physiology and anatomy, radiopharmaceuticals in pulmonary medicine, pulmonary embolism, obstructive pulmonary disease, diffuse infiltrative lung disease, pneumoconioses, tumor localization scans in primary lung tumors, the interactions of heart diseases and lung diseases on radionuclide tests of lung anatomy and function, radionuclide imaging in pediatric lung diseases, and future possibilities in pulmonary nuclear medicine.

  14. Nuclear spectroscopic studies. Progress report

    SciTech Connect

    Bingham, C.R.; Guidry, M.W.; Riedinger, L.L.; Sorensen, S.P.

    1993-02-08

    The Nuclear Physics group at the University of Tennessee, Knoxville is involved in several aspects of heavy-ion physics including both nuclear structure and reaction mechanisms. While our main emphasis is on experimental problems involving heavy-ion accelerators, we have maintained a strong collaboration with several theorists in order to best pursue the physics of our measurements. During the last year we have led several experiments at the Holifield Heavy Ion Research Facility and participated in others at Argonne National Laboratory. Also, we continue to be very active in the collaboration to study ultra-relativistic heavy ion physics utilizing the SPS accelerator at CERN in Geneva, Switzerland and in a RHIC detector R&D project. Our experimental work is in four broad areas: (1) the structure of nuclei at high angular momentum, (2) heavy-ion induced transfer reactions, (3) the structure of nuclei far from stability, and (4) ultra-relativistic heavy-ion physics. The results of studies in these particular areas will be described in this document in sections IIA, IIB, IIC, and IID, respectively. Areas (1), (3), and (4) concentrate on the structure of nuclear matter in extreme conditions of rotational motion, imbalance of neutrons and protons, or very high temperature and density. Area (2) pursues the transfer of nucleons to states with high angular momentum, both to learn about their structure and to understand the transfer of particles, energy, and angular momentum in collisions between heavy ions. An important component of our program is the strong emphasis on the theoretical aspects of nuclear structure and reactions.

  15. 42 CFR 482.53 - Condition of participation: Nuclear medicine services.

    Code of Federal Regulations, 2014 CFR

    2014-10-01

    ... Condition of participation: Nuclear medicine services. 482.53 Section 482.53... Condition of participation: Nuclear medicine services. If the hospital provides nuclear medicine services, those services must meet...

  16. 42 CFR 482.53 - Condition of participation: Nuclear medicine services.

    Code of Federal Regulations, 2012 CFR

    2012-10-01

    ... Condition of participation: Nuclear medicine services. 482.53 Section 482.53... Condition of participation: Nuclear medicine services. If the hospital provides nuclear medicine services, those services must meet...

  17. 42 CFR 482.53 - Condition of participation: Nuclear medicine services.

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... Condition of participation: Nuclear medicine services. 482.53 Section 482.53... Condition of participation: Nuclear medicine services. If the hospital provides nuclear medicine services, those services must meet...

  18. 42 CFR 482.53 - Condition of participation: Nuclear medicine services.

    Code of Federal Regulations, 2011 CFR

    2011-10-01

    ... Condition of participation: Nuclear medicine services. 482.53 Section 482.53... Condition of participation: Nuclear medicine services. If the hospital provides nuclear medicine services, those services must meet...

  19. 42 CFR 482.53 - Condition of participation: Nuclear medicine services.

    Code of Federal Regulations, 2013 CFR

    2013-10-01

    ... Condition of participation: Nuclear medicine services. 482.53 Section 482.53... Condition of participation: Nuclear medicine services. If the hospital provides nuclear medicine services, those services must meet...

  20. Progress in oral personalized medicine: contribution of ‘omics’

    PubMed Central

    Glurich, Ingrid; Acharya, Amit; Brilliant, Murray H.; Shukla, Sanjay K.

    2015-01-01

    Background Precision medicine (PM), representing clinically applicable personalized medicine, proactively integrates and interprets multidimensional personal health data, including clinical, ‘omics’, and environmental profiles, into clinical practice. Realization of PM remains in progress. Objective The focus of this review is to provide a descriptive narrative overview of: 1) the current status of oral personalized medicine; and 2) recent advances in genomics and related ‘omic’ and emerging research domains contributing to advancing oral-systemic PM, with special emphasis on current understanding of oral microbiomes. Design A scan of peer-reviewed literature describing oral PM or ‘omic’-based research conducted on humans/data published in English within the last 5 years in journals indexed in the PubMed database was conducted using mesh search terms. An evidence-based approach was used to report on recent advances with potential to advance PM in the context of historical critical and systematic reviews to delineate current state-of-the-art technologies. Special focus was placed on oral microbiome research associated with health and disease states, emerging research domains, and technological advances, which are positioning realization of PM. Results This review summarizes: 1) evolving conceptualization of personalized medicine; 2) emerging insight into roles of oral infectious and inflammatory processes as contributors to both oral and systemic diseases; 3) community shifts in microbiota that may contribute to disease; 4) evidence pointing to new uncharacterized potential oral pathogens; 5) advances in technological approaches to ‘omics’ research that will accelerate PM; 6) emerging research domains that expand insights into host–microbe interaction including inter-kingdom communication, systems and network analysis, and salivaomics; and 7) advances in informatics and big data analysis capabilities to facilitate interpretation of host and microbiome-associated datasets. Furthermore, progress in clinically applicable screening assays and biomarker definition to inform clinical care are briefly explored. Conclusion Advancement of oral PM currently remains in research and discovery phases. Although substantive progress has been made in advancing the understanding of the role of microbiome dynamics in health and disease and is being leveraged to advance early efforts at clinical translation, further research is required to discern interpretable constituency patterns in the complex interactions of these microbial communities in health and disease. Advances in biotechnology and bioinformatics facilitating novel approaches to rapid analysis and interpretation of large datasets are providing new insights into oral health and disease, potentiating clinical application and advancing realization of PM within the next decade. PMID:26344171

  1. NMR clinical imaging and spectroscopy: Its impact on nuclear medicine

    SciTech Connect

    Not Available

    1990-02-02

    This is a collection of four papers describing aspects of past and future use of nuclear magnetic resonance as a clinical diagnostic tool. The four papers are entitled (1) What Does NMR Offer that Nuclear Medicine Does Not by Jerry W. Froelich, (2) Oncological Imaging: Now, Future and Impact Jerry W. Froelich, (3) Magnetic Resonance Spectroscopy/Spectroscopic Imaging and Nuclear Medicine: Past, Present and Future by H. Cecil Charles, and (4) MR Cardiology: Now, Future and Impact by Robert J. Herfkens.

  2. NMR clinical imaging and spectroscopy: Its impact on nuclear medicine

    SciTech Connect

    Not Available

    1990-02-02

    This is a collection of four papers describing aspects of past and future use of nuclear magnetic resonance as a clinical diagnostic tool. The four papers are entitled (1) What Does NMR Offer that Nuclear Medicine Does Not? by Jerry W. Froelich, (2) Oncological Imaging: Now, Future and Impact Jerry W. Froelich, (3) Magnetic Resonance Spectroscopy/Spectroscopic Imaging and Nuclear Medicine: Past, Present and Future by H. Cecil Charles, and (4) MR Cardiology: Now, Future and Impact by Robert J. Herfkens.

  3. Theoretical studies in nuclear reactions and nuclear structure. Progress report

    SciTech Connect

    Not Available

    1992-05-01

    Research in the Maryland Nuclear Theory Group focusses on problems in four basic areas of current relevance. Hadrons in nuclear matter; the structure of hadrons; relativistic nuclear physics and heavy ion dynamics and related processes. The section on hadrons in nuclear matter groups together research items which are aimed at exploring ways in which the properties of nucleons and the mesons which play a role in the nuclear force are modified in the nuclear medium. A very interesting result has been the finding that QCD sum rules supply a new insight into the decrease of the nucleon`s mass in the nuclear medium. The quark condensate, which characterizes spontaneous chiral symmetry breaking of the late QCD vacuum, decreases in nuclear matter and this is responsible for the decrease of the nucleon`s mass. The section on the structure of hadrons contains progress reports on our research aimed at understanding the structure of the nucleon. Widely different approaches are being studied, e.g., lattice gauge calculations, QCD sum rules, quark-meson models with confinement and other hedgehog models. A major goal of this type of research is to develop appropriate links between nuclear physics and QCD. The section on relativistic nuclear physics represents our continuing interest in developing an appropriate relativistic framework for nuclear dynamics. A Lorentz-invariant description of the nuclear force suggests a similar decrease of the nucleon`s mass in the nuclear medium as has been found from QCD sum rules. Work in progress extends previous successes in elastic scattering to inelastic scattering of protons by nuclei. The section on heavy ion dynamics and related processes reports on research into the e{sup +}e{sup {minus}} problem and heavy ion dynamics.

  4. [Progress in interventional radiology (IVR) in emergency medicine].

    PubMed

    Nishimaki, H; Takigawa, M; Sohma, K; Ohwada, T; Matsubayashi, T

    1999-07-01

    IVR has attracted much attention in Japan over the past decade, and it is expected to be rapidly developed and widely used. Not surprisingly, IVR has already become essential in emergency medicine. This paper addresses IVR of the thoracic and abdominal areas and the pelvis in emergency medicine, in particular the recent IVR focus on the vasculature. CO2-DSA, which enables extravasation and easy detection of a arteriovenous or portal shunt, is also useful in the detection of bleeding in emergency situations. In trauma cases, TAE, originating from an expanded concept of "damage control," is commonly used to stop bleeding in order to perform surgical treatment or used during surgery. Occasionally the two applications are combined when appropriate. TAE is effective in controlling retroperitoneal bleeding resulting from pelvic fracture and parenchymatous organ injuries in the abdominal area. Treatment with stent-grafts, originally used to treat true aneurysms, has recently been used for treatment of injuries of the aorta or arteries and for entry closure due to aortic dissection. Furthermore, stent placement is expected to become an effective cure for organ ischemia, resulting from acute dissections. Is addition, in order to cure rupture of esophagus or gastric varices, such new treatments as TIPS and BRTO have increasingly been used, coupled with the conventional PTO treatment. Continuous regional arterial infusion of protease inhibitor, in an attempt to cure severe acute pancreatitis, significantly reduced the infectious rate at the necrotic lesion, and its resulting mortality rate. It is certain that great progress has been made in emergency medicine. We also should realize that it is desirable to be well versed even in new IVR. PMID:10481849

  5. Yindanxinnaotong, a Chinese compound medicine, synergistically attenuates atherosclerosis progress

    PubMed Central

    Cheng, Long; Pan, Guo-feng; Zhang, Xiao-dong; Wang, Jian-lu; Wang, Wan-dan; Zhang, Jian-yong; Wang, Hui; Liang, Ri-xin; Sun, Xiao-bo

    2015-01-01

    Yindanxinnaotong (YD), a traditional Chinese medicine, has been introduced to clinical medicine for more than a decade, while its pharmacological properties are still not to be well addressed. This report aimed to explore the anti-atherosclerosis properties and underlying mechanisms of YD. We initially performed a computational prediction based on a network pharmacology simulation, which clued YD exerted synergistically anti-atherosclerosis properties by vascular endothelium protection, lipid-lowering, anti-inflammation, and anti-oxidation. These outcomes were then validated in atherosclerosis rats. The experiments provided evidences indicating YD’s contribution in this study included, (1) significantly reduced the severity of atherosclerosis, inhibited reconstruction of the artery wall and regulated the lipid profile; (2) enhanced antioxidant power, strengthened the activity of antioxidant enzymes, and decreased malondialdhyde levels; (3) significantly increased the viability of umbilical vein endothelial cells exposed to oxidative stress due to pretreatment with YD; (4) significantly reduced the level of pro-inflammatory cytokines; (5) significantly down-regulated NF-kB/p65 and up-regulated IkB in the YD-treated groups. Overall, these results demonstrated that YD intervention relieves atherosclerosis through regulating lipids, reducing lipid particle deposition in the endothelial layer of artery, enhancing antioxidant power, and repressing inflammation activity by inhibiting the nuclear factor-kappa B signal pathway. PMID:26196108

  6. Radiation safety audit of a high volume Nuclear Medicine Department

    PubMed Central

    Jha, Ashish Kumar; Singh, Abhijith Mohan; Shetye, Bhakti; Shah, Sneha; Agrawal, Archi; Purandare, Nilendu Chandrakant; Monteiro, Priya; Rangarajan, Venkatesh

    2014-01-01

    Introduction: Professional radiation exposure cannot be avoided in nuclear medicine practices. It can only be minimized up to some extent by implementing good work practices. Aim and Objectives: The aim of our study was to audit the professional radiation exposure and exposure rate of radiation worker working in and around Department of nuclear medicine and molecular imaging, Tata Memorial Hospital. Materials and Methods: We calculated the total number of nuclear medicine and positron emission tomography/computed tomography (PET/CT) procedures performed in our department and the radiation exposure to the radiation professionals from year 2009 to 2012. Results: We performed an average of 6478 PET/CT scans and 3856 nuclear medicine scans/year from January 2009 to December 2012. The average annual whole body radiation exposure to nuclear medicine physician, technologist and nursing staff are 1.74 mSv, 2.93 mSv and 4.03 mSv respectively. Conclusion: Efficient management and deployment of personnel is of utmost importance to optimize radiation exposure in a high volume nuclear medicine setup in order to work without anxiety of high radiation exposure. PMID:25400361

  7. Diagnostic Services and Communication Protocols for Remote Nuclear Medicine Laboratories

    PubMed Central

    Herbig, F.K.; Daly, J.L.; Gooch, N.E.; Donati, R.M.; Fletcher, J.W.

    1980-01-01

    A telecommunications system has been designed and implemented which provides diagnostic services to nuclear medicine laboratories established in smaller primary care medical facilities. These remote laboratories are located in areas where nuclear medicine patient services were not previously available because of the lack of trained nuclear physicians. The system provides through the use of computerized data acquisition and telephone data communication capability all routine and specialized imaging procedures with a degree of quality and sophistication normally available only in large urban medical centers. Nuclear image data acquired remotely is transmitted to Saint Louis, Missouri for interpretation by specialists in the Nuclear Medicine Service of the Veterans Administration Medical Center. The functions of hardware and software protocols necessary to assure the correctness and completeness of transmitted data are presented together with essential data descriptors for identification and format.

  8. [Research progress of genetic engineering on medicinal plants].

    PubMed

    Teng, Zhong-qiu; Shen, Ye

    2015-02-01

    The application of genetic engineering technology in modern agriculture shows its outstanding role in dealing with food shortage. Traditional medicinal plant cultivation and collection have also faced with challenges, such as lack of resources, deterioration of environment, germplasm of recession and a series of problems. Genetic engineering can be used to improve the disease resistance, insect resistance, herbicides resistant ability of medicinal plant, also can improve the medicinal plant yield and increase the content of active substances in medicinal plants. Thus, the potent biotechnology can play an important role in protection and large area planting of medicinal plants. In the development of medicinal plant genetic engineering, the safety of transgenic medicinal plants should also be paid attention to. A set of scientific safety evaluation and judgment standard which is suitable for transgenic medicinal plants should be established based on the recognition of the particularity of medicinal plants. PMID:26137675

  9. Applications of CdTe to nuclear medicine. Final report

    SciTech Connect

    Entine, G.

    1985-05-07

    Uses of cadmium telluride (CdTe) nuclear detectors in medicine are briefly described. They include surgical probes and a system for measuring cerebral blood flow in the intensive care unit. Other uses include nuclear dentistry, x-ray exposure control, cardiology, diabetes, and the testing of new pharmaceuticals. (ACR)

  10. Development of more efficacious Tc-99m organ imaging agents for use in nuclear medicine by analytical characterization of radiopharmaceutical mixtures. Progress report, September 1, 1989--January 31, 1992

    SciTech Connect

    Heineman, W.R.

    1992-01-24

    The long-range objective of this research program is the development of more efficacious technetium-99m radiopharmaceuticals for use as imaging agents in diagnostic nuclear medicine. We seek to isolate and develop distinct site imaging agents, each of which has properties optimized to provide diagnostic information concerning a given pathological condition. The specific objectives during the period (9/1/89 to 8/31/92) include: (1) Development of strategies for improving yields of specific Tc-diphosphonate complexes with optimum imaging properties; (2) Development of electrodes for rapid in situ electrochemical generation of skeletal imaging agents; (3) Development of electrochemical sensors for {Tc} and Re imaging agents; (4) Characterization of stable {Tc}- and Re-diphosphonate complexes obtainable in high yield by structural studies with techniques such as NMR, EXAFS, and Raman spectroscopy; (5) Development of improved separation techniques for the characterization of diphosphonate skeletal imaging agents; (6) Evaluation of the effect of the biological milieu on {Tc}-diphosphonate complexes; and (7) Electrochemical studies of technetium and rhenium complexes synthesized by Professor Deutsch`s research group for heart and brain imaging.

  11. Training requirements for chemists in radiotracer development for nuclear medicine

    SciTech Connect

    Finn, R.; Fowler, J.

    1988-01-01

    This panel was organized to address the current and anticipated future shortage of chemists with advanced training to fill positions in the nuclear medicine field. Although hard data and statistics are difficult to acquire, we will attempt to highlight the impact of chemistry on nuclear medicine and to describe the growth of the field which has led to an increasing need for chemists resulting in the current manpower shortage. We also will make recommendations for attracting Ph.D. chemists to careers in nuclear medicine research and possible mechanisms for postgraduate training. Solving this problem and establishing a long term committment and mechanism for advanced training is critically important to meet the current needs of the profession and to assure future growth and innovation. 3 tabs.

  12. Progress in Nuclear Nonproliferation Education in Russia

    SciTech Connect

    Killinger, Mark H.

    2005-08-01

    The U.S. Department of Energy actively supports the development of Russian nuclear nonproliferation expertise through education and training. This support includes assistance to Russian academic institutions in offering courses in safeguards and in nonproliferation policy. In particular, DOE has assisted the Moscow Engineering Physics Institute (MEPhI) in establishing a master’s degree program in nuclear material protection, control, and accounting (MPC&A), the first such program in the world. DOE is currently helping MEPhI develop a 5½ year engineering degree program in MPC&A, which is tailored to the needs of Russian nuclear facilities. Further, DOE is supporting nonproliferation curriculum at the high school level and the development of nonproliferation courses in Russian universities in Novouralsk, Tomsk, Seversk, Ozersk, Sarov, and Snezhinsk. DOE is beginning to also assist Tomsk Polytechnic University in developing its new engineering degree program in MPC&A. The Tomsk program is oriented toward serving students east of the Ural Mountains, while the MEPhI engineering degree program tends to serve students west of the Urals. DOE’s goal is to foster interest and knowledge in nonproliferation and support the establishment of self-sustaining degree programs that produce the next generation of safeguards experts. This paper describes progress on these education programs and our vision for the future.

  13. Nuclear Waste Management. Semiannual progress report, October 1984-March 1985

    SciTech Connect

    McElroy, J.L.; Powell, J.A.

    1985-06-01

    Progress reports are presented for the following studies on radioactive waste management: defense waste technology; nuclear waste materials characterization center; and supporting studies. 19 figs., 29 tabs.

  14. Nuclear waste management. Semiannual progress report, October 1983-March 1984

    SciTech Connect

    McElroy, J.L.; Powell, J.A.

    1984-06-01

    Progress in the following studies on radioactive waste management is reported: defense waste technology; Nuclear Waste Materials Characterization Center; waste isolation; and supporting studies. 58 figures, 22 tables.

  15. Nuclear Waste Management. Semiannual progress report, April 1984-September 1984

    SciTech Connect

    McElroy, J.L.; Powell, J.A.

    1984-12-01

    Progress in the following studies on radioactive waste management is reported: defense waste technology; Nuclear Waste Materials Characterization Center; and supporting studies. 33 figures, 13 tables.

  16. [Research progress on mutation by spaceflight in medicinal plants breeding].

    PubMed

    Yan, Shuo; Gao, Wenyuan; Lu, Fuping; Zhao, Runhuai

    2010-02-01

    Space breeding in medicinal plants is special characteristics in China. Compared with other plants, in spite of a relatively small number, Medicinal plants have more obvious characteristics and advantages. Research on medicinal plants has also been carried into all aspects, such as biological traits, physiology and biochemistry, genomics, as well as differences in chemical composition, and chemical composition analysis is also involved. However, compared with other plants, especially crops and vegetables, biological research is an obvious deficiency, that is mainly reflected in the insufficient genetics and breeding researches, the stability of genetic traits from generation to generation were not followed up and in-depth study in breeding areas was not carried out. If medicinal plants resources from space with the genetic stability good quality were selected, it would address the problem of lack of resources and ease the pressure on wild resources of medicinal plants. It would at the same time play an important role in promoting the development of medicinal botany space breeding and the implementation of modernization of traditional Chinese medicine. PMID:20423012

  17. Theoretical nuclear physics. 1998 progress report

    SciTech Connect

    1998-09-01

    Summaries of progress made on the following topics are given: (1) nonresonant contributions to inelastic N{r_arrow}{Delta}(1232) parity violation; (2) neutron distribution effects in elastic nuclear parity violation; (3) Wilson RG for scalar-plus-fermion field theories at finite density; (4) Perturbation theory for spin ladders using angular momentum coupled bases; (5) mean-field theory for spin ladders using angular momentum density; (6) finite temperature renormalization group effective potentials for the linear Sigma model; (7) negative-parity baryon resonances from lattice QCD; (8) the N{r_arrow}{Delta} electromagnetic transition amplitudes from QCD sum rules; and (9) higher nucleon resonances in exclusive reactions ({gamma}, {pi}N) on nuclei.

  18. Pioneers of nuclear medicine, Madame Curie.

    PubMed

    Grammaticos, Philip C

    2004-01-01

    Among those who have made important discoveries in the field of radioactivity and thus helped in the development of nuclear medicine as an identical entity are: Heinrich Hertz who in 1886 demonstrated the existence of radiowaves. In 1895 Wilhelm Röntgen discovered the X-rays. In 1896 H. Becquerel described the phenomenon of radioactivity. He showed that a radioactive uranium salt was emitting radioactivity which passing through a metal foil darkened a photographic plate. An analogous experiment performed by S.Thomson in London was announced to the president of the Royal Society of London before the time H.Becquerel announced his discovery but Thomson never claimed priority for his discovery. Muarie Sklodowska Curie (1867-1934) was undoubtedly the most important person to attribute to the discovery of radioactivity. In 1898 she discovered radium as a natural radioactive element. This is how she describes the hard time she had, working with her husband Pierre Curie (1859-1906) for the discovery of radium and polonium: "During the first year we did not go to the theater or to a concert or visited friends. I miss my relatives, my father and my daughter that I see every morning and only for a little while. But I do not complain...". In presenting her discovery of radium, Madame Curie said: " ...in the hands of a criminal, radium is very dangerous. So we must often ask ourselves: will humanity earn or lose from this discovery? I, myself belong to those who believe the former...". The notebooks that Madame Curie had when she was working with radium and other radioactive elements like polonium, thorium and uranium are now kept in Paris. They are contaminated with radioactive materials having very long half-lives and for this reason anyone who wishes to have access to these notes should sign that he takes full responsibility. There are some more interesting points in Madame Curie's life which may not be widely known like: Although her full name is Maria Sklodowska-Curie, she is not known neither by that full name nor as Maria Sklodowska but as Marie Curie. Madame Curie was the second of five children. At the age of 24 she went to Sorbonne-Paris after being invited by her sister Bronja to study for about 2-3 years; instead she stayed in Paris for her whole life. Her doctorate was on the subject: "Research on radioactive substances" which she completed in six years under the supervision of H. Becquerel. Pierre Curie was Director of the Physics Laboratory of the Ecole Municipale of Physics and Industrial Chemistry when he married M. Curie in 1895. Pierre Curie left his other research projects and worked full time with his wife. In this laboratory M. Curie and her husband Pierre discovered radium and polonium. In 1901 Pierre Curie induced a radiation burn on his forearm by applying on his skin radiferous barium chloride for 10 hours. During World War I, M.Curie organized for the Red Cross a fleet of radiological ambulances each with X-ray apparates which were called "Little Curies". The X-ray tubes of these apparates were unshielded and so M.Curie was exposed to high doses of radiation. Once an ambulance fell into a ditch and M.Curie who was inside the ambulance was badly bruised and stayed at home for 3 days. M. Curie with her daughters, Irene and Eve, was invited and visited America in 1921. She led a successful campaign to collect radium for her experiments. Before leaving America, President Harding donated through her to the Radium Institute of Paris 1 g of radium for research purposes. At that time the process to obtain 0.5 g of pure radium bromide required 1 ton of ore and 5 tons of chemicals. No measures of radiation protection were taken back then. In 1929 Madame Curie visited the United States for a second time. She met with President Hoover and with the help of the Polish women's association in America collected funds for another gram of radium. Madame Curie died of leukemia on July 4, 1934. Sixty years after her death her remnants were laid to rest under the dome of the Pantheon. Th

  19. Lung Cancer Precision Medicine Trials: Adapting to Progress

    Cancer.gov

    Patients with lung cancer are benefiting from the boom in targeted and immune-based therapies. With a series of precision medicine trials, NCI is keeping pace with the rapidly changing treatment landscape for lung cancer.

  20. Nuclear Medicine Technology: A Suggested Two-Year Curriculum Manual.

    ERIC Educational Resources Information Center

    Hunter, David

    This curriculum guide prescribes an educational program for training nuclear medicine technologists. Following a brief section on program development, the curriculum is both outlined and presented in detail. For each of the 44 courses, the following information is given: (1) sequential placement of the course in the curriculum; (2) course…

  1. Essentials of nuclear medicine imaging. 3rd edition

    SciTech Connect

    Mettler, F.A.; Guiberteau, M.J.

    1991-01-01

    This book covers topics ranging from basic physics and instrumentation to various aspects of clinical imaging and regulatory issues. It includes a section on single photon emission computed tomography (SPECT). The clinical sections include newer aspects of nuclear medicine, such as antibody imaging, pharmacologic stress, bone mineral analysis, evaluation of renovascular hypertension, and the role of gallium in patients with acquired immunodeficiency syndrome.

  2. Replenishment prioritization of highly perishable goods : a case study on nuclear medicine

    E-print Network

    Yea, Young-bai Michael

    2007-01-01

    Serving customers in a nuclear medicine supply chain requires frequent and responsive replenishments. Nuclear medicine is a special category of perishable goods that is subject to rapid, but predictable radioactive decay. ...

  3. What You Should Know About Pediatric Nuclear Medicine and Radiation Safety

    MedlinePLUS

    ... You Should Know About Pediatric Nuclear Medicine and Radiation Safety www.imagegently.org What is nuclear medicine? ... using a mask. The radiotracer gives off invisible rays called gamma rays. These rays can be seen ...

  4. High Performance Organ-Specific Nuclear Medicine Imagers.

    NASA Astrophysics Data System (ADS)

    Majewski, Stan

    2006-04-01

    One of the exciting applications of nuclear science is nuclear medicine. Well-known diagnostic imaging tools such as PET and SPECT (as well as MRI) were developed as spin-offs of basic scientific research in atomic and nuclear physics. Development of modern instrumentation for applications in particle physics experiments offers an opportunity to contribute to development of improved nuclear medicine (gamma and positron) imagers, complementing the present set of standard imaging tools (PET, SPECT, MRI, ultrasound, fMRI, MEG, etc). Several examples of new high performance imagers developed in national laboratories in collaboration with academia will be given to demonstrate this spin-off activity. These imagers are designed to specifically image organs such as breast, heart, head (brain), or prostate. The remaining and potentially most important challenging application field for dedicated nuclear medicine imagers is to assist with cancer radiation treatments. Better control of radiation dose delivery requires development of new compact in-situ imagers becoming integral parts of the radiation delivery systems using either external beams or based on radiation delivery by inserting or injecting radioactive sources (gamma, beta or alpha emitters) into tumors.

  5. Application of Technetium and Rhenium in Nuclear Medicine

    NASA Astrophysics Data System (ADS)

    Alberto, Roger

    2012-06-01

    Technetium and Rhenium are the two lower elements in the manganese triad. Whereas rhenium is known as an important part of high resistance alloys, technetium is mostly known as a cumbersome product of nuclear fission. It is less known that its metastable isotope 99mTc is of utmost importance in nuclear medicine diagnosis. The technical application of elemental rhenium is currently complemented by investigations of its isotope 188Re, which could play a central role in the future for internal, targeted radiotherapy. This article will briefly describe the basic principles behind diagnostic methods with radionuclides for molecular imaging, review the 99mTc-based radiopharmaceuticals currently in clinical routine and focus on the chemical challenges and current developments towards improved, radiolabeled compounds for diagnosis and therapy in nuclear medicine.

  6. Modeling and Simulation of Nuclear Medicine Patient Service Management in DEVS

    E-print Network

    Ntaimo, Lewis

    Modeling and Simulation of Nuclear Medicine Patient Service Management in DEVS Eduardo P identified as one of the causes of increased health care costs in the U.S. Nuclear medicine, a sub patient service in nuclear medicine is a very challenging problem with very little research attention

  7. 42 CFR 482.53 - Condition of participation: Nuclear medicine services.

    Code of Federal Regulations, 2013 CFR

    2013-10-01

    ... 42 Public Health 5 2013-10-01 2013-10-01 false Condition of participation: Nuclear medicine... HOSPITALS Optional Hospital Services § 482.53 Condition of participation: Nuclear medicine services. If the hospital provides nuclear medicine services, those services must meet the needs of the patients...

  8. 42 CFR 482.53 - Condition of participation: Nuclear medicine services.

    Code of Federal Regulations, 2011 CFR

    2011-10-01

    ... 42 Public Health 5 2011-10-01 2011-10-01 false Condition of participation: Nuclear medicine... HOSPITALS Optional Hospital Services § 482.53 Condition of participation: Nuclear medicine services. If the hospital provides nuclear medicine services, those services must meet the needs of the patients...

  9. 42 CFR 482.53 - Condition of participation: Nuclear medicine services.

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... 42 Public Health 5 2010-10-01 2010-10-01 false Condition of participation: Nuclear medicine... HOSPITALS Optional Hospital Services § 482.53 Condition of participation: Nuclear medicine services. If the hospital provides nuclear medicine services, those services must meet the needs of the patients...

  10. 42 CFR 482.53 - Condition of participation: Nuclear medicine services.

    Code of Federal Regulations, 2014 CFR

    2014-10-01

    ... 42 Public Health 5 2014-10-01 2014-10-01 false Condition of participation: Nuclear medicine... HOSPITALS Optional Hospital Services § 482.53 Condition of participation: Nuclear medicine services. If the hospital provides nuclear medicine services, those services must meet the needs of the patients...

  11. 42 CFR 482.53 - Condition of participation: Nuclear medicine services.

    Code of Federal Regulations, 2012 CFR

    2012-10-01

    ... 42 Public Health 5 2012-10-01 2012-10-01 false Condition of participation: Nuclear medicine... HOSPITALS Optional Hospital Services § 482.53 Condition of participation: Nuclear medicine services. If the hospital provides nuclear medicine services, those services must meet the needs of the patients...

  12. Discharges of nuclear medicine radioisotopes in Spanish hospitals.

    PubMed

    Krawczyk, E; Piñero-García, F; Ferro-García, M A

    2013-02-01

    Given the increasing use of radiopharmaceuticals in medicine, the aim of this paper is to determine radioactivity levels in the effluents of hospitals with Nuclear Medicine Departments. The radiological study of hospital discharges was carried out by gamma spectrometry, and liquid scintillation spectrometry to determine (14)C and (3)H contents. On March 9th and April 19th, 2010, daily radioactivity levels were monitored from 8:30 a.m. to 7:30 p.m. Each sample was collected at a specific control point of two major public hospitals in Granada (Spain). The analytical results show the presence of radionuclides such as (99m)Tc, (131)I, (67)Ga, and (111)In.They are frequently used in nuclear medicine for diagnostic and/or therapeutic purposes. This study shows the differences between direct and after-storage discharges and also justifies the need of storage tanks in hospitals with nuclear medicine departments. Moreover, monitoring of (99m)Tc released at hospital control points can be a useful tool for optimizing the safety conditions of storage tanks and discharge of radionuclides. PMID:23103581

  13. Nuclear structure at intermediate energies. Progress report

    SciTech Connect

    Bonner, B.E.; Mutchler, G.S.

    1992-07-15

    We report here oil the progress that we made for the nine months beginning October 1, 1991 for DOE Grant No. DE-FG05-87ER40309. The report covers the third year of a three year grant. Since we are submitting an accompanying Grant Renewal Proposal, we provide in this report more background information than usual for the different projects. The theme that unites the experiments undertaken by the Bonner Lab Medium Energy Group is a determination to understand in detail the many facets and manifestations of the strong interaction, that which is now referred to as nonperturbative QCD. Whether we are investigating the question of just what does carry the spin of baryons, or the extent of the validity of the SU(6) wavefunctions for the excited hyperons (as will be measured in our CEBAF experiment), or questions associated with the formation of a new state of matter predicted by QCD (the subject of AGS {bar p} experiment E854, AGS heavy ion experiment E810, as-well as the approved STAR experiment at RHIC), - all these projects share this common goal. FNAL E683 may well open a new field of investigation in nuclear physics: That of just how colored quarks and gluons interact with nuclear matter as they traverse nuclei of different-sizes. In most all of the experiments mentioned, above, the Bonner Lab Group is playing major leadership roles as well as doing a big fraction of the hard work that such experiments require. We use many of the facilities that are available to the intermediate energy physics community and we use our expertise to design and fabricate the detectors and instrumentation that are required to perform the measurements which we decide to do. The format we follow in the Progress Report is,to provide a concise, but fairly complete write-up on each project. The publications listed in Section In give much greater detail on many of the projects. The aim in this report is to focus on the physics goals, the results, and their significance.

  14. Evaluation of metallic osseous implants with nuclear medicine

    SciTech Connect

    Wellman, H.N.; Schauwecker, D.S.; Capello, W.N.

    1988-04-01

    Nuclear medicine has proven to have a valuable role in the evaluation of osseous metallic implants, particularly with joint prostheses, but can assist with evaluation of other appliances as well. The nuclear arthrogram has become an invaluable adjunct to simultaneously performed radiographic contrast arthrography. This application has been best evaluated in what is one of the most common of orthopedic prosthesis problems, namely, loosening of total hip prostheses. Experience indicates that both sensitivity and specificity of loosening of the femoral component can be increased to over 90% through combined use of nuclear with radiographic contrast arthrography. Furthermore the combination of routine skeletal scintimaging with the nuclear arthrogram adds a significant dimension to precise localizing of the nuclear arthrographics agent In-111 chloride. Nuclear medicine also plays an important role in further evaluating the presence of infection associated with metallic implants with In-111 WBC preparations being superior to Ga-67 as the radiopharmaceutical tracer. Infection has been detected with a sensitivity of 73% and a specificity of 93% in our series using combined In-111 WBC and simultaneous skeletal imaging with conventional Tc-99m MDP. Acute infections are more readily identifiable than chronic in association with prostheses. 29 references.

  15. * DESCRIPTION OF THE PROFESSION Nuclear medicine uses radioactivity to diagnose and treat disease. It is a multi-

    E-print Network

    Delgado, Mauricio

    1 * DESCRIPTION OF THE PROFESSION Nuclear medicine uses radioactivity to diagnose and treat disease, and medicine. Though there are many diagnostic techniques currently available, nuclear medicine uniquely medicine from other imaging modalities, such as X-ray. Nuclear medicine procedures are safe, they involve

  16. Forensic Medicine: Age Written in Teeth by Nuclear Bomb Tests

    SciTech Connect

    Lawrence Livermore National Laboratory

    2005-05-04

    Establishing the age of individuals is an important step in identification and a frequent challenge in forensic medicine. This can be done with high precision up to adolescence by analysis of dentition, but establishing the age of adults has remained difficult. Here we show that measuring {sup 14}C from nuclear bomb tests in tooth enamel provides a sensitive way to establish when a person was born.

  17. American College of Nuclear Physics 1991 DOE day symposium: Aids and nuclear medicine

    SciTech Connect

    1991-12-31

    Since first described in 1981, the acquired immunodeficiency syndrome (AIDS) has become the medical dilemma of the century. AIDS retrovirus, and the economic consequences of this exposure are staggering. AIDS has been the topic of conferences and symposia worldwide. This symposium, to be held on January 25, 1991, at the 17th Annual Meeting and Scientific Sessions of the American College of Nuclear Physicians, will expose the Nuclear Medicine Physicians/Radiologists to their role in the diagnosis of AIDS, and will educate them on the socio-economic and ethical issues related to this problem. In addition, the Nuclear Medicine Physicians/Radiologists must be aware of their role in the management of their departments in order to adequately protect the health care professionals working in their laboratories. Strategies are currently being developed to control the spread of bloodborne diseases within the health care setting, and it is incumbent upon the Nuclear Medicine community to be aware of such strategies.

  18. Assessment of OEP health's risk in nuclear medicine

    NASA Astrophysics Data System (ADS)

    Santacruz-Gomez, K.; Manzano, C.; Melendrez, R.; Castaneda, B.; Barboza-Flores, M.; Pedroza-Montero, M.

    2012-10-01

    The use of ionizing radiation has been increased in recent years within medical applications. Nuclear Medicine Department offers both treatment and diagnosis of diseases using radioisotopes to controlled doses. Despite the great benefits to the patient, there is an inherent risk to workers which remains in contact with radiation sources for long periods. These personnel must be monitored to avoid deterministic effects. In this work, we retrospectively evaluated occupationally exposed personnel (OEP) to ionizing radiation in nuclear medicine during the last five years. We assessed both area and personal dosimetry of this department in a known Clinic in Sonora. Our results show an annual equivalent dose average of 4.49 ± 0.70 mSv in OEP without showing alarming changes in clinical parameters analyzed. These results allow us to conclude that health of OEP in nuclear medicine of this clinic has not been at risk during the evaluated period. However, we may suggest the use of individual profiles based on specific radiosensitivity markers.

  19. Liver phantom for quality control and training in nuclear medicine

    NASA Astrophysics Data System (ADS)

    Lima Ferreira, Fernanda Carla; Souza, Divanizia do Nascimento

    2011-10-01

    In nuclear medicine, liver scintigraphy aims to verify organ function based on the radionuclide concentration in the liver and bile flow and is also used to detect tumors. Therefore it is necessary to perform quality control tests in the gamma camera before running the exam to prevent false results. Quality control tests of the gamma camera should thus be performed before running the exam to prevent false results. Such tests generally use radioactive material inside phantoms for evaluation of gamma camera parameters in quality control procedures. Phantoms can also be useful for training doctors and technicians in nuclear medicine procedures. The phantom proposed here has artifacts that simulate nodules; it may take on different quantities, locations and sizes and it may also be mounted without the introduction of nodules. Thus, its images may show hot or cold nodules or no nodules. The phantom consists of acrylic plates hollowed out in the centre, with the geometry of an adult liver. Images for analyses of simulated liver scintigraphy were obtained with the detector device at 5 cm from the anterior surface of the phantom. These simulations showed that this object is suitable for quality control in nuclear medicine because it was possible to visualize artifacts larger than 7.9 mm using a 256×256 matrix and 1000 kcpm. The phantom constructed in this work will also be useful for training practitioners and technicians in order to prevent patients from repeat testing caused by error during examinations.

  20. Antimalarial Drug Discovery: Approaches and Progress towards New Medicines

    PubMed Central

    Flannery, Erika L.; Chatterjee, Arnab K.; Winzeler, Elizabeth A.

    2014-01-01

    Malaria elimination has recently been reinstated as a global health priority but current therapies seem to be insufficient for the task. Elimination efforts require new drug classes that alleviate symptoms, prevent transmission and provide a radical cure. To develop these next generation medicines, public-private partnerships are funding innovative approaches to identify compounds that target multiple parasite species at multiple stages of the parasite lifecycle. Here, we review the cell-, chemistry- and target-based approaches used to discover new drug candidates that are currently in clinical trials or undergoing preclinical testing. PMID:24217412

  1. 42 CFR Appendix F to Part 75 - Standards for Licensing Radiographers, Nuclear Medicine Technologists, and Radiation Therapy...

    Code of Federal Regulations, 2011 CFR

    2011-10-01

    ... Medicine Technologists, and Radiation Therapy Technologists F Appendix F to Part 75 Public Health PUBLIC..., App. F Appendix F to Part 75—Standards for Licensing Radiographers, Nuclear Medicine Technologists... licensed as Radiographers, Nuclear Medicine Technologists, or Radiation Therapy Technologists. 2....

  2. 42 CFR Appendix F to Part 75 - Standards for Licensing Radiographers, Nuclear Medicine Technologists, and Radiation Therapy...

    Code of Federal Regulations, 2014 CFR

    2014-10-01

    ... Medicine Technologists, and Radiation Therapy Technologists F Appendix F to Part 75 Public Health PUBLIC..., App. F Appendix F to Part 75—Standards for Licensing Radiographers, Nuclear Medicine Technologists... licensed as Radiographers, Nuclear Medicine Technologists, or Radiation Therapy Technologists. 2....

  3. 42 CFR Appendix F to Part 75 - Standards for Licensing Radiographers, Nuclear Medicine Technologists, and Radiation Therapy...

    Code of Federal Regulations, 2013 CFR

    2013-10-01

    ... Medicine Technologists, and Radiation Therapy Technologists F Appendix F to Part 75 Public Health PUBLIC..., App. F Appendix F to Part 75—Standards for Licensing Radiographers, Nuclear Medicine Technologists... licensed as Radiographers, Nuclear Medicine Technologists, or Radiation Therapy Technologists. 2....

  4. 42 CFR Appendix F to Part 75 - Standards for Licensing Radiographers, Nuclear Medicine Technologists, and Radiation Therapy...

    Code of Federal Regulations, 2012 CFR

    2012-10-01

    ... Medicine Technologists, and Radiation Therapy Technologists F Appendix F to Part 75 Public Health PUBLIC..., App. F Appendix F to Part 75—Standards for Licensing Radiographers, Nuclear Medicine Technologists... licensed as Radiographers, Nuclear Medicine Technologists, or Radiation Therapy Technologists. 2....

  5. 42 CFR Appendix F to Part 75 - Standards for Licensing Radiographers, Nuclear Medicine Technologists, and Radiation Therapy...

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... Medicine Technologists, and Radiation Therapy Technologists F Appendix F to Part 75 Public Health PUBLIC..., App. F Appendix F to Part 75—Standards for Licensing Radiographers, Nuclear Medicine Technologists... licensed as Radiographers, Nuclear Medicine Technologists, or Radiation Therapy Technologists. 2....

  6. Center of Excellence in laser medicine. Progress performance report

    SciTech Connect

    Parrish, J.A.

    1993-04-29

    Achievements during the last 12 months of funding to initiate a Center of Excellence in biomedical laser development include: seven specific research projects within the Center`s three broad interest areas, and program development to establish the MGH Laser Center and its activities. Progress in the three interest areas namely new medical laser systems development, optical diagnostics and photo sensitization is reported. Feasibility studies and prototype development were emphasized, to enhance establishing a substantial Center through future support. Specific projects are outlined below. In addition, the interdepartmental MGH Laser Center`s activities and accomplishments.

  7. Recent progress in the study of anticancer drugs originating from plants and traditional medicines in China.

    PubMed

    Han, R

    1994-03-01

    Drugs of plant origin have received much attention due to their enormous potential for the prevention and treatment of cancer. Recent progress in the study of anticancer drugs originating from plants and traditional medicines in China is reviewed in this paper, with particular emphasis on taxol, daidzein, acetyl boswellic acid, curcumin and ginsenosid Rh2. PMID:7916218

  8. Center of excellence in laser medicine. Progress report

    SciTech Connect

    Parrish, J.A.

    1992-09-01

    Achievements during the first six months of funding to prepare for a Center of Excellence in biomedical laser development include limited specific research projects within the Center`s three broad interest areas, and program development to establish the Center and its activities. Progress in the three interest areas -- new medical laser systems development, optical diagnostics, and photosensitization, is reported. Feasibility studies and prototype development were emphasized, to enhance establishing a substantial Center through future support. Specific projects are an optimized laser-catheter system for reversal of vasospasm; optical detection of major skin burn depth and cancers using fluorescent drugs, and photosensitization of vascular tissues. In addition, an interdepartmental Laser Center was established at MGH to enhance collaborations and institutional committment to the Center of Excellence. Competitive postdoctoral research fellowships, with provision for matching funds from other departments, have been announced.

  9. Photons across medicine: relating optical and nuclear imaging

    PubMed Central

    Nordstrom, Robert; Cherry, Simon; Azhdarinia, Ali; Sevick-Muraca, Eva; VanBrocklin, Henry

    2013-01-01

    The Optics in the Life Sciences conference sponsored by the Optical Society of America was held in Waikoloa Beach, HI on April 14 – 18, 2013. Papers were presented in the areas of Bio-Optics: Design & Application, Novel Techniques in Microscopy, Optical Molecular Probes, Imaging & Drug Delivery, and Optical Trapping Applications. A focal point of the meeting was a special symposium entitled “Photons Across Medicine”, organized by Adam Wax, Duke University, highlighting activities of joint interest between the Optical Society of America (OSA) and the Society for Nuclear Medicine and Molecular Imaging (SNMMI). This paper is a synopsis of the presentations made at this joint symposium. Central to the special symposium presentations was the fact that the optical and nuclear imaging communities share common interests and challenges. These are highlighted in this article. Also discussed was the fact that the nuclear technologies in imaging have found their way into general clinical utility, a feat that has yet to be achieved by optical methods. Because of the common ground shared by the two technologies, coordination between the two societies should be planned. PMID:24409377

  10. Nuclear Medicine in Thyroid Diseases in Pediatric and Adolescent Patients

    PubMed Central

    Volkan-Salanc?, Bilge; Özgen K?ratl?, P?nar

    2015-01-01

    Both benign and malignant diseases of the thyroid are rare in the pediatric and adolescent population, except congenital hypothyroidism. Nuclear medicine plays a major role, both in the diagnosis and therapy of thyroid pathologies. Use of radioactivity in pediatric population is strictly controlled due to possible side effects such as secondary cancers; therefore, management of pediatric patients requires detailed literature knowledge. This article aims to overview current algorithms in the management of thyroid diseases and use of radionuclide therapy in pediatric and adolescent population. PMID:26316469

  11. Evolving Important Role of Lutetium-177 for Therapeutic Nuclear Medicine.

    PubMed

    Pillai, Ambikalmajan M R; Knapp, Furn F Russ

    2015-01-01

    Lutetium-177 ((177)Lu) is a late entrant into the nuclear medicine therapy arena but is expected to become one of the most widely used therapeutic radionuclides. This paper analyses the reason for the increasing preference of (177)Lu as a therapeutic radionuclide. While the radionuclidic properties favor its use for several therapeutic applications, the potential for large scale production of (177)Lu is also an important aspect for its acceptability as a therapeutic radionuclide. This introductory discussion also summarizes some developing clinical uses and suggested future directions for applications of (177)Lu. PMID:25771380

  12. Personalized medicine and pharmacogenetic biomarkers: progress in molecular oncology testing

    PubMed Central

    Ong, Frank S; Das, Kingshuk; Wang, Jay; Vakil, Hana; Kuo, Jane Z; Blackwell, Wendell-Lamar B; Lim, Stephen W; Goodarzi, Mark O; Bernstein, Kenneth E; Rotter, Jerome I; Grody, Wayne W

    2012-01-01

    In the field of oncology, clinical molecular diagnostics and biomarker discoveries are constantly advancing as the intricate molecular mechanisms that transform a normal cell into an aberrant state in concert with the dysregulation of alternative complementary pathways are increasingly understood. Progress in biomarker technology, coupled with the companion clinical diagnostic laboratory tests, continue to advance this field, where individualized and customized treatment appropriate for each individual patient define the standard of care. Here, we discuss the current commonly used predictive pharmacogenetic biomarkers in clinical oncology molecular testing: BRAF V600E for vemurafenib in melanoma; EML4–ALK for crizotinib and EGFR for erlotinib and gefitinib in non-small-cell lung cancer; KRAS against the use of cetuximab and panitumumab in colorectal cancer; ERBB2 (HER2/neu) for trastuzumab in breast cancer; BCR–ABL for tyrosine kinase inhibitors in chronic myeloid leukemia; and PML/RAR? for all-trans-retinoic acid and arsenic trioxide treatment for acute promyelocytic leukemia. PMID:22845480

  13. [Study progress of spectral color science and its prospect of application in the field of Chinese medicine].

    PubMed

    Yin, Fang-zhou; Wu, Xiao-yan; Mao, Chun-qing; Ji, De; Cai, Bao-chang; Lu, Tu-lin

    2013-09-01

    The paper reviewed the research progress in the spectral color science, including the common model, color measurement instrument in recent years, application of color measurement technology in agriculture, food, industry, medicine and other fields. The possibility to achieve the color quantization of Chinese medicine was explored by color measurement technology, and analyzed its application prospect in the field of Chinese medicine, provided a model for the study on quality control for Chinese medicine non-destructive online PMID:24369622

  14. Choosing transportation alternatives for highly perishable goods : a case study on nuclear medicine

    E-print Network

    Yang, Xiaowen, M. Eng. Massachusetts Institute of Technology

    2006-01-01

    The transport of highly perishable goods, in particular nuclear medicine, is subject to stringent regulations. Carefully designed transport selection criteria considering available alternatives, product attributes, decay ...

  15. Image Reconstruction for Prostate Specific Nuclear Medicine imagers

    SciTech Connect

    Mark Smith

    2007-01-11

    There is increasing interest in the design and construction of nuclear medicine detectors for dedicated prostate imaging. These include detectors designed for imaging the biodistribution of radiopharmaceuticals labeled with single gamma as well as positron-emitting radionuclides. New detectors and acquisition geometries present challenges and opportunities for image reconstruction. In this contribution various strategies for image reconstruction for these special purpose imagers are reviewed. Iterative statistical algorithms provide a framework for reconstructing prostate images from a wide variety of detectors and acquisition geometries for PET and SPECT. The key to their success is modeling the physics of photon transport and data acquisition and the Poisson statistics of nuclear decay. Analytic image reconstruction methods can be fast and are useful for favorable acquisition geometries. Future perspectives on algorithm development and data analysis for prostate imaging are presented.

  16. [Research progress on medicinal resources of Mylabris and close origin species].

    PubMed

    Zhang, Jianhui; Chen, Jianwei; Li, Xiang

    2009-03-01

    The paper summarizes the research progress on the medicinal resources of Mylabris and close origin species in recent years. Besides the 45 species in 7 genus within Meloidae insects which contain cantharidin, there are also more 9 species in 7 close origin genus containing cantharidin which include Zanna, Fulgora and Lycorma within Fulgoridae of Homoptera, Oxocopis, Heliocis Xanthochroa and Oedemera within Oedemeridae of Coleoptera. New medicinal resources of cantharidin are redundant, there are biological relationships in the biosynthesis of cantharidin, the emerge of cantharidin is related to ecology and there is more attention on the new methods of utilizing Mylabris resources such as living body extraction. PMID:19623996

  17. Problems in detection and measurement in nuclear medicine

    NASA Astrophysics Data System (ADS)

    Aysun Ugur, Fatma

    2015-07-01

    Nuclear Medicine studies are performed with a variety of types of radiation measurement instruments, depending on the kind of radiation source that is being measured and the type of information sought. For example, some instruments are designed for in vitro measurements on blood samples, urine specimens, and so forth. Others are designed for in vivo measurements of radioactivity in patients. All these instruments have special design characteristics to optimize them for their specific tasks, as described in this study; however, some considerations of design characteristics and performance limitations are common to all of them. An important consideration for any radiation measurement instrument is its detection efficiency. Maximum detection efficiency is desirable because one thus obtains maximum information with a minimum amount of radioactivity. Also important are instrument's counting rate limitations. There are finite counting rate limits for all counting and imaging instruments used in nuclear medicine, above which accurate results are obtained because of data losses and other data distortions. Non penetrating radiations, such as ß particles, have special detection and measurement problems. In this study, some of these general considerations have been discussed.

  18. Nuclear Medicine in Diagnosis of Prosthetic Valve Endocarditis: An Update

    PubMed Central

    Musso, Maria; Petrosillo, Nicola

    2015-01-01

    Over the past decades cardiovascular disease management has been substantially improved by the increasing introduction of medical devices as prosthetic valves. The yearly rate of infective endocarditis (IE) in patient with a prosthetic valve is approximately 3 cases per 1,000 patients. The fatality rate of prosthetic valve endocarditis (PVE) remains stable over the years, in part due to the aging of the population. The diagnostic value of echocardiography in diagnosis is operator-dependent and its sensitivity can decrease in presence of intracardiac devices and valvular prosthesis. The modified Duke criteria are considered the gold standard for diagnosing IE; their sensibility is 80%, but in clinical practice their diagnostic accuracy in PVE is lower, resulting inconclusively in nearly 30% of cases. In the last years, these new imaging modalities have gained an increasing attention because they make it possible to diagnose an IE earlier than the structural alterations occurring. Several studies have been conducted in order to assess the diagnostic accuracy of various nuclear medicine techniques in diagnosis of PVE. We performed a review of the literature to assess the available evidence on the role of nuclear medicine techniques in the diagnosis of PVE. PMID:25695043

  19. Prediction of tumour hypoxia and radioresistance with nuclear medicine markers.

    PubMed Central

    Chapman, J. D.; Coia, L. R.; Stobbe, C. C.; Engelhardt, E. L.; Fenning, M. C.; Schneider, R. F.

    1996-01-01

    Second-generation nuclear medicine markers of tumour hypoxia have been synthesised and screened for hypoxic marking activity in cell cultures and in mouse tumours (EMT-6). Markers of the iodinated azomycin nucleoside class with greater water solubility and faster plasma clearance rates relative to iodoazomycin arabinoside (IAZA) were of particular interest. The test systems used to characterise hypoxic marking activity of compounds included (1) covalent linkage of radiolabelled markers to cells in suspension culture equilibrated with specific O2 concentrations; (2) biodistribution of radiolabelled markers in EMT-6 tumour-bearing mice; and (3) biodistribution in R3327-AT tumour-bearing rats by nuclear medicine procedures. Of the iodinated azomycin nucleosides produced to date, beta-D-iodoazomycin galactoside (beta-D-IAZG) and beta-D-iodoazomycin xylopyranoside (beta-D-IAZXP) exhibited high metabolism-dependent hypoxic cell uptake, rapid clearance kinetics from the blood and excellent tumour marking activity in vivo. Tumour-blood (T/B) ratio (a measure of tumour hypoxic fraction) was dependent upon EMT-6 tumour size and implantation site. The radioresistance of individual tumours was measured by in vivo/in vitro assay and correlated well with the T/B ratio of hypoxic marker. These studies have identified beta-D-IAZG and beta-D-IAZXP as effective hypoxic markers for planar and single photon emission computerised tomography (SPECT) imaging studies of tumour oxygenation. PMID:8763881

  20. Progress in noise thermometry for nuclear applications

    SciTech Connect

    Lopez, A. L.; Villard, J. F.

    2011-07-01

    The effects of nuclear radiations on conventional thermocouples (type K, C and N) mainly used in irradiation experiments may create significant drifts of the signals. In order to solve these difficulties, the CEA (French Nuclear Energy Commission) has developed and qualified in laboratory conditions miniature devices, which combine a noise thermometer and intrinsic thermocouples (NT-TC), for future application in a research reactor. In this paper, a particular approach of combined NT-TC sensors is described. Present measurements, based on a correlation and a comparison technique, have been performed in a typical laboratory environment between 200 and 400 deg. C which are typical temperatures in materials irradiation experiments. (authors)

  1. Nuclear rocket propulsion. NASA plans and progress, FY 1991

    NASA Technical Reports Server (NTRS)

    Clark, John S.; Miller, Thomas J.

    1991-01-01

    NASA has initiated planning for a technology development project for nuclear rocket propulsion systems for space explorer initiative (SEI) human and robotic missions to the moon and Mars. An interagency project is underway that includes the Department of Energy National Laboratories for nuclear technology development. The activities of the project planning team in FY 1990 and 1991 are summarized. The progress to date is discussed, and the project plan is reviewed. Critical technology issues were identified and include: (1) nuclear fuel temperature, life, and reliability; (2) nuclear system ground test; (3) safety; (4) autonomous system operation and health monitoring; and (5) minimum mass and high specific impulse.

  2. Theoretical nuclear structure and astrophysics. Progress report for 1996

    SciTech Connect

    Guidry, M.W.; Nazarewicz, W.; Strayer, M.R.

    1996-12-31

    This research effort is directed toward theoretical support and guidance for the fields of radioactive ion beam physics, gamma ray spectroscopy, computational and nuclear astrophysics, and the interface between these disciplines. The authors report substantial progress in all those areas. One measure of progress is publications and invited material. The research described here has led to more than 43 papers that are published, accepted, or submitted to refereed journals, and to 15 invited presentations at conferences and workshops.

  3. Research progress on flavonoids isolated from traditional Chinese medicine in treatment of Alzheimer's disease

    PubMed Central

    Gao, Jianjun; Inagaki, Yoshinori; Liu, Yang

    2013-01-01

    Summary Alzheimer's disease (AD) is a severe condition in aging countries. The currently used drugs including donepezil, rivastigmine, galantamine, and memantine are effective in managing the symptoms. However, they are hardly capable of preventing, halting, or reversing the disease. In the long history of development of traditional Chinese medicine, much experience has accumulated and is summarized in treatment of diseases that correspond to the concept of AD. In recent years, exploration of natural active ingredients from medicinal herbs for treatment of AD has attracted substantial attention. Some flavonoids have been revealed to have a variety of biological actions such as scavenging free radicals, inhibiting neuron apoptosis, and nurturing neuronal cells that constitute the basis for treatment of AD. In this article, we review recent research progress on flavonoids isolated from traditional Chinese medicine against AD and their underlying mechanisms. PMID:25343094

  4. Progressing a human embryonic stem-cell-based regenerative medicine therapy towards the clinic.

    PubMed

    Whiting, Paul; Kerby, Julie; Coffey, Peter; da Cruz, Lyndon; McKernan, Ruth

    2015-10-19

    Since the first publication of the derivation of human embryonic stem cells in 1998, there has been hope and expectation that this technology will lead to a wave of regenerative medicine therapies with the potential to revolutionize our approach to managing certain diseases. Despite significant resources in this direction, the path to the clinic for an embryonic stem-cell-based regenerative medicine therapy has not proven straightforward, though in the past few years progress has been made. Here, with a focus upon retinal disease, we discuss the current status of the development of such therapies. We also highlight some of our own experiences of progressing a retinal pigment epithelium cell replacement therapy towards the clinic. PMID:26416684

  5. The A-bomb, 50 years later: The evolution of nuclear medicine

    SciTech Connect

    Kotz, D.

    1995-08-01

    In the wake of the Hiroshima and Nagasaki bombings, the U.S. government began to invest heavily in its nuclear program. Nuclear medicine stood to gain from these postwar policies, but it also suffered some setbacks. Fifty years ago this month, two atomic bombs were dropped on Japan, killing thousands of civilians and ushering in a quick and final end to World War II. The beginning of the post-war era signaled the birth of nuclear medicine as it is widely applied today. In fact, the same nuclear reactor that produced elements for the A-bomb project was turned over for the mass production of radionuclides for medicine and industry. The link between the A-bomb and nuclear medicine, however, has always been a sensitive subject among nuclear physicians whose patients may associate radionuclide injections with mushroom clouds. Although this link is not justified, the government`s interest in developing nuclear technology following World War II did have a significant impact on nuclear medicine: on the upside, millions of federal dollars were funneled into the production of radionuclides for research and medicine. On the downside, Congress established the Atomic Energy Commission (AEC)-which later became the Nuclear Regulatory Commission (NRC)-to oversee safety issues, making nuclear medicine the only medical field regulated by a federal agency.

  6. Measurement of doses to the extremities of nuclear medicine staff

    NASA Astrophysics Data System (ADS)

    Shousha, Hany A.; Farag, Hamed; Hassan, Ramadan A.

    Medical uses of ionizing radiation now represent>95% of all man-made radiation exposure, and is the largest single radiation source after natural background radiation. Therefore, it is important to quantify the amount of radiation received by occupational individuals to optimize the working conditions for staff, and further, to compare doses in different departments to ensure compatibility with the recommended standards. For some groups working with unsealed sources in nuclear medicine units, the hands are more heavily exposed to ionizing radiation than the rest of the body. A personal dosimetry service runs extensively in Egypt. But doses to extremities have not been measured to a wide extent. The purpose of this study was to investigate the equivalent radiation doses to the fingers for five different nuclear medicine staff occupational groups for which heavy irradiation of the hands was suspected. Finger doses were measured for (1) nuclear medicine physicians, (2) technologists, (3) nurses and (4) physicists. The fifth group contains three technicians handling 131I, while the others handled 99mTc. Each staff member working with the radioactive material wore two thermoluminescent dosimeters (TLDs) during the whole testing period, which lasted from 1 to 4 weeks. Staff performed their work on a regular basis throughout the month, and mean annual doses were calculated for these groups. Results showed that the mean equivalent doses to the fingers of technologist, nurse and physicist groups were 30.24±14.5, 30.37±17.5 and 16.3±7.7 ?Sv/GBq, respectively. Equivalent doses for the physicians could not be calculated per unit of activity because they did not handle the radiopharmaceuticals directly. Their doses were reported in millisieverts (mSv) that accumulated in one week. Similarly, the dose to the fingers of individuals in Group 5 was estimated to be 126.13±38.2 ?Sv/GBq. The maximum average finger dose, in this study, was noted in the technologists who handled therapeutic 131I (2.5 mSv). In conclusion, the maximum expected annual dose to extremities is less than the annual limit (500 mSv/y).

  7. Nuclear Medicine Program progress report, quarter ending March 31, 1992

    SciTech Connect

    Knapp, F.F. Jr.; Ambrose, K.R.; Callahan, A.P.; McPherson, D.W.; Mirzadeh, S.; Hasan, A.; Lambert, C.R.; Rice, D.E.

    1992-07-01

    We describe the design synthesis and initial animal testing of a new iodine-131-labeled triglyceride analogue for the potential evaluation of clinical pancreatic insufficiency. The new agent is 1,2-dipalmitoyl-3-((15-p-iodophenyl)pentadecanoyl) rac-glycerol(1,2-Pal-3-IPPA). Following oral administration of the iodine-125-labeled agent to rats, 34.5+8.8% of the administered activity was excreted in the urine within one day, demonstrating that radioiodinated IPPA is absorbed in the intestine after release from the triglyceride by pancreatic lipase. The final catabolic product of IPPA is then conjugated and excreted via the urinary bladder. Urine analysis following oral administration of this new agent to patients may thus be a new, simple method for the clinical evaluation of various gastrointestinal diseases. The synthesis and the initial biological evaluation of the 3R-isomer of ({sup 125}I)IQNP are also described.

  8. Nuclear medicine technology. Progress report, quarter ending March 31, 1980

    SciTech Connect

    Knapp, F.F. Jr.

    1980-10-01

    The successful detection of experimentally produced myocardial infarctions in rats and dogs using /sup 123m/Te-9-telluraheptadecanoic acid (9-(/sup 123m/Te)-THDA) is described. Preferential localization of radioactivity in normal myocardial tissue of rats that had experimentally produced infarctions was also demonstrated by tissue distribution studies following injection of 9-(/sup 123m/Te)-THDA. The effects of chain length on the myocardial uptake of /sup 75/Se-labeled long-chain fatty acids was also studied further. Selenium-75-labeled 13-selenaheneicosonic acid (H/sub 3/C-(CH/sub 2/)/sub 7/-/sup 75/Se-(CH/sub 2/)/sub 11/-COOH, 13-(/sup 75/Se)-SHCA) shows the highest heart uptake in rats of the agents studied. These results indicate that myocardial imaging may be possible with 13-(/sup 75/Se)-SHCA and also suggest that potential positron emission tomography of the myocardium with the /sup 73/Se-labeled agent should be explored. The results of continuing studies with /sup 11/C and /sup 195m/Pt-labeled agents are also described. A variety of /sup 11/C-labeled amino acids were prepared and tested as pancreas and tumor localizing agents in a Medical Cooperative Program with the Oak Ridge Associated Universities. The microscale synthesis of /sup 195m/Pt-labeled cis-dichloro-trans-dihydroxy-bis-(isopropylamine)platinum(IV) (/sup 195m/Pt-CHIP) was developed further and preliminary tissue distribution studies with this important second-generation antitumor drug were completed in rats. Platinum-195m-labeled cis-dichlorodiammineplatinum(II) (/sup 195m/Pt-cis-DDP) was supplied for testing to a number of Medical Cooperative Programs. Studies of arsenic trioxide (As/sub 2/O/sub 3/) toxicity for human cells in the diffusion chamber assay system have continued. Further investigation of this arsenic-induced cytotoxicity has demonstrated a linear dose-response relationship and a difference in the permanence of the growth inhibitory effect using different doses.

  9. Nuclear medicine: Progress report for quarter ending June 30, 1986

    SciTech Connect

    Knapp, F.F. Jr.; Ambrose, K.R.; Goodman, M.M.; Srivastava. P.C.

    1986-12-01

    The development of a new method of protein radiolabeling involving the attachment of radioiodinated N-substituted maleimides to the sulfhydryl groups of proteins is described. Maleimides are known to form strong, sulfide bonds by reaction with organic thiols, and this method thus represents a new alternative to minimize the deiodination of radiolabeled proteins. As a model radioiodinating agent, N-(p(/sup 125/I)-iodophenyl)maleimide (IPM), was prepared by coupling p-iodoaniline with maleic anhydride, followed by subsequent ring closure. When administered to rats, the (I-125) IPM resulted in the retention of high levels of radioactivity in the blood pool. Further analysis demonstrated about 90% binding to red blood cells. It was also demonstrated that this agent effectively radiolabels model proteins such as BSA and IgG. An evaluation of the relative lipid pool distribution in rat heart extracts after intravenous administration of the straight-chain 15-(p-iodophenyl)pentadecanoic acid and 3,3-dimethyl-branched terminal iodophenyl-substituted fatty acid analogues to normotensive and hypertensive rats has been evaluated. Six shipments of osmium-191 were made to the University of Liege, Belgium, for preparation of radionuclide generators for clinical use and two generators were supplied to the Massachusetts General Hospital for continuous infusion studies in animals. 7 refs., 3 figs., 4 tabs.

  10. Nuclear Medicine Program progress report, quarter ending March 31, 1992

    SciTech Connect

    Knapp, F.F. Jr.; Ambrose, K.R.; Callahan, A.P.; McPherson, D.W.; Mirzadeh, S.; Hasan, A.; Lambert, C.R.; Rice, D.E.

    1992-07-01

    We describe the design synthesis and initial animal testing of a new iodine-131-labeled triglyceride analogue for the potential evaluation of clinical pancreatic insufficiency. The new agent is 1,2-dipalmitoyl-3-[(15-p-iodophenyl)pentadecanoyl] rac-glycerol(1,2-Pal-3-IPPA). Following oral administration of the iodine-125-labeled agent to rats, 34.5+8.8% of the administered activity was excreted in the urine within one day, demonstrating that radioiodinated IPPA is absorbed in the intestine after release from the triglyceride by pancreatic lipase. The final catabolic product of IPPA is then conjugated and excreted via the urinary bladder. Urine analysis following oral administration of this new agent to patients may thus be a new, simple method for the clinical evaluation of various gastrointestinal diseases. The synthesis and the initial biological evaluation of the 3R-isomer of [{sup 125}I]IQNP are also described.

  11. ACR-SNM Task Force on Nuclear Medicine Training: report of the task force.

    PubMed

    Guiberteau, Milton J; Graham, Michael M

    2011-06-01

    The expansion of knowledge and technological advances in nuclear medicine and radiology require physicians to have more expertise in functional and anatomic imaging. The convergence of these two specialties into the new discipline of molecular imaging has also begun to place demands on residency training programs for additional instruction in physiology and molecular biology. These changes have unmasked weaknesses in current nuclear medicine and radiology training programs. Adding to the impetus for change are the attendant realities of the job market and uncertain employment prospects for physicians trained in nuclear medicine but not also trained in diagnostic radiology. With this background, the ACR and the Society of Nuclear Medicine convened the Task Force on Nuclear Medicine Training to define the issues and develop recommendations for resident training. PMID:21571791

  12. ACR-SNM Task Force on Nuclear Medicine Training: report of the task force.

    PubMed

    Guiberteau, Milton J; Graham, Michael M

    2011-06-01

    The expansion of knowledge and technological advances in nuclear medicine and radiology require physicians to have more expertise in functional and anatomic imaging. The convergence of these two specialties into the new discipline of molecular imaging has also begun to place demands on residency training programs for additional instruction in physiology and molecular biology. These changes have unmasked weaknesses in current nuclear medicine and radiology training programs. Adding to the impetus for change are the attendant realities of the job market and uncertain employment prospects for physicians trained in nuclear medicine but not also trained in diagnostic radiology. With this background, the ACR and the Society of Nuclear Medicine convened the Task Force on Nuclear Medicine Training to define the issues and develop recommendations for resident training. PMID:21636052

  13. Evaluation of routine telephone transmission of nuclear medicine studies

    SciTech Connect

    Orlin, J.A.; Tal, I.; Parker, J.A.; Front, D.; Israel, O.; Kolodny, G.M. )

    1989-01-01

    Rapid and reliable transmission of nuclear medicine studies using conventional telephone lines and commercially available modems and computer systems has been accomplished through use of software developed within the authors' hospital. Original digital images of all-night and weekend studies, acquired on any of the acquisition computers from different manufacturers, are now routinely sent for remote reading at the physician's home. Data, software, and letters are routinely exchanged using modems and standard telephone lines with a sister institution in Haifa, Israel. The software has been designed to achieve no loss data compression and minimal turnaround time loss. Thus, an average lung perfusion image or gallbladder study requires about 1-3 minutes of transmission time. Full analysis and display software is available on the remote computer.

  14. Development of thyroid anthropomorphic phantoms for use in nuclear medicine

    NASA Astrophysics Data System (ADS)

    Cerqueira, R. A. D.; Maia, A. F.

    2014-02-01

    The objective of this study was to develop thyroid anthropomorphic phantoms to be used in control tests of medical images in scintillation cameras. The main difference among the phantoms was the neck shape: in the first, called OSCT, it was geometrically shaped, while in the second, called OSAP, it was anthropomorphically shaped. In both phantoms, thyroid gland prototypes, which were made of acrylic and anthropomorphically shaped, were constructed to allow the simulation of a healthy thyroid and of thyroids with hyperthyroidism and hypothyroidism. Images of these thyroid anthropomorphic phantoms were obtained using iodine 131 with an activity of 8.695 MBq. The iodine 131 was chosen because it is widely used in studies of thyroid scintigraphy. The images obtained proved the effectiveness of the phantoms to simulate normal or abnormal thyroids function. These phantoms can be used in medical imaging quality control programs and, also in the training of professionals involved in the analysis of images in nuclear medicine centers.

  15. NMINT--introductory courseware for nuclear medicine: database design.

    PubMed Central

    Mankovich, N. J.; Verma, R. C.; Yue, A.; Veyne, D.; Ratib, O.; Bennett, L. R.

    1991-01-01

    Computer-Aided Instruction (CAI) provides a dynamic and self-paced learning experience to the medical trainee. Microcomputer based hypermedia systems integrate text, graphics, and image information. We present the design of an introductory CAI course for nuclear medicine called NMINT and elaborate on the underlying relational database that contains clinically relevant information and links to local or remote image storage over high speed networks. The IBM PS/2 Windows system uses Toolbook software augmented by C language modules for image and image-overlay database access. The current implementation stores text, graphical lesson material, and image index information on microcomputer magnetic disk; image data are stored on the attached optical disk. The storage architecture is described in detail. We emphasize its multi-access methods and its expandability into department-wide image networks. PMID:1807706

  16. Flexible nuclear medicine camera and method of using

    DOEpatents

    Dilmanian, F. Avraham (Yaphank, NY); Packer, Samuel (Great Neck, NY); Slatkin, Daniel N. (Sound Beach, NY)

    1996-12-10

    A nuclear medicine camera 10 and method of use photographically record radioactive decay particles emitted from a source, for example a small, previously undetectable breast cancer, inside a patient. The camera 10 includes a flexible frame 20 containing a window 22, a photographic film 24, and a scintillation screen 26, with or without a gamma-ray collimator 34. The frame 20 flexes for following the contour of the examination site on the patient, with the window 22 being disposed in substantially abutting contact with the skin of the patient for reducing the distance between the film 24 and the radiation source inside the patient. The frame 20 is removably affixed to the patient at the examination site for allowing the patient mobility to wear the frame 20 for a predetermined exposure time period. The exposure time may be several days for obtaining early qualitative detection of small malignant neoplasms.

  17. Flexible nuclear medicine camera and method of using

    DOEpatents

    Dilmanian, F.A.; Packer, S.; Slatkin, D.N.

    1996-12-10

    A nuclear medicine camera and method of use photographically record radioactive decay particles emitted from a source, for example a small, previously undetectable breast cancer, inside a patient. The camera includes a flexible frame containing a window, a photographic film, and a scintillation screen, with or without a gamma-ray collimator. The frame flexes for following the contour of the examination site on the patient, with the window being disposed in substantially abutting contact with the skin of the patient for reducing the distance between the film and the radiation source inside the patient. The frame is removably affixed to the patient at the examination site for allowing the patient mobility to wear the frame for a predetermined exposure time period. The exposure time may be several days for obtaining early qualitative detection of small malignant neoplasms. 11 figs.

  18. Nuclear medicine in acute and chronic renal failure

    SciTech Connect

    Sherman, R.A.; Byun, K.J.

    1982-07-01

    The diagnostic value of renal scintiscans in patients with acute or chronic renal failure has not been emphasized other than for the estimation of renal size. /sup 131/I OIH, /sup 67/gallium, /sup 99m/TcDTPA, glucoheptonate and DMSA all may be valuable in a variety of specific settings. Acute renal failure due to acute tubular necrosis, hepatorenal syndrome, acute interstitial nephritis, cortical necrosis, renal artery embolism, or acute pyelonephritis may be recognized. Data useful in the diagnosis and management of the patient with obstructive or reflux nephropathy may be obtained. Radionuclide studies in patients with chronic renal failure may help make apparent such causes as renal artery stenosis, chronic pyelonephritis or lymphomatous kidney infiltration. Future correlation of scanning results with renal pathology promises to further expand nuclear medicine's utility in the noninvasive diagnosis of renal disease.

  19. Space nuclear safety program. Progress report, October-December 1984

    SciTech Connect

    George, T.G.

    1986-05-01

    This quarterly report covers studies related to the use of /sup 238/PuO/sub 2/ in radioisotope power systems carried out for the Office of Special Nuclear Projects of the US Department of Energy by Los Alamos National Laboratory. Most of the studies discussed are ongoing; the results and conclusions described may change as the work progresses.

  20. Space Nuclear Safety Program. Progress report, August 1984

    SciTech Connect

    George, T.G.

    1985-11-01

    This technical monthly report covers studies related to the use of /sup 238/PuO/sub 2/ in radioisotope power systems carried out for the Office of Special Nuclear Projects of the US Department of Energy by Los Alamos National Laboratory. Most of the studies discussed are ongoing; the results and conclusions described may change as the work progresses. 41 figs.

  1. Space nuclear safety program: Progress report, July--September 1987

    SciTech Connect

    George, T.G.

    1989-02-01

    This quarterly report describes studies related to the use of /sup 238/PuO/sub 2/ in radioisotope power systems, carried out for the Office of Special Nuclear Projects of the US Department of Energy by Los Alamos National Laboratory. The studies discussed are ongoing; the results and conclusions described may change as the work progresses. 20 figs., 4 tabs.

  2. NASA's progress in nuclear electric propulsion technology

    NASA Technical Reports Server (NTRS)

    Stone, James R.; Doherty, Michael P.; Peecook, Keith M.

    1993-01-01

    The National Aeronautics and Space Administration (NASA) has established a requirement for Nuclear Electric Propulsion (NEP) technology for robotic planetary science mission applications with potential future evolution to systems for piloted Mars vehicles. To advance the readiness of NEP for these challenging missions, a near-term flight demonstration on a meaningful robotic science mission is very desirable. The requirements for both near-term and outer planet science missions are briefly reviewed, and the near-term baseline system established under a recent study jointly conducted by the Lewis Research Center (LeRC) and the Jet Propulsion Laboratory (JPL) is described. Technology issues are identified where work is needed to establish the technology for the baseline system, and technology opportunities which could provide improvement beyond baseline capabilities are discussed. Finally, the plan to develop this promising technology is presented and discussed.

  3. Special Radiation Protection Precautions in Therapeutic Nuclear Medicine

    NASA Astrophysics Data System (ADS)

    Stefanoyiannis, A. P.; Gerogiannis, J.

    2010-01-01

    Therapeutic Nuclear Medicine concerns the administration of appropriate amounts of radioactivity of certain isotopes, in order to achieve internal localized irradiation of neoplasmatic cells. Due to the increased level and the specific isotope characteristics of administered radioactivity, special Radiation Protection precautions must be taken. This study addresses such issues, based on national as well as international legislation and guidelines. Application of the principle of optimization is of outmost importance and is based on individual dose planning. The decision about the release of Nuclear Medicine patients after therapy is determined on an individual basis, taking into account patients' pattern of contact with other people, their age and that of persons in the home environment, in addition to other factors. Estimation of the absorbed dose given to the treated organ is based on uptake measurements and other biokinetic data, as well as on the mass of the treated tissue or organ. Concerning pregnant women, the rule of thumb is that they should not be treated, unless the radionuclide therapy is required to save their lives. In that case, the potential absorbed dose and risk to the foetus should be estimated and conveyed to the patient. After radionuclide therapy, a female should be advised to avoid pregnancy for the period of time depending on the specific radionuclide. This is to ensure that the dose to a conceptus/foetus would probably not exceed 1 mGy (the member of the public dose limit). The radiation risk for relatives and caregivers is small and unlikely to exceed the legal dose constraints during the period of the patient's treatment. Solid waste from the patient's stay in hospital is a different matter, and is normally incinerated or held for a period until radioactive decay brings the activity to an acceptable level.

  4. IBA-Europhysics Prize in Applied Nuclear Science and Nuclear Methods in Medicine

    NASA Astrophysics Data System (ADS)

    MacGregor, I. J. Douglas

    2014-03-01

    The Nuclear Physics Board of the European Physical Society is pleased to announce that the 2013 IBA-Europhysics Prize in Applied Nuclear Science and Nuclear Methods in Medicine is awarded to Prof. Marco Durante, Director of the Biophysics Department at GSI Helmholtz Center (Darmstadt, Germany); Professor at the Technical University of Darmstadt (Germany) and Adjunct Professor at the Temple University, Philadelphia, USA. The prize was presented in the closing Session of the INPC 2013 conference by Mr. Thomas Servais, R&D Manager for Accelerator Development at the IBA group, who sponsor the IBA Europhysics Prize. The Prize Diploma was presented by Dr. I J Douglas MacGregor, Chair-elect of the EPS Nuclear Physics Division and Chair of the IBA Prize committee.

  5. Nuclear structure research. Annual progress report

    SciTech Connect

    Wood, J.L.

    1995-07-31

    The most significant development this year has been the realization of a method for estimating EO transition strength in nuclei and the prediction that the de-excitation (draining) of superdeformed bands must take place, at least in some cases, by strong EO transitions. A considerable effort has been devoted to planning the nuclear structure physics that will be pursued using the Holifield Radioactive Ion Beam Facility (HRIBF) at Oak Ridge. A significant effort has been devoted to HRIBF target development. This is a critical component of the HRIBF project. Exhaustive literature searches have been made for a variety of target materials with emphasis on thermodynamic properties. Vapor pressure measurements have been carried out. Experimental data sets for radioactive decays in the very neutron-deficient Pr-Eu and Ir-Tl regions have been under analysis. These decay schemes constitute parts of student Ph.D. theses. These studies are aimed at elucidating the onset of deformation in the Pr-Sm region and the characteristics of shape coexistence in the Ir-Bi region. Further experiments on shape coexistence in the neutron-deficient Ir-Bi region are planned using {alpha} decay studies at the FMA at ATLAS. The first experiment is scheduled for later this year.

  6. Progress report on nuclear spectroscopic studies

    SciTech Connect

    Bingham, C.R.; Riedinger, L.L.; Sorensen, S.P.

    1996-01-16

    The experimental program in nuclear physics at the University of Tennessee, Knoxville, is led by Professors Carrol Bingham, Lee Riedinger, and Soren Sorenseni who respectively lead the studies of the exotic decay modes of nuclei far from stability, the program of high-spin research, and our effort in relativistic heavy-ion physics. Over the years, this broad program of research has been successful partially because of the shared University resources applied to this group effort. The proximity of the Oak Ridge National Laboratory has allowed us to build extremely strong programs of joint research, and in addition to play an important leadership role in the Joint Institute for Heavy Ion Research (JIHIR). Our experimental program is also very closely linked with those at other national laboratories: Argonne (collaborations involving the Fragment Mass Analyzer (FMA) and {gamma}-ray arrays), Brookhaven (the RHIC and Phenix projects), and Berkeley (GAMMASPHERE). We have worked closely with a variety of university groups in the last three years, especially those in the UNISOR and now UNIRIB collaborations. And, in all aspects of our program, we have maintained close collaborations with theorists, both to inspire the most exciting experiments to perform and to extract the pertinent physics from the results. The specific areas discussed in this report are: properties of high-spin states; study of low-energy levels of nuclei far from stability; and high energy heavy-ion physics.

  7. PREFACE: International Conference on Image Optimisation in Nuclear Medicine (OptiNM)

    NASA Astrophysics Data System (ADS)

    Christofides, Stelios; Parpottas, Yiannis

    2011-09-01

    Conference logo The International Conference on Image Optimisation in Nuclear Medicine was held at the Atlantica Aeneas Resort in Ayia Napa, Cyprus between 23-26 March 2011. It was organised in the framework of the research project "Optimising Diagnostic Value in SPECT Myocardial Perfusion Imaging" (Y????/?Y????/0308/11), funded by the Cyprus Research Promotion Foundation and the European Regional Development Fund, to present the highlights of the project, discuss the progress and results, and define future related goals. The aim of this International Conference was to concentrate on image optimization approaches in Nuclear Medicine. Experts in the field of nuclear medicine presented their latest research results, exchanged experiences and set future goals for image optimisation while balancing patient dose and diagnostic value. The conference was jointly organized by the Frederick Research Centre in Cyprus, the Department of Medical and Public Health Services of the Cyprus Ministry of Health, the Biomedical Research Foundation in Cyprus and the AGH University of Science and Technology in Poland. It was supported by the Cyprus Association of Medical Physics and Biomedical Engineering, and the Cyprus Society of Nuclear Medicine. The conference was held under the auspices of the European Federation of Organisations for Medical Physics and the European Association of Nuclear Medicine. The conference scientific programme covered several important topics such as functional imaging; image optimization; quantification for diagnosis; justification; simulations; patient dosimetry, staff exposures and radiation risks; quality assurance and clinical audit; education, training and radiation protection culture; hybrid systems and image registration; and new and competing technologies. The programme consisted of 13 invited and keynote presentations as well as workshops, round table discussions and a number of scientific sessions. A total of 51 speakers presented their research and results to more than 150 participants from 14 countries. During the conference, exhibitors presented medical equipment used in nuclear medicine. We gratefully acknowledge the financial support of the Cyprus Research Promotion Foundation, the European Regional Development Fund and the Cyprus Biomedical Research Foundation. Also, we appreciate the support of the various local sponsors listed in the conference programme. We would like to express our sincere thanks and gratitude to the organising committee, the scientific committee and the supporting professional organizations for the success of the conference. We also thank all of speakers for their excellent contributions, all the participants for their input, and the exhibitors for their valuable presentations. Special thanks go to Demetris Kaolis, Maria Christofidou, Isabelle Chrysanthou, Charalambos Yiannakkaras, Ourania Demetriadou, and Elena Christofidou for their invaluable contribution to the conference. The conference volume consists of 26 selected proceedings papers. We would like to thank all of the authors for their time and genuine efforts and the reviewers for their fruitful comments. The Conference Chairpersons Stelios Christofides and Yiannis Parpottas

  8. 42 CFR Appendix D to Part 75 - Standards for Accreditation of Educational Programs for Nuclear Medicine Technologists

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ...safety and protection; (c) Nuclear medicine physics; (d) Radiation physics; (e) Nuclear instrumentation; (f) Statistics... (1) Human anatomy and physiology; (2) Physics; (3) Mathematics; (4) Medical...

  9. 42 CFR Appendix D to Part 75 - Standards for Accreditation of Educational Programs for Nuclear Medicine Technologists

    Code of Federal Regulations, 2011 CFR

    2011-10-01

    ...safety and protection; (c) Nuclear medicine physics; (d) Radiation physics; (e) Nuclear instrumentation; (f) Statistics... (1) Human anatomy and physiology; (2) Physics; (3) Mathematics; (4) Medical...

  10. 42 CFR Appendix D to Part 75 - Standards for Accreditation of Educational Programs for Nuclear Medicine Technologists

    Code of Federal Regulations, 2014 CFR

    2014-10-01

    ...safety and protection; (c) Nuclear medicine physics; (d) Radiation physics; (e) Nuclear instrumentation; (f) Statistics... (1) Human anatomy and physiology; (2) Physics; (3) Mathematics; (4) Medical...

  11. 42 CFR Appendix D to Part 75 - Standards for Accreditation of Educational Programs for Nuclear Medicine Technologists

    Code of Federal Regulations, 2012 CFR

    2012-10-01

    ...safety and protection; (c) Nuclear medicine physics; (d) Radiation physics; (e) Nuclear instrumentation; (f) Statistics... (1) Human anatomy and physiology; (2) Physics; (3) Mathematics; (4) Medical...

  12. 42 CFR Appendix D to Part 75 - Standards for Accreditation of Educational Programs for Nuclear Medicine Technologists

    Code of Federal Regulations, 2013 CFR

    2013-10-01

    ...safety and protection; (c) Nuclear medicine physics; (d) Radiation physics; (e) Nuclear instrumentation; (f) Statistics... (1) Human anatomy and physiology; (2) Physics; (3) Mathematics; (4) Medical...

  13. Radiation protection and regulations for the nuclear medicine physician.

    PubMed

    Chen, Man Yu

    2014-05-01

    As authorized users of radioactive material, nuclear medicine (NM) physicians play a leading role in the use and management of these agents. Regarding patient management, NM physicians are responsible for ensuring both the appropriateness of exams and the associated patient doses. Along with radiologists, NM physicians are the ones developing and implementing processes that provide guidance to and dialog with referring physicians to ensure that patients receive the most appropriate type of imaging exams. Regarding regulatory compliance, in collaboration with radiation safety officers, NM physicians are the ones educating their staff about principles of radiation protection and radiation safety with adherence to regulations from agencies such as the Nuclear Regulatory Commission, the Department of Transportation, the Environmental Protection Agency, and the Food and Drug Administration. On occasion, these regulations and standards can be difficult to comprehend. This article is intended to serve as a condensed guide for NM physicians who are in the process of applying for a radioactive materials license, establishing a new radiation protection program, or want to ensure continued compliance and maintenance of safety and security of licensed materials in the clinical or research settings. PMID:24832587

  14. 42 CFR Appendix D to Part 75 - Standards for Accreditation of Educational Programs for Nuclear Medicine Technologists

    Code of Federal Regulations, 2012 CFR

    2012-10-01

    ... for Nuclear Medicine Technologists D Appendix D to Part 75 Public Health PUBLIC HEALTH SERVICE...—Standards for Accreditation of Educational Programs for Nuclear Medicine Technologists A. Sponsorship 1... of patient care; (b) Radiation safety and protection; (c) Nuclear medicine physics; (d)...

  15. 42 CFR Appendix D to Part 75 - Standards for Accreditation of Educational Programs for Nuclear Medicine Technologists

    Code of Federal Regulations, 2011 CFR

    2011-10-01

    ... for Nuclear Medicine Technologists D Appendix D to Part 75 Public Health PUBLIC HEALTH SERVICE...—Standards for Accreditation of Educational Programs for Nuclear Medicine Technologists A. Sponsorship 1... of patient care; (b) Radiation safety and protection; (c) Nuclear medicine physics; (d)...

  16. 42 CFR Appendix D to Part 75 - Standards for Accreditation of Educational Programs for Nuclear Medicine Technologists

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... for Nuclear Medicine Technologists D Appendix D to Part 75 Public Health PUBLIC HEALTH SERVICE...—Standards for Accreditation of Educational Programs for Nuclear Medicine Technologists A. Sponsorship 1... of patient care; (b) Radiation safety and protection; (c) Nuclear medicine physics; (d)...

  17. 42 CFR Appendix D to Part 75 - Standards for Accreditation of Educational Programs for Nuclear Medicine Technologists

    Code of Federal Regulations, 2014 CFR

    2014-10-01

    ... for Nuclear Medicine Technologists D Appendix D to Part 75 Public Health PUBLIC HEALTH SERVICE...—Standards for Accreditation of Educational Programs for Nuclear Medicine Technologists A. Sponsorship 1... of patient care; (b) Radiation safety and protection; (c) Nuclear medicine physics; (d)...

  18. 42 CFR Appendix D to Part 75 - Standards for Accreditation of Educational Programs for Nuclear Medicine Technologists

    Code of Federal Regulations, 2013 CFR

    2013-10-01

    ... for Nuclear Medicine Technologists D Appendix D to Part 75 Public Health PUBLIC HEALTH SERVICE...—Standards for Accreditation of Educational Programs for Nuclear Medicine Technologists A. Sponsorship 1... of patient care; (b) Radiation safety and protection; (c) Nuclear medicine physics; (d)...

  19. Benchmarking progress in tackling the challenges of intellectual property, and access to medicines in developing countries.

    PubMed

    Musungu, Sisule F

    2006-05-01

    The impact of intellectual property protection in the pharmaceutical sector on developing countries has been a central issue in the fierce debate during the past 10 years in a number of international fora, particularly the World Trade Organization (WTO) and WHO. The debate centres on whether the intellectual property system is: (1) providing sufficient incentives for research and development into medicines for diseases that disproportionately affect developing countries; and (2) restricting access to existing medicines for these countries. The Doha Declaration was adopted at WTO in 2001 and the Commission on Intellectual Property, Innovation and Public Health was established at WHO in 2004, but their respective contributions to tackling intellectual property-related challenges are disputed. Objective parameters are needed to measure whether a particular series of actions, events, decisions or processes contribute to progress in this area. This article proposes six possible benchmarks for intellectual property-related challenges with regard to the development of medicines and ensuring access to medicines in developing countries. PMID:16710545

  20. Nuclear iASPP may facilitate prostate cancer progression

    PubMed Central

    Morris, E V; Cerundolo, L; Lu, M; Verrill, C; Fritzsche, F; White, M J; Thalmann, G N; ten Donkelaar, C S; Ratnayaka, I; Salter, V; Hamdy, F C; Lu, X; Bryant, R J

    2014-01-01

    One of the major challenges in prostate cancer (PCa) research is the identification of key players that control the progression of primary cancers to invasive and metastatic disease. The majority of metastatic PCa express wild-type p53, whereas loss of p63 expression, a p53 family member, is a common event. Here we identify inhibitor of apoptosis-stimulating protein of p53 (iASPP), a common cellular regulator of p53 and p63, as an important player of PCa progression. Detailed analysis of the prostate epithelium of iASPP transgenic mice, iASPP?8/?8 mice, revealed that iASPP deficiency resulted in a reduction in the number of p63 expressing basal epithelial cells compared with that seen in wild-type mice. Nuclear and cytoplasmic iASPP expression was greater in PCa samples compared with benign epithelium. Importantly nuclear iASPP associated with p53 accumulation in vitro and in vivo. A pair of isogenic primary and metastatic PCa cell lines revealed that nuclear iASPP is enriched in the highly metastatic PCa cells. Nuclear iASPP is often detected in PCa cells located at the invasive leading edge in vivo. Increased iASPP expression associated with metastatic disease and PCa-specific death in a clinical cohort with long-term follow-up. These results suggest that iASPP function is required to maintain the expression of p63 in normal basal prostate epithelium, and nuclear iASPP may inactivate p53 function and facilitate PCa progression. Thus iASPP expression may act as a predictive marker of PCa progression. PMID:25341046

  1. Progress of Recurrent Education for the Development of Engineering Enhanced Medicine “REDEEM” at Tohoku University

    NASA Astrophysics Data System (ADS)

    Yamano, Masahiro; Matsuki, Noriaki; Numayama, Keiko; Takeda, Motohiro; Hayasaka, Tomoaki; Ishikawa, Takuji; Yamaguchi, Takami

    Tohoku University promotes the “REDEEM” project, which is a national project of Recurrent Education for the Development of Engineering Enhanced Medicine. This education system provides a curriculum for engineers who belong to bio-medical R&D. In Japan, most of industrial engineers have been excluded from systemized bio-medical education, while medical and co-medical personnel lack engineering education. This difference of backgrounds causes a discrepancy between medicine and engineering bringing difficulty in collaboration for development of medical equipments or drugs. In this project, we focus on the engineering side, and we try to develop and provide a bio-medical engineering course for engineers. In this paper, we report and discuss on the outline and the progress of the “REDEEM” project.

  2. From prenatal genomic diagnosis to fetal personalized medicine: progress and challenges

    PubMed Central

    Bianchi, Diana W

    2015-01-01

    Thus far, the focus of personalized medicine has been the prevention and treatment of conditions that affect adults. Although advances in genetic technology have been applied more frequently to prenatal diagnosis than to fetal treatment, genetic and genomic information is beginning to influence pregnancy management. Recent developments in sequencing the fetal genome combined with progress in understanding fetal physiology using gene expression arrays indicate that we could have the technical capabilities to apply an individualized medicine approach to the fetus. Here I review recent advances in prenatal genetic diagnostics, the challenges associated with these new technologies and how the information derived from them can be used to advance fetal care. Historically, the goal of prenatal diagnosis has been to provide an informed choice to prospective parents. We are now at a point where that goal can and should be expanded to incorporate genetic, genomic and transcriptomic data to develop new approaches to fetal treatment. PMID:22772565

  3. Nuclear waste management. Quarterly progress report, October-December 1979

    SciTech Connect

    Platt, A.M.; Powell, J.A.

    1980-04-01

    Progress and activities are reported on the following: high-level waste immobilization, alternative waste forms, nuclear waste materials characterization, TRU waste immobilization programs, TRU waste decontamination, krypton solidification, thermal outgassing, iodine-129 fixation, monitoring of unsaturated zone transport, well-logging instrumentation development, mobile organic complexes of fission products, waste management system and safety studies, assessment of effectiveness of geologic isolation systems, waste/rock interactions technology, spent fuel and fuel pool integrity program, and engineered barriers. (DLC)

  4. Pitfalls in classical nuclear medicine: myocardial perfusion imaging

    NASA Astrophysics Data System (ADS)

    Fragkaki, C.; Giannopoulou, Ch

    2011-09-01

    Scintigraphic imaging is a complex functional procedure subject to a variety of artefacts and pitfalls that may limit its clinical and diagnostic accuracy. It is important to be aware of and to recognize them when present and to eliminate them whenever possible. Pitfalls may occur at any stage of the imaging procedure and can be related with the ?-camera or other equipment, personnel handling, patient preparation, image processing or the procedure itself. Often, potential causes of artefacts and pitfalls may overlap. In this short review, special interest will be given to cardiac scintigraphic imaging. Most common causes of artefact in myocardial perfusion imaging are soft tissue attenuation as well as motion and gating errors. Additionally, clinical problems like cardiac abnormalities may cause interpretation pitfalls and nuclear medicine physicians should be familiar with these in order to ensure the correct evaluation of the study. Artefacts or suboptimal image quality can also result from infiltrated injections, misalignment in patient positioning, power instability or interruption, flood field non-uniformities, cracked crystal and several other technical reasons.

  5. Therapeutic radionuclides in nuclear medicine: current and future prospects

    PubMed Central

    Yeong, Chai-Hong; Cheng, Mu-hua; Ng, Kwan-Hoong

    2014-01-01

    The potential use of radionuclides in therapy has been recognized for many decades. A number of radionuclides, such as iodine-131 (131I), phosphorous-32 (32P), strontium-90 (90Sr), and yttrium-90 (90Y), have been used successfully for the treatment of many benign and malignant disorders. Recently, the rapid growth of this branch of nuclear medicine has been stimulated by the introduction of a number of new radionuclides and radiopharmaceuticals for the treatment of metastatic bone pain and neuroendocrine and other malignant or non-malignant tumours. Today, the field of radionuclide therapy is enjoying an exciting phase and is poised for greater growth and development in the coming years. For example, in Asia, the high prevalence of thyroid and liver diseases has prompted many novel developments and clinical trials using targeted radionuclide therapy. This paper reviews the characteristics and clinical applications of the commonly available therapeutic radionuclides, as well as the problems and issues involved in translating novel radionuclides into clinical therapies. PMID:25294374

  6. New filter for iodine applied in nuclear medicine services.

    PubMed

    Ramos, V S; Crispim, V R; Brandão, L E B

    2013-12-01

    In Nuclear Medicine, radioiodine, in various chemical forms, is a key tracer used in diagnostic practices and/or therapy. Medical professionals may incorporate radioactive iodine during the preparation of the dose to be administered to the patient. In radioactive iodine therapy doses ranging from 3.7 to 7.4 GBq per patient are employed. Thus, aiming at reducing the risk of occupational contamination, we developed a low cost filter to be installed at the exit of the exhaust system (where doses of radioiodine are handled within fume hoods, and new filters will be installed at their exit), using domestic technology. The effectiveness of radioactive iodine retention by silver impregnated silica [10%] crystals and natural activated carbon was verified using radiotracer techniques. The results showed that natural activated carbon and silver impregnated silica are effective for I2 capture with large or small amounts of substrate but the use of activated carbon is restricted due to its low flash point (423 K). Besides, when poisoned by organic solvents, this flash point may become lower, causing explosions if absorbing large amounts of nitrates. To hold the CH3I gas, it was necessary to use natural activated carbon since it was not absorbed by SiO2+Ag crystals. We concluded that, for an exhaust flow range of (145 ± 2)m(3)/h, a double stage filter using SiO2+Ag in the first stage and natural activated carbon in the second stage is sufficient to meet radiological safety requirements. PMID:23974306

  7. Thesis proposal CSF Brazil 2014 Quality control of herbal medicines assessed by Nuclear Magnetic Resonance

    E-print Network

    Bordenave, Charles

    Thesis proposal CSF Brazil 2014 Title: Quality control of herbal medicines assessed by Nuclear. With the tremendous expansion in their use, their safety and efficacy as well as the control of their quality have) will be employed for controlling the quality of plant extracts or commercial herbal medicines. The combination of 1

  8. Nuclear Medicine at Berkeley Lab: From Pioneering Beginnings to Today (LBNL Summer Lecture Series)

    ScienceCinema

    Budinger, Thomas [LBNL, Center for Functional Imaging

    2011-10-04

    Summer Lecture Series 2006: Thomas Budinger, head of Berkeley Lab's Center for Functional Imaging, discusses Berkeley Lab's rich history pioneering the field of nuclear medicine, from radioisotopes to medical imaging.

  9. Current progress of nuclear astrophysics experiments at CIAE

    SciTech Connect

    Liu Weiping; Li Zhihong; Su Jun; Bai Xixiang; Wang Youbao; Lian Gang; Guo Bing; Zeng Sheng; Yan Shengquan; Wang Baoxiang; Shu Nengchuan; Chen Yongshou

    2006-07-12

    This paper described current progress of nuclear astrophysical studies using the unstable ion beam facility GIRAFFE. We measured the angular distributions for some low energy reactions, such as 11C(d,n)12N, 8Li(d,p)9Li and 17F(d,n)18Ne in inverse kinematics, and indirectly derived the astrophysical S-factors or reaction rates of 11C(p,{gamma})12N, 8Li(n,{gamma})9Li, 8B(p,{gamma})9C at astrophysically relevant energies.

  10. Recent progress and some open questions in nuclear astrophysics

    NASA Astrophysics Data System (ADS)

    Langanke, K.; Martínez-Pinedo, G.

    2015-11-01

    We discuss recent advances in modelling two topics of current interest in nuclear astrophysics: electron capture onto nuclei in core-collapse supernovae and simulations of the astrophysical r-process in neutron-star mergers. Despite this progress open questions remain. The answers to these questions will highly benefit from experimental data expected from current and future radioactive ion beam facilities, in particular from the Facility for Antiproton and Ion Research which is currently under construction at the GSI Helmholtzzentrum für Schwerionenforschung in Darmstadt, Germany.

  11. Designing HIGH-COST medicine: hospital surveys, health planning, and the paradox of progressive reform.

    PubMed

    Perkins, Barbara Bridgman

    2010-02-01

    Inspired by social medicine, some progressive US health reforms have paradoxically reinforced a business model of high-cost medical delivery that does not match social needs. In analyzing the financial status of their areas' hospitals, for example, city-wide hospital surveys of the 1910s through 1930s sought to direct capital investments and, in so doing, control competition and markets. The 2 national health planning programs that ran from the mid-1960s to the mid-1980s continued similar strategies of economic organization and management, as did the so-called market reforms that followed. Consequently, these reforms promoted large, extremely specialized, capital-intensive institutions and systems at the expense of less complex (and less costly) primary and chronic care. The current capital crisis may expose the lack of sustainability of such a model and open up new ideas and new ways to build health care designed to meet people's health needs. PMID:20019312

  12. Designing HIGH-COST Medicine Hospital Surveys, Health Planning, and the Paradox of Progressive Reform

    PubMed Central

    2010-01-01

    Inspired by social medicine, some progressive US health reforms have paradoxically reinforced a business model of high-cost medical delivery that does not match social needs. In analyzing the financial status of their areas’ hospitals, for example, city-wide hospital surveys of the 1910s through 1930s sought to direct capital investments and, in so doing, control competition and markets. The 2 national health planning programs that ran from the mid-1960s to the mid-1980s continued similar strategies of economic organization and management, as did the so-called market reforms that followed. Consequently, these reforms promoted large, extremely specialized, capital-intensive institutions and systems at the expense of less complex (and less costly) primary and chronic care. The current capital crisis may expose the lack of sustainability of such a model and open up new ideas and new ways to build health care designed to meet people's health needs. PMID:20019312

  13. Chemotherapy-induced peripheral neurotoxicity and complementary and alternative medicines: progress and perspective

    PubMed Central

    Cheng, Xiao L.; Liu, Hong Q.; Wang, Qi; Huo, Jie G.; Wang, Xiao N.; Cao, Peng

    2015-01-01

    Chemotherapy-induced peripheral neurotoxicity (CIPN) is a severe and dose-limiting side effect of antineoplastic drugs. It can cause sensory, motor and autonomic system dysfunction, and ultimately force patients to discontinue chemotherapy. Until now, little is understood about CIPN and no consistent caring standard is available. Since CIPN is a multifactorial disease, the clinical efficacy of single pharmacological drugs is disappointing, prompting patients to seek alternative treatment options. Complementary and alternative medicines (CAMs), especially herbal medicines, are well known for their multifaceted implications and widely used in human health care. Up to date, several phytochemicals, plant extractions, and herbal formulas have been evaluated for their potential therapeutic benefit of preventing the onset and progression of CIPN in experimental models. Clinical acupuncture has also been shown to improve CIPN symptoms. In this review, we will give an outline of our current knowledge regrading the advanced research of CIPN, the role of CAMs in alleviating CIPN and possible lacunae in research that needs to be addressed. PMID:26557088

  14. Nuclear medicine technologists are able to accurately determine when a myocardial perfusion rest study is necessary

    PubMed Central

    2012-01-01

    Background In myocardial perfusion scintigraphy (MPS), typically a stress and a rest study is performed. If the stress study is considered normal, there is no need for a subsequent rest study. The aim of the study was to determine whether nuclear medicine technologists are able to assess the necessity of a rest study. Methods Gated MPS using a 2-day 99mTc protocol for 121 consecutive patients were studied. Visual interpretation by 3 physicians was used as gold standard for determining the need for a rest study based on the stress images. All nuclear medicine technologists performing MPS had to review 82 training cases of stress MPS images with comments regarding the need for rest studies, and thereafter a test consisting of 20 stress MPS images. After passing this test, the nuclear medicine technologists in charge of a stress MPS study assessed whether a rest study was needed or not or if he/she was uncertain and wanted to consult a physician. After that, the physician in charge interpreted the images and decided whether a rest study was required or not. Results The nuclear medicine technologists and the physicians in clinical routine agreed in 103 of the 107 cases (96%) for which the technologists felt certain regarding the need for a rest study. In the remaining 14 cases the technologists were uncertain, i.e. wanted to consult a physician. The agreement between the technologists and the physicians in clinical routine was very good, resulting in a kappa value of 0.92. There was no statistically significant difference in the evaluations made by technicians and physicians (P?=?0.617). Conclusions The nuclear medicine technologists were able to accurately determine whether a rest study was necessary. There was very good agreement between nuclear medicine technologists and physicians in the assessment of the need for a rest study. If the technologists can make this decision, the effectiveness of the nuclear medicine department will improve. PMID:22947251

  15. Recent Progress on the Standardized DOE Spent Nuclear Fuel Canister

    SciTech Connect

    Morton, Dana Keith; Snow, Spencer David; Rahl, Tommy Ervin; Hill, Thomas Johnathan; Morissette, R. P.

    2002-08-01

    The Department of Energy (DOE) has developed a set of containers for the handling, interim storage, transportation, and disposal in the national repository of DOE spent nuclear fuel (SNF). This container design, referred to as the standardized DOE SNF canister or standardized canister, was developed by the Department's National Spent Nuclear Fuel Storage Program (NSNFP) working in conjunction with the Office of Civilian Radioactive Waste Management (OCRWM) and the DOE spent fuel sites. This canister had to have a standardized design yet be capable of accepting virtually all of the DOE SNF, be placed in a variety of storage and transportation systems, and still be acceptable to the repository. Since specific design details regarding the storage, transportation, and repository disposal of DOE SNF were not finalized, the NSNFP recognized the necessity to specify a complete DOE SNF canister design. This allowed other evaluations of canister performance and design to proceed as well as providing standardized canister users adequate information to proceed with their work. This paper is an update of a paper presented to the 1999 American Nuclear Society of Mechanical Engineers (ASME) Pressure Vessels and Piping (PVP) Conference. It discusses recent progress achieved in various areas to enhance acceptance of this canister not only by the DOE complex but also fabricators and regulatory agencies.

  16. Nuclear waste management. Quarterly progress report, October through December 1980

    SciTech Connect

    Chikalla, T.D.; Powell, J.A.

    1981-03-01

    Progress reports and summaries are presented under the following headings: high-level waste process development; alternative waste forms; nuclear waste materials characterization center; TRU waste immobilization; TRU waste decontamination; krypton solidification; thermal outgassing; iodine-129 fixation; monitoring and physical characterization of unsaturated zone transport; well-logging instrumentation development; mobility of organic complexes of radionuclides in soils; waste management system studies; waste management safety studies; assessment of effectiveness of geologic isolation systems; waste/rock interactions technology; high level waste form preparation; development of backfill material; development of structural engineered barriers; ONWI disposal charge analysis; spent fuel and fuel component integrity program; analysis of spent fuel policy implementation; analysis of postulated criticality events in a storage array of spent LWR fuel; asphalt emulsion sealing of uranium tailings; liner evaluation for uranium mill tailings; multilayer barriers for sealing of uranium tailings; application of long-term chemical biobarriers for uranium tailings; revegetation of inactive uranium tailing sites; verification instrument development.

  17. Medicines

    MedlinePLUS

    ... better. In the United States, the Food and Drug Administration is in charge of assuring the safety ... prescription and over-the-counter medicines. Even safe drugs can cause unwanted side effects or interactions with ...

  18. Tracking patient radiation exposure: challenges to integrating nuclear medicine with other modalities.

    PubMed

    Mercuri, Mathew; Rehani, Madan M; Einstein, Andrew J

    2012-10-01

    The cumulative radiation exposure to the patient from multiple radiological procedures can place some individuals at significantly increased risk for stochastic effects and tissue reactions. Approaches, such as those in the International Atomic Energy Agency's Smart Card program, have been developed to track cumulative radiation exposures to individuals. These strategies often rely on the availability of structured dose reports, typically found in the DICOM header. Dosimetry information is currently readily available for many individual x-ray-based procedures. Nuclear medicine, of which nuclear cardiology constitutes the majority of the radiation burden in the US, currently lags behind x-ray-based procedures with respect to reporting of radiation dosimetric information. This article discusses qualitative differences between nuclear medicine and x-ray-based procedures, including differences in the radiation source and measurement of its strength, the impact of biokinetics on dosimetry, and the capability of current scanners to record dosimetry information. These differences create challenges in applying, monitoring, and reporting strategies used in x-ray-based procedures to nuclear medicine, and integrating dosimetry information across modalities. A concerted effort by the medical imaging community, dosimetry specialists, and manufacturers of imaging equipment is required to develop strategies to improve the reporting of radiation dosimetry data in nuclear medicine. Some ideas on how to address this issue are suggested. PMID:22695788

  19. [The progress of the concentration technology of extract of traditional Chinese medicine].

    PubMed

    Liu, Ming-Yan; Yu, Gen; Wang, Hong

    2006-02-01

    The concentration of extract of traditional Chinese medicine (TCM) is one of the important unit operations that affect the quality of the pharmaceutical products. However, there are some problems to be solved. The concentration process has the shortages of relatively high temperature, relatively long time or low efficient, some losses of active and volatile ingredients, more operation steps, easy fouling and emission of waste water. In order to solve these problems, many new technologies and installations have been developed in the past thirty years, including suspension freeze-concentration, progressive freeze-concentration, single- or multi-effect evaporation with an external natural circulating flow, on-line preventing fouling evaporation with vapor-liquid-solid flow, reverse osmosis concentration, membrane distillation, osmotic distillation, macro-porous resin adsorption etc. The system of the extract of TCM is very complex. The extract includes water and alcohol extracts. The composition of TCM is made of active and inactive ingredients. Hence, it is necessary to master the features of every concentration technologies and installations, including their merits and demerits, flexibilities, degree of maturations of techniques and so on to get a wise choice for the industry applications. New concentration technologies and installations of the extract of TCM developed recently are reviewed in this paper. The characteristics of each method are analyzed and discussed in order to guide the industry applications. At the same time, the further research directions of concentration techniques of extract of TCM are also given. PMID:16572992

  20. Neutron interaction tool, PyNIC, for advanced applications in nuclear power, nuclear medicine, and nuclear security

    NASA Astrophysics Data System (ADS)

    Moffitt, Gregory Bruce

    A neutron interaction simulation tool, PyNIC, was developed for the calculation of neutron activation products and prompt gamma ray emission from neutron capture, neutron inelastic scattering, and fission interactions. This tool was developed in Python with a graphical user interface to facilitate its easy applications. The tool was validated for neutron activation analysis of a number of samples irradiated in the University of Utah TRIGA Reactor. These samples included nickel wire and the NIST standard for coal fly ash. The experimentally determined isotopes for coal fly ash were 56Mn, 40K, and 139Ba. The samples were irradiated at reactor power levels from 1 kW to 90 kW, and the average percent difference between PyNIC estimated and laboratory measured values was 4%, 24%, 38%, and 22% for 64Ni, 56Mn, 40K, and 139Ba, respectively. These differences are mainly attributed to calibration of the high-purity germanium detector and too short of count times. The PyNIC tool is applicable to neutron activation analysis but also can find its applications in nuclear power, nuclear medicine, and in homeland security such as predicting the contents of explosives and special nuclear materials in samples of complex and unknown origins.

  1. Progress in Nuclear Energy 76 (2014) 137 147 Contents lists available at ScienceDirect

    E-print Network

    Demazière, Christophe

    2014-01-01

    of responses in AO from power regulation could reduce the negative impact of such intelligent regulatingProgress in Nuclear Energy 76 (2014) 137 147 Contents lists available at ScienceDirect Progress in Nuclear Energy journal homepage: www.elsevier.com/locate/pnucene Reducing axial offset and improving

  2. Progress in Nuclear Energy 53 (2011) 618 625 Contents lists available at ScienceDirect

    E-print Network

    Demazière, Christophe

    2011-01-01

    Progress in Nuclear Energy 53 (2011) 618 625 Contents lists available at ScienceDirect Progress in Nuclear Energy journal homepage: www.elsevier.com/locate/pnucene Comparison of thorium-based fuels Fhager a , Christophe Demazière b a Thor Energy, Sommerrogaten 13 15, NO-0255 Oslo, Norway b Chalmers

  3. The IAEA technical cooperation programme and nuclear medicine in the developing world: objectives, trends, and contributions.

    PubMed

    Casas-Zamora, Juan Antonio; Kashyap, Ridhi

    2013-05-01

    The International Atomic Energy Agency's technical cooperation (TC) programme helps Member States in the developing world with limited infrastructure and human resource capacity to harness the potential of nuclear technologies in meeting socioeconomic development challenges. As a part of its human health TC initiatives, the Agency, through the TC mechanism, has the unique role of promoting nuclear medicine applications of fellowships, scientific visits, and training courses, via technology procurement, and in the past decade has contributed nearly $54 million through 180 projects in supporting technology procurement and human resource capacity development among Member States from the developing world (low- and middle-income countries). There has been a growing demand in nuclear medicine TC, particularly in Africa and ex-Soviet Union States where limited infrastructure presently exists, based on cancer and cardiovascular disease management projects. African Member States received the greatest allocation of TC funds in the past 10 years dedicated to building new or rehabilitating obsolete nuclear medicine infrastructure through procurement support of single-photon emission computed tomography machines. Agency support in Asia and Latin America has emphasized human resource capacity building, as Member States in these regions have already acquired positron emission tomography and hybrid modalities (positron emission tomography/computed tomography and single-photon emission computed tomography/computed tomography) in their health systems. The strengthening of national nuclear medicine capacities among Member States across different regions has enabled stronger regional cooperation among developing countries who through the Agency's support and within the framework of regional cooperative agreements are sharing expertise and fostering the sustainability and productive integration of nuclear medicine within their health systems. PMID:23561454

  4. Accessibility and use of essential medicines in health care: Current progress and challenges in India

    PubMed Central

    Bansal, Dipika; Purohit, Vilok K.

    2013-01-01

    Essential Medicine Concept, a major breakthrough in health care, started in 1977 when World Health Organization (WHO) published its first list. Appropriate use of essential medicines is one of the most cost-effective components of modern health care. The selection process has evolved from expert evaluation to evidence-based selection. The first Indian list was published in 1996 and the recent revision with 348 medicines was published in 2011 after 8 years. Health expenditure is less in India as compared to developed countries. India faces a major challenge in providing access to medicines for its 1.2 billion people by focusing on providing essential medicines. In the future, countries will face challenges in selecting high-cost medicines for oncology, orphan diseases and other conditions. There is a need to develop strategies to improve affordable access to essential medicines under the current health care reform. PMID:23662019

  5. Possibilities for the production of radioisotopes for nuclear-medicine problems by means of photonuclear reactions

    SciTech Connect

    Dzhilavyan, L. Z.; Karev, A. I.; Raevsky, V. G.

    2011-12-15

    For electrons of energy about 55 MeV that create an average current of about 40 Micro-Sign A, it is shown that the production of many of the radioisotopes important for nuclear medicine is possible in significant amounts.

  6. Development of Career Opportunities for Technicians in the Nuclear Medicine Field. Final Report.

    ERIC Educational Resources Information Center

    Technical Education Research Center, Cambridge, MA.

    This report describes a nationally coordinated program development project whose purpose was to catalyze the implementation of needed postsecondary educational programs in the field of nuclear medicine technology (NMT). The NMT project was carried out during the six year period 1968-74 in cooperation with more than 36 community/junior colleges and…

  7. [Electromagnetic studies of nuclear structure and reactions]. Progress summary

    SciTech Connect

    Not Available

    1992-12-31

    The experimental goals are focused on developing an understanding of strong interactions and the structure of hadronic systems by determination of the electromagnetic response; these goals will be accomplished through coincidence detection of final states. Nuclear modeling objectives are to organize and interpret the data through a consistent description of a broad spectrum of reaction observables; calculations are performed in a nonrelativistic diagrammatic framework as well as a relativistic QHD approach. Work is described according to the following arrangement: direct knockout reactions (completion of {sup 16}O(e,e{prime}p), {sup 12}C(e,e{prime}pp) progress, large acceptance detector physics simulations), giant resonance studies (intermediate-energy experiments with solid-state detectors, the third response function in {sup 12}C(e,e{prime}p{sub 0}) and {sup 16}O(e,e{prime}p{sub 0}), comparison of the {sup 12}C(e, e{prime}p{sub 0}) and {sup 16}O(e,e{prime}p{sub 3}) reactions, quadrupole strength in the {sup 16}O(e,e{prime}{alpha}{sub 0}) reaction, quadrupole strength in the {sup 12}C(e,e{prime}{alpha}) reaction, analysis of the {sup 12}C(e,e{prime}p{sub 1}) and {sup 16}O(e,e{prime}p{sub 3}) angular distributions, analysis of the {sup 40}Ca(e,e{prime}x) reaction at low q, analysis of the higher-q {sup 12}C(e,e{prime}x) data from Bates), models of nuclear structure (experimental work, Hartree-Fock calculations, phonon excitations in spherical nuclei, shell model calculations, variational methods for relativistic fields), and instrumentation development efforts (developments at CEBAF, CLAS contracts, BLAST developments).

  8. Nuclear DNA Amounts in Angiosperms: Progress, Problems and Prospects

    PubMed Central

    BENNETT, M. D.; LEITCH, I. J.

    2005-01-01

    CONTENTSINTRODUCTION45PROGRESS46????Improved systematic representation (species and families)46????????(i) First estimates for species46????????(ii) First estimates for families47PROBLEMS48????Geographical representation and distribution48????Plant life form48????Obsolescence time bomb49????Errors and inexactitudes49????Genome size, ‘complete’ genome sequencing, and, the euchromatic genome50????The completely sequenced genome50????Weeding out erroneous data52????What is the smallest reliable C-value for an angiosperm?52????What is the minimum C-value for a free-living angiosperm and other free-living organisms?53PROSPECTS FOR THE NEXT TEN YEARS54????Holistic genomics55LITERATURE CITED56APPENDIX59????Notes to the Appendix59????Original references for DNA values89 • Background The nuclear DNA amount in an unreplicated haploid chromosome complement (1C-value) is a key diversity character with many uses. Angiosperm C-values have been listed for reference purposes since 1976, and pooled in an electronic database since 1997 (http://www.kew.org/cval/homepage). Such lists are cited frequently and provide data for many comparative studies. The last compilation was published in 2000, so a further supplementary list is timely to monitor progress against targets set at the first plant genome size workshop in 1997 and to facilitate new goal setting. • Scope The present work lists DNA C-values for 804 species including first values for 628 species from 88 original sources, not included in any previous compilation, plus additional values for 176 species included in a previous compilation. • Conclusions 1998–2002 saw striking progress in our knowledge of angiosperm C-values. At least 1700 first values for species were measured (the most in any five-year period) and familial representation rose from 30 % to 50 %. The loss of many densitometers used to measure DNA C-values proved less serious than feared, owing to the development of relatively inexpensive flow cytometers and computer-based image analysis systems. New uses of the term genome (e.g. in ‘complete’ genome sequencing) can cause confusion. The Arabidopsis Genome Initiative C-value for Arabidopsis thaliana (125 Mb) was a gross underestimate, and an exact C-value based on genome sequencing alone is unlikely to be obtained soon for any angiosperm. Lack of this expected benchmark poses a quandary as to what to use as the basal calibration standard for angiosperms. The next decade offers exciting prospects for angiosperm genome size research. The database (http://www.kew.org/cval/homepage) should become sufficiently representative of the global flora to answer most questions without needing new estimations. DNA amount variation will remain a key interest as an integrated strand of holistic genomics. PMID:15596457

  9. The Physician and His Practice—1980 to 2000 Sixth Progress Report of the Committee on Role of Medicine in Society

    PubMed Central

    1972-01-01

    Members of the Committee on the Role of Medicine in Society, together with medical student representatives of the medical schools in California worked for a period of close to two years preparing this Sixth Progress Report. Names of the committee members, ex-officio members, consultants and medical student members who served during the discussions and the drafting of the report are listed on the final page. PMID:5019110

  10. Radioactivity appearing at landfills in household trash of nuclear medicine patients: much ado about nothing?

    PubMed

    Siegel, Jeffry A; Sparks, Richard B

    2002-03-01

    The U.S. NRC in 1997 removed its arbitrary 1.11 GBq (30 mCi) rule, which had been in existence for almost 50 y, and now many more patients receiving radionuclide therapy in nuclear medicine can be treated as outpatients. However, another problem has the potential to limit the short-lived reality of outpatient treatment unless nuclear medicine practitioners and the health physics community gets involved. Radioactive articles in the household trash of nuclear medicine patients are appearing at solid waste landfills that have installed radiation monitors to prevent the entry of any detectable radioactivity, and alarms are going off around the country. These monitors are set to alarm at extremely low activity levels. Some states may actually hold licensees responsible if a patient's radioactive household trash is discovered in a solid waste stream; this is another major reason [along with continued use of the 1.11 GBq (30 mCi) rule] why many licensees are still not releasing their radionuclide therapy patients. This is in spite of the fact that the radioactivity contained in released nuclear medicine therapy patients, let alone the much lower activity level contained in their potentially radioactive household wastes, poses a minimal hazard to the public health and safety or to the environment. Currently, there are no regulations governing the disposal of low-activity, rapidly-decaying radioactive materials found in the household trash of nuclear medicine patients, the performance of landfill radiation monitors, or the necessity of spectrometry equipment. Resources are, therefore, being unnecessarily expended by regulators and licensees in responding to radiation monitor alarms that are caused by these unregulated short-lived materials that may be mixed with municipal trash. Recommendations are presented that would have the effect of modifying the existing landfill regulations and practices so as to allow the immediate disposal of such wastes. PMID:11845839

  11. Standardization of administered activities in pediatric nuclear medicine: a report of the first nuclear medicine global initiative project, part 1-statement of the issue and a review of available resources.

    PubMed

    Fahey, Frederic H; Bom, Henry Hee-Seong; Chiti, Arturo; Choi, Yun Young; Huang, Gang; Lassmann, Michael; Laurin, Norman; Mut, Fernando; Nuñez-Miller, Rodolfo; O'Keeffe, Darin; Pradhan, Prasanta; Scott, Andrew M; Song, Shaoli; Soni, Nischal; Uchiyama, Mayuki; Vargas, Luis

    2015-04-01

    The Nuclear Medicine Global Initiative (NMGI) was formed in 2012 and consists of 13 international organizations with direct involvement in nuclear medicine. The underlying objectives of the NMGI were to promote human health by advancing the field of nuclear medicine and molecular imaging, encourage global collaboration in education, and harmonize procedure guidelines and other policies that ultimately lead to improvements in quality and safety in the field throughout the world. For its first project, the NMGI decided to consider the issues involved in the standardization of administered activities in pediatric nuclear medicine. This article presents part 1 of the final report of this initial project of the NMGI. It provides a review of the value of pediatric nuclear medicine, the current understanding of the carcinogenic risk of radiation as it pertains to the administration of radiopharmaceuticals in children, and the application of dosimetric models in children. A listing of pertinent educational and reference resources available in print and online is also provided. The forthcoming part 2 report will discuss current standards for administered activities in children and adolescents that have been developed by various organizations and an evaluation of the current practice of pediatric nuclear medicine specifically with regard to administered activities as determined by an international survey of nuclear medicine clinics and centers. Lastly, the part 2 report will recommend a path forward toward global standardization of the administration of radiopharmaceuticals in children. PMID:25766899

  12. Self-assessment of current knowledge in nuclear medicine (second edition)

    SciTech Connect

    Selby, J.B.; Frey, G.D.; Cooper, J.F.; Klobukoski, C.J.

    1981-01-01

    In this updated second edition, the order of contents of the textbook has been reorganized. It has been divided into main parts: Basic Science and Clinical Nuclear Medicine. Basic Science, Part I, encompasses basic physics, radiation protection, interaction of radiation with matter and radiation detection, imaging, nuclear pharmacy, and radiation biology. Part II, Clinical Nuclear Medicine, covers the central nervous system, bone, gastroenterology (liver/spleen), cardiovascular system, pulmonary system, genitourinary system, thyroid and endocrine systems, gallium studies, radioassay, hematology, and therapy. The total number of pages of the current edition is increased to 250 from the 213 of the first edition but there are fewer questions because those in the basic science area have been carefully selected to 60 of the original 98 questions. Compared with the previous edition, there are two advantages in the current one: (1) the addition of explanatory answers; and (2) the inclusion of up-to-date scintiphotos replacing rectilinear scan illustrations.

  13. Applied nuclear data research and development. Semiannual progress report, April 1-September 30, 1983

    SciTech Connect

    Arthur, E.D.

    1984-06-01

    This progress report describes the activities of the Los Alamos Nuclear Data Group for April 1, 1983 through September 30, 1983. Topics covered include theory and evaluation of nuclear cross sections; nuclear cross-section processing and testing; neutron activation; fission products, and actinides; and core neutronics code development in support of LMFBR carbide core assessment. (GHT)

  14. Nuclear medicine and imaging research (quantitative studies in radiopharmaceutical science)

    SciTech Connect

    Cooper, M.; Beck, R.N.

    1992-06-01

    This report describes three studies aimed at using radiolabeled pharmaceuticals to explore brain function and anatomy. The first section describes the chemical preparation of (F18)fluorinated benzamides (dopamine D-2 receptor tracers), (F18)fluorinated benzazepines (dopamine D-1 receptor tracers), and tissue distribution of (F18)-fluoxetine (serotonin reuptake site tracer). The second section relates pharmacological and behavioral studies of amphetamines. The third section reports on progress made with processing of brain images from CT, MRI and PET/SPECT with regards to brain metabolism of glucose during mental tasks.

  15. Radiation risk and nuclear medicine: An interview with a Nobel Prize winner

    SciTech Connect

    Yalow, R.S.

    1995-12-01

    In a speech given years ago at the Veterans Administration Medical Center, Bronx, NY, Rosalyn S. Yalow, 1977 Nobel Prize recipient for her invention of radioimmunoassay, made several salient points on the perception of fear or hazards from exposure to low-level radiation and low-level radioactive wastes. For the past three years, Yalow has been concerned with the general fear of radiation. In this interview, Newsline solicited Yalow`s views on public perceptions on radiation risk and what the nuclear medicine community can do to emphasize the fact that, if properly managed, the use of isotopes in medicine and other cases is not dangerous.

  16. Nuclear medicine and imaging research: Quantitative studies in radiopharmaceutical science

    SciTech Connect

    Copper, M.; Beck, R.N.

    1991-06-01

    During the past three years the program has undergone a substantial revitalization. There has been no significant change in the scientific direction of this grant, in which emphasis continues to be placed on developing new or improved methods of obtaining quantitative data from radiotracer imaging studies. However, considerable scientific progress has been made in the three areas of interest: Radiochemistry, Quantitative Methodologies, and Experimental Methods and Feasibility Studies, resulting in a sharper focus of perspective and improved integration of the overall scientific effort. Changes in Faculty and staff, including development of new collaborations, have contributed to this, as has acquisition of additional and new equipment and renovations and expansion of the core facilities. 121 refs., 30 figs., 2 tabs.

  17. Modular 64x64 CdZnTe arrays with multiplexer readout for high-resolution nuclear medicine imaging

    SciTech Connect

    Woolfenden, J.M.; Barber, H.B.; Barrett, H.H.; Barrett, H.H.; Dereniak, E.L.; Eskin, J.D.; Marks, D.G.; Matherson, K.J.; Young, E.T.; Augustine, F.L.

    1998-12-31

    The authors are developing modular arrays of CdZnTe radiation detectors for high-resolution nuclear medicine imaging. Each detector is delineated into a 64x64 array of pixels; the pixel pitch is 380 {micro}m. Each pixel is connected to a corresponding pad on a multiplexer readout circuit. The imaging system is controlled by a personal computer. They obtained images of standard nuclear medicine phantoms in which the spatial resolution of approximately 1.5 mm was limited by the collimator that was used. Significant improvements in spatial resolution should be possible with different collimator designs. These results are promising for high-resolution nuclear medicine imaging.

  18. STATUS AND FUTURE PROSPECT OF NUCLEAR MEDICINE AND HADRON THERAPY IN NORTH-WEST REGION OF RUSSIA

    E-print Network

    Titov, Anatoly

    for produc- tion of the PET emitters. PNPI can also produce radioisotopes in nuclear reactors. This line nuclear reactor WWR-M, are supplied to the Radium Institute in St. Petersburg for production of variousSTATUS AND FUTURE PROSPECT OF NUCLEAR MEDICINE AND HADRON THERAPY IN NORTH-WEST REGION OF RUSSIA N

  19. Nuclear medicine and imaging research (quantitative studies in radiopharmaceutical science)

    SciTech Connect

    Cooper, M.D.; Beck, R.N.

    1990-09-01

    This is a report of progress in Year Two (January 1, 1990--December 31, 1990) of Grant FG02-86ER60438, Quantitative Studies in Radiopharmaceutical Science,'' awarded for the three-year period January 1, 1989--December 31, 1991 as a competitive renewal following site visit in the fall of 1988. This program addresses the problems involving the basic science and technology underlying the physical and conceptual tools of radioactive tracer methodology as they relate to the measurement of structural and functional parameters of physiologic importance in health and disease. The principal tool is quantitative radionuclide imaging. The overall objective of this program is to further the development and transfer of radiotracer methodology from basic theory to routine clinical practice in order that individual patients and society as a whole will receive the maximum net benefit from the new knowledge gained. The focus of the research is on the development of new instruments and radiopharmaceuticals, and the evaluation of these through the phase of clinical feasibility. 25 refs., 13 figs., 1 tab.

  20. Therapeutic strategy of papillary microcarcinoma of the thyroid gland: a nuclear medicine perspective.

    PubMed

    Riemann, B; Schober, O

    2009-03-01

    According to the literature, the prevalence of papillary thyroid microcarcinoma (PTMC) is increasing. To date, PMTC account for up to 30% of all differentiated thyroid cancers. Patients with PTMC have an excellent prognosis with a normal life expectancy. Because of the differential definitions of the PTMC, the therapeutic approaches of the national Scien-tific Societies have not been standardized. The therapeutic algorithms have to be adjusted with regard to thyroid surgery, radioiodine ablation and thyrotropin-suppressive therapy as well as follow-up. Recently, the Therapy Committee of the European Society of Nuclear Medicine (EANM) has recommended a risk-adapted therapy and follow-up. Risk factors which require a more aggressive therapeutic approach are multifocality, thyroid capsule infiltration, evidence of locoregional or distant metastasis and unfavourable histology. It was the aim of this review to evaluate the current therapeutic concepts in patients with PTMC from a nuclear medicine perspective. PMID:19209130

  1. MAGIC-f Gel in Nuclear Medicine Dosimetry: study in an external beam of Iodine-131

    NASA Astrophysics Data System (ADS)

    Schwarcke, M.; Marques, T.; Garrido, C.; Nicolucci, P.; Baffa, O.

    2010-11-01

    MAGIC-f gel applicability in Nuclear Medicine dosimetry was investigated by exposure to a 131I source. Calibration was made to provide known absorbed doses in different positions around the source. The absorbed dose in gel was compared with a Monte Carlo Simulation using PENELOPE code and a thermoluminescent dosimetry (TLD). Using MRI analysis for the gel a R2-dose sensitivity of 0.23 s-1Gy-1was obtained. The agreement between dose-distance curves obtained with Monte Carlo simulation and TLD was better than 97% and for MAGIC-f and TLD was better than 98%. The results show the potential of polymer gel for application in nuclear medicine where three dimensional dose distribution is demanded.

  2. Monitoring the Durability Performance of Concrete in Nuclear Waste Containment. Technical Progress Report No. 3

    SciTech Connect

    Ulm, Franz-Josef

    2000-03-31

    OAK-B135 Monitoring the Durability Performance of Concrete in Nuclear Waste Containment. Technical Progress Report No. 3(NOTE: Part II A item 1 indicates ''PAPER'', but a report is attached electronically)

  3. Applications of CdTe to nuclear medicine. Annual report, February 1, 1979-January 31, 1980

    SciTech Connect

    Entine, G

    1980-01-01

    The application of CdTe gamma detectors in nuclear medicine is reported on. An internal probe was developed which can be inserted into the heart to measure the efficiency of various radiopharmaceuticals in the treatment of heart attacks. A second application is an array of detectors which is light enough to be worn by ambulatory patients and can measure the change in cardiac output over an eight hour period during heart attack treatment. The instrument includes an on board tape recorder. (ACR)

  4. Refurbishing of a Freeze Drying Machine, used in Nuclear Medicine for Radiopharmaceuticals Production

    SciTech Connect

    Gaytan-Gallardo, E.; Desales-Galeana, G.

    2006-09-08

    The refurbishing of a freeze drying machine used in the radiopharmaceuticals production, applied in nuclear medicine in the Radioactive Materials Department of the Nuclear Research National Institute in Mexico (ININ in Spanish), is presented. The freeze drying machine was acquired in the 80's decade and some components started having problems. Then it was necessary to refurbish this equipment by changing old cam-type temperature controllers and outdated recording devices, developing a sophisticated software system that substitutes those devices. The system is composed by a freeze drying machine by Hull, AC output modules for improved temperature control, a commercial data acquisition card, and the software system.

  5. Short- and long-term responses to molybdenum-99 shortages in nuclear medicine

    PubMed Central

    Ballinger, J R

    2010-01-01

    Most nuclear medicine studies use 99Tcm, which is the decay product of 99Mo. The world supply of 99Mo comes from only five nuclear research reactors and availability has been much reduced in recent times owing to problems at the largest reactors. In the short-term there are limited actions that can be taken owing to capacity issues on alternative imaging modalities. In the long-term, stability of 99Mo supply will rely on a combination of replacing conventional reactors and developing new technologies. PMID:20965898

  6. Reactor production and processing of radioisotopes for therapeutic applications in nuclear medicine

    SciTech Connect

    Knapp, F.F. Jr.; Mirzadeh, S.; Beets, A.L.

    1995-02-01

    Nuclear reactors continue to play an important role in providing radioisotopes for nuclear medicine. Many reactor-produced radioisotopes are ``neutron rich`` and decay by beta-emission and are thus of interest for therapeutic applications. This talk discusses the production and processing of a variety of reactor-produced radioisotopes of current interest, including those produced by the single neutron capture process, double neutron capture and those available from beta-decay of reactorproduced radioisotopes. Generators prepared from reactorproduced radioisotopes are of particular interest since repeated elution inexpensively provides many patient doses. The development of the alumina-based W-188/Re-188 generator system is discussed in detail.

  7. Patients' and personnel's perceptions of service quality and patient satisfaction in nuclear medicine.

    PubMed

    De Man, Stefanie; Gemmel, Paul; Vlerick, Peter; Van Rijk, Peter; Dierckx, Rudi

    2002-09-01

    Patients' and personnel's perceptions of service quality were analysed to position nuclear medicine organisations in the service triangle theory of Haywood-Farmer [ Int J Production and Operations Management 1988; 6:19-29]. After distinguishing the service quality dimensions of nuclear medicine, a comparison was made between the service quality perceptions of patients ( n=259) and those of personnel ( n=24). We examined the importance of different service quality dimensions by studying their relationship to patient satisfaction. The proposed five dimensions of SERVQUAL, the most commonly used service quality measurement scale, were not confirmed. Patients considered tangibles and assurance as one dimension, while the original empathy dimension was separated into empathy and convenience. Personnel perceived all service quality dimensions as less good than did patients, except for empathy. Results indicated that patients' perception of service quality was correlated with patient satisfaction, especially in terms of reliability and tangibles-assurance. Based on these service quality dimensions, we suggest that nuclear medicine services need to optimise their physical and process component and the technical skills of personnel. PMID:12192553

  8. A Poisson resampling method for simulating reduced counts in nuclear medicine images

    NASA Astrophysics Data System (ADS)

    White, Duncan; Lawson, Richard S.

    2015-05-01

    Nuclear medicine computers now commonly offer resolution recovery and other software techniques which have been developed to improve image quality for images with low counts. These techniques potentially mean that these images can give equivalent clinical information to a full-count image. Reducing the number of counts in nuclear medicine images has the benefits of either allowing reduced activity to be administered or reducing acquisition times. However, because acquisition and processing parameters vary, each user should ideally evaluate the use of images with reduced counts within their own department, and this is best done by simulating reduced-count images from the original data. Reducing the counts in an image by division and rounding off to the nearest integer value, even if additional Poisson noise is added, is inadequate because it gives incorrect counting statistics. This technical note describes how, by applying Poisson resampling to the original raw data, simulated reduced-count images can be obtained while maintaining appropriate counting statistics. The authors have developed manufacturer independent software that can retrospectively generate simulated data with reduced counts from any acquired nuclear medicine image.

  9. A Poisson resampling method for simulating reduced counts in nuclear medicine images.

    PubMed

    White, Duncan; Lawson, Richard S

    2015-05-01

    Nuclear medicine computers now commonly offer resolution recovery and other software techniques which have been developed to improve image quality for images with low counts. These techniques potentially mean that these images can give equivalent clinical information to a full-count image. Reducing the number of counts in nuclear medicine images has the benefits of either allowing reduced activity to be administered or reducing acquisition times. However, because acquisition and processing parameters vary, each user should ideally evaluate the use of images with reduced counts within their own department, and this is best done by simulating reduced-count images from the original data. Reducing the counts in an image by division and rounding off to the nearest integer value, even if additional Poisson noise is added, is inadequate because it gives incorrect counting statistics. This technical note describes how, by applying Poisson resampling to the original raw data, simulated reduced-count images can be obtained while maintaining appropriate counting statistics. The authors have developed manufacturer independent software that can retrospectively generate simulated data with reduced counts from any acquired nuclear medicine image. PMID:25880881

  10. Improving efficiency management of radiopharmaceutical materials at a nuclear medicine department

    PubMed Central

    Al Ahmed, Ali; Al-Surimi, Khaled

    2015-01-01

    The cost of radiopharmaceutical materials is highly expensive compared with other resources employed in nuclear medicine department. Hence, inefficient utilization of these costly materials will lead to waste and more financial burden on the healthcare system, increasing the patient waiting list for important diagnostic procedures, especially in those with need urgent care on time. The available data for the previous 12 months about positron emission tomography / computed tomography (PET/CT) unit at nuclear medicine departments showed that over 16% of radiopharmaceutical materials were not utilized and being wasted due to increased number of cancelled or rescheduled oncology patients. The overall financial cost for the underutilized radiopharmaceutical materials due to cancelled and rescheduled procedures for 142 patient were about 39,760 US dollar. Most of these are the oncology patients with diabetes arriving at the nuclear medicine department with high blood glucose level and so are not fit for the procedure. This project aims to improve the oncology diabetic patients preparation for PET/CT procedure to avoid wasting the radiopharmaceutical materials. After implementing the PDSA cycles on 14 oncology patients we found that the quantity of not utilized radiopharmaceuticals were significantly reduced. On the other hand, majority of oncology diabetic patients became more aware about the importance of following the required preparation instruction.

  11. Nuclear physics for medicine: how nuclear research is improving human health

    NASA Astrophysics Data System (ADS)

    Bracco, Angela

    2015-05-01

    The Nuclear Physics European Collaboration Committee (NuPECC) is an associated Committee of the European Science Foundation (ESF). Its mission is to strengthen European Collaboration in nuclear science through the promotion of nuclear physics, and its trans-disciplinary use and application in collaborative ventures between research groups.

  12. 76 FR 78702 - Progress Energy Florida, Inc. (Combined License Application for Levy County Nuclear Power Plant...

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-12-19

    ... From the Federal Register Online via the Government Printing Office NUCLEAR REGULATORY COMMISSION Progress Energy Florida, Inc. (Combined License Application for Levy County Nuclear Power Plant, Units 1 and 2) Notice of Atomic Safety and Licensing Board Reconstitution Pursuant to 10 CFR 2.313(c) and...

  13. Nuclear Data Covariances in the Indian Context - Progress, Challenges, Excitement and Perspectives

    NASA Astrophysics Data System (ADS)

    Ganesan, S.

    2015-01-01

    We present a brief overview of progress, challenges, excitement and perspectives in developing nuclear data covariances in the Indian context in relation to target accuracies and sensitivity studies that are of great importance to Bhabha's 3-stage nuclear programme for energy and non-energy applications.

  14. SUS in nuclear medicine in Brazil: analysis and comparison of data provided by Datasus and CNEN*

    PubMed Central

    Pozzo, Lorena; Coura Filho, George; Osso Júnior, João Alberto; Squair, Peterson Lima

    2014-01-01

    Objective To investigate the outpatient access to nuclear medicine procedures by means of the Brazilian Unified Health System (SUS), analyzing the correspondence between data provided by this system and those from Comissão Nacional de Energia Nuclear (CNEN) (National Commission of Nuclear Energy). Materials and Methods Data provided by Datasus regarding number of scintillation chambers, outpatient procedures performed from 2008 to 2012, administrative responsibility for such procedures, type of service providers and outsourced services were retrieved and evaluated. Also, such data were compared with those from institutions certified by CNEN. Results The present study demonstrated that the system still lacks maturity in terms of correct data input, particularly regarding equipment available. It was possible to list the most common procedures and check the growth of the specialty along the study period. Private centers are responsible for most of the procedures covered and reimbursed by SUS. However, many healthcare facilities are not certified by CNEN. Conclusion Datasus provides relevant data for analysis as done in the present study, although some issues still require attention. The present study has quantitatively depicted the Brazilian reality regarding access to nuclear medicine procedures offered by/for SUS. PMID:25741070

  15. Pictorial review of SPECT/CT imaging applications in clinical nuclear medicine

    PubMed Central

    Bhargava, Peeyush; He, Guocheng; Samarghandi, Amin; Delpassand, Ebrahim S

    2012-01-01

    Integrated SPECT/CT scanners are gaining popularity as hybrid molecular imaging devices which can acquire SPECT and CT in a single exam. CT can be a low dose non-contrast enhanced scan for attenuation correction and anatomical localization, or a contrast enhanced diagnostic quality scan for additional anatomical characterization. We present a pictorial review highlighting the usefulness of this emerging technology. We present SPECT/CT images of 13 patients where additional information was provided by the co-registered low dose non-contrast enhanced CT scan. They belong to 12 male and 1 female patients with age ranging from 28 to 76 yrs, who were referred to the Nuclear Medicine Department for various indications. We describe these cases under in the following categories: bone scintigraphy (2), leukocyte scintigraphy (2), nuclear oncology (5), nuclear cardiology (1), and general nuclear medicine (3). Additional information provided by the co-registered low dose CT improves the diagnostic confidence in image interpretation of SPECT imaging. PMID:23133813

  16. Nuclear waste programs; Semiannual progress report, October 1991--March 1992

    SciTech Connect

    Bates, J.K.; Bradley, C.R.; Buck, E.C.; Dietz, N.L.; Ebert, W.L.; Emery, J.W.; Feng, X.; Finn, P.A.; Gerding, T.J.; Hoh, J.C.

    1993-11-01

    This document reports on the work done by the Nuclear Waste Programs of the Chemical Technology Division (CMT), Argonne National Laboratory, in the period October 1991-March 1992. In these programs, studies are underway on the performance of waste glass and spent fuel in projected nuclear repository conditions to provide input to the licensing of the nation`s high-level waste repositories

  17. Nuclear Waste Programs semiannual progress report, April--September 1992

    SciTech Connect

    Bates, J.K.; Bradley, C.R.; Buck, E.C.

    1994-05-01

    This document reports on the work done by the Nuclear Waste Programs of the Chemical Technology Division (CMT), Argonne National Laboratory, in the period April--September 1992. In these programs, studies are underway on the performance of waste glass and spent fuel in projected nuclear repository conditions to provide input to the licensing of the nation`s high-level waste repositories.

  18. Chemistry-Nuclear Chemistry Division. Progress report, October 1980-September 1981

    SciTech Connect

    Ryan, R.R.

    1982-05-01

    This report describes major progress in the research and development programs pursued by the Chemistry-Nuclear Chemistry Division of the Los Alamos National Laboratory during FY 1981. Topics covered include advanced analytical methods, atmospheric chemistry and transport, biochemistry, biomedical research, medical radioisotopes research, element migration and fixation, nuclear waste isolation research, inorganic and structural chemistry, isotope separation, analysis and applications, the newly established Nuclear Magnetic Resonance Center, atomic and molecular collisions, molecular spectroscopy, nuclear cosmochemistry, nuclear structure and reactions, pion charge exchange, radiochemical separations, theoretical chemistry, and unclassified weapons research.

  19. Applied nuclear science research and development progress report, June 1, 1985-November 30, 1985

    SciTech Connect

    Arthur, E.D.; Mutschlecner, A.D.

    1986-04-01

    This six month progress report reviews activities in nuclear reaction research. Specific content includes theory and evaluation of nuclear cross sections for neutron, proton, and deuteron reactions for a number of isotopes; the processing and testing of nuclear cross section data; studies of neutron activation, fission products and actinides; and short notes on applications. Data are included in graphic and tabular form and include experimental, evaluated, and theoretical calculations and spectra. 136 refs., 81 figs., 17 tabs. (DWL)

  20. A background to nuclear transfer and its applications in agriculture and human therapeutic medicine*

    PubMed Central

    Campbell, Keith HS

    2002-01-01

    The development of a single celled fertilized zygote to an animal capable of reproduction involves not only cell division but the differentiation or specialization to numerous cell types forming each tissue and organ of the adult animal. The technique of nuclear transfer allows the reconstruction of an embryo by the transfer of genetic material from a single donor cell, to an unfertilized egg from which the genetic material has been removed. Successful development of live offspring from such embryos demonstrates that the differentiated state of the donor nucleus is not fixed and can be reprogrammed by the egg cytoplasm to control embryo and fetal development. Nuclear transfer has many applications in agriculture and human medicine. This article will review some of the factors associated with the success of embryo development following nuclear transfer and outline the potential uses of the technology. PMID:12033731

  1. Progress in bright ion beams for industry, medicine and fusion at LBNL

    SciTech Connect

    Kwan, Joe W.

    2002-05-31

    Recent progresses at LBNL in developing ion beams for industry, radiation therapy and inertial fusion applications were discussed. The highlights include ion beam lithography, boron neutron capture therapy (BNCT), and heavy ion fusion (HIF) drivers using multiple linacs.

  2. Nuclear structure from radioactive decay. Annual progress report

    SciTech Connect

    Wood, J.L.

    1991-09-30

    This report discusses nuclear structure from radioactive decay of the following: Neutron-Deficient Iridium Isotopes; Neutron-Deficient Platinum Isotopes; Neutron-Deficient Gold Isotopes; Neutron-Deficient Mercury Isotopes; Neutron-Deficient Thallium Isotopes; Neutron-Deficient Lead Isotopes; Neutron-Deficient Samarium Isotopes; Neutron-Deficient Promethium Isotopes; Neutron-Deficient Neodymium Isotopes; and Neutron-Deficient Praseodymium Isotopes. Also discussed are Nuclear Systematics and Models.

  3. Nuclear research with the electromagnetic probe. Final progress report

    SciTech Connect

    Meziani, Z.E.

    1994-10-01

    This is the final report on the research carried at Stanford University under contract DE-FG03-88ER40439. All the work accomplished under this grant is reported in the publications listed as part of the Principal Investigator bibliography at the end of this report. In the last few years our research was directed at some of the forefront questions in nuclear physics. We investigated the nuclear medium effects on the intrinsic properties of bound nucleons, specifically the ectromagnetic form factors. For these studies we performed a number of specialized electron scattering experiments with specific sensitivity to nuclear medium effects. At the next level of structure, elementary constituents of matter are quarks and gluons. Defining the energy regime where the quark-gluon description of nuclear systems becomes more relevant than the nucleon-meson description is of great importance in thoroughly understanding the nuclear structure. To explore this transition region, we studied the scaling region in the disintegration of the deuteron, the simplest nuclear system with high energy photons. Finally we focused on the investigation of the nucleon internal spin structure along with the test of the Bjoerken sum rule a fundamental sum rule of QCD.

  4. Diagnostic and therapeutic applications of diode lasers and solid state lasers in medicine. Progress report

    SciTech Connect

    Jacques, S.L.; Welch, A.J.; Motamedi, M.; Rastegar, S.; Tittel, F.; Esterowitz, L.

    1992-05-01

    The Texas Medical Center in Houston and the nearby UT Medical Branch at Galveston together constitute a major center of medical research activities. Laser applications in medicine are under development with the engineering assistance of the colloborating engineering centers at Rice University, UT-Austin, and Texas A&M Univ. In addition, this collective is collaborating with the Naval Research Laboratory, where new developments in laser design are underway, in order to transfer promising new laser technology rapidly into the medical environment.

  5. Diagnostic and therapeutic applications of diode lasers and solid state lasers in medicine. Progress report

    SciTech Connect

    Jacques, S.L.; Welch, A.J.; Motamedi, M.; Rastegar, S.; Tittel, F.; Esterowitz, L.

    1993-05-01

    The Texas Medical Center in Houston and the nearby UT Medical Branch at Galveston together constitute a major center of medical research activities. Laser applications in medicine are under development with the engineering assistance of the collaborating engineering enters at Rice University, UT-Austin, Texas A&M Univ. In addition, this collective is collaborating with the naval Research Laboratory, where new developments in laser design are underway, in order to transfer promising new laser technology rapidly into the medical environment.

  6. Nuclear waste management. Semiannual progress report, October 1982-March 1983

    SciTech Connect

    Chikalla, T.D.; Powell, J.A.

    1983-06-01

    This document is one of a series of technical progress reports designed to report radioactive waste management programs at the Pacific Northwest Laboratory. Accomplishments in the following programs are reported: waste stabilization; Materials Characterization Center; waste isolation; low-level waste management; remedial action; and supporting studies.

  7. Three years' experience with an all-digital nuclear medicine department.

    PubMed

    Cohen, A M; Parker, J A; Donohoe, K; Jansons, D; Kolodny, G M

    1990-07-01

    We describe our all-digital, filmless, department of nuclear medicine, which has been fully operational for 3 years. The approach to the design and implementation of a nuclear medicine picture archiving and communication system (PACS) is discussed, as well as enhancements found to be necessary or desirable during our 3 years of experience using the system. Studies are initially viewed on remote monitors in the reading room, and transferred from multiple vendor's computers to the PACS by floppy disc network. Scans are analyzed on networked image workstations using a variety of software imaging tools. Reports are dictated into a digital voice storage system, allowing the referring physician immediate telephone access. The dictated report is typed into a computer, electronically edited, reviewed, billed, and printed for appropriate distribution on an integrated medical information system. The final report is stored on the PACS, along with the scan image and other patient information on 1-gigabyte removable optical discs. Two networked optical disc drives allow us to have approximately 3 years of our department's studies available instantly, allowing recall of previous studies for comparison with the current scan. Emergency night and weekend studies are sent via modern over normal phone lines to the on-call physician, who has a similar image workstation at home. Digital image storage allows for easy manipulation of the data, such as gray scale manipulation and cine (movie) display. Cost analysis shows significant savings compared with a film-based department. We conclude that an all-digital nuclear medicine department is practical, cost effective, and beneficial to both patients and staff. PMID:2367870

  8. National comparison of 131I measurement among nuclear medicine clinics of eight countries.

    PubMed

    Olsovcová, Veronika; Iwahara, Akira; Oropesa, Pilar; Joseph, Leena; Ravindra, Anuradha; Ghafoori, Mostafa; Son, Hye-Kyung; Sahagia, Maria; Tastan, Selma; Zimmerman, Brian

    2010-01-01

    A generally applicable protocol for organizing comparisons among nuclear medicine clinics created within the IAEA project CRP E2.10.05 was tested in Brazil, Cuba, Czech Republic, India, Iran, Republic of Korea, Romania and Turkey in 2007. Comparisons of measurement of (131)I were organized by local pilot laboratories with different backgrounds and levels of experience in this field. The results and experiences gained were compared and analyzed. A majority of results in each national comparison were within 10% of the reference value. PMID:20006521

  9. A strategy for intensive production of molybdenum-99 isotopes for nuclear medicine using CANDU reactors.

    PubMed

    Morreale, A C; Novog, D R; Luxat, J C

    2012-01-01

    Technetium-99m is an important medical isotope utilized worldwide in nuclear medicine and is produced from the decay of its parent isotope, molybdenum-99. The online fueling capability and compact fuel of the CANDU(®)(1) reactor allows for the potential production of large quantities of (99)Mo. This paper proposes (99)Mo production strategies using modified target fuel bundles loaded into CANDU fuel channels. Using a small group of channels a yield of 89-113% of the weekly world demand for (99)Mo can be obtained. PMID:21816619

  10. Detection of thoracic infections by nuclear medicine techniques in the acquired immunodeficiency syndrome

    SciTech Connect

    Kramer, E.L.; Sanger, J.J. )

    1989-11-01

    The challenge of the acquired immunodeficiency syndrome (AIDS) for nuclear medicine has been the early detection of related intrathoracic opportunistic infections, inflammatory conditions, and neoplasms. Gallium-67 citrate scanning has proved a sensitive test not only for Pneumocystis carinii pneumonia but for many of the other opportunistic infections and malignancies, including mycobacterial infections and lymphoma. Patterns and intensity of gallium uptake may suggest more specific diagnoses. Indium-111-labeled white blood cells may also be a valuable diagnostic tool in the AIDS patient.41 references.

  11. The Hotelling Trace Criterion Used for System Optimization and Feature Enhancement in Nuclear Medicine

    NASA Astrophysics Data System (ADS)

    Fiete, Robert Dean

    The Hotelling trace criterion (HTC) is a measure of class separability used in pattern recognition to find a set of linear features that optimally separate two classes of objects. In this dissertation we use the HTC not as a figure of merit for features, but as a figure of merit for characterizing imaging systems and designing filters for feature enhancement in nuclear medicine. If the HTC is to be used to optimize systems, then it must correlate with human observer performance. In our first study, a set of images, created by overlapping ellipses, was used to simulate images of livers. Two classes were created, livers with and without tumors, with noise and blur added to each image to simulate nine different imaging systems. Using the ROC parameter d_ {rm a} as our measure, we found that the HTC has a correlation of 0.988 with the ability of humans to separate these two classes of objects. A second study was performed to demonstrate the use of the HTC for system optimization in a realistic task. For this study we used a mathematical model of normal and diseased livers and of the imaging system to generate a realistic set of liver images from nuclear medicine. A method of adaptive, nonlinear filtering which enhances the features that separate two sets of images has also been developed. The method uses the HTC to find the optimal linear feature operator for the Fourier moduli of the images, and uses this operator as a filter so that the features that separate the two classes of objects are enhanced. We demonstrate the use of this filtering method to enhance texture features in simulated liver images from nuclear medicine, after using a training set of images to obtain the filter. We also demonstrate how this method of filtering can be used to reconstruct an object from a single photon-starved image of it, when the object contains a repetitive feature. When power spectrums for real liver scans from nuclear medicine are calculated, we find that the three classifications that a physician uses, normal, patchy, and focal, can be described by the fractal dimension of the texture in the liver. This fractal dimension can be calculated even for images that suffer from much noise and blur. Given a simulated image of a liver that has been blurred and imaged with only 5000 photons, a texture with the same fractal dimension as the liver can be reconstructed.

  12. Nuclear Physics Laboratory, University of Colorado, Final Progress Report

    SciTech Connect

    Kinney, E.R., ed.

    2004-05-12

    OAK-B135 The results and progress of research funded by DOE grant number DOE-FG03-95ER40913 at the University of Colorado at Boulder is described. Includes work performed at the HERMES experiment at DESY to study the quark structure of the nucleon and the hadronization process in nuclei, as well as hadronic reactions studied at LAMPF, KEK, and Fermilab.

  13. Nuclear Receptor Activity and Liver Cancer Lesion Progression

    EPA Science Inventory

    Nuclear receptors (NRs) are ligand-activated transcription factors that control diverse cellular processes. Chronic stimulation of some NRs is a non-genotoxic mechanism of rodent liver cancer with unclear relevance to humans. We explored this question using human CAR, PXR, PPAR?,...

  14. Space Nuclear Safety Program. Progress report, April 1984

    SciTech Connect

    George, T.G.

    1985-10-01

    This technical monthly report covers studies related to the use of /sup 238/PuO/sub 2/ in radioisotope power systems carried out for the Office of Special Nuclear Projects of the US Department of Energy by Los Alamos National Laboratory. Covered are: general-purpose heat source testing and recovery, and safety technology program (biaxial testing, iridium chemistry).

  15. Dose equivalent rate constants and barrier transmission data for nuclear medicine facility dose calculations and shielding design.

    PubMed

    Kusano, Maggie; Caldwell, Curtis B

    2014-07-01

    A primary goal of nuclear medicine facility design is to keep public and worker radiation doses As Low As Reasonably Achievable (ALARA). To estimate dose and shielding requirements, one needs to know both the dose equivalent rate constants for soft tissue and barrier transmission factors (TFs) for all radionuclides of interest. Dose equivalent rate constants are most commonly calculated using published air kerma or exposure rate constants, while transmission factors are most commonly calculated using published tenth-value layers (TVLs). Values can be calculated more accurately using the radionuclide's photon emission spectrum and the physical properties of lead, concrete, and/or tissue at these energies. These calculations may be non-trivial due to the polyenergetic nature of the radionuclides used in nuclear medicine. In this paper, the effects of dose equivalent rate constant and transmission factor on nuclear medicine dose and shielding calculations are investigated, and new values based on up-to-date nuclear data and thresholds specific to nuclear medicine are proposed. To facilitate practical use, transmission curves were fitted to the three-parameter Archer equation. Finally, the results of this work were applied to the design of a sample nuclear medicine facility and compared to doses calculated using common methods to investigate the effects of these values on dose estimates and shielding decisions. Dose equivalent rate constants generally agreed well with those derived from the literature with the exception of those from NCRP 124. Depending on the situation, Archer fit TFs could be significantly more accurate than TVL-based TFs. These results were reflected in the sample shielding problem, with unshielded dose estimates agreeing well, with the exception of those based on NCRP 124, and Archer fit TFs providing a more accurate alternative to TVL TFs and a simpler alternative to full spectral-based calculations. The data provided by this paper should assist in improving the accuracy and tractability of dose and shielding calculations for nuclear medicine facility design. PMID:24849904

  16. Identifying disease mutations in genomic medicine settings: current challenges and how to accelerate progress

    PubMed Central

    2012-01-01

    The pace of exome and genome sequencing is accelerating, with the identification of many new disease-causing mutations in research settings, and it is likely that whole exome or genome sequencing could have a major impact in the clinical arena in the relatively near future. However, the human genomics community is currently facing several challenges, including phenotyping, sample collection, sequencing strategies, bioinformatics analysis, biological validation of variant function, clinical interpretation and validity of variant data, and delivery of genomic information to various constituents. Here we review these challenges and summarize the bottlenecks for the clinical application of exome and genome sequencing, and we discuss ways for moving the field forward. In particular, we urge the need for clinical-grade sample collection, high-quality sequencing data acquisition, digitalized phenotyping, rigorous generation of variant calls, and comprehensive functional annotation of variants. Additionally, we suggest that a 'networking of science' model that encourages much more collaboration and online sharing of medical history, genomic data and biological knowledge, including among research participants and consumers/patients, will help establish causation and penetrance for disease causal variants and genes. As we enter this new era of genomic medicine, we envision that consumer-driven and consumer-oriented efforts will take center stage, thus allowing insights from the human genome project to translate directly back into individualized medicine. PMID:22830651

  17. [Somatic mutations in nuclear and mitochondrial DNA]. Progress report

    SciTech Connect

    Not Available

    1992-09-01

    The study is concerned the design of new assays that may detect rare somatic mutations in nuclear and mitochondrial DNA, which may increase upon exposure to mutagens, and thus become a marker of human exposure to such mutagens. Two assays for somatic mutation were presented, one for mitochondrial DNA deletions which was developed by the author, and one for deletions of the ADA gene which resides in the nucleus.

  18. Nuclear waste management. Quarterly progress report, January-March 1980

    SciTech Connect

    Platt, A.M.; Powell, J.A.

    1980-06-01

    Reported are: high-level waste immobilization, alternative waste forms, nuclear waste materials characterization, TRU waste immobilization, TRU waste decontamination, krypton solidification, thermal outgassing, iodine-129 fixation, unsaturated zone transport, well-logging instrumentation development, mobile organic complexes of fission products, waste management system and safety studies, assessment of effectiveness of geologic isolation systems, waste/rock interactions, engineered barriers, criteria for defining waste isolation, and spent fuel and pool component integrity. (DLC)

  19. Nuclear Technology Programs semiannual progress report, October 1990--March 1991

    SciTech Connect

    1992-12-01

    This document reports on the work done by the Nuclear Technology Programs of the Chemical Technology Division, Argonne National Laboratory, in the period October 1990--March 1991. These programs involve R&D in three areas: applied physical chemistry, separation science and technology, and nuclear waste management. The work in applied physical chemistry includes investigations into the processes that control the release and transpose of fission products under accident-like conditions in a light water reactor, the thermophysical properties of the metal fuel in the Integral Fast Reactor, and the properties of selected materials in environments simulating those of fusion energy systems. In the area of separation science and technology, the bulk of the effort is concerned with developing and implementing processes for the removal and concentration of actinides from waste streams contaminated by transuranic elements. In the area of waste management, investigations are underway on the performance of materials in projected nuclear repository conditions to provide input to the licensing of the nation`s high-level waste repositories.

  20. Nuclear Technology Programs semiannual progress report, April-- September 1990

    SciTech Connect

    Harmon, J.E.

    1992-06-01

    This document reports on the work done by the Nuclear Technology Programs of the Chemical Technology Division, Argonne National Laboratory, in the period April--September 1990. These programs involve R D in three areas: applied physical chemistry, separation science and technology, and nuclear waste management. The work in applied physical chemistry includes investigations into the processes that control the release and transport of fission products under accident-like conditions in a light water reactor, the thermophysical properties of the metal fuel in the Integral Fast Reactor, and the properties of selected materials in environments simulating those of fusion energy systems. In the area of separation science and technology, the bulk of the effort is concerned with developing and implementing processes for the removal and concentration of actinides from waste streams contaminated by transuranic elements. In the area of waste management, investigations are underway on the performance of materials in projected nuclear repository conditions to provide input to the licensing of the nation's high-level waste repositories.

  1. Nuclear Technology Programs semiannual progress report, April-- September 1990

    SciTech Connect

    Harmon, J.E.

    1992-06-01

    This document reports on the work done by the Nuclear Technology Programs of the Chemical Technology Division, Argonne National Laboratory, in the period April--September 1990. These programs involve R&D in three areas: applied physical chemistry, separation science and technology, and nuclear waste management. The work in applied physical chemistry includes investigations into the processes that control the release and transport of fission products under accident-like conditions in a light water reactor, the thermophysical properties of the metal fuel in the Integral Fast Reactor, and the properties of selected materials in environments simulating those of fusion energy systems. In the area of separation science and technology, the bulk of the effort is concerned with developing and implementing processes for the removal and concentration of actinides from waste streams contaminated by transuranic elements. In the area of waste management, investigations are underway on the performance of materials in projected nuclear repository conditions to provide input to the licensing of the nation`s high-level waste repositories.

  2. Nuclear technology programs. Semiannual progress report, April--September 1991

    SciTech Connect

    Not Available

    1993-07-01

    This document reports on the work done by the Nuclear Technology Programs of the Chemical Technology Division, Argonne National Laboratory, in the period April through September 1991. These programs involve R & D in three areas: applied physical chemistry, separation science and technology, and nuclear waste management. The work in applied physical chemistry includes investigations into the processes that control the release and transport of fission products under accident-like conditions in a light water reactor, the thermophysical properties of the metal fuel in the Integral Fast Reactor, and the properties of selected materials in environments simulating those of fusion energy systems. In the area of separation science and technology, the bulk of the effort is concerned with developing and implementing processes for the removal and concentration of actinides from waste streams contaminated by transuranic elements. In the area of waste management, investigations are underway on the performance of materials in projected nuclear repository conditions to provide input to the licensing of the nation`s high-level waste repositories.

  3. Nuclear Technology Programs semiannual progress report, October 1988--March 1989

    SciTech Connect

    Harmon, J.E.

    1990-12-01

    This document reports on the work done by the Nuclear Technology Programs of the Chemical Technology Division, Argonne National Laboratory, in the period October 1988--March 1989. These programs involve R&D in three areas: applied physical chemistry, separation science and technology, and nuclear waste management. The work in applied physical chemistry includes investigations into the processes that control the release and transport of fission products under accident-like conditions, the thermophysical properties of metal fuel and blanket materials of the Integral Fast Reactor, and the properties of selected materials in environments simulating those of fusion energy systems. In the area of separation science and technology, the bulk of the effort is concerned with developing and implementing processes for the removal and concentration of actinides from waste streams contaminated by transuranic elements. Another effort is concerned with examining the feasibility of substituting low-enriched for high-enriched uranium in the production of fission product {sup 99}Mo. In the area of waste management, investigations are underway on the performance of materials in projected nuclear repository conditions to provide input to the licensing of the nation`s high-level waste repositories. 127 refs., 76 figs., 103 tabs.

  4. Nuclear technology programs; Semiannual progress report, October 1989--March 1990

    SciTech Connect

    Harmon, J.E.

    1992-01-01

    This document reports on the work done by the Nuclear Technology Programs of the Chemical Technology Division, Argonne National Laboratory, in the period October 1989--March 1990. These programs involve R&D in three areas: applied physical chemistry, separation science and technology, and nuclear waste management. The work in applied physical chemistry includes investigations into the processes that control the release and transport of fission products under accident-like conditions, the thermophysical properties of metal fuel and blanket materials of the Integral Fast Reactor, and the properties of selected materials in environments simulating those of fusion energy systems. In the area of separation science and technology, the bulk of the effort is concerned with developing and implementing processes for the removal and concentration of actinides from waste streams contaminated by transuranic elements. Another effort is concerned water waste stream generated in production of 2,4,6-trinitrotoluene. In the area of waste management, investigations are underway on the performance of materials in projected nuclear repository conditions to provide input to the licensing of the nation`s high-level waste repositories.

  5. SiPM MEPhI Megagrant Developments in Nuclear Medicine

    NASA Astrophysics Data System (ADS)

    Popova, E. V.; Belyaev, V. N.; Berdnikov, V. V.; Buzhan, P. Zh.; Ilyin, A. L.; Lazarenko, E. O.; Philippov, D. E.; Skryabin, A. A.; Stifutkin, A. A.

    Three projects has been started in our laboratory as part of megagrant "High energy physics and nuclear medicine with silicon photomultiplier detectors" in NRNU MEPHI. The goal of these projects is development of devices for nuclear medicine in which replacement of photomultiplier tubes (PMT) with solid-state silicon photomultipliers promises various advantages. The first project is full-body SPECT, where replacement of PMT's could reduce size of the detector module and improve spatial resolution while keeping other parameters. The second project is development of a TOF-PET module. Replacement of PMTs with silicon photomultipliers makes it possible to use that detector not only in high magnetic fields but also for Time-of-Flight measurements (higher signal-to-noise ratio on final image) due to very high timing resolution of a SiPM. And the last project is the SiPM-based position-sensitive Gamma-spectrometer for dose monitoring in neutron-capture therapy based on SiPM's.

  6. TOPICAL REVIEW: Application of mathematical methods in dynamic nuclear medicine studies

    NASA Astrophysics Data System (ADS)

    Lawson, Richard S.

    1999-04-01

    Dynamic nuclear medicine studies can generate large quantities of data, and their analysis consists essentially of a reduction of these data to a small number of relevant parameters which will assist in clinical decision making. This review examines some of the mathematical techniques that have been used in the process of data reduction and attempts to explain the principles behind their application. It particularly identifies the techniques that have stood the test of time and demonstrated their usefulness, many of which are now available as standard tools on nuclear medicine processing computers. These include curve processing tools such as smoothing, fitting and factor analysis, as well as tools based on empirical models, such as the Patlak/Rutland plot and deconvolution. Compartmental models and vascular models are also examined and the review finishes with a summary of some functional images and condensed images. It is concluded that an appreciation of the principles and limitations of these mathematical tools is valuable for their correct usage and interpretation of the results produced.

  7. Radiation accidents and their management: emphasis on the role of nuclear medicine professionals.

    PubMed

    Bomanji, Jamshed B; Novruzov, Fuad; Vinjamuri, Sobhan

    2014-10-01

    Large-scale radiation accidents are few in number, but those that have occurred have subsequently led to strict regulation in most countries. Here, different accident scenarios involving exposure to radiation have been reviewed. A triage of injured persons has been summarized and guidance on management has been provided in accordance with the early symptoms. Types of casualty to be expected in atomic blasts have been discussed. Management at the scene of an accident has been described, with explanation of the role of the radiation protection officer, the nature of contaminants, and monitoring for surface contamination. Methods for early diagnosis of radiation injuries have been then described. The need for individualization of treatment according to the nature and grade of the combined injuries has been emphasized, and different approaches to the treatment of internal contamination have been presented. The role of nuclear medicine professionals, including physicians and physicists, has been reviewed. It has been concluded that the management of radiation accidents is a very challenging process and that nuclear medicine physicians have to be well organized in order to deliver suitable management in any type of radiation accident. PMID:25004166

  8. Radiation accidents and their management: emphasis on the role of nuclear medicine professionals

    PubMed Central

    Novruzov, Fuad; Vinjamuri, Sobhan

    2014-01-01

    Large-scale radiation accidents are few in number, but those that have occurred have subsequently led to strict regulation in most countries. Here, different accident scenarios involving exposure to radiation have been reviewed. A triage of injured persons has been summarized and guidance on management has been provided in accordance with the early symptoms. Types of casualty to be expected in atomic blasts have been discussed. Management at the scene of an accident has been described, with explanation of the role of the radiation protection officer, the nature of contaminants, and monitoring for surface contamination. Methods for early diagnosis of radiation injuries have been then described. The need for individualization of treatment according to the nature and grade of the combined injuries has been emphasized, and different approaches to the treatment of internal contamination have been presented. The role of nuclear medicine professionals, including physicians and physicists, has been reviewed. It has been concluded that the management of radiation accidents is a very challenging process and that nuclear medicine physicians have to be well organized in order to deliver suitable management in any type of radiation accident. PMID:25004166

  9. Annual progress report, July 1, 1979-June 30, 1980

    SciTech Connect

    Not Available

    1980-01-01

    Research progress is reported for the year 1979-1980. The report is divided into sections dealing individually with the divisions of Biomolecular and Cellular Science, Environmental Biology, and Nuclear Medicine. The sections have been individually entered into EDB. (ACR)

  10. Some recent progress on quark pairings in dense quark and nuclear matter

    E-print Network

    Jin-yi Pang; Jin-cheng Wang; Qun Wang

    2011-09-14

    We give a brief overview on some recent progress in quark pairings in dense quark/nuclear matter mostly developed in the past five years. We focus on following aspects in particular: the BCS-BEC crossover in the CSC phase, the baryon formation and dissociation in dense quark/nuclear matter, the Ginzburg-Landau theory for three-flavor dense matter with $U_{A}$(1) anomaly, and the collective and Nambu-Goldstone modes for the spin-one CSC.

  11. Progress in Understanding the Nuclear Equation of State at the Quark Level

    SciTech Connect

    A.W. Thomas; P.A.M. Guichon

    2007-01-03

    At the present time there is a lively debate within the nuclear community concerning the relevance of quark degrees of freedom in understanding nuclear structure. We outline the key issues and review the impressive progress made recently within the framework of the quark-meson coupling model. In particular, we explain in quite general terms how the modification of the internal structure of hadrons in-medium leads naturally to three- and four-body forces, or equivalently, to density dependent effective interactions.

  12. Review of progress in the Canadian nuclear fuel waste management program

    SciTech Connect

    Lyon, R.B.; Johnson, L.H.

    1986-01-01

    The Canadian Nuclear Fuel Waste Management Program is reviewed, illustrating the progress that has been made in assessing the concept of disposal of nuclear fuel waste in plutonic rock of the Canadian Shield. Research is being conducted into used fuel storage and transportation, fuel waste immobilization, site characterization and selection methods, and performance assessment modelling. Details of achievements in these areas are outlined, and results of the most recent interim assessment are discussed.

  13. BOOK REVIEW: Therapeutic Applications of Monte Carlo Calculations in Nuclear Medicine

    NASA Astrophysics Data System (ADS)

    Coulot, J.

    2003-08-01

    H Zaidi and G Sgouros (eds) Bristol: Institute of Physics Publishing (2002) £70.00, ISBN: 0750308168 Monte Carlo techniques are involved in many applications in medical physics, and the field of nuclear medicine has seen a great development in the past ten years due to their wider use. Thus, it is of great interest to look at the state of the art in this domain, when improving computer performances allow one to obtain improved results in a dramatically reduced time. The goal of this book is to make, in 15 chapters, an exhaustive review of the use of Monte Carlo techniques in nuclear medicine, also giving key features which are not necessary directly related to the Monte Carlo method, but mandatory for its practical application. As the book deals with `therapeutic' nuclear medicine, it focuses on internal dosimetry. After a general introduction on Monte Carlo techniques and their applications in nuclear medicine (dosimetry, imaging and radiation protection), the authors give an overview of internal dosimetry methods (formalism, mathematical phantoms, quantities of interest). Then, some of the more widely used Monte Carlo codes are described, as well as some treatment planning softwares. Some original techniques are also mentioned, such as dosimetry for boron neutron capture synovectomy. It is generally well written, clearly presented, and very well documented. Each chapter gives an overview of each subject, and it is up to the reader to investigate it further using the extensive bibliography provided. Each topic is discussed from a practical point of view, which is of great help for non-experienced readers. For instance, the chapter about mathematical aspects of Monte Carlo particle transport is very clear and helps one to apprehend the philosophy of the method, which is often a difficulty with a more theoretical approach. Each chapter is put in the general (clinical) context, and this allows the reader to keep in mind the intrinsic limitation of each technique involved in dosimetry (for instance activity quantitation). Nevertheless, there are some minor remarks to be made, about the goal and general organization of the discussion. First, the book could not be considered to be strictly about the Monte Carlo method, but maybe also internal dosimetry and related Monte Carlo issues. Then, it must be noted that the discussion would sometimes have been clearer if SI units had been used instead of rad, or mCi, especially for European readers. There are some confusing features, which could lead to misconceptions, since sometimes authors refer to treatment planning softwares as Monte Carlo codes. If the precious contribution of a software like MIRDOSE to the field of radiation protection dosimetry must be underlined, it should not be considered, strictly speaking, as a Monte Carlo code. It would have been more interesting and relevant to provide a more exhaustive review of Monte Carlo codes (history of the code, transport algorithm, pros and cons), and to make a separate chapter for treatment planning and radiation protection softwares (3D-ID, MABDOS, MIRDOSE3) which are of clinical routine interest. However, this book is very interesting, of practical interest, and it should have its utility in all modern nuclear medicine departments interested in dosimetry, providing up-to-date data and references. It should be viewed as a good and well-documented handbook, or as a general introduction for beginners and students.

  14. From regenerative dentistry to regenerative medicine: progress, challenges, and potential applications of oral stem cells

    PubMed Central

    Xiao, Li; Nasu, Masanori

    2014-01-01

    Adult mesenchymal stem cells (MSCs) and epithelial stem cells play essential roles in tissue repair and self-healing. Oral MSCs and epithelial stem cells can be isolated from adult human oral tissues, for example, teeth, periodontal ligament, and gingiva. Cocultivated adult oral epithelial stem cells and MSCs could represent some developmental events, such as epithelial invagination and tubular structure formation, signifying their potentials for tissue regeneration. Oral epithelial stem cells have been used in regenerative medicine over 1 decade. They are able to form a stratified cell sheet under three-dimensional culture conditions. Both experimental and clinical data indicate that the cell sheets can not only safely and effectively reconstruct the damaged cornea in humans, but also repair esophageal ulcer in animal models. Oral MSCs include dental pulp stem cells (DPSCs), stem cells from exfoliated deciduous teeth (SHED), stem cells from apical papilla (SCAP), periodontal ligament stem cells (PDLSCs), and mesenchymal stem cells from gingiva (GMSCs). They are widely applied in both regenerative dentistry and medicine. DPSCs, SHED, and SCAP are able to form dentin–pulp complex when being transplanted into immunodeficient animals. They have been experimentally used for the regeneration of dental pulp, neuron, bone muscle and blood vessels in animal models and have shown promising results. PDLSCs and GMSCs are demonstrated to be ideal cell sources for repairing the damaged tissues of periodontal, muscle, and tendon. Despite the abovementioned applications of oral stem cells, only a few human clinical trials are now underway to use them for the treatment of certain diseases. Since clinical use is the end goal, their true regenerative power and safety need to be further examined. PMID:25506228

  15. "Nuclear" medicine physicians as communicators: their point of view on the aftermath of "nuclear" disaster.

    PubMed

    Staudenherz, Anton; Sinzinger, Helmut

    2012-02-01

    On March 11th, 2011 earthquakes and a subsequent tsunami devastated northern Japan. The consecutive technical catastrophe in the Fukushima Daiichi nuclear power plant was not only an additional local tragedy, it also turned out to be a global disaster. In this review we intend to discuss emerging problems and enlighten a way to communicate in such events, tell people how to react in such scenarios and prevent panic by providing rational information. PMID:22476594

  16. Nuclear waste management. Quarterly progress report, April-June 1980

    SciTech Connect

    Platt, A.M.; Powell, J.A.

    1980-09-01

    The status of the following programs is reported: high-level waste immobilization; alternative waste forms; Nuclear Waste Materials Characterization Center; TRU waste immobilization; TRU waste decontamination; krypton solidification; thermal outgassing; iodine-129 fixation; monitoring and physical characterization of unsaturated zone transport; well-logging instrumentation development; mobility of organic complexes of fission products in soils; waste management system studies; waste management safety studies; assessment of effectiveness of geologic isolation systems; waste/rock interactions technology; systems study on engineered barriers; criteria for defining waste isolation; spent fuel and fuel pool component integrity program; analysis of spent fuel policy implementation; asphalt emulsion sealing of uranium tailings; application of long-term chemical biobarriers for uranium tailings; and development of backfill material.

  17. Nuclear waste management. Quarterly progress report, April-June 1981

    SciTech Connect

    Chikalla, T.D.; Powell, J.A.

    1981-09-01

    Reports and summaries are presented for the following: high-level waste process development; alternative waste forms; TMI zeolite vitrification demonstration program; nuclear waste materials characterization center; TRU waste immobilization; TRU waste decontamination; krypton implantation; thermal outgassing; iodine-129 fixation; NWVP off-gas analysis; monitoring and physical characterization of unsaturated zone transport; well-logging instrumentation development; verification instrument development; mobility of organic complexes of radionuclides in soils; handbook of methods to decrease the generation of low-level waste; waste management system studies; waste management safety studies; assessment of effectiveness of geologic isolation systems; waste/rock interactions technology program; high-level waste form preparation; development of backfill materials; development of structural engineered barriers; disposal charge analysis; and analysis of spent fuel policy implementation.

  18. UCLA Particle and Nuclear Physics Research Group, 1993 progress report

    SciTech Connect

    Nefkens, B.M.K.; Clajus, M.; Price, J.W.; Tippens, W.B.; White, D.B.

    1993-09-01

    The research programs of the UCLA Particle and Nuclear Physics Research Group, the research objectives, results of experiments, the continuing activities and new initiatives are presented. The primary goal of the research is to test the symmetries and invariances of particle/nuclear physics with special emphasis on investigating charge symmetry, isospin invariance, charge conjugation, and CP. Another important part of our work is baryon spectroscopy, which is the determination of the properties (mass, width, decay modes, etc.) of particles and resonances. We also measure some basic properties of light nuclei, for example the hadronic radii of {sup 3}H and {sup 3}He. Special attention is given to the eta meson, its production using photons, electrons, {pi}{sup {plus_minus}}, and protons, and its rare and not-so-rare decays. In Section 1, the physics motivation of our research is outlined. Section 2 provides a summary of the research projects. The status of each program is given in Section 3. We discuss the various experimental techniques used, the results obtained, and we outline the plans for the continuing and the new research. Details are presented of new research that is made possible by the use of the Crystal Ball Detector, a highly segmented NaI calorimeter and spectrometer with nearly 4{pi} acceptance (it was built and used at SLAC and is to be moved to BNL). The appendix contains an update of the bibliography, conference participation, and group memos; it also indicates our share in the organization of conferences, and gives a listing of the colloquia and seminars presented by us.

  19. Advancing the science of dissemination and implementation in behavioral medicine: evidence and progress.

    PubMed

    Chan, Carina K Y; Oldenburg, Brian; Viswanath, Kasisomayajula

    2015-06-01

    The enormous time lag between the discovery of new knowledge and its implementation poses a significant challenge to improving public health because of the very slow uptake into policy and practice. The field of dissemination and implementation research in behavioral medicine is receiving increased attention because of the keen interest in accelerating knowledge transfer from relevant research to improve the health and wellbeing of populations in many different settings, contexts, and countries around the world. This is particularly important in high-risk populations, resource-poor and developing regions of the world where the difference in health systems, languages, and cultures very significantly influences the translation of evidence into policy and practice. Moreover, demonstrating the broader societal and economic value of behavioral interventions in settings where they are implemented can further support the sustainability, uptake, and implementation of these findings in other settings and contexts. This special issue presents a series of empirical studies, reviews, and case studies that address dissemination, implementation, and translation issues in both developed and developing countries. Specifically, the learnings from the application of many and varied theories and research methodologies are very relevant for bridging the current division between research findings and their translation and uptake into policy and practice. PMID:26001382

  20. Studies of nuclear processes at the Triangle Universities Nuclear Laboratory. Progress report, 1 September 1994--31 August 1995

    SciTech Connect

    Ludwig, E.J.

    1995-09-01

    The Triangle Universities Nuclear Laboratory (TUNL)--a collaboration of Duke University, North Carolina State University, and the University of North Carolina at Chapel Hill--has had a very productive year. This report covers the second year of a three-year grant between the US Department of Energy and the three collaborating universities. The TUNL research program focuses on the following areas of nuclear physics: parity violation in neutron and charged-particle resonances--the mass and energy dependence of the weak interaction spreading width; chaotic behavior in {sup 30}P from studies of eigenvalue fluctuations in nuclear level schemes; studies of few-body systems; nuclear astrophysics; nuclear data evaluation for A = 3--20, for which TUNL is now the international center; high-spin spectroscopy and superdeformation in nuclei, involving collaborations at Argonne National Laboratory. Developments in technology and instrumentation have been vital to the research and training program. In this progress report the author describes: a proposed polarized {gamma}-beam facility at the Duke Free Electron Laser Laboratory; cryogenic systems and microcalorimeter development; continuing development of the Low Energy Beam Facility. The research summaries presented in this progress report are preliminary.

  1. Theoretical studies in hadronic and nuclear physics. Progress report, December 1, 1992--June 30 , 1993

    SciTech Connect

    Griffin, J.J.; Cohen, T.D.

    1993-07-01

    Research in the Maryland Nuclear Theory Group focusses on problems in four basic areas of current relevance. The section on Hadrons in Nuclei reports research into the ways in which the properties of nucleons and the mesons which play a role in the nuclear force are modified in the nuclear medium. QCD sum rules supply a new insight into the decrease of the nucleon`s mass in the nuclear medium. The quark condensate decreases in nuclear matter, and this is responsible for the decrease of the nucleon`s mass. The section on the Structure of Hadrons reports progress in understanding the structure of the nucleon. These results cover widely different approaches -- lattice gauge calculations, QCD sum rules, quark-meson models with confinement and other hedgehog models. Progress in Relativistic Nuclear Physics is reported on electromagnetic interactions in a relativistic bound state formalism, with applications to elastic electron scattering by deuterium, and on application of a two-body quasipotential equation to calculate the spectrum of mesons formed as bound states of a quark and antiquark. A Lorentz-invariant description of the nuclear force suggests a decrease of the nucleon`s mass in the nuclear medium similar to that found from QCD sum rules. Calculations of three-body bound states with simple forms of relativistic dynamics are also discussed. The section on Heavy Ion Dynamics and Related Processes describes progress on the (e{sup +}e{sup {minus}}) problem and heavy-on dynamics. In particular, the sharp electrons observed in {beta}{sup +} irradiation of heavy atoms have recently been subsumed into the ``Composite Particle Scenario,`` generalizing the ``(e{sup +}e{sup {minus}}-Puzzle`` of the pairs from heavy ion collisions to the ``Sharp Lepton Problem.``

  2. A program in medium-energy nuclear physics. Progress report, August 1, 1991--August 31, 1992

    SciTech Connect

    Berman, B.L.; Dhuga, K.S.

    1998-06-01

    This report reviews progress on our nuclear-physics program for the last year, and includes as well copies of our publications and other reports for that time period, The structure of this report follows that of our 1991 Renewal Proposal and Progress Report: Sec. II outlines our research activities aimed at future experiments at CEBAF, NIKHEF, and Bates; Sec. III gives results of our recent research activities at NIKHEF, LAMPF, and elsewhere; Sec. IV provides an update of our laboratory activities at GWU, including the acquisition of our new Nuclear Detector Laboratory at our new Virginia campus; and Sec. V is a list of our publications, proposals, and other reports. Copies of those on medium-energy nuclear physics are reproduced in the Appendix.

  3. [Leprosy and medicine II--progress and establishment of an absolute isolation policy].

    PubMed

    Mori, Shuichi; Ishii, Norihisa

    2007-02-01

    The leprosy policy of Japan began from when the government enacted "law No. 11 (The leprosy prevention act)" in 1907 (Meiji 40) and several leprosy sanatoriums were built to receive previously homeless patients. Then, with the rise of totalitarianism, the isolation policy of Japan gained national support under the slogan "Patient Relief", which would become a major factor behind the enactment of "Leprosy Prevention Law" in 1931 (Showa 6) by which the leprosy policy was changed to one of absolute isolation aimed at the internment of all leprosy patients. From recent research on the leprosy policy of Japan, the internment of all leprosy patients, isolation for life, social defense, and neglect of patients' human-rights had tragic results in many cases. However, there is little research which can reply clearly to the question of whether the leprosy policy of Japan was really original and what factors led to the formation of the absolute isolation policy. This paper focuses on the relation between leprosy policy and treatment, and from this, I make clear the similarities, or peculiarities, of the isolation policy between Japan and the rest of the world, while clarifying the factors associated with the progress of the absolute isolation policy. The processes involved were historical and medical historical in that the relation between the formation of a national health system and the progress of the isolation policy of Meiji Era, the proposal of the isolation policy by Dr. Keizo Dohi, Dr. Shibasaburo Kitasato, and Dr. Masatsugu Yamane; the practical application of this policy by Dr. Kensuke Mitsuda, and the decision to enact this policy and its support by the Health and Medical Bureau and the Department of the Interior, as well as many other factors, all contributed to the final implementation of the absolute isolation policy. PMID:17315749

  4. Nuclear waste management. Quarterly progress report, January-March, 1981

    SciTech Connect

    Chikalla, T.D.; Powell, J.A.

    1981-06-01

    Reports and summaries are provided for the following programs: high-level waste process development; alternative waste forms; nuclear waste materials characterization center; TRU waste immobilization; TRU waste decontamination; krypton solidification; thermal outgassing; iodine-129 fixation; NWVP off-gas analysis; monitoring and physical characterization of unsaturated zone transport; well-logging instrumentation development; verification instrument development; mobility of organic complexes of radionuclide in soils; low-level waste generation reduction handbook; waste management system studies; assessment of effectiveness of geologic isolation systems; waste/rock interactions technology program; high-level waste form preparation; development of backfill materials; development of structural engineered barriers; disposal charge analysis; analysis of spent fuel policy implementation; spent fuel and pool component integrity program; analysis of postulated criticality events in a storage array of spent LWR fuel; asphalt emulsion sealing of uranium mill tailings; liner evaluation for uranium mill tailings; multilayer barriers for sealing of uranium tailings; application of long-term chemical biobarriers for uranium tailings; and revegetation of inactive uranium tailings sites.

  5. Essential Roles for Caenorhabditis elegans Lamin Gene in Nuclear Organization, Cell Cycle Progression, and Spatial Organization of Nuclear Pore Complexes

    PubMed Central

    Liu, Jun; Ben-Shahar, Tom Rolef; Riemer, Dieter; Treinin, Millet; Spann, Perah; Weber, Klaus; Fire, Andrew; Gruenbaum, Yosef

    2000-01-01

    Caenorhabditis elegans has a single lamin gene, designated lmn-1 (previously termed CeLam-1). Antibodies raised against the lmn-1 product (Ce-lamin) detected a 64-kDa nuclear envelope protein. Ce-lamin was detected in the nuclear periphery of all cells except sperm and was found in the nuclear interior in embryonic cells and in a fraction of adult cells. Reductions in the amount of Ce-lamin protein produce embryonic lethality. Although the majority of affected embryos survive to produce several hundred nuclei, defects can be detected as early as the first nuclear divisions. Abnormalities include rapid changes in nuclear morphology during interphase, loss of chromosomes, unequal separation of chromosomes into daughter nuclei, abnormal condensation of chromatin, an increase in DNA content, and abnormal distribution of nuclear pore complexes (NPCs). Under conditions of incomplete RNA interference, a fraction of embryos escaped embryonic arrest and continue to develop through larval life. These animals exhibit additional phenotypes including sterility and defective segregation of chromosomes in germ cells. Our observations show that lmn-1 is an essential gene in C. elegans, and that the nuclear lamins are involved in chromatin organization, cell cycle progression, chromosome segregation, and correct spacing of NPCs. PMID:11071918

  6. [Conservative calibration of a clearance monitor system for waste material from nuclear medicine].

    PubMed

    Wanke, Carsten; Geworski, Lilli

    2014-09-01

    Clearance monitor systems are used for gross gamma measurements of waste potentially contaminated with radioactivity. These measurements are to make sure that legal requirements, e.g. clearance criteria according to the german radiation protection ordinance, are met. This means that measurement results may overestimate, but must not underestimate the true values. This paper describes a pragmatic way using a calibrated Cs-137 point source to generate a conservative calibration for the clearance monitor system used in the Medizinische Hochschule Hannover (MHH). The most important nuclides used in nuclear medicine are considered. The measurement result reliably overestimates the true value of the activity present in the waste. The calibration is compliant with the demands for conservativity and traceability to national standards. PMID:24560040

  7. Assessment of metabolic bone disease: review of new nuclear medicine procedures

    SciTech Connect

    Wahner, H.W.

    1985-12-01

    In the management of patients with metabolic bone disease, nuclear medicine laboratories offer two nontraumatic procedures of potential clinical importance: bone mineral measurements and bone scintigraphy. Bone mineral measurements from the radius, lumbar spine, and hip obtained with use of absorptiometry or computed tomography can be used to predict the risk of fracture at these skeletal sites, can determine the severity of bone loss for the assessment of a benefit-versus-risk ratio on which appropriate therapy can be based, and can substantiate the effectiveness of therapy over time. Bone scintigraphy with use of labeled diphosphonate allows assessment of focal and, in defined circumstances, of total skeletal bone turnover in patients with normal kidney function. Both of these techniques have been used successfully in studies of population groups for the evaluation of trends. Their application to the management of individual patients is currently being evaluated. 41 references.

  8. Nuclear Medicine Imaging of Infection in Cancer Patients (With Emphasis on FDG-PET)

    PubMed Central

    Vos, Fidel J.; van der Graaf, Winette T.A.; Oyen, Wim J.G.

    2011-01-01

    Infections are a common cause of death and an even more common cause of morbidity in cancer patients. Timely and adequate diagnosis of infection is very important. This article provides clinicians as well as nuclear medicine specialists with a concise summary of the most important and widely available nuclear medicine imaging techniques for infectious and inflammatory diseases in cancer patients with an emphasis on fluorodeoxyglucose positron emission tomography (FDG-PET). 67Ga-citrate has many unfavorable characteristics, and the development of newer radiopharmaceuticals has resulted in the replacement of 67Ga-citrate scintigraphy by scintigraphy with labeled leukocytes or FDG-PET for the majority of conditions. The sensitivity of labeled leukocyte scintigraphy in non-neutropenic cancer patients is comparable with that in patients without malignancy. The specificity, however, is lower because of the uptake of labeled leukocytes in many primary tumors and metastases, most probably as a result of their inflammatory component. In addition, labeled leukocyte scintigraphy cannot be used for febrile neutropenia because of the inability to harvest sufficient peripheral leukocytes for in vitro labeling. FDG-PET has several advantages over these conventional scintigraphic techniques. FDG-PET has shown its usefulness in diagnosing septic thrombophlebitis in cancer patients. It has also been shown that imaging of infectious processes using FDG-PET is possible in patients with severe neutropenia. Although larger prospective studies examining the value of FDG-PET in cancer patients suspected of infection, especially in those with febrile neutropenia, are needed, FDG-PET appears to be the most promising scintigraphic technique for the diagnosis of infection in this patient group. PMID:21680576

  9. Self-irradiation of the blood from selected nuclides in nuclear medicine

    NASA Astrophysics Data System (ADS)

    Hänscheid, H.; Fernández, M.; Eberlein, U.; Lassmann, M.

    2014-03-01

    Nuclear medicine dosimetry and research in biodosimetry often require the knowledge of the absorbed dose to the blood. This study provides coefficients for the absorbed dose rates to the blood related to the activity concentration in the blood as a function of the vessel radius for radionuclides commonly used in targeted radiotherapy and in PET-diagnostics: C-11, F-18, Ga-68, Y-90, Tc-99 m, I-124, I-131, and Lu-177. The energy deposition patterns after nuclear disintegrations in blood vessel lumina (cylinders homogeneously filled with blood) with radii from 0.01 to 25.0 mm were simulated with the Monte-Carlo radiation transport code MCNPX. An additional contribution from photon radiation from activity in blood in the remainder of the body was taken into account based on a reasonable blood distribution model. The fraction of energy absorbed from non-penetrating radiation in the blood is low in thin blood vessels but approaches the total energy emitted by particles with increasing lumen radius. For photon radiation, irradiation to blood in small vessels is almost completely due to radioactive decays in distant blood distributed throughout the body, whereas the contribution from activity in the vessel becomes dominant for lumen radii exceeding 13 mm. The dependences of the absorbed dose rates on the lumen radius can be described with good accuracy by empirical functions which can be used to determine the absorbed doses to the blood and to the surrounding tissue.

  10. Ambient Dose Equivalent measured at the Instituto Nacional de Cancerología Department of Nuclear Medicine

    NASA Astrophysics Data System (ADS)

    Ávila, O.; Torres-Ulloa, C. L.; Medina, L. A.; Trujillo-Zamudio, F. E.; de Buen, I. Gamboa; Buenfil, A. E.; Brandan, M. E.

    2010-12-01

    Ambient dose equivalent values were determined in several sites at the Instituto Nacional de Cancerología, Departmento de Medicina Nuclear, using TLD-100 and TLD-900 thermoluminescent dosemeters. Additionally, ambient dose equivalent was measured at a corridor outside the hospitalization room for patients treated with 137Cs brachytherapy. Dosemeter calibration was performed at the Instituto Nacional de Investigaciones Nucleares, Laboratorio de Metrología, to known 137Cs gamma radiation air kerma. Radionuclides considered for this study are 131I, 18F, 67Ga, 99mTc, 111In, 201Tl and 137Cs, with main gamma energies between 93 and 662 keV. Dosemeters were placed during a five month period in the nuclear medicine rooms (containing gamma-cameras), injection corridor, patient waiting areas, PET/CT study room, hot lab, waste storage room and corridors next to the hospitalization rooms for patients treated with 131I and 137Cs. High dose values were found at the waste storage room, outside corridor of 137Cs brachytherapy patients and PET/CT area. Ambient dose equivalent rate obtained for the 137Cs brachytherapy corridor is equal to (18.51±0.02)×10-3 mSv/h. Sites with minimum doses are the gamma camera rooms, having ambient dose equivalent rates equal to (0.05±0.03)×10-3 mSv/h. Recommendations have been given to the Department authorities so that further actions are taken to reduce doses at high dose sites in order to comply with the ALARA principle (as low as reasonably achievable).

  11. Ambient Dose Equivalent measured at the Instituto Nacional de Cancerologia Department of Nuclear Medicine

    SciTech Connect

    Avila, O.; Torres-Ulloa, C. L.; Medina, L. A.; Trujillo-Zamudio, F. E.; Gamboa de Buen, I.; Buenfil, A. E.; Brandan, M. E.

    2010-12-07

    Ambient dose equivalent values were determined in several sites at the Instituto Nacional de Cancerologia, Departmento de Medicina Nuclear, using TLD-100 and TLD-900 thermoluminescent dosemeters. Additionally, ambient dose equivalent was measured at a corridor outside the hospitalization room for patients treated with {sup 137}Cs brachytherapy. Dosemeter calibration was performed at the Instituto Nacional de Investigaciones Nucleares, Laboratorio de Metrologia, to known {sup 137}Cs gamma radiation air kerma. Radionuclides considered for this study are {sup 131}I, {sup 18}F, {sup 67}Ga, {sup 99m}Tc, {sup 111}In, {sup 201}Tl and {sup 137}Cs, with main gamma energies between 93 and 662 keV. Dosemeters were placed during a five month period in the nuclear medicine rooms (containing gamma-cameras), injection corridor, patient waiting areas, PET/CT study room, hot lab, waste storage room and corridors next to the hospitalization rooms for patients treated with {sup 131}I and {sup 137}Cs. High dose values were found at the waste storage room, outside corridor of {sup 137}Cs brachytherapy patients and PET/CT area. Ambient dose equivalent rate obtained for the {sup 137}Cs brachytherapy corridor is equal to (18.51{+-}0.02)x10{sup -3} mSv/h. Sites with minimum doses are the gamma camera rooms, having ambient dose equivalent rates equal to (0.05{+-}0.03)x10{sup -3} mSv/h. Recommendations have been given to the Department authorities so that further actions are taken to reduce doses at high dose sites in order to comply with the ALARA principle (as low as reasonably achievable).

  12. The American College of nuclear physicians 18th annual meeting and scientific sessions DOE day: Substance abuse and nuclear medicine abstracts

    SciTech Connect

    Not Available

    1992-02-01

    Despite the enormous personal and social cost Of substance abuse, there is very little knowledge with respect to the mechanisms by which these drugs produce addiction as well as to the mechanisms of toxicity. Similarly, there is a lack of effective therapeutic intervention to treat the drug abusers. In this respect, nuclear medicine could contribute significantly by helping to gather information using brain imaging techniques about mechanisms of drug addiction which, in turn, could help design better therapeutic interventions, and by helping in the evaluation and diagnosis of organ toxicity from the use of drugs of abuse. This volume contains six short descriptions of presentations made at the 18th Meeting of the American College of Nuclear Physicians -- DOE Day: Substance Abuse and Nuclear Medicine.

  13. Nuclear magnetic resonance studies of granular flows: Technical progress report, quarter ending 09/30/93

    SciTech Connect

    Not Available

    1993-10-27

    This Technical Progress Report for the quarter ending 09/30/93 describes work on two tasks which are part of nuclear magnetic resonance studies of granular flows. (1) Research has been directed toward improving concentration measurements under reasonably fast conditions. (2) The process continues of obtaining comprehensive velocity, concentration, and diffusion information at several angular velocities of the cylinder for seeds (mustard, sesame, and sunflower seeds) flowing in a half-filled cylinder.

  14. A program in medium energy nuclear physics. Progress report, January 1, 1992--March 31, 1995

    SciTech Connect

    Berman, B.L.; Dhuga, K.S.

    1995-10-01

    This progress report and continuation proposal summarizes our achievements for the period from July 1, 1994 to September 30, 1995 and requests continued funding for our program in experimental medium-energy nuclear physics. The focus of our program remains the understanding of the short-range part of the strong interaction in the nuclear medium. In the past year we have focused our attention ever more sharply on experiments with real tagged photons, and we have successfully defended two new experimental proposals: Photofission of Actinide and Preactinide Nuclei at SAL and Photoproduction of the {rho} Meson from the Proton with Linearly Polarized Photons at CEBAF. (We are co-spokespersons on two previously approved Hall-B experiments at CEBAF, Photoreactions on {sup 3}He and Photoabsorption and Photofission of Nuclei.) As part of the team that is instrumenting the Photon Tagger for Hall B; we report excellent progress on the focal-plane detector array that is being built at our Nuclear Detector Laboratory, as well as progress on our plans for instrumentation of a tagged polarized-photon beam using coherent bremsstrahlung. Also, we shall soon receive a large computer system (from the SSC) which will form the basis for our new Data Analysis Center, which, like the Nuclear Detector Laboratory, will be operated under the auspices of The George Washington University Center for Nuclear Studies. Finally, during the past year we have published six more papers on the results of our measurements of pion scattering at LAMPF and of electron scattering at NIKHEF and Bates, and we can report that nearly all of the remaining papers documenting this long series of measurements are in the pipeline.

  15. Nuclear medicine techniques in Merkel cell carcinoma: A case report and review of the literature

    PubMed Central

    KRITIKOS, NIKOLAOS; PRIFTAKIS, DIMITRIOS; STAVRINIDES, STAVROS; KLEANTHOUS, STEFANOS; SARAFIANOU, ELENI

    2015-01-01

    Merkel cell carcinoma (MCC) is a rare and aggressive type of neuroendocrine cancer of the skin. It predominantly affects the elderly, with a predilection for the sun-exposed skin of the head and neck. Risk factors include immune-suppressing diseases, such as human immunodeficiency virus (HIV), chronic lymphocytic leukemia and multiple myeloma, organ transplantation, and the presence of the newly-identified Merkel cell polyomavirus (MCPyV). Diagnosis is based on pathological findings, primarily the immunohistochemical determination of cytokeratin 20 positivity. By contrast, staging relies on conventional imaging methods, such as ultrasonography, computed tomography (CT) and magnetic resonance imaging, and nuclear medicine techniques, such as sentinel lymph node scintigraphy, somatostatin receptor scintigraphy (SRS), and positron emission tomography (PET)/CT with 18F-fluorodeoxyglucose (FDG) or alternative radiopharmaceuticals. The treatment of MCC is primarily surgical, with possible adjuvant radiation, while the use of chemotherapy appears to be an alternative therapeutic option that is used only in specific cases. The present study describes the case of a 43-year-old HIV-positive Caucasian man with MCC located on the posterior surface of the left thigh, which was identified by cytological and histological examination of tissue sampled by fine needle aspiration and biopsy performed under CT. SRS demonstrated a high uptake of 111In-diethylene triamine pentaacetic acid-octreotide at the affected site. Therefore, the lesion was surgically excised, and the patient received chemotherapy and adjuvant radiotherapy. Three months subsequent to treatment, the patient underwent a PET/CT scan with 18F-FDG that demonstrated uptake in the cervical lymph nodes and the area of the excised lesion. These findings indicated that the disease was in remission. The aim of the present study was to highlight the value and contribution of nuclear medicine in the diagnosis, staging and follow-up, using PET/CT, octreoscan and sentinel lymph node scintigraphy, of patients with MCC, as well as the therapeutic strategy of radiolabelled somatostatin analogue scintigraphy. PMID:26622719

  16. Application of the ARRAMIS Risk and Reliability Software to the Nuclear Accident Progression

    SciTech Connect

    Wyss, Gregory D.; Daniel, Sharon L.; Hays, Kelly M.; Brown, Thomas D.

    1997-06-01

    The ARRAMIS risk and reliability analysis software suite developed by Sandia National Laboratories enables analysts to evaluate the safety and reliability of a wide range of complex systems whose failure results in high consequences. This software was originally designed to model the systems, responses, and phenomena associated with potential severe accidents at commercial nuclear power reactors by solving very large fault tree and event tree models. However, because of its power and versatility, ARRAMIS and its constituent analysis engines have recently been used to evaluate a wide variety of systems, including nuclear weapons, telecommunications facilities, robotic material handling systems, and aircraft systems using hybrid fault tree event tree analysis techniques incorporating fully integrated uncertainty analysis capabilities. This paper describes recent applications in the area of nuclear reactor accident progression analysis using a large event tree methodology and the ARRAMIS package.

  17. Division of Nuclear Physics Mentoring Award Talk: Progress in Mentoring of Young Scientists in Nuclear Physics

    NASA Astrophysics Data System (ADS)

    Thoennessen, Michael

    2012-10-01

    The future of nuclear physics depends on attracting and retaining bright students. Several initiatives have begun to address issues related to successful recruiting and retention on various levels. Examples for undergraduate students, graduate students, post-docs, and faculty include the Conference Experience for Undergraduates at DNP meetings, the APS/AAPT Conference on Graduate Education, the NSF requirement for a post-doctoral mentoring plan, and the AAPT/AAS/APS New Faculty Workshops, respectively. In addition to these organized efforts, each member of the community can and should contribute to portraying nuclear physics as the exciting field that it is.

  18. Agency for Nuclear Projects/Nuclear Waste Project Office final progress report

    SciTech Connect

    1992-12-31

    The Nevada Agency for Nuclear Projects/Nuclear Waste Project Office (NWPO) was formally established by Executive Policy in 1983 following passage of the federal Nuclear Waste Policy Act of 1982 (Act). That Act provides for the systematic siting, construction, operation, and closure of high-level radioactive defense and research by-products and other forms of high-level radioactive waste from around the country which will be stored at such repositories. In 1985 the Nevada legislature formally established the NWPO as a distinct and statutorily authorized agency to provide support to the Governor and State Legislature on matters concerning the high-level nuclear waste programs. The NWPO utilized a small, central staff supplemented by contractual services for needed technical and specialized expertise in order to provide high quality oversight and monitoring of federal activities, to conduct necessary independent studies, and to avoid unnecessary duplication of efforts. This report summarizes the results of this ongoing program to ensure that risks to the environment and to human safety are minimized. It includes findings in the areas of hydrogeology, geology, quality assurance activities, repository engineering, legislature participation, socioeconomic affects, risk assessments, monitoring programs, public information dissemination, and transportation activities. The bulk of the reporting deals with the Yucca Mountain facility.

  19. Dose received by occupationally exposed workers at a nuclear medicine department

    NASA Astrophysics Data System (ADS)

    Ávila, O.; Sánchez-Uribe, N. A.; Rodríguez-Laguna, A.; Medina, L. A.; Estrada, E.; Buenfil, A. E.; Brandan, M. E.

    2012-10-01

    Personal Dose Equivalent (PDE) values were determined for occupational exposed workers (OEW) at the Nuclear Medicine Department (NMD) of "Instituto Nacional de Cancerología" (INCan), Mexico, using TLD-100 thermoluminescent dosemeters. OEW at NMD, INCan make use of radiopharmaceuticals for diagnosis and treatment of diseases. Radionuclides associated to a pharmaceutical compound used at this Department are 131I, 18F, 68Ga, 99mTc, 111In and 11C with main gamma emission energies between 140 and 511 keV. Dosemeter calibration was performed at the metrology department of "Instituto Nacional de Investigaciones Nucleares" (ININ), Mexico. Every occupational worker used dark containers with three dosimeters which were replaced monthly for a total of 5 periods. Additionally, control dosemeters were also placed at a site free of radioactive sources in order to determine the background radiation. Results were adjusted to find PDE/day and estimating annual PDE values in the range between 2 mSv (background) and 9 mSv. The mean annual value is 3.51 mSv and the standard deviation SD is 0.78 mSv. Four of the 16 OEW received annual doses higher than the average +1 SD (4.29 mSv). Results depend on OEW daily activities and were consistent for each OEW for the 5 studied periods as well as with PDE values reported by the firm that performs the monthly service. All obtained values are well within the established annual OEW dose limit stated in the "Reglamento General de Seguridad Radiológica", México (50 mSv), as well as within the lower limit recommended by the "International Commission on Radiation Protection" (ICRP), report no.60 (20 mSv). These results verify the adequate compliance of the NMD at INCan, Mexico with the norms given by the national regulatory commission.

  20. Current Status of Nuclear Medicine Practice in Latin America and the Caribbean.

    PubMed

    Páez, Diana; Orellana, Pilar; Gutiérrez, Claudia; Ramirez, Raúl; Mut, Fernando; Torres, Leonel

    2015-10-01

    The practice of nuclear medicine (NM) in the Latin American and Caribbean region has experienced important growth in the last decade. However, there is great heterogeneity among countries regarding the availability of technology and human resources. According to data collected through June 2014 by the International Atomic Energy Agency (IAEA), the total number of ? cameras in the region is 1,231, with an average of 2.16 per million inhabitants. Over 90% of the equipment is SPECT cameras; 7.6% of which have hybrid technology. There are 161 operating PET or PET/CT cameras in 12 member states, representing a rate of 0.3 per million people. Most NM centers belong to the private health system and are in capitals or major cities. Only 4 countries have the capability of assembling 99Mo-99mTc generators, and 2 countries produce 99mTc from nuclear reactors. Cold kits are produced in some countries, and therapeutic agents are mostly imported from outside the region. There are 35 operative cyclotrons. In relation to human resources: there is 1 physician per ? camera, 1.6 technologists per ? camera, 0.1 medical physicist per center, and approximately 0.1 radiochemist or radiopharmacist per center. Nearly 94% of the procedures are diagnostic. PET studies represent about 4% of the total. The future of NM in the Latin American and Caribbean region is promising, with great potential and possibilities. Some of the most important factors driving the region toward greater homogeneity in the availability and application of NM, and bridging the gaps between countries, are clinician awareness of the importance of NM in managing diseases prevalent in the region, increased building of capacity, continuous and strong support from international organizations such as the IAEA through national and regional projects, and strong public-private partnerships and government commitment. PMID:26229143

  1. Dose received by occupationally exposed workers at a nuclear medicine department

    SciTech Connect

    Avila, O.; Sanchez-Uribe, N. A.; Rodriguez-Laguna, A.; Medina, L. A.; Estrada, E.; Buenfil, A. E.; Brandan, M. E.

    2012-10-23

    Personal Dose Equivalent (PDE) values were determined for occupational exposed workers (OEW) at the Nuclear Medicine Department (NMD) of 'Instituto Nacional de Cancerologia' (INCan), Mexico, using TLD-100 thermoluminescent dosemeters. OEW at NMD, INCan make use of radiopharmaceuticals for diagnosis and treatment of diseases. Radionuclides associated to a pharmaceutical compound used at this Department are {sup 131}I, {sup 18}F, {sup 68}Ga, {sup 99m}Tc, {sup 111}In and {sup 11}C with main gamma emission energies between 140 and 511 keV. Dosemeter calibration was performed at the metrology department of 'Instituto Nacional de Investigaciones Nucleares' (ININ), Mexico. Every occupational worker used dark containers with three dosimeters which were replaced monthly for a total of 5 periods. Additionally, control dosemeters were also placed at a site free of radioactive sources in order to determine the background radiation. Results were adjusted to find PDE/day and estimating annual PDE values in the range between 2 mSv (background) and 9 mSv. The mean annual value is 3.51 mSv and the standard deviation SD is 0.78 mSv. Four of the 16 OEW received annual doses higher than the average +1 SD (4.29 mSv). Results depend on OEW daily activities and were consistent for each OEW for the 5 studied periods as well as with PDE values reported by the firm that performs the monthly service. All obtained values are well within the established annual OEW dose limit stated in the {sup R}eglamento General de Seguridad Radiologica{sup ,} Mexico (50 mSv), as well as within the lower limit recommended by the 'International Commission on Radiation Protection' (ICRP), report no.60 (20 mSv). These results verify the adequate compliance of the NMD at INCan, Mexico with the norms given by the national regulatory commission.

  2. Nuclear medicine program progress report for quarter ending December 31, 1991

    SciTech Connect

    Knapp, F.F. Jr.; Ambrose, K.R.; Callahan, A.P.; McPherson, D.W.; Mirzadeh, S.; Srivastava, P.C.; Hasan, A.; Lambert, C.R.; Lambert, S.J.; Rice, D.E.

    1992-04-01

    This report presents information on (1) a new improved synthesis of carrier-free rhenium-188-labeled Re(V) dimercaptosuccinic acid (DMSA) complex as a potential therapeutic agent for treatment of thyroid medullary carcinoma; and (2) the synthesis and evaluation of a series of iodine-125-labeled analogues of altanserine for imaging of serotonin receptors.

  3. Progress on the Development of High Spatial Resolution Imaging Techniques in Nuclear Medicine

    E-print Network

    period mt, or in a combination in a time period less than mt (where mt is much shorter than the half-life for PET are random coincidence, movement of positron from the decay site, etc. As a trivial example

  4. Nuclear Medicine Program progress report for quarter ending September 30, 1990

    SciTech Connect

    Knapp, F.F. Jr.; Ambrose, K.R.; Callahan, A.P.; McPherson, D.W.; Mirzadeh, S.; Srivastava, P.C.; Allred, J.F.; Hasan, A.; Lambert, C.R.; Lambert, S.J.; Rice, D.E.

    1991-02-01

    An evaluation of the Oak Ridge National Laboratory (ORNL) alumina-based tungsten-188/rhenium-188 (W-188/Re-188) generator system has continued. Our goal is to develop a prototype system which will provide sufficient levels of Re-188 for radiolabeling of tumor-specific antibodies for radioimmunotherapy. During this review period several samples were supplied for collaborative studies. Samples of rhenium-188 from the ORNL W-188/Re-188 generators were supplied to the National Institutes of Standards and Technology (NIST) as a calibration standard. Iodine-125-labeled IMP protein labeling agent was supplied to the University of Michigan for antibody radiolabeling studies (D. Buchsbaum, Ph.D.). The iodine-123-labeled BMIPP fatty acid analogue developed at ORNL was also supplied to collaborators at BNL for SPECT imaging studies of the effects of cocaine intoxication on myocardial fatty acid uptake in a canine model. Iodine-125-BMIPP was also supplied to the University of Bonn, Germany for continuing metabolic studies in an isolated heart model. In this report the resumption of radioisotope production in the HFIR following the restart of this important facility in July 1990 and the preparation and review and evaluation of issues for the DOE Tiger Team visit to ORNL on November 1--December 7 are also discussed. 2 figs., 1 tab.

  5. Nuclear medicine program progress report for quarter ending December 31, 1992

    SciTech Connect

    Knapp, F.F. Jr.; Ambrose, K.R.; Beets, A.L.; Callahan, A.P.; McPherson, D.W.; Mirzadeh, S.; Hasan, A.; Lambert, C.R.

    1993-03-01

    We describe the synthesis of the cis- and trans-iodovinyl isomers of the new ORNL cholinergic-muscarinicreceptorligand, 1 -azabicyclo[2.2-2]oct-3-yl[alpha]-hydroxy-[alpha]-(1-iodo-l-propen-3-yl)-[alpha]-phenylacetate ( IQNP''). This agent is prepared in high radiochemical yield, and the racemic mixture shows high specificity and selectivity for the cerebral and myocardial receptors. Since two chiral centers are present in this molecule, it is important to evaluate the importance of the absolute configuration of the two centers on receptor specificity. The tributyltin substrates were carefully separated by column chromatography, converted to the iodine-125 analogues by iododestannylation, and evaluated in rats in vivo. While the E'' (trans) isomer cleared rapidly from the receptor-rich areas of rat brain, the Z'' (cis) isomer showed high uptake in these areas but also high concentration in the cerebellum. In contrast, the E,Z-isomeric mixture showed good uptake and retention in the receptor rich areas. Also described in this report is a description of neutron flux measurements in the hydraulic tube position at the ORNL High Flux Isotope Reactor (HFIR). Also during this period, samples of [l-125]- and [l-131]-labeled racemic IQNP'' were supplied through a collaborative program with the Brookhaven National Laboratory for high resolution autoradiographic studies in rat tissues.

  6. Nuclear Medicine Program progress report for quarter ending March 31, 1993

    SciTech Connect

    Knapp, F.F. Jr.; Ambrose, K.R.; Beets, A.L.; Callahan, A.P.; McPherson, D.W.; Mirzadeh, S.; Lambert, C.R.

    1993-04-01

    We have exploring the possibility of measuring urinary radioactivity as an index of pancreatic lipase activity after oral administration of a new triglyceride containing a radioactive iodine-1 25-labeled fatty acid moiety. The new agent, 1,2-dipalmitoyl-3[15-(p-iodophenyl)pentandecan-l-oyl]-racglycerol (1,2-Pal-3-IPPA), was prepared by the thallation-iodide displacement method. Following oral gavage of the radioiodinated triglyceride to rats, about 30% of the administered activity was excreted in 24 hours in the urine. In normal human controls an higher urinary excretion (of about 75% was observed. In this report, we describe an evaluation of the metabolites excreted in the urine and the chemical species stored in adipose from rats. The urine activity co-chromatographed with hippuric acid by TLC indicating conjugation of the IPPA metabolites. Release of the acidic components from the conjugated excretory products by acid hydrolysis of the urine provided the radioactive acidic IPPA metabolites. Analysis of the Folch extracts of fat samples from rats demonstrated that the radioactive components co-chromatographed In the triglyceride region. Recent studies in patients with compromised pancreatic exocrine function have demonstrated significantly decreased 24 hr. urinary excretion of about 25%, following oral administration of [1 -1 31]-1,2-Pal-3-IPPA. Thus, urine analysis after oral administration of [I -1 31]-1,2-Pal-3-IPPA may be a simple, non-invasive tool for the clinical evaluation of various diseases involving dietary fat digestion.

  7. [Radiopharmacokinetics: Utilization of nuclear medicine]. Comprehensive progress report, [1986--1989

    SciTech Connect

    Wolf, W.

    1989-12-31

    The work performed in the 1986/1989 period can be characterized as one of testing and documenting that the Radiopharmacokinetic technique is both feasible and applicable to human studies, as well as developing spectroscopic methods for undertaking noninvasive human studies. Main accomplishments include studies which: show that drug targeting can be monitored noninvasively using radiolabeled drugs. The study that documented this finding involved an analysis of the comparative kinetics of biodistribution of {sup 195m}Pt-cisplatin to brain tumors, when administered intravenously and intra-arterially; show that such differential targeting of Platinum represents a differential quantity of drug and a differential amount of the active component reaching the target site; show that in vivo NMRS studies of drugs are possible, as documented by our studies of 5-fluorouracil; show that 5-fluorouracil can be trapped in tumors, and that such trapping may be directly correlatable to patient response; show that the radiopharmacokinetic technique can also be used effectively for the study of radiopharmaceuticals used for imaging, as documented in our studies with {sup 99m}T{sub c}-DMSA.

  8. Nuclear medicine technology progress report for quarter ending June 30, 1980

    SciTech Connect

    Knapp, Jr., F. F.

    1981-01-01

    Results of experiments demonstrated that the alkyl portion of 9-telluraheptadecanoic acid (9-THDA) is retained in the myocardial tissue of rats to the same extent as radioactivity from /sup 123m/Te-9-THDA. Tissue distribution experiments in rats one hr after injection of 10-(/sup 14/C)-9-telluraheptadecanoic acid were compared with the results of a parallel study using /sup 123m/Te-9-THDA. The results indicate that the alkyl region of 9-THDA is retained in the myocardium and that labeling of this portion of the 9-THDA molecule with radiohalogens such as /sup 123/I may be an attractive approach for evaluation of myocardial function. Results of preliminary studies for the development of radiolabeled barbiturates as a new class of agents for the measurement of regional blood perfusion in the brain are also described. Several new barbiturates substituted at the C-5 position were prepared and characterized. These compounds will be labeled with /sup 117m/Sn, /sup 75/Se, and /sup 123m/Te and brain uptake studies performed in rats. Studies of arsenic trioxide (As/sub 2/O/sub 3/) toxicity for human cells in the diffusion chamber assay system have continued. Studies employing /sup 74/As/sub 2/O/sub 3/ have demonstrated that uptake of radioactivity from test substances administered to rats can be detected in cells taken from the intraperitoneally-implanted diffusion chambers. Preliminary synthetic studies of gold-based antirheumatoid complexes are also reported. Several /sup 11/C-labeled amino acids have been prepared for clinical testing. Platinum-195m-labeled-cis-dichlorodiammine-platinum(II) was supplied to collaborators for further testing and /sup 75/Se- and /sup 123m/Te-labeled long-chain fatty acids were supplied to several medical investigators for the evaluation of myocardial function in experimental animals. (ERB)

  9. Nuclear medicine program. Progress report for quarter ending June 30, 1995

    SciTech Connect

    Knapp, F.F. Jr.; Ambrose, K.R.; Beets, A.L.

    1995-09-01

    In this report we describe the first synthesis of the (-)(-) and (-)(+) isomers of 1-azabicyclo oct-3-yl {alpha}-(1-fluoropent-5-yl)-{alpha}-hydroxy-{alpha}-phenylacetate ({open_quotes}FQNPe{close_quotes}). Earlier studies with the racemic FQNPe mixture had demonstrated high in vitro binding affinity for the muscarinic-cholinergic receptor and showed that pre-treatment of rats with this new agent significantly blocked receptor localization of subsequently injected -Z-(-,-)-IQNP. Because of the potential important use of fluorine-18-labeled analogues for clinical evaluation of changes in muscarinic-cholinergic receptors by positron emission tomography (PET), we have now synthesized the diastereomeric isomers of FQNPe. Multi-gram quantities of ethyl-{alpha}- (1-chloropent-5-yl)-{alpha}-hydroxy-{alpha}-phenylacetate were prepared and then saponified into the racemic {alpha}-(1-chloropent-5-yl)-{alpha}-hydroxy-{alpha}-phenylacetic acid mixture. The racemic acid was resolved into (-)- and (+)-{alpha}-(1-chloropent-5-yl)-{alpha}-hydroxy-{alpha}-phenylacetic acid enantiomers by isolation of the (-) salt of (S-)-(-)-{alpha}-methylbenzylamine and the (+) salt of (R)-(+)-{alpha}-methylbenzylamine. The resolved (-)- ([{alpha}]{sub D} = -12.1{degrees}, c = 5.8, chloroform) and (+)-acetic acids ([{alpha}]{sub D} = + 11.6{degrees}, c = 6.0, chloroform) were fully characterized and then converted to the enantiomeric ethyl-{alpha}-(1-fluoropent-5-yl)-{alpha}-hydroxy-{alpha}-phenylacetates by a four-step reaction sequence. The (-)- and (+)-ethyl-{alpha}-(1-fluoropent-5-yl)-{alpha}-hydroxy-{alpha}-phenylacetates were then each transesterified with (-)-quinuclidinol to form the (-)(-) FQNPe and (-)(+) FQNPe diastereomers. These diastereomeric esters will now be evaluated in in vitro studies. The availability of the substrates for preparation of the fluorine-18-labeled enantiomers will now allow evaluation of the radiolabeled compounds in animals.

  10. Nuclear medicine program progress report for quarter ending December 31, 1992

    SciTech Connect

    Knapp, F.F. Jr.; Ambrose, K.R.; Beets, A.L.; Callahan, A.P.; McPherson, D.W.; Mirzadeh, S.; Hasan, A.; Lambert, C.R.

    1993-03-01

    We describe the synthesis of the cis- and trans-iodovinyl isomers of the new ORNL cholinergic-muscarinicreceptorligand, 1 -azabicyclo[2.2-2]oct-3-yl{alpha}-hydroxy-{alpha}-(1-iodo-l-propen-3-yl)-{alpha}-phenylacetate (``IQNP``). This agent is prepared in high radiochemical yield, and the racemic mixture shows high specificity and selectivity for the cerebral and myocardial receptors. Since two chiral centers are present in this molecule, it is important to evaluate the importance of the absolute configuration of the two centers on receptor specificity. The tributyltin substrates were carefully separated by column chromatography, converted to the iodine-125 analogues by iododestannylation, and evaluated in rats in vivo. While the ``E`` (trans) isomer cleared rapidly from the receptor-rich areas of rat brain, the ``Z`` (cis) isomer showed high uptake in these areas but also high concentration in the cerebellum. In contrast, the E,Z-isomeric mixture showed good uptake and retention in the receptor rich areas. Also described in this report is a description of neutron flux measurements in the hydraulic tube position at the ORNL High Flux Isotope Reactor (HFIR). Also during this period, samples of [l-125]- and [l-131]-labeled racemic ``IQNP`` were supplied through a collaborative program with the Brookhaven National Laboratory for high resolution autoradiographic studies in rat tissues.

  11. Nuclear medicine program progress report for quarter ending September 30, 1996

    SciTech Connect

    Knapp, F.F. Jr.; Ambrose, K.R.; Beets, A.L.; Boll, R.; Luo, H.; McPherson, D.W.; Mirzadeh, S.

    1997-01-01

    The reactor production yields of tungsten-188 produced by neutron capture by enriched tungsten-186 in the HFIR and other reactors are nearly an order of magnitude lower than expected by calculation using established cross section values. Since neutron capture of tungsten-188 may be the major factor which significantly reduces the observed yields of tungsten-188, the authors have evaluated the possible burn-up cross section of the tungsten-188 product. Tungsten-189 was produced by irradiating a radioactive target containing a known amount of {sup 188}W. In order to reduce the radiation level to an acceptable level (<20% detector dead time), the authors chemically removed >90% of {sup 188}Re, which is the decay product of {sup 188}W, prior to irradiation. They were able to confirm the two predominant {gamma}-rays in the decay of {sup 189}W, 260.1 {+-} 1.4 and 421.5 {+-} 1.6 keV. By following the decay of these {gamma}-rays in two sets of experiments, a half-life of 10.8 {+-} 0.3 m was obtained for {sup 189}W. Based on a knowledge of the {sup 188}W content of target (52.6 mBq), neutron flux of 5 {times} 10{sup 13} n {center_dot} s{sup {minus}1} {center_dot} cm{sup {minus}2}, irradiation time of 10 min and with the assumption of 100% intensity for 260.1 and 421.5 keV {gamma}-rays, a cross-section of 12.0 {+-} 2.5 b was calculated for burn-up cross-section of {sup 188}W, which helps explain the greatly reduced production yields of {sup 188}W.

  12. Nuclear medicine program progress report for quarter ending March 31, 1994

    SciTech Connect

    Knapp, F.F. Jr.; Ambrose, K.R.; Beets, A.L.; Lambert, C.R.; McPherson, D.W.; Mirzadeh, S.; Luo, H.

    1994-05-01

    The authors` new radioiodinated ``IQNP`` agent, an analogue of ``4-IQNB``, has a high affinity for the muscarinic-cholinergic receptor (m-AChR). Iodine is stabilized in ``IQNP`` by attachment as a vinyl iodide. To evaluate the potential usefulness of a [Br-76]-labeled analogue as a candidate for positron emission tomography (PET), they have synthesized the trans-3-bromopropenyl analogue (BrQNP) and evaluated its ability in vivo to block uptake of [I-125]-Z-(R,R)-IQNP. Reaction of bromine with the trans-tributylstannyl substrate prepared from ethyl -{alpha}-hydroxy -{alpha}-phenyl-{alpha}-(1-propyn-3-yl)acetate, followed by column purification and transesterification with (R,S)-3-quinuclidinol gave BrQNP. Female rats were pre-treated with the oxalate salt of BrQNP one hour prior to I.V. injection of [I-125]-IQNP. While the brain and heart uptake in BrQNP pre-treated animals was significantly decreased, the control animals showed the expected high uptake of IQNP in these tissues. The ease of preparation and ability to block m-AChR suggest that [Br-76]-labeled BrQNP is a potential candidate for PET studies. In this report, the authors also summarize their current on-going collaborative studies assessing the usefulness of various rhenium-188-labeled therapeutic agents. In addition, collaborative programs have been established to evaluate rhenium-188-labeled particles for treatment of arthritis (synovectomy), treatment of bone pain resulting from cancer metastheses with rhenium-188-phosphonates (palliation), and other applications.

  13. Nuclear medicine program progress report for quarter ending March 31, 1995

    SciTech Connect

    Knapp, F.F. Jr.; Ambrose, K.R.; Beets, A.L.; Luo, H.; McPherson, D.W.; Mirzadeh, S.

    1995-06-01

    In this report the conditions for ``direct`` labeling of the anti-granulocyte (MAb) BW 250/183 monoclonal antibody with rhenium-188 (Re-188) from a generator are described. Re-188-BW 250/183 is of interest for potential use for bone marrow ablation. The labeling time, temperature, pH, and the amount of tin and citric acid were optimized utilizing IgG. Radiolabeling yields of greater than 97% were achieved using 1 mL of a phthalate/tartrate buffer (pH 5.{und M}=?), 250 {micro} g BW 250/183, 1.0 mg citric acid, 400 {micro} g tin (II) chloride, and 1 mL of the tungsten-188/rhenium-188 generator eluent (200--800 {micro} Ci of Re-188). Analysis of the Re-188-labeled IgG and BW 250/183 was performed by Instant Thin Layer Chromatography (ITLC), Sephadex purification and High Performance Liquid Chromatography (HPLC). When the labeling was performed at room temperature or 37 C, in vitro stability studies performed in HSA solution, cysteine solution, 6 {und M} urea solution and a 1% casein solution showed that the Re-188 label demonstrated a similar stability profile in all solutions. Initial studies indicate that Re-188-BW 250/183 retained {approximately} 90% of immunoreactivity when compared to the technetium-99m labeled antibody prepared from the same kit. During this period, several radioisotopes prepared in the ORNL HFIR were also supplied on a cost-recovery basis or provided to collaborators for ongoing collaborative projects. These include tin-117m, processed tungsten-188 and the ORNL alumina-based tungsten-188/rhenium-188 generators.

  14. Nuclear medicine program progress report for quarter ending December 31, 1995

    SciTech Connect

    Knapp, F.F., Jr.; Ambrose, K.R.; Beets, A.L.; Luo, H.; McPherson, D.W.; Mirzadeh, S.; Mokler, F

    1995-12-31

    In this report we describe the first resolution of the 3R-(+)-and 3S- ({minus})-methyl BMIPP methyl-branched fatty acid stereoisomers and biodistribution of the radioiodinated isomers in rats to investigate the effects of the configuration of the 3({beta})-methyl group on the organ distribution and myocardial uptake and release kinetics. Synthesesis of 3R-(+)BMIPP was accompanied by initial acylation of the thiophene template with the acid chloride of ethyl 3R- methylglutarate. The amide of the synthetic 3R-BMIPP isomer prepared S-(-)-{alpha}-methylbenzylamine exhibited identical spectral and chromatographic properties with the chromatographically more polar isomer (TLC and HPLC) which was separated from the mixture of amides prepared from reaction of the acid chloride of racemic BMIPP with the S-(-)-{alpha}-methylbenzylamine. The second less chromatographically polar amide isomer was assigned the 3S-(-)-methyl configuration. The free acids were obtained by acid hydrolysis of the amides and converted to the radioiodinated analogues. While biodistribution studies in separate groups of rats demonstrated greater myocardial uptake of 3R-BMIPP compared with the 3S-isomer values for most other tissues evaluated (blood, lungs, kidneys and thyroid) were similar, whereas the 3S-BMIPP isomer consistently showed higher liver uptake. These results were confirmed in a [l-131]-3S-BMIPP/[l-125]-3R-BMIPP dual label study and both isomers had similar myocardial wash-out curves (5-180 min). These studies suggest that [l-123]-3R-BMIPP is a candidate for clinical evaluation and may show greater myocardial uptake than the 3S-isomer and thus may require a reduced injected dose compared to racemic BMIPP.

  15. Nuclear medicine program progress report for quarter ending June 30, 1994

    SciTech Connect

    Knapp, F.F. Jr.; Ambrose, K.R.; Beets, A.L.; Lambert, C.R.; McPherson, D.W.; Mirzadeh, S.; Luo, H.

    1994-08-01

    In this report we describe tile first successful synthesis and in vivo evaluation of a fluorinated analogue of the IQNP muscarinic-cholinergic receptor ligand. Unanticipated synthetic hurdles lead to several unsuccessful approaches before the synthesis of a model compound was achieved. The successful route involved introduction of the fluoroethyl moiety at an early stage of the synthesis by alkylation of ethyl 1,3-dithiane-2-carboxylate with 1-fluoro-2-bromoethane. Subsequent unmasking of the carbonyl, followed by introduction of the phenyl group with phenylmagnesium bromide and subsequent transesterification with racemic quinuclidinol afforded the target compound, 1-azabicyclo[2.2.2]oct-3-yl {alpha}-(1-fluoroethan-2-yl)-{alpha}-hydroxy-{alpha}-phenylacetate (QNF). Pretreatment of Fisher rats with QNF one hour prior to the intravenous administration of the [I-131]-Z-(R,R) IQNP isomer demonstrated that the new fluoro analogue blocked uptake of iodine-131 in those regions of the brain rich in muscarinic-cholinergic receptors measured three hours after injection. As an example, the control values for group of nontreated animals were (5 animals; mean {+-} SD): cortex, 1.20{+-}0.27; striatum, 0.73{+-}0.19; pons, 0.70{+-}0.20; cerebellum, 0.43{+-}0.114. Brains from animals pretreated with the fluoro analogue had the following values (mean{+-}SD; % decrease): cortex, 0.67{+-}0.15 (65%); striatum, 0.35{+-}0.114 (52%); pons, 0.40{+-}0.08 (43%); cerebellum, 0.16{+-}0.09(63%). Also during this period several tungsten-188/rhenium-188 generators and tin-117m samples were provided for collaborative studies.

  16. Nuclear Medicine Program progress report for quarter ending June 30, 1996

    SciTech Connect

    Knapp, F.F. Jr.; Ambrose, K.R.; Beets, A.L.; Guhlke, S.; Luo, H.; McPherson, D.W.; Mirzadeh, S.

    1996-12-31

    The four stereoisomers of 1-azabicyclo[2.2.2]oct-3-yl {alpha}-(1fluoropent-5-yl)-{alpha}-hydroxy-{alpha}-phenylacetate (FQNPe, 4) have been resolved and were evaluated as potential candidates for PET imaging agents. Labeling with fluorine-18 involved a two-step synthesis via fluoride displacement of a mesylate intermediate at the ethyl ester stage followed by transesterification with (R)-quinuclidinol. In vitro data utilizing cloned human receptor subtypes demonstrated that while the (+,+)-isomer did not have significant receptor binding, the other stereoisomers of FNPe bound with high affinity to the various mA ChR subtypes tested (K{sub i}, nm: m1, ({minus},{minus}), 0.33; ({minus},+), 1.4; (+,{minus}), 3.8; m2, ({minus},{minus}), 0.1; ({minus},+), 4.2; +,{minus}), < 75% binding; m3, ({minus},{minus}), 0.34; ({minus},+), 3.1; (+;{minus}), 7.6. [{sup 18}F]-({minus},{minus})- and [{sup 18}F]-({minus},+)-FQNPe (4) were prepared in decay corrected radiochemical yields of 14% ([{sup 18}F]-({minus},{minus})-4) and 8% ([{sup 18}F]-({minus},+)-4). In vivo biodistribution studies were conducted in female rats with [18F]-({minus},{minus})- and (+,{minus})-FQNPe (4). [{sup 18}F]({minus},{minus})-4 demonstrated high uptake in mA ChR regions of the brain up to 3 hours post injection and low accumulation of radioactivity in the bone indicated good in vivo stability.

  17. Nuclear medicine program progress report for quarter ending December 31, 1994

    SciTech Connect

    Knapp, F.F. Jr.; Ambrose, K.R.; Beets, A.L.; Lambert, C.R.; McPherson, D.W.; Mirzadeh, S.; Luo, H.

    1995-02-01

    1-Azabicyclo[2.2.2]oct-3-yl {alpha}-(l-fluoropentan-5-yl)-{alpha}-hydroxy-{alpha}-phenylacetate (PQNPe) has been prepared and evaluated as a new candidate for the determination of muscarinic cholinergic receptor density by positron emission tomography (PET). The results of in vitro binding assays demonstrated that FONPe has high affinity for m{sub l} and M{sub 2} muscarinic receptor subtypes. Pretreatment of female Fisher rats with unlabeled FQNPe one hour prior to the intravenous administration of radioiodinated Z-(R,R)-IQNP, a high affinity muscarinic ligand, demonstrated FONPE significantly blocked the uptake of radioactivity in the brain and heart measured three hours post-injection of the radiolabeled ligand. These results demonstrate that this new fluoro analogue of QNB has high affinity for the muscarinic receptor and is able to effectively pass the blood-brain-barrier and localize in tissues rich in muscarinic receptors. The fluorine-18-labeled analogue thus represents an important target ligands for evaluation as potential receptor imaging agents in conjunction with PET. During this period several radioisotopes were provided to collaborators. Tungsten-188/rhenium-188 generators were provided as part of a CRADA project.

  18. Nuclear Medicine Program progress report for quarter ending September 30, 1994

    SciTech Connect

    Knapp, F.F. Jr.; Ambrose, K.R.; Beets, A.L.; Lambert, C.R.; McPherson, D.W.; Mirzadeh, S.; Luo, H.

    1995-01-01

    In this report we describe the synthesis of the Z (cis) isomers of R-l-azabicyclo [2.2.2] oct-3-yl R-and S-{alpha}-hydroxy-{alpha}-(liodo-l-propen-3-yl) - {alpha}-phenylacetate. We also report the results of the in vitro binding assays of the E and Z isomers of the (R, R)- and (R, S)-isomers of IQNP. The Z isomers of IQNP were prepared by there action of (R, R)- or (R, S)-l-azabicyclo [2.2.2] oct-3-yl - {alpha} - hydroxy - {alpha} - phenyl - {alpha} - (l-propyn-3-yl) acetate with tributyltin hydride in HMPA followed by subsequent reaction of the cis tributylstannyl substrate with iodine. In an attempt to increase the yield of the Z isomers, the preparation of the Z isomers of the R-or S-ethyl {alpha}-hydroxy-{alpha}-phenyl-{alpha}-(l-propyn-3-yl)acetate was also investigated under a variety of reaction conditions. Results of the in vitro binding assays demonstrated that although all the isomers showed high affinity for the muscarinic receptor, the E-(R, R)-IQNP isomer had a 100 times greater higher affinity for m{sub 1} and m{sub 3} receptor subtypes as compared to m{sub 2} subtype. We are currently evaluating the in vivo biodistribution properties and pharmocokinetic and autoradiographic analyses of these promising new ligands in detail for potential use of the iodine-123-labeled agents to study muscarinic receptors by Single Photon Emission Computed Tomography (SPECT).

  19. Nuclear medicine program progress report for quarter ending December 31, 1993

    SciTech Connect

    Knapp, F.F. Jr.; Ambrose, K.R.; Beets, A.L.; Callahan, A.P.; Luo, H.; McPherson, D.W.; Mirzadeh, S.; Lambert, C.R.

    1994-02-01

    The results of preliminary in vivo metabolic studies of the iodine-125-labeled E-(R,R)-IQNP in rats are described. The E-(R,R) isomer demonstrates highly selective and specific localization in cerebral regions rich in the m{sub 1} and m{sub 4} muscarinic-cholinergic receptor subtypes and is a good candidate for potential human studies. Since the external evaluation of receptor-ligand complexes requires that only uptake of the unmetabolized agent is measured, these studies were performed to evaluate the metabolism of the radioiodinated ligand in the whole brain, heart, liver and serum from rats at several time points after intravenous administration. Radioactivity was very rapidly excreted in the first 24-hour period (urine = 46; feces = 26). Folch extracts of the different tissue samples showed that the lipid-soluble extract from brain tissue contained 87 of the activity at 24 hours. In the heart, 62 of the activity was extracted in the lipid soluble extract after 30 minutes and decreased to 51 after 4 hours. Thin-layer chromatographic analysis of the lipid soluble extracts indicated that only the unmetabolized E-(R,R)-IQNP was detected in brain extracts. Also in this report, the predicted medical radioisotope production capabilities of the proposed Advanced Neutron Source (ANS) are discussed.

  20. Nuclear medicine program progress report for quarter ending March 31, 1996

    SciTech Connect

    Knapp, F.F. Jr.; Ambrose, K.R.; Beets, A.L.; Guhlke, S.; Luo, H.; McPherson, D.W.; Mirzadeh, S.; Mokler, F.

    1996-10-01

    Biodistribution studies with the radioiodinated 3(R)- and 3(S)-BMIPP isomers in rats have shown that 3(R)-BMIPP has 20-25% higher heart uptake (15-180 min) than 3(S)-BMIPP, while uptake in other tissues examined is similar. To evaluate the possible differences in metabolic fate of the two isomers, a mixture of [I-125]-3(R)/[I-131]- 3(S)-BMIPP was administered to fasted female Fisher rats. Groups (n=3 rats per group) were sacrificed after 15, 60 and 180 min, and urine and feces collected from another group. Samples of blood, heart, liver, lungs, kidney, and urine were Folch-extracted. The distribution of I-125 and I-131 in the organic, aqueous, and pellet samples were determined. Organic samples were then analyzed by thin-layer chromatography (TLC) and high performance liquid chromatography (HPLC). The relative distribution of I-125/I-131 in the lipid, aqueous, and pellet samples was similar for both isomers. Distribution of I-125/I-131 in the various components of the lipid extracts observed by TLC was similar, with principal incorporation into the free fatty acid (FFA) and triglyceride (TG) pools. HPLC analyses (Cl8) of the FFA fraction showed similar I-125/I-131 profiles, corresponding to BMIPP, and the {alpha}-methyl-C,4 (PIPA) and C12, Cl0 and C6 carbon chain-length catabolites. By TLC, urine I-125/I-131 chromatographed with hippuric acid. HPLC analyses (Cl 8) of acid-hydrolyzed urine gave a single I-125/I-131 component with the same RRT as 2-({beta}-iodophenyl)acetic acid, the final {alpha}/{beta}-oxidative BMIPP catabolite. Unexpectedly, HPLC of lipids from base hydrolyzed TG from the heart tissue, showed I-125/I-125 co-chromatographing with short-chain fatty acids, with only levels in BMIPP. These unexpected results demonstrate that the 3(R)-BMIPP and 3(S)-BMIPP isomers are metabolized similarly in rat tissues, and that the higher myocardial extraction observed for the 3(R)-BMIPP may reflect differences in the relative membrane transport of the two isomers.

  1. Nuclear medicine program: Progress report for quarter ending June 30, 1988

    SciTech Connect

    Knapp, F.F. Jr.; Ambrose, A.P.; Callahan, A.P.; Allred, J.F.; Blystone, S.L.; Lisic, E.C.; McPherson, D.W.; Srivastava, P.C.; Rice, D.E.; Rogers, C.J.; Umbricht, G.

    1989-02-01

    This report describes our initial studies on developing techniques of attaching radioisotopes of copper (Cu-64 and Cu-67) and rhenium (Re-186 and Re-188) to proteins. Our work has focussed on the synthesis of para-carboxyalkylphenylglyoxal-bis-(N/sub 4/-methylthiosemi-carbazone) ligands (TSC). Because of the strong binding of Cu(II) to the bis-TSC ligand, the development of bifunctional chelates for attachment of radioisotopes of copper to antibodies is of interest. We have developed an improved synthesis of the requisite ..cap alpha..-ketoaldehyde and 1,2-diketone substrates used for derivatization to the bis-TSC ligand chelates. This approach uses the ''Kornbloom'' method which provides a simple alternative to the usual method for fabrication of the 1,2-bis-thiosemicarbazone compounds and avoids the use of selenium dioxide for oxidation of substituted acetophenones. Acylation of the -phenyl carboxylic acid with bromoacetyl chloride or 2-bromopropionyl chloride followed by treatment with silver nitrate readily provides the nitrate esters. Oxidative elimination with sodium acetate in DMSO then provides the ..cap alpha..-ketoaldehyde or 1,2-diketo products. The overall yields are in the 40-60% range. Also in this report are the results of studies with the Langendorff-perfused rat heart system. Comparison of the incorporation of (I-131)IPPA and (I-125)BMIPP in dual-labeled studies under normoxia and hypoxia (pO/sub 2/ > 120 mm) clearly showed the expected preferential incorporation into triglyceride (TG) storage products. Basic hydrolysis of the TG fraction purified by chromatography showed release of the radioactivity into products chromatographing in the free fatty acid fraction.

  2. Safety research programs sponsored by Office of Nuclear Regulatory Research: Progress report, January 1--March 31, 1989

    SciTech Connect

    Weiss, A.J.

    1989-08-01

    This progress report describes current activities and technical progress in the programs at Brookhaven National Laboratory sponsored by the Division of Regulatory Applications, Division of Engineering, Division of Safety Issue Resolution, and Division of Systems Research of the US Nuclear Regulatory Commission, Office of Nuclear Regulatory Research following the reorganization in July 1988. The previous reports have covered the period October 1, 1976 through December 31, 1988.

  3. Bone metastases: assessment of therapeutic response through radiological and nuclear medicine imaging modalities.

    PubMed

    Vassiliou, V; Andreopoulos, D; Frangos, S; Tselis, N; Giannopoulou, E; Lutz, S

    2011-11-01

    Radiological and nuclear medicine imaging modalities used for assessing bone metastases treatment response include plain and digitalised radiography (XR), skeletal scintigraphy (SS), dual-energy X-ray absorptiometry (DEXA), computed tomography (CT), magnetic resonance imaging (MRI), [(18)F] fluorodeoxyglucose positron emission tomography (FDG-PET) and PET/CT. Here we discuss the advantages and disadvantages of these assessment modalities as evident through different clinical trials. Additionally, we present the more established response criteria of the International Union Against Cancer and the World Health Organization and compare them with newer MD Anderson criteria. Even though serial XR and SS have been used to assess the therapeutic response for decades, several months are required before changes are evident. Newer techniques, such as MRI or PET, may allow an earlier evaluation of response that may be quantified through monitoring changes in signal intensity and standard uptake value, respectively. Moreover, the application of PET/CT, which can follow both morphological and metabolic changes, has yielded interesting and promising results that give a new insight into the natural history of metastatic bone disease. However, only a few studies have investigated the application of these newer techniques and further clinical trials are needed to corroborate their promising results and establish the most suitable imaging parameters and evaluation time points. Last, but not least, there is an absolute need to adopt uniform response criteria for bone metastases through an international consensus in order to better assess treatment response in terms of accuracy and objectivity. PMID:21530193

  4. Lanthanides in Nuclear Medicine. The Production of Terbium-149 by Heavy Ion Beams

    E-print Network

    Dmitriev, S N; Zaitseva, N G; Maslov, O D; Molokanova, L G; Starodub, G Ya; Shishkin, S V; Shishkina, T V

    2001-01-01

    Among radioactive isotopes of lanthanide series elements, finding the increasing using in nuclear medicine, alpha-emitter {149}Tb (T_{1/2} = 4.118 h; EC 76.2 %; beta^+ 7.1 %; alpha 16.7 %) is considered as a perspective radionuclide for radioimmunotherapy. The aim of the present work is to study experimental conditions of the {149}Tb production in reactions Nd({12}C, xn){149}Dy (4.23 min; beta^+, EC)\\to {149}Tb when the Nd targets have been irradiated by heavy ions of carbon. On the basis of results of formation and decay of {149}Dy\\to{149}Tb evaluation of the {149}Tb activity, is made which can be received under optimum conditions (enriched {142}Nd target, {12}C ions with the energy 120 MeV and up to current 100 mu A, time of irradiating 8-10 hours). Under these conditions {149}Tb can be obtained up to 30 GBq (up to 0.8 Ci).

  5. A Spartan 6 FPGA-based data acquisition system for dedicated imagers in nuclear medicine

    NASA Astrophysics Data System (ADS)

    Fysikopoulos, E.; Loudos, G.; Georgiou, M.; David, S.; Matsopoulos, G.

    2012-12-01

    We present the development of a four-channel low-cost hardware system for data acquisition, with application in dedicated nuclear medicine imagers. A 12 bit octal channel high-speed analogue to digital converter, with up to 65 Msps sampling rate, was used for the digitization of analogue signals. The digitized data are fed into a field programmable gate array (FPGA), which contains an interface to a bank of double data rate 2 (DDR2)-type memory. The FPGA processes the digitized data and stores the results into the DDR2. An ethernet link was used for data transmission to a personal computer. The embedded system was designed using Xilinx's embedded development kit (EDK) and was based on Xilinx's Microblaze soft-core processor. The system has been evaluated using two different discrete optical detector arrays (a position-sensitive photomultiplier tube and a silicon photomultiplier) with two different pixelated scintillator arrays (BGO, LSO:Ce). The energy resolution for both detectors was approximately 25%. A clear identification of all crystal elements was achieved in all cases. The data rate of the system with this implementation can reach 60 Mbits s-1. The results have shown that this FPGA data acquisition system is a compact and flexible solution for single-photon-detection applications. This paper was originally submitted for inclusion in the special feature on Imaging Systems and Techniques 2011.

  6. Quantitation of SPECT performance: Report of Task Group 4, Nuclear Medicine Committee.

    PubMed

    Graham, L S; Fahey, F H; Madsen, M T; van Aswegen, A; Yester, M V

    1995-04-01

    A comprehensive performance testing program is an essential ingredient of high-quality single-photon emission computed tomography (SPECT). Many of the procedures previously published are complicated, time consuming, or require a special testing environment. This Task Group developed a protocol for evaluating SPECT imaging systems that was simple, practical, required minimal test equipment, and could be performed in a few hours using processing software available on all nuclear medicine computers. It was designed to test rotational stability of uniformity and sensitivity, tomographic spatial resolution, uniformity and contrast, and the accuracy of attenuation correction. It can be performed in less than three hours and requires only a Co-57 flood source, a line source, and a tomographic cylindrical phantom. The protocol was used 51 times on 42 different cameras (seven vendors) by four different individuals. The results were used to establish acceptable ranges for the measured parameters. The variation between vendors was relatively small and appeared to reflect slight differences in basic camera performance, collimation, and reconstruction software. Individuals can use the tabulated values to evaluate the performance of individual systems. PMID:7609720

  7. The development of new radionuclide generator systems for nuclear medicine applications

    SciTech Connect

    Knapp, F.F. Jr.; Callahan, A.P.; Mirzadeh, S. ); Brihaye, C.; Guillaume, M. . Cyclotron Research Center)

    1991-01-01

    Radioisotope generator systems have traditionally played a central role in nuclear medicine in providing radioisotopes for both research and clinical applications. In this paper, the development of several tungsten-188/rhenium-188 prototype generators which provide rhenium-188 for radioimmunotherapy (RAIT) is discussed. The authors have recently demonstrated that carrier-free iridium-194 can be obtained from the activated carbon system from decay of reactor-produced osmium-194 for potential RAIT applications. Instrumentation advances such as the new generation of high-count-rate (fast) gamma camera systems for first-pass technology require the availability of generator-produced ultra short-lived radioisotopes for radionuclide angiography (RNA). The activated carbon generator is an efficient system to obtain ultra short-lived iridium-191 m from osmium-191 for RNA. In addition, the growing number of PET centers has stimulated research in generators which provide positron-emitting radioisotopes. Copper-62, obtained from the zinc-62 generator, is currently used for PET evaluation of organ perfusion. The availability of the parent radioisotopes, the fabrication and use of these generators, and the practical factors for use of these systems in the radiopharmacy are discussed. 74 refs., 6 figs., 5 tabs.

  8. A Perspective of the Future of Nuclear Medicine Training and Certification.

    PubMed

    Arevalo-Perez, Julio; Paris, Manuel; Graham, Michael M; Osborne, Joseph R

    2016-01-01

    Nuclear Medicine (NM) has evolved from a medical subspecialty using quite basic tests to one using elaborate methods to image organ physiology and has truly become "Molecular Imaging." Concurrently, there has also been a timely debate about who has to be responsible for keeping pace with all of the components of the developmental cycle-imaging, radiopharmaceuticals, and instrumentation. Since the foundation of the American Board of NM, the practice of NM and the process toward certification have undergone major revisions. At present, the debate is focused on the inevitable future convergence of Radiology and NM. The potential for further cooperation or fusion of the American Board of Radiology and the American Board of NM is likely to bring about a new path for NM and Molecular Imaging training. If the merger is done carefully, respecting the strengths of both partners equally, there is an excellent potential to create a hybrid NM-Radiology specialty that combines Physiology and Molecular Biology with detailed anatomical imaging that sustains the innovation that has been central to NM residency and practice. We introduce a few basic trends in imaging use in the United States. These trends do not predict future use, but highlight the need for an appropriately credentialed practitioner to interpret these examination results and provide value to the health care system. PMID:26687859

  9. Proceedings of the DOE workshop on the role of a high-current accelerator in the future of nuclear medicine

    SciTech Connect

    Moody, D.C.; Peterson, E.J.

    1989-05-01

    The meeting was prompted by recent problems with isotope availability from DOE accelerator facilities; these difficulties have resulted from conflicting priorities between physics experiments and isotope production activities. The workshop was a forum in which the nuclear medicine community, isotope producers, industry, and other interested groups could discuss issues associated with isotope availability (including continuous supply options), the role of DOE and industry in isotope production, and the importance of research isotopes to the future of nuclear medicine. The workshop participants endorsed DOE's presence in supplying radioisotopes for research purposes and recommended that DOE should immediately provide additional support for radionuclide production in the form of personnel and supplies, DOE should establish a policy that would allow income from sales of future ''routine'' radionuclide production to be used to support technicians, DOE should obtain a 70-MeV, 500-/mu/A variable-energy proton accelerator as soon as possible, and DOE should also immediately solicit proposals to evaluate the usefulness of a new or upgraded high-energy, high-current machine for production of research radionuclides. This proceedings volume is a summary of workshop sessions that explored the future radionuclide needs of the nuclear medicine community and discussed the DOE production capabilities that would be required to meet these needs.

  10. 76 FR 11522 - In the Matter of Progress Energy Florida, Inc. (Combined License Application, Levy County Nuclear...

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-03-02

    ... From the Federal Register Online via the Government Printing Office NUCLEAR REGULATORY COMMISSION In the Matter of Progress Energy Florida, Inc. (Combined License Application, Levy County Nuclear Power Plant, Units 1 and 2); Notice of Appointment of Adjudicatory Employee Commissioners: Gregory...

  11. Progress in Nuclear Energy 60 (2012) 73 88 Contents lists available at SciVerse ScienceDirect

    E-print Network

    Demazière, Christophe

    2012-01-01

    Direct Progress in Nuclear Energy journal homepage: www.elsevier.com/locate/pnucene Comments on local power , Christophe Demazière b a Department of Hydrogen and Nuclear Energy, Institute of Power Engineering, Faculty global power oscillation. The effect of the local neutron flux oscillating sources on the space and time

  12. Progress and challenges of nuclear science development in Vietnam - an outlook on the occassion of the 10-th anniversary of the Dalat Nuclear Research Reactor

    SciTech Connect

    Hien, P.D.

    1994-12-31

    Over ten years since the commissioning of the Dalat nuclear research reactor a number of nuclear techniques have been developed and applied in Vietnam Manufacturing of radioisotopes and nuclear instruments, development of isotope tracer and nuclear analytical techniques for environmental studies, exploitation of filtered neutron beams, ... have been major activities of reactor utilizations. Efforts made during ten years of reactor operation have resulted also in establishing and sustaining the applications of nuclear techniques in medicine, industry, agriculture, etc. The successes achieved and lessons teamed over the past ten years are discussed illustrating the approaches taken for developing the nuclear science in the conditions of a country having a very low national income and experiencing a transition from a centrally planned to a market-oriented economic system.

  13. [Recent progress in nuclear magnetic resonance spectrum for drug research and development].

    PubMed

    Zhong, Jun; Jiang, Xue-mei

    2015-01-01

    In the process of modern drug research, the new methods and technologies which can detect drug molecules' chemical composition, structure and interaction with biomolecules are always the key scientific problems people care about. Spectra (including IR, UV and NMR) are the most common analytical methods, of which NMR can obtain detailed parameter about the nucleus of organic molecules through researching the laws of nuclear transition in the impact of surrounding chemical environment. The parameter contains rich information about the chemical composition, structure and interaction with other molecules of organic molecules. In many complex environments, such as liquid, solid or gas state, even biological in situ environment, NMR can provide molecules' chemical composition, atomic-resolution three-dimensional structure, information of interaction with each other and dynamic process, especially the information about drug interacting with biomacromolecules. In recent years, the applications of nuclear magnetic resonance spectrum in drug research and development are more and more widespread. This paper reviewed its recent progress in structure and dynamic of targeted biological macromolecules, drug design and screening and drug metabolism in drug research and development. In the first part, we gave a brief introduction of nuclear magnetic resonance technology and its applications in drug research. In the second part, we explained the basic principles briefly and summarized progress in methods and techniques for drug research. In the third part, we discussed applications of nuclear magnetic resonance ir structure and dynamic of targeted biological macromolecules, drug design and screening and drug metabolism in detail. The conclusions were stated in the last part. PMID:25993865

  14. Nuclear physics and astrophysics. Progress report for period June 15, 1992--June 14, 1993

    SciTech Connect

    Schramm, D.N.; Olinto, A.V.

    1993-06-01

    The authors report on recent progress of research at the interface of nuclear physics and astrophysics. During the past year, the authors continued to work on Big Bang and stellar nucleosynthesis, the solar neutrino problem, the equation of state for dense matter, the quark-hadron phase transition, and the origin of gamma-ray bursts; and began studying the consequences of nuclear reaction rates in the presence of strong magnetic fields. They have shown that the primordial production of B and Be cannot explain recent detections of these elements in halo stars and have looked at spallation as the likely source of these elements. By looking at nucleosynthesis with inhomogeneous initial conditions, they concluded that the Universe must have been very smooth before nucleosynthesis. They have also constrained neutrino oscillations and primordial magnetic fields by Big Bang nucleosynthesis. On the solar neutrino problem, they have analyzed the implications of the SAGE and GALLEX experiments. They also showed that the presence of dibaryons in neutron stars depends weakly on uncertainties of nuclear equations of state. They have started to investigate the consequences of strong magnetic fields on nuclear reactions and implications for neutron star cooling and supernova nucleosynthesis.

  15. Microfluidic labeling of biomolecules with radiometals for use in nuclear medicine.

    PubMed

    Wheeler, Tobias D; Zeng, Dexing; Desai, Amit V; Önal, Birce; Reichert, David E; Kenis, Paul J A

    2010-12-21

    Radiometal-based radiopharmaceuticals, used as imaging and therapeutic agents in nuclear medicine, consist of a radiometal that is bound to a targeting biomolecule (BM) using a bifunctional chelator (BFC). Conventional, macroscale radiolabeling methods use an excess of the BFC-BM conjugate (ligand) to achieve high radiolabeling yields. Subsequently, to achieve maximal specific activity (minimal amount of unlabeled ligand), extensive chromatographic purification is required to remove unlabeled ligand, often resulting in longer synthesis times and loss of imaging sensitivity due to radioactive decay. Here we describe a microreactor that overcomes the above issues through integration of efficient mixing and heating strategies while working with small volumes of concentrated reagents. As a model reaction, we radiolabel 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) conjugated to the peptide cyclo(Arg-Gly-Asp-DPhe-Lys) with (64)Cu(2+). We show that the microreactor (made from polydimethylsiloxane and glass) can withstand 260 mCi of activity over 720 hours and retains only minimal amounts of (64)Cu(2+) (<5%) upon repeated use. A direct comparison between the radiolabeling yields obtained using the microreactor and conventional radiolabeling methods shows that improved mixing and heat transfer in the microreactor leads to higher yields for identical reaction conditions. Most importantly, by using small volumes (~10 µL) of concentrated solutions of reagents (>50 µM), yields of over 90% can be achieved in the microreactor when using a 1:1 stoichiometry of radiometal to BFC-BM. These high yields eliminate the need for use of excess amounts of often precious BM and obviate the need for a chromatographic purification process to remove unlabeled ligand. The results reported here demonstrate the potential of microreactor technology to improve the production of patient-tailored doses of radiometal-based radiopharmaceuticals in the clinic. PMID:20941431

  16. Activity based costing of diagnostic procedures at a nuclear medicine center of a tertiary care hospital

    PubMed Central

    Hada, Mahesh Singh; Chakravarty, Abhijit; Mukherjee, Partha

    2014-01-01

    Context: Escalating health care expenses pose a new challenge to the health care environment of becoming more cost-effective. There is an urgent need for more accurate data on the costs of health care procedures. Demographic changes, changing morbidity profile, and the rising impact of noncommunicable diseases are emphasizing the role of nuclear medicine (NM) in the future health care environment. However, the impact of emerging disease load and stagnant resource availability needs to be balanced by a strategic drive towards optimal utilization of available healthcare resources. Aim: The aim was to ascertain the cost of diagnostic procedures conducted at the NM Department of a tertiary health care facility by employing activity based costing (ABC) method. Materials and Methods: A descriptive cross-sectional study was carried out over a period of 1 year. ABC methodology was utilized for ascertaining unit cost of different diagnostic procedures and such costs were compared with prevalent market rates for estimating cost effectiveness of the department being studied. Results: The cost per unit procedure for various procedures varied from Rs. 869 (USD 14.48) for a thyroid scan to Rs. 11230 (USD 187.16) for a meta-iodo-benzyl-guanidine (MIBG) scan, the most cost-effective investigations being the stress thallium, technetium-99 m myocardial perfusion imaging (MPI) and MIBG scan. The costs obtained from this study were observed to be competitive when compared to prevalent market rates. Conclusion: ABC methodology provides precise costing inputs and should be used for all future costing studies in NM Departments. PMID:25400363

  17. Characterisation of crystal matrices and single pixels for nuclear medicine applications

    NASA Astrophysics Data System (ADS)

    Herbert, D. J.; Belcari, N.; Camarda, M.; Guerra, A. Del; Vaiano, A.

    2005-01-01

    Commercially constructed crystal matrices are characterised for use with PSPMT detectors for PET system developments and other nuclear medicine applications. The matrices of different scintillation materials were specified with pixel dimensions of 1.5×1.5 mm2 in cross-section and a length corresponding to one gamma ray interaction length at 511 keV. The materials used in this study were BGO, LSO, LYSO, YSO and CsI(Na). Each matrix was constructed using a white TiO loaded epoxy that forms a 0.2 mm septa between each pixel. The white epoxy is not the optimum choice in terms of the reflective properties, but represents a good compromise between cost and the need for optical isolation between pixels. We also tested a YAP matrix that consisted of pixels of the same size specification but was manufactured by a different company, who instead of white epoxy, used a thin aluminium reflective layer for optical isolation that resulted in a septal thickness of just 0.01 mm, resulting in a much higher packing fraction. The characteristics of the scintillation materials, such as the light output and energy resolution, were first studied in the form of individual crystal elements by using a single pixel HPD. A comparison of individual pixels with and without the epoxy/dielectric coatings was also performed. Then the matrices themselves were coupled to a PSPMT in order to study the imaging performance. In particular, the system pixel resolution and the peak to valley ratio were measured at 511 and 122 keV.

  18. General-purpose heat source project and space nuclear safety and fuels program. Progress report

    SciTech Connect

    Maraman, W.J.

    1980-02-01

    Studies related to the use of /sup 238/PuO/sub 2/ in radioisotopic power systems carried out for the Advanced Nuclear Systems and Projects Division of LASL are presented. The three programs involved are: general-purpose heat source development; space nuclear safety; and fuels program. Three impact tests were conducted to evaluate the effects of a high temperature reentry pulse and the use of CBCF on impact performance. Additionally, two /sup 238/PuO/sub 2/ pellets were encapsulated in Ir-0.3% W for impact testing. Results of the clad development test and vent testing are noted. Results of the environmental tests are summarized. Progress on the Stirling isotope power systems test and the status of the improved MHW tests are indicated. The examination of the impact failure of the iridium shell of MHFT-65 at a fuel pass-through continued. A test plan was written for vibration testing of the assembled light-weight radioisotopic heater unit. Progress on fuel processing is reported.

  19. Colorado School of Mines Low Energy Nuclear Physics Project technical progress report

    SciTech Connect

    Cecil, F.E.

    1990-01-05

    This report summarizes the activity and accomplishments of the Colorado School of Mines Low Energy Nuclear Physics project during the calendar year 1989. Many of the projects which were anticipated in the original grant proposal have been completed. Among these completed projects we include of study of the radiative capture of low energy protons on {sup 6}Li, {sup 7}Li, {sup 9}Be, and {sup 11}B. Preliminary measurements of the branching ratios and yields of these reactions were reported in last year's Technical Progress Report. These measurements are now complete and have been used to extract the respective astrophysical S-factors and the corresponding thermonuclear reactivities. While not complete, progress has been made in some of the other originally proposed studies. Among these include a fairly extensive study of the interaction of low energy deuterons with {sup 6}Li and {sup 7}Li. In the course of this study we have made a solid observation of the Oppenheimer-Phillips effect in the D-{sup 6}Li system. Progress has been made in our study of the radiative capture of alpha particles by deuterons, {sup 6}Li, and {sup 7}Li but considerable work remains in these studies. In our earlier reports we noted the observation of d-d reactions during the bombardment of deuterated targets with energetic beams of protons, alpha particles, and other light-to-medium ions. We believe we now understand this phenomenon and feel it has some fairly significant consequences both for our studies and for those of other researchers. Our susceptibility to mob hysteria led us to invest a significant effort in cold nuclear fusion, both employing a fairly unique accelerator based approach at CSM and as one of the gamma ray diagnosticians on the Princeton Plasma Physics Laboratory's Cold Fusion Task Force.

  20. Progress of teaching and learning of nuclear engineering courses at College of Engineering, Universiti Tenaga Nasional (UNITEN)

    SciTech Connect

    Hamid, Nasri A. Mohamed, Abdul Aziz; Yusoff, Mohd. Zamri

    2015-04-29

    Developing human capital in nuclear with required nuclear background and professional qualifications is necessary to support the implementation of nuclear power projects in the near future. Sufficient educational and training skills are required to ensure that the human resources needed by the nuclear power industry meets its high standard. The Government of Malaysia has made the decision to include nuclear as one of the electricity generation option for the country, post 2020 in order to cater for the increasing energy demands of the country as well as to reduce CO{sub 2} emission. The commitment by the government has been made clearer with the inclusion of the development of first NPP by 2021 in the Economic Transformation Program (ETP) which was launched by the government in October 2010. The In tandem with the government initiative to promote nuclear energy, Center for Nuclear Energy, College of Engineering, Universiti Tenaga Nasional (UNITEN) is taking the responsibility in developing human capital in the area of nuclear power and technology. In the beginning, the College of Engineering has offered the Introduction to Nuclear Technology course as a technical elective course for all undergraduate engineering students. Gradually, other nuclear technical elective courses are offered such as Nuclear Policy, Security and Safeguards, Introduction to Nuclear Engineering, Radiation Detection and Nuclear Instrumentation, Introduction to Reactor Physics, Radiation Safety and Waste Management, and Nuclear Thermal-hydraulics. In addition, another course Advancement in Nuclear Energy is offered as one of the postgraduate elective courses. To enhance the capability of teaching staffs in nuclear areas at UNITEN, several junior lecturers are sent to pursue their postgraduate studies in the Republic of Korea, United States and the United Kingdom, while the others are participating in short courses and workshops in nuclear that are conducted locally and abroad. This paper describes the progress of teaching and learning in nuclear engineering and technology at UNITEN that include curriculum development, students’ enrolment and performance, and teaching staff’s human resource development.

  1. Progress of teaching and learning of nuclear engineering courses at College of Engineering, Universiti Tenaga Nasional (UNITEN)

    NASA Astrophysics Data System (ADS)

    Hamid, Nasri A.; Mohamed, Abdul Aziz; Yusoff, Mohd. Zamri

    2015-04-01

    Developing human capital in nuclear with required nuclear background and professional qualifications is necessary to support the implementation of nuclear power projects in the near future. Sufficient educational and training skills are required to ensure that the human resources needed by the nuclear power industry meets its high standard. The Government of Malaysia has made the decision to include nuclear as one of the electricity generation option for the country, post 2020 in order to cater for the increasing energy demands of the country as well as to reduce CO2 emission. The commitment by the government has been made clearer with the inclusion of the development of first NPP by 2021 in the Economic Transformation Program (ETP) which was launched by the government in October 2010. The In tandem with the government initiative to promote nuclear energy, Center for Nuclear Energy, College of Engineering, Universiti Tenaga Nasional (UNITEN) is taking the responsibility in developing human capital in the area of nuclear power and technology. In the beginning, the College of Engineering has offered the Introduction to Nuclear Technology course as a technical elective course for all undergraduate engineering students. Gradually, other nuclear technical elective courses are offered such as Nuclear Policy, Security and Safeguards, Introduction to Nuclear Engineering, Radiation Detection and Nuclear Instrumentation, Introduction to Reactor Physics, Radiation Safety and Waste Management, and Nuclear Thermal-hydraulics. In addition, another course Advancement in Nuclear Energy is offered as one of the postgraduate elective courses. To enhance the capability of teaching staffs in nuclear areas at UNITEN, several junior lecturers are sent to pursue their postgraduate studies in the Republic of Korea, United States and the United Kingdom, while the others are participating in short courses and workshops in nuclear that are conducted locally and abroad. This paper describes the progress of teaching and learning in nuclear engineering and technology at UNITEN that include curriculum development, students' enrolment and performance, and teaching staff's human resource development.

  2. Selective inhibitors of nuclear export avert progression in preclinical models of inflammatory demyelination

    PubMed Central

    Haines, Jeffery D.; Herbin, Olivier; de la Hera, Belén; Vidaurre, Oscar G.; Moy, Gregory A.; Sun, Qingxiang; Fung, Ho Yee Joyce; Albrecht, Stephanie; Alexandropoulos, Konstantina; McCauley, Dilara; Chook, Yuh Min; Kuhlmann, Tanja; Kidd, Grahame J.; Shacham, Sharon; Casaccia, Patrizia

    2015-01-01

    Axonal damage has been associated with aberrant protein trafficking. This study characterizes a novel class of compounds targeting nucleo-cytoplasmic shuttling, by binding to the catalytic groove of the nuclear export protein XPO1/CRM1 (chromosome region maintenance protein1). Oral administration of novel reversible CRM1 inhibitors in preclinical murine models of demyelination significantly attenuated disease progression, even when started after the onset of paralysis. Clinical efficacy was associated with decreased proliferation of immune cells, characterized by nuclear accumulation of cell cycle inhibitors, and preservation of cytoskeletal integrity even in demyelinated axons. Neuroprotection was not limited to models of demyelination, but observed also in other mouse models of axonal damage (i.e. kainic acid injection) and detected in cultured neurons after knockdown of Xpo1, the gene encoding for CRM1. A proteomic screen for target molecules revealed that CRM1 inhibitors in neurons prevented nuclear export of molecules associated with axonal damage while retaining transcription factors modulating neuroprotection. PMID:25706475

  3. Radiotherapy and Nuclear Medicine Project for an Integral Oncology Center at the Oaxaca High Specialization Regional Hospital

    NASA Astrophysics Data System (ADS)

    De Jesús, M.; Trujillo-Zamudio, F. E.

    2010-12-01

    A building project of Radiotherapy & Nuclear Medicine services (diagnostic and therapy), within an Integral Oncology Center (IOC), requires interdisciplinary participation of architects, biomedical engineers, radiation oncologists and medical physicists. This report focus on the medical physicist role in designing, building and commissioning stages, for the final clinical use of an IOC at the Oaxaca High Specialization Regional Hospital (HRAEO). As a first step, during design stage, the medical physicist participates in discussions about radiation safety and regulatory requirements for the National Regulatory Agency (called CNSNS in Mexico). Medical physicists propose solutions to clinical needs and take decisions about installing medical equipment, in order to fulfill technical and medical requirements. As a second step, during the construction stage, medical physicists keep an eye on building materials and structural specifications. Meanwhile, regulatory documentation must be sent to CNSNS. This documentation compiles information about medical equipment, radioactivity facility, radiation workers and nuclear material data, in order to obtain the license for the linear accelerator, brachytherapy and nuclear medicine facilities. As a final step, after equipment installation, the commissioning stage takes place. As the conclusion, we show that medical physicists are essentials in order to fulfill with Mexican regulatory requirements in medical facilities.

  4. Radiotherapy and Nuclear Medicine Project for an Integral Oncology Center at the Oaxaca High Specialization Regional Hospital

    SciTech Connect

    De Jesus, M.; Trujillo-Zamudio, F. E.

    2010-12-07

    A building project of Radiotherapy and Nuclear Medicine services (diagnostic and therapy), within an Integral Oncology Center (IOC), requires interdisciplinary participation of architects, biomedical engineers, radiation oncologists and medical physicists. This report focus on the medical physicist role in designing, building and commissioning stages, for the final clinical use of an IOC at the Oaxaca High Specialization Regional Hospital (HRAEO). As a first step, during design stage, the medical physicist participates in discussions about radiation safety and regulatory requirements for the National Regulatory Agency (called CNSNS in Mexico). Medical physicists propose solutions to clinical needs and take decisions about installing medical equipment, in order to fulfill technical and medical requirements. As a second step, during the construction stage, medical physicists keep an eye on building materials and structural specifications. Meanwhile, regulatory documentation must be sent to CNSNS. This documentation compiles information about medical equipment, radioactivity facility, radiation workers and nuclear material data, in order to obtain the license for the linear accelerator, brachytherapy and nuclear medicine facilities. As a final step, after equipment installation, the commissioning stage takes place. As the conclusion, we show that medical physicists are essentials in order to fulfill with Mexican regulatory requirements in medical facilities.

  5. Conventional and Nuclear Medicine Imaging in Ectopic Cushing's Syndrome: A Systematic Review

    PubMed Central

    Isidori, Andrea M.; Sbardella, Emilia; Zatelli, Maria Chiara; Boschetti, Mara; Vitale, Giovanni; Colao, Annamaria

    2015-01-01

    Context: Ectopic Cushing's Syndrome (ECS) can be a diagnostic challenge with the hormonal source difficult to find. This study analyzes the accuracy of imaging studies in ECS localization. Evidence Acquisition: Systematic review of medical literature for ECS case series providing individual patient data on at least one conventional imaging technique (computed tomography [CT]/magnetic resonance imaging) and one of the following: 111In-pentetreotide (OCT), 131I/123I-metaiodobenzylguanidine, 18F-fluoro-2-deoxyglucose-positron emission tomography (FDG-PET), 18F-fluorodopa-PET (F-DOPA-PET), 68Ga-DOTATATE-PET/CT or 68Ga-DOTATOC-PET/CT scan (68Gallium-SSTR-PET/CT). Evidence Summary: The analysis comprised 231 patients (females, 50.2%; age, 42.6 ± 17 y). Overall, 52.4% (121/231) had “overt” ECS, 18.6% had “occult” ECS, and 29% had “covert” ECS. Tumors were located in the lung (55.3%), mediastinum-thymus (7.9%), pancreas (8.5%), adrenal glands (6.4%), gastrointestinal tract (5.4%), thyroid (3.7%), and other sites (12.8%), and primary tumors were mostly bronchial neuroendocrine tumors (NETs) (54.8%), pancreatic NETs (8%), mediastinum-thymus NETs (6.9%), gastrointestinal NETs (5.3%), pheochromocytoma (6.4%), neuroblastoma (3.2%), and medullary thyroid carcinoma (3.2%). Tumors were localized by CT in 66.2% (137/207), magnetic resonance imaging in 51.5% (53/103), OCT in 48.9% (84/172), FDG-PET in 51.7% (46/89), F-DOPA-PET in 57.1% (12/21), 131/123I-metaiodobenzylguanidine in 30.8% (4/13), and 68Gallium-SSTR-PET/CT in 81.8% (18/22) of cases. Molecular imaging discovered 79.1% (53/67) of tumors unidentified by conventional radiology, with OCT the most commonly used, revealing the tumor in 64%, followed by FDG-PET in 59.4%. F-DOPA-PET was used in only seven covert cases (sensitivity, 85.7%). Notably, 68Gallium-SSTR-PET/CT had 100% sensitivity among covert cases. Conclusions: Nuclear medicine improves the sensitivity of conventional radiology when tumor site identification is problematic. OCT offers a good availability/reliability ratio, and FDG-PET was proven useful. 68Gallium-SSTR-PET/CT use was infrequent, despite offering the highest sensitivity. PMID:26158607

  6. Development and validation of a fast voxel-based dose evaluation system in nuclear medicine

    NASA Astrophysics Data System (ADS)

    Lu, Cheng-Chang; Lin, Hsin-Hon; Chuang, Keh-Shih; Dong, Shang-Lung; Wu, Jay; Ni, Yu-Ching; Jan, Meei-Ling

    2014-11-01

    PET imaging has been widely used in the detection and staging of malignancies and the evaluation of patient-specific dosimetry for PET scans is important in nuclear medicine. However, patient-specific dosimetry can be estimated only by Monte Carlo methods which are usually time-consuming. The purpose of this study is to develop a fast dose evaluation system namely SimDOSE. SimDOSE is a Monte Carlo code embedded in SimSET with a dose scoring routine to record the deposited energy of the photons and electrons. Fluorine-18 is one of the most commonly used radionuclides that decay predominantly by positron emission. Only a 635 keV (Emax) positron and two annihilation photons should be concerned in F-18 radiation dosimetry, hence simulation is relatively simple. To evaluate the effects of resolution, an F-18 point source placed in a 20 cm diameter sphere filled with water was simulated by SimDOSE and GATE v6.1. Grid sizes of 1 mm, 3 mm, and 5 mm were tested and each was simulated with a total of 107 decays. The resultant dose distribution functions were compared. Dose evaluation on ORNL phantom was also performed to validate the accuracy of SimDOSE. The grid size of phantom was set as 3 mm and the number of decays was 107. The S-values of liver computed by SimDOSE were compared with GATE and OLINDA (Organ Level INternal Dose Assessment) for 11C, 15O, and 18F.Finally, the CPU time of simulations was compared between SimDOSE and GATE. The dose profiles show the absorption doses located 3 mm outside the center are similar between SimDOSE and GATE. However, 71% (19%) difference of the center dose between SimDOSE and GATE are observed for 1 mm (3 mm) grid. The differences of the profile lie in the assumption in SimDOSE that all kinetic energies of electrons are locally absorbed. The ratios of S values of (SimDOSE/OLINDA) range from 0.95 to 1.11 with a mean value of 1.02±0.043. To compare simulation time from SimDOSE to GATE for calculation of 1 mm, 3 mm, 5 mm gird point source and S values of ORNL phantom are 1.3%, 1.2%, 1.2% and 1.2%, respectively. In conclusion, SimDOSE is an efficient and accurate toolkit to generate patient-specific dose distribution in clinical PET application.

  7. Implementation of test for quality assurance in nuclear medicine gamma camera

    SciTech Connect

    Montoya Moreno, A.; Rodriguez Laguna, A.; Trujillo Zamudio, Flavio E

    2012-10-23

    In nuclear medicine (NM) over 90% of procedures are performed for diagnostic purposes. To ensure adequate diagnostic quality of images and the optimization of the doses received by patients originated from the radioactive material is essential for regular monitoring and equipment performance through a quality assurance program (QAP). The QAP consists of 15 proposed performance tomographic and not tomographic gamma camera (GC) tests, and is based on recommendations of international organizations. We describe some results of the performance parameters of QAP applied to a GC model e.cam Siemens, of the Department of NM of the National Cancer Institute of Mexico (INCan). The results were: (1) The average intrinsic spatial resolution (R{sub in}) was 4.67 {+-} 0.25 mm at the limit of acceptance criterion of 4.4 mm. (2) The sensitivity extrinsic (S{sub ext}), with maximum variations of 1.8% (less than 2% which is the criterion of acceptance). (3) Rotational Uniformity (U{sub rot}), with values of integral uniformity (IU) in the useful field of view detector (UFOV), with maximum percentage change of 0.97% and monthly variations equal angles, ranging from 0.13 to 0.99% less than 1%. (4) The displacement of the center of rotation (DCOR), indicated a maximum deviation of 0.155 {+-} 0.039 mm less than 4.795 mm, an absolute deviation of less than 0.5 where pixel 0.085 pixel is suggested, the criteria are assigned to low-energy collimator high resolution. (5) In tomographic uniformity (U{sub tomo}), UI values (%) and percentage noise level (rms%) were 7.54 {+-} 1.53 and 4.18 {+-} 1.69 which are consistent with the limits of acceptance of 7.0-12.0% and 3.0-6.0% respectively. The smallest cold sphere has a diameter of 11.4 mm. The implementation of a QAP allows for high quality diagnostic images, optimization of the doses given to patients, a reduction of exposure to occupationally exposed workers (POE, by its Spanish acronym), and generally improves the productivity of the service. This proposal can be used to develop a similar QAP in other facilities and may serve as a precedent for the proposed regulations for quality assurance (QA) teams in MN.

  8. Nuclear physics research at the University of Richmond. Progress report, November 1, 1994--October 31, 1995

    SciTech Connect

    Vineyard, M.F.; Gilfoyle, G.P.; Major, R.W.

    1995-12-31

    Summarized in this report is the progress achieved during the period from November 1, 1994 to October 31, 1995. The experimental work described in this report is in electromagnetic and heavy-ion nuclear physics. The effort in electromagnetic nuclear physics is in preparation for the research program at the Continuous Electron Beam Accelerator Facility (CEBAF) and is focused on the construction and use of the CEBAF Large Acceptance Spectrometer (CLAS). The heavy-ion experiments were performed at the Argonne National Laboratory ATLAS facility and SUNY, Stony Brook. The physics interests driving these efforts at CEBAF are in the study of the structure, interactions, and nuclear-medium modifications of mesons and baryons. This year, an extension of the experiment to measure the magnetic form factor of the neutron was approved by the CEBAF Program Advisory Committee Nine (PAC9) for beam at 6 GeV. The authors also submitted updates to PAC9 on the experiments to measure inclusive {eta} photoproduction in nuclei and electroproduction of the {Lambda}, {Lambda}*(1520), and f{sub 0}(975). In addition to these experiments, the authors collaborated on a proposal to measure rare radiative decays of the {phi} meson which was also approved by PAC9. Their contributions to the construction of the CLAS include the development of the drift-chamber gas system, drift-chamber software, and controls software. Major has been leading the effort in the construction of the gas system. In the last year, the Hall B gas shed was constructed and the installation of the gas system components built at the University of Richmond has begun. Over the last six years, the efforts in low-energy heavy-ion physics have decreased due to the change in focus to electromagnetic nuclear physics at CEBAF. Most of the heavy-ion work is completed and there are now new experiments planned. Included in this report are two papers resulting from collaborations on heavy-ion experiments.

  9. Recent progress in research on tungsten materials for nuclear fusion applications in Europe

    NASA Astrophysics Data System (ADS)

    Rieth, M.; Dudarev, S. L.; Gonzalez de Vicente, S. M.; Aktaa, J.; Ahlgren, T.; Antusch, S.; Armstrong, D. E. J.; Balden, M.; Baluc, N.; Barthe, M.-F.; Basuki, W. W.; Battabyal, M.; Becquart, C. S.; Blagoeva, D.; Boldyryeva, H.; Brinkmann, J.; Celino, M.; Ciupinski, L.; Correia, J. B.; De Backer, A.; Domain, C.; Gaganidze, E.; García-Rosales, C.; Gibson, J.; Gilbert, M. R.; Giusepponi, S.; Gludovatz, B.; Greuner, H.; Heinola, K.; Höschen, T.; Hoffmann, A.; Holstein, N.; Koch, F.; Krauss, W.; Li, H.; Lindig, S.; Linke, J.; Linsmeier, Ch.; López-Ruiz, P.; Maier, H.; Matejicek, J.; Mishra, T. P.; Muhammed, M.; Muñoz, A.; Muzyk, M.; Nordlund, K.; Nguyen-Manh, D.; Opschoor, J.; Ordás, N.; Palacios, T.; Pintsuk, G.; Pippan, R.; Reiser, J.; Riesch, J.; Roberts, S. G.; Romaner, L.; Rosi?ski, M.; Sanchez, M.; Schulmeyer, W.; Traxler, H.; Ureña, A.; van der Laan, J. G.; Veleva, L.; Wahlberg, S.; Walter, M.; Weber, T.; Weitkamp, T.; Wurster, S.; Yar, M. A.; You, J. H.; Zivelonghi, A.

    2013-01-01

    The current magnetic confinement nuclear fusion power reactor concepts going beyond ITER are based on assumptions about the availability of materials with extreme mechanical, heat, and neutron load capacity. In Europe, the development of such structural and armour materials together with the necessary production, machining, and fabrication technologies is pursued within the EFDA long-term fusion materials programme. This paper reviews the progress of work within the programme in the area of tungsten and tungsten alloys. Results, conclusions, and future projections are summarized for each of the programme's main subtopics, which are: (1) fabrication, (2) structural W materials, (3) W armour materials, and (4) materials science and modelling. It gives a detailed overview of the latest results on materials research, fabrication processes, joining options, high heat flux testing, plasticity studies, modelling, and validation experiments.

  10. Progress in Norwegian-Russian Regulatory Cooperation in Management of the Nuclear Legacy

    SciTech Connect

    Sneve, M.K.; Shandala, N.K.; Smith, G.M.

    2008-07-01

    The Norwegian Radiation Protection Authority (NRPA) and the Federal Medical-Biological Agency (FMBA) of the Russian Federation have a collaboration programme which forms part of the Norwegian government's Plan of Action to improve radiation and nuclear safety in northwest Russia. The background to the NRPA-FMBA collaboration programme has been described in previous WM presentations. This paper presents the substantial progress made within that programme, describes ongoing progress within specific projects and sets out the value arising from wider involvement in the programme of other organisations such as NATO and the technical support derived from other national agencies such as the IAEA, and regulatory authorities from the USA, the UK and France. The main activities of the cooperation projects are concerned with the management of the nuclear legacy in northwest Russia, in particular the remediation of facilities, and related spent fuel and radioactive waste management, at the former Shore Technical Bases at Andreeva Bay and Gremikha Village. New regulatory guidance documents have been developed, necessary because of the special abnormal situation at these sites, now designated as Sites of Temporary Storage (STS), but also because of the transition from military to civilian regulatory supervision and the evolving regulatory system in the Russian Federation. The work has involved major technical inputs from the Russian Federation Institute of Biophysics, as well as review and advice on international recommendations and good practice in other countries provided by other technical support organisations. Projects on-going in 2007 are described which involve regulatory guidance on very Low-Level Waste management, specifically for the licensing and operation of new VLLW disposal facilities; optimisation of operational radiation protection, particularly in areas of high ambient radiation dose rate as are found in some parts of the STSs; determination of factors which can be used to identify when to apply emergency procedures before the full emergency is obvious; and development of the radio-ecological basis for identifying radiation supervision area boundaries. (authors)

  11. Mutation of the nuclear lamin gene LMNB2 in progressive myoclonus epilepsy with early ataxia.

    PubMed

    Damiano, John A; Afawi, Zaid; Bahlo, Melanie; Mauermann, Monika; Misk, Adel; Arsov, Todor; Oliver, Karen L; Dahl, Hans-Henrik M; Shearer, A Eliot; Smith, Richard J H; Hall, Nathan E; Mahmood, Khalid; Leventer, Richard J; Scheffer, Ingrid E; Muona, Mikko; Lehesjoki, Anna-Elina; Korczyn, Amos D; Herrmann, Harald; Berkovic, Samuel F; Hildebrand, Michael S

    2015-08-15

    We studied a consanguineous Palestinian Arab family segregating an autosomal recessive progressive myoclonus epilepsy (PME) with early ataxia. PME is a rare, often fatal syndrome, initially responsive to antiepileptic drugs which over time becomes refractory and can be associated with cognitive decline. Linkage analysis was performed and the disease locus narrowed to chromosome 19p13.3. Fourteen candidate genes were screened by conventional Sanger sequencing and in one, LMNB2, a novel homozygous missense mutation was identified that segregated with the PME in the family. Whole exome sequencing excluded other likely pathogenic coding variants in the linked interval. The p.His157Tyr mutation is located in an evolutionarily highly conserved region of the alpha-helical rod of the lamin B2 protein. In vitro assembly analysis of mutant lamin B2 protein revealed a distinct defect in the assembly of the highly ordered fibrous arrays typically formed by wild-type lamin B2. Our data suggests that disruption of the organisation of the nuclear lamina in neurons, perhaps through abnormal neuronal migration, causes the epilepsy and early ataxia syndrome and extends the aetiology of PMEs to include dysfunction in nuclear lamin proteins. PMID:25954030

  12. Radioactive Waste Management and Nuclear Facility Decommissioning Progress in Iraq - 13216

    SciTech Connect

    Al-Musawi, Fouad; Shamsaldin, Emad S.; Jasim, Hadi; Cochran, John R.

    2013-07-01

    Management of Iraq's radioactive wastes and decommissioning of Iraq's former nuclear facilities are the responsibility of Iraq's Ministry of Science and Technology (MoST). The majority of Iraq's former nuclear facilities are in the Al-Tuwaitha Nuclear Research Center located a few kilometers from the edge of Baghdad. These facilities include bombed and partially destroyed research reactors, a fuel fabrication facility and radioisotope production facilities. Within these facilities are large numbers of silos, approximately 30 process or waste storage tanks and thousands of drums of uncharacterised radioactive waste. There are also former nuclear facilities/sites that are outside of Al-Tuwaitha and these include the former uranium processing and waste storage facility at Jesira, the dump site near Adaya, the former centrifuge facility at Rashdiya and the former enrichment plant at Tarmiya. In 2005, Iraq lacked the infrastructure needed to decommission its nuclear facilities and manage its radioactive wastes. The lack of infrastructure included: (1) the lack of an organization responsible for decommissioning and radioactive waste management, (2) the lack of a storage facility for radioactive wastes, (3) the lack of professionals with experience in decommissioning and modern waste management practices, (4) the lack of laws and regulations governing decommissioning or radioactive waste management, (5) ongoing security concerns, and (6) limited availability of electricity and internet. Since its creation eight years ago, the MoST has worked with the international community and developed an organizational structure, trained staff, and made great progress in managing radioactive wastes and decommissioning Iraq's former nuclear facilities. This progress has been made, despite the very difficult implementing conditions in Iraq. Within MoST, the Radioactive Waste Treatment and Management Directorate (RWTMD) is responsible for waste management and the Iraqi Decommissioning Directorate (IDD) is responsible for decommissioning activities. The IDD and the RWTMD work together on decommissioning projects. The IDD has developed plans and has completed decommissioning of the GeoPilot Facility in Baghdad and the Active Metallurgical Testing Laboratory (LAMA) in Al-Tuwaitha. Given this experience, the IDD has initiated work on more dangerous facilities. Plans are being developed to characterize, decontaminate and decommission the Tamuz II Research Reactor. The Tammuz Reactor was destroyed by an Israeli air-strike in 1981 and the Tammuz II Reactor was destroyed during the First Gulf War in 1991. In addition to being responsible for managing the decommissioning wastes, the RWTMD is responsible for more than 950 disused sealed radioactive sources, contaminated debris from the first Gulf War and (approximately 900 tons) of naturally-occurring radioactive materials wastes from oil production in Iraq. The RWTMD has trained staff, rehabilitated the Building 39 Radioactive Waste Storage building, rehabilitated portions of the French-built Radioactive Waste Treatment Station, organized and secured thousands of drums of radioactive waste organized and secured the stores of disused sealed radioactive sources. Currently, the IDD and the RWTMD are finalizing plans for the decommissioning of the Tammuz II Research Reactor. (authors)

  13. Forensic Medicine in South Africa: Associations between Medical Practice and Legal Case Progression and Outcomes in Female Murders

    PubMed Central

    Abrahams, Naeemah; Jewkes, Rachel; Martin, Lorna J.; Mathews, Shanaaz

    2011-01-01

    Background Forensic medicine has been largely by-passed by the tide of health systems research and evidence based medicine. Murder victims form a central part of forensic medical examiners' case load, and women murdered by intimate partners are an important subgroup, representing the most severe form and consequence of intimate partner violence. Our aim was to describe the epidemiology of female murder in South Africa (by intimate and non-intimate partners); and to describe and compare autopsy findings, forensic medical management of cases and the contribution of these to legal outcomes. Methods We did a retrospective national study in a proportionate random sample of 25 medico-legal laboratories to identify all homicides in 1999 of women aged 14 years and over. Data were abstracted from the mortuary file and autopsy report, and collected from a police interview. Findings In 21.5% of cases the perpetrator was convicted. Factors associated with a conviction for the female murders included having a history of intimate partner violence 1.18 (95%CI: 0.16–2.20), weapon recovered 1.36 (95% CI:0.58–2.15) and a detective visiting the crime scene 1.57 (95% CI:0.14–3.00). None of the forensic medical activities increased the likelihood of a conviction. Conclusion The findings raise important questions about the role of forensic medicine in these cases. PMID:22194868

  14. Recent Progress of Research on Herbal Products Used in Traditional Chinese Medicine: the Herbs belonging to The Divine Husbandman's Herbal Foundation Canon (????? Shén Nóng B?n C?o J?ng)

    PubMed Central

    Lee, Kuo-Hsiung; Morris-Natschke, Susan; Qian, Keduo; Dong, Yizhou; Yang, Xiaoming; Zhou, Ting; Belding, Eileen; Wu, Shou-Fang; Wada, Koji; Akiyama, Toshiyuki

    2012-01-01

    This article will review selected herbal products from Chinese Materia Medica that are used in Traditional Chinese Medicine. The herbs come from the upper, middle, and lower class medicines as listed in The Divine Husbandman's Herbal Foundation Canon (????? Shén Nóng B?n C?o J?ng). The review will focus on the active constituents of the herbs and their bioactivities, with emphasis on the most recent progress in research for the period of 2003 to 2011. PMID:24716110

  15. Introduction In nuclear medicine, a pharmaceutical tagged with a radioactive isotope (a radio

    E-print Network

    Duncan, James S.

    tomographic imaging methods in medicine. The first medical scanner to perform x­ray computed tomography (x­ray the gamma rays emitted in the radioactive decay of the isotope. Unlike x­ray techniques, where the radiation a given organ typically yields information about the physi­ ological function of the organ, whereas an x­ray

  16. Thesis proposal CSF Brazil 2014 Authentication and quality control of herbal medicines assessed by Nuclear Magnetic

    E-print Network

    Bordenave, Charles

    Thesis proposal CSF Brazil 2014 Title: Authentication and quality control of herbal medicines as the control of their quality have become important concerns. For the quality control of an herbal drug Spectrometry experiments. During the PhD, several NMR methods will be employed for controlling the quality

  17. Comparison of 4-Dimensional Computed Tomography Ventilation With Nuclear Medicine Ventilation-Perfusion Imaging: A Clinical Validation Study

    SciTech Connect

    Vinogradskiy, Yevgeniy; Koo, Phillip J.; Castillo, Richard; Castillo, Edward; Guerrero, Thomas; Gaspar, Laurie E.; Miften, Moyed; Kavanagh, Brian D.

    2014-05-01

    Purpose: Four-dimensional computed tomography (4DCT) ventilation imaging provides lung function information for lung cancer patients undergoing radiation therapy. Before 4DCT-ventilation can be implemented clinically it needs to be validated against an established imaging modality. The purpose of this work was to compare 4DCT-ventilation to nuclear medicine ventilation, using clinically relevant global metrics and radiologist observations. Methods and Materials: Fifteen lung cancer patients with 16 sets of 4DCT and nuclear medicine ventilation-perfusion (VQ) images were used for the study. The VQ-ventilation images were acquired in planar mode using Tc-99m-labeled diethylenetriamine-pentaacetic acid aerosol inhalation. 4DCT data, spatial registration, and a density-change-based model were used to compute a 4DCT-based ventilation map for each patient. The percent ventilation was calculated in each lung and each lung third for both the 4DCT and VQ-ventilation scans. A nuclear medicine radiologist assessed the VQ and 4DCT scans for the presence of ventilation defects. The VQ and 4DCT-based images were compared using regional percent ventilation and radiologist clinical observations. Results: Individual patient examples demonstrate good qualitative agreement between the 4DCT and VQ-ventilation scans. The correlation coefficients were 0.68 and 0.45, using the percent ventilation in each individual lung and lung third, respectively. Using radiologist-noted presence of ventilation defects and receiver operating characteristic analysis, the sensitivity, specificity, and accuracy of the 4DCT-ventilation were 90%, 64%, and 81%, respectively. Conclusions: The current work compared 4DCT with VQ-based ventilation using clinically relevant global metrics and radiologist observations. We found good agreement between the radiologist's assessment of the 4DCT and VQ-ventilation images as well as the percent ventilation in each lung. The agreement lessened when the data were analyzed on a regional level. Our study presents an important step for the integration of 4DCT-ventilation into thoracic clinical practice.

  18. Nuclear medicine practices in the 1950s through the mid-1970s and occupational radiation doses to technologists from diagnostic radioisotope procedures.

    PubMed

    Drozdovitch, Vladimir; Brill, Aaron B; Mettler, Fred A; Beckner, William M; Goldsmith, Stanley J; Gross, Milton D; Hays, Marguerite T; Kirchner, Peter T; Langan, James K; Reba, Richard C; Smith, Gary T; Bouville, André; Linet, Martha S; Melo, Dunstana R; Lee, Choonsik; Simon, Steven L

    2014-10-01

    Data on occupational radiation exposure from nuclear medicine procedures for the time period of the 1950s through the 1970s is important for retrospective health risk studies of medical personnel who conducted those activities. However, limited information is available on occupational exposure received by physicians and technologists who performed nuclear medicine procedures during those years. To better understand and characterize historical radiation exposures to technologists, the authors collected information on nuclear medicine practices in the 1950s, 1960s, and 1970s. To collect historical data needed to reconstruct doses to technologists, a focus group interview was held with experts who began using radioisotopes in medicine in the 1950s and the 1960s. Typical protocols and descriptions of clinical practices of diagnostic radioisotope procedures were defined by the focus group and were used to estimate occupational doses received by personnel, per nuclear medicine procedure, conducted in the 1950s to 1960s using radiopharmaceuticals available at that time. The radionuclide activities in the organs of the reference patient were calculated using the biokinetic models described in ICRP Publication 53. Air kerma rates as a function of distance from a reference patient were calculated by Monte Carlo radiation transport calculations using a hybrid computational phantom. Estimates of occupational doses to nuclear medicine technologists per procedure were found to vary from less than 0.01 ?Sv (thyroid scan with 1.85 MBq of administered I-iodide) to 0.4 ?Sv (brain scan with 26 MBq of Hg-chlormerodin). Occupational doses for the same diagnostic procedures starting in the mid-1960s but using Tc were also estimated. The doses estimated in this study show that the introduction of Tc resulted in an increase in occupational doses per procedure. PMID:25162420

  19. Early Prediction of Cancer Progression by Depth-Resolved Nanoscale Mapping of Nuclear Architecture from Unstained Tissue Specimens.

    PubMed

    Uttam, Shikhar; Pham, Hoa V; LaFace, Justin; Leibowitz, Brian; Yu, Jian; Brand, Randall E; Hartman, Douglas J; Liu, Yang

    2015-11-15

    Early cancer detection currently relies on screening the entire at-risk population, as with colonoscopy and mammography. Therefore, frequent, invasive surveillance of patients at risk for developing cancer carries financial, physical, and emotional burdens because clinicians lack tools to accurately predict which patients will actually progress into malignancy. Here, we present a new method to predict cancer progression risk via nanoscale nuclear architecture mapping (nanoNAM) of unstained tissue sections based on the intrinsic density alteration of nuclear structure rather than the amount of stain uptake. We demonstrate that nanoNAM detects a gradual increase in the density alteration of nuclear architecture during malignant transformation in animal models of colon carcinogenesis and in human patients with ulcerative colitis, even in tissue that appears histologically normal according to pathologists. We evaluated the ability of nanoNAM to predict "future" cancer progression in patients with ulcerative colitis who did and did not develop colon cancer up to 13 years after their initial colonoscopy. NanoNAM of the initial biopsies correctly classified 12 of 15 patients who eventually developed colon cancer and 15 of 18 who did not, with an overall accuracy of 85%. Taken together, our findings demonstrate great potential for nanoNAM in predicting cancer progression risk and suggest that further validation in a multicenter study with larger cohorts may eventually advance this method to become a routine clinical test. Cancer Res; 75(22); 4718-27. ©2015 AACR. PMID:26383164

  20. A Network Model and Computational Approach Mo Supply Chain for Nuclear Medicine

    E-print Network

    Nagurney, Anna

    Sections of the American Physical Society, the American Association Physics Teachers, and the Society in nuclear medical imaging, which is routinely utilized by physicians for diagnostic analysis for both cancer

  1. Cyclotron-based nuclear science. Progress report, April 1, 1979-March 31, 1980

    SciTech Connect

    Not Available

    1980-06-01

    Research at the cyclotron institute is summarized. These major areas are covered: nuclear structure; nuclear reactions and scattering; polarization studies; interdisciplinary nuclear science; instrumentation and systems development; and publications. (GHT)

  2. Adjusting to progress: interactions between the National Library of Medicine and health sciences librarians, 1961–2001*

    PubMed Central

    Humphreys, Betsy L.

    2002-01-01

    Most health sciences librarians would agree that the National Library of Medicine's (NLM's) leadership and its services have been highly beneficial to the field, but this does not prevent specific NLM actions—or lack of action—from being perceived as annoying or infuriating. Over the past forty years, NLM's interactions with health sciences librarians have been affected by significant additions to NLM's mission and services, the expansion of NLM's direct user groups, and the growing range of possible relationships between health sciences librarians and NLM. The greatest friction between NLM and health services librarians occurs when there is a fundamental change in the way NLM carries out its mission—a change that adds to the web of relationships that link librarians and NLM and prompts corresponding changes in the way other libraries do business. Between 1961 and 2001, there were two such fundamental changes: the implementation of the National Network of Libraries of Medicine and the development and promotion of services targeted toward individual health professionals. On a lesser scale, each new service that connects NLM and health sciences librarians is another potential source of irritation, ready to flare up when the service is interrupted, changed, or eliminated. Other factors—including strong personalities, mistakes, and poor communication—add to, but do not cause, the intermittent problems between NLM and its most longstanding and engaged user group. These problems are in essence the price we pay for the leadership and vision of NLM's directors and for NLM's success in developing excellent services and in enhancing them based on advice from librarians and other users. PMID:11838459

  3. Nuclear-waste-management. Quarterly progress report, July-September 1981

    SciTech Connect

    Chikalla, T.D.; Powell, J.A.

    1981-12-01

    Progress reports and summaries are presented for the following: high-level waste process development, alternate waste forms; TMI zeolite vitrification demonstration program; nuclear waste materials characterization center; TRU waste immobilization; TRU waste decontamination; krypton implantation; thermal outgassing; iodine-129 fixation; NWVP off-gas analysis; monitoring and physical characterization of unsaturated zone transport; well-logging instrumentation development; verification instrument development; mobility of organic complexes of radionuclides in soils; handbook of methods to decrease the generation of low-level waste; waste management system studies; waste management safety studies; assessment of effectiveness of geologic isolation systems; waste/rock interactions technology program; high-level waste form preparation; development of backfill materials; development of structural engineered barriers; disposal charge analysis; analysis of spent fuel policy implementation; spent fuel and fuel pool component integrity program; analysis of postulated criticality events in a storage array of spent LWR fuel; asphalt emulsion sealing of uranium mill tailings; liner evaluation for uranium mill tailings; multilayer barriers for sealing uranium tailings; application of long-term chemical biobarriers for uranium tailings; and revegetation of inactive uranium tailings sites.

  4. Progress on an integrated multi-physics simulation predictive capability for plasma chamber nuclear components

    SciTech Connect

    A. Ying; M. Abdou; H. Zhang; R. Munipalli; M. Ulrickson; M. Sawan; B. Merrill

    2010-12-01

    Understanding the behavior of a plasma chamber component in the fusion environment requires a simulation technique that is capable of integrating multi-disciplinary computational codes while appropriately treating geometric heterogeneity and complexity. Such a tool should be able to interpret phenomena from mutually dependent scientific disciplines and predict performance with sufficient accuracy and consistency. Integrated multi-physics simulation predictive capability (ISPC) relies upon advanced numerical simulation techniques and is being applied to ITER first wall/shield and Test Blanket Module (TBM) designs. In this paper, progress in ISPC development is described through the presentation of a number of integrated simulations. The simulations cover key physical phenomena encountered in a fusion plasma chamber system, including tritium permeation, fluid dynamics, and structure mechanics. Interface engines were developed in order to pass field data, such as surface deformation or nuclear heating rate, from the structural analysis to the thermo-fluid MHD analysis code for magnetohydrodynamic (MHD) velocity profile assessments, or from the neutronics analysis to the thermo-fluid analysis for temperature calculations, respectively. Near-term effort toward further ISPC development is discussed.

  5. Applied nuclear data research and development. Semiannual progress report, October 1, 1981-March 31, 1982

    SciTech Connect

    Young, P.G.

    1982-08-01

    This progress report describes the activities of the Los Alamos Nuclear Data Group for October 1, 1981, through March 31, 1982. Topics covered include: peripheral effects in R-matrix theory; charged-particle elastic cross sections; energy-angle correlated emission spectra from the D(n,2n)P reaction; new ENDF/B-V evaluation of n+/sup 7/Li reactions; calculation of proton emission spectra from p+/sup 91/Zr and p+/sup 87/Sr reactions; thulium cross-section calculations; production of a new evaluation for natural tungsten between 0.1 and 20 MeV; application and further development of the improved COMNUC fission model; inelastic cross-section calculations on /sup 239/Pu; new calculation of prompt fission neutron spectrum N(E) and average prompt neutron multiplicity anti nu/sub p/; new fission neutron spectrum representation for ENDF; calculation of the prompt neutron spectrum and average prompt neutron multiplicity for the spontaneous fission of /sup 252/Cf; calculation of excited-state cross sections for actinide nuclei; NJOY code development; new 80-group fast reactor cross-section library; NJOY covariance modules, ERRORR and COVR; integral data testing of representations of /sup 235/U and /sup 239/Pu thermal fission spectra; ENDF/B-VI yields; delayed neutron data; CRAY code conversions; calculating fission-product decay-energies and spectra using adjusted data; and calculated neutron sources in Pu process solutions.

  6. Discovery of rhenium and masurium (technetium) by Ida Noddack-Tacke and Walter Noddack. Forgotten heroes of nuclear medicine.

    PubMed

    Biersack, H-J; Stelzner, F; Knapp, F F

    2015-11-30

    The history of the early identification of elements and their designation to the Mendeleev Table of the Elements was an important chapter in German science in which Ida (1896-1978) and Walter (1893-1960) Noddack played an important role in the first identification of rhenium (element 75, 1925) and technetium (element 43, 1933). In 1934 Ida Noddack was also the first to predict fission of uranium into smaller atoms. Although the Noddacks did not for some time later receive the recognition for the first identification of technetium-99m, their efforts have appropriately more recently been recognized. The discoveries of these early pioneers are even more astounding in light of the limited technologies and resources which were available during this period. The Noddack discoveries of elements 43 and 75 are related to the subsequent use of rhenium-188 (beta/gamma emitter) and technetium-99m (gamma emitter) in nuclear medicine. In particular, the theranostic relationship between these two generator-derived radioisotopes has been demonstrated and offers new opportunities in the current era of personalized medicine. PMID:26478117

  7. Design and manufacturing of anthropomorphic thyroid-neck phantom for use in nuclear medicine centres in Chile.

    PubMed

    Hermosilla, A; Díaz Londoño, G; García, M; Ruíz, F; Andrade, P; Pérez, A

    2014-12-01

    Anthropomorphic phantoms are used in nuclear medicine for imaging quality control, calibration of gamma spectrometry system for the study of internal contamination with radionuclides and for internal dosimetric studies. These are constructed of materials that have radiation attenuation coefficients similar to those of the different organs and tissues of the human body. The material usually used for the manufacture of phantoms is polymethyl methacrylate. Other materials used for this purpose are polyethylene, polystyrene and epoxy resin. This project presents the design and manufacture of an anthropomorphic thyroid-neck phantom that includes the cervical spine, trachea and oesophagus, using a polyester resin (? = 1.1 g cm(-3)). Its linear and mass attenuation coefficients were experimentally determined and simulated by means of XCOM software, finding that this material reproduces the soft tissue ICRU-44 in a range of energies between 80 keV and 11 MeV, with less than a 5 % difference. PMID:24567500

  8. X-ray imaging physics for nuclear medicine technologists. Part 1: Basic principles of x-ray production.

    PubMed

    Seibert, J Anthony

    2004-09-01

    The purpose is to review in a 4-part series: (i) the basic principles of x-ray production, (ii) x-ray interactions and data capture/conversion, (iii) acquisition/creation of the CT image, and (iv) operational details of a modern multislice CT scanner integrated with a PET scanner. Advances in PET technology have lead to widespread applications in diagnostic imaging and oncologic staging of disease. Combined PET/CT scanners provide the high-resolution anatomic imaging capability of CT with the metabolic and physiologic information by PET, to offer a significant increase in information content useful for the diagnostician and radiation oncologist, neurosurgeon, or other physician needing both anatomic detail and knowledge of disease extent. Nuclear medicine technologists at the forefront of PET should therefore have a good understanding of x-ray imaging physics and basic CT scanner operation, as covered by this 4-part series. After reading the first article on x-ray production, the nuclear medicine technologist will be familiar with (a) the physical characteristics of x-rays relative to other electromagnetic radiations, including gamma-rays in terms of energy, wavelength, and frequency; (b) methods of x-ray production and the characteristics of the output x-ray spectrum; (c) components necessary to produce x-rays, including the x-ray tube/x-ray generator and the parameters that control x-ray quality (energy) and quantity; (d) x-ray production limitations caused by heating and the impact on image acquisition and clinical throughput; and (e) a glossary of terms to assist in the understanding of this information. PMID:15347692

  9. Boron in nuclear medicine: New synthetic approaches to PET and SPECT

    SciTech Connect

    Kabalka, G.W.

    1992-09-01

    This annual progress report describes new methods of incorporation of radioiodine into physiologically active compounds (amphetamines), and the use of organoboranes to labeled radiopharmaceuticals with Oxygen- 15, Nitrogen-13, carbon-11 and fluorine-18. Preclinical studies are also reported on evaluation of butyothiophenones as agents acting at dopaminergic or serotonic synapses.

  10. Lincoln County nuclear waste project quarterly progress report, April 1, 1992--June 30, 1992

    SciTech Connect

    1996-03-01

    This document included the following three progress reports to the Yucca Mountain Project Office on radioactive waste storage in Lincoln County, Nevada: financial status report; federal cash transactions report; and technical progress report.

  11. Lincoln County nuclear waste project. Quarterly progress report, January 1, 1992--March 31, 1992

    SciTech Connect

    1996-03-01

    This document included the following three progress reports to the Yucca Mountain Project Office on radioactive waste storage in Lincoln County, Nevada: financial status report; federal cash transactions report; and technical progress report.

  12. Lincoln County nuclear waste project. Quarterly progress report, October 1, 1991--December 31, 1991

    SciTech Connect

    1996-03-01

    This document included the following three progress reports to the Yucca Mountain Project Office on radioactive waste storage in Lincoln County, Nevada: financial status report; federal cash transactions report; and technical progress report.

  13. Managing the Nuclear Legacy in the United Kingdom: Strategies and Progress in the Formation of a Liabilities Management Authority

    SciTech Connect

    Edwards, A.; Meyers, B.

    2003-02-25

    This presentation describes the status of recent initiatives undertaken by the United Kingdom Government to address the long-standing problems confronting it with regards to discharge of public sector civil nuclear liabilities. It describes the enabling steps taken thus far in the creation of a Liabilities Management Unit (LMU) to prepare the ground for this important work, with specific reference to some of the more technically challenging problems which must be resolved in order to make progress towards cleaning up the UK's nuclear legacy facilities and waste materials. Finally, it addresses some of the approaches proposed by the LMU as it seeks to establish a robust, permanent entity to meet the challenges.

  14. PROGRESS REPORT. CORROSION OF SPENT NUCLEAR FUEL: THE LONG-TERM ASSESSMENT

    EPA Science Inventory

    The successful disposal of spent nuclear fuel (SNF) is one of the most serious challenges to the success of the nuclear fuel cycle and the future of nuclear power generation. Spent nuclear fuel is essentially UO2 with approximately 4-5 atomic percent actinides and fission product...

  15. Dictionary of radiation protection, radiobiology and nuclear medicine: English, German, French and Russian

    SciTech Connect

    Sube, R.

    1986-01-01

    This dictionary is a thematic enlargement of the four-language Dictionary of Nuclear Engineering, compiled by the same author. It comprises about 12,000 terms in each language. The subject matter dealt with is indicated in detail on the interleaves preceding each separate part of the dictionary. The majority of terms have been compiled from texts in the same language. Care has been taken to use standard terms. The terminology employed by the International Nuclear Information System (INIS) as part of the International Atomic Energy Organization has been incorporated in full.

  16. Compartmental analysis of renal physiology using nuclear medicine data and statistical optimization

    E-print Network

    Garbarino, Sara; Brignone, Massimo; Massollo, Michela; Sambuceti, Gianmario; Piana, Michele

    2012-01-01

    This paper describes a general approach to the compartmental modeling of nuclear data based on spectral analysis and statistical optimization. We utilize the renal physiology as test case and validate the method against both synthetic data and real measurements acquired during two micro-PET experiments with murine models.

  17. High resolution positron Q-value measurements and nuclear structure studies far from the stability line. Progress report

    SciTech Connect

    Avignone, F.T. III

    1982-02-28

    Research progress in briefly described, and details are presented in the attached preprints and reprints: (1) precision mass differences in light rubidium and krypton isotopes utilizing beta endpoint measurements; (2) precision mass measurements utilizing beta endpoints; (3) Monte Carlo calculations predicting the response of intrinsic GE detectors to electrons and positrons; and (4) reactor antineutrino spectra and nuclear spectroscopy of isotopes far from beta stability. (WHK)

  18. Differential Predictive Roles of A- and B-Type Nuclear Lamins in Prostate Cancer Progression

    PubMed Central

    Saarinen, Irena; Mirtti, Tuomas; Seikkula, Heikki; Boström, Peter J.; Taimen, Pekka

    2015-01-01

    Background Prostate cancer (PCa) is the most common cancer among men in western countries. While active surveillance is increasingly utilized, the majority of patients are currently treated with radical prostatectomy. In order to avoid over-treatment, there is an indisputable need for reliable biomarkers to identify the potentially aggressive and lethal cases. Nuclear intermediate filament proteins called lamins play a role in chromatin organization, gene expression and cell stiffness. The expression of lamin A is associated with poor outcome in colorectal cancer but to date the prognostic value of the lamins has not been tested in other solid tumors. Methods We studied the expression of different lamins with immunohistochemistry in a tissue microarray material of 501 PCa patients undergoing radical prostatectomy and lymph node dissection. Patients were divided into two staining categories (low and high expression). The correlation of lamin expression with clinicopathological variables was tested and the association of lamin status with biochemical recurrence (BCR) and disease specific survival (DSS) was further analyzed. Results Low expression of lamin A associated with lymph node positivity (p<0.01) but not with other clinicopathological variables and low expression had a borderline independent significant association with DSS (HR = 0.4; 95% CI 0.2–1.0; p = 0.052). Similarly, low lamin C expression associated with poorer survival (HR = 0.2; 95% CI 0.1–0.6; p = 0.004). Lamin B1 expression did not associate with clinicopathological variables but high expression independently predicted BCR in multivariable Cox regression analysis (HR = 1.8; 95% CI 1.1–2.9; p = 0.023). Low expression of lamin B2 correlated with lymph node positivity (p<0.01) and predicted unfavorable DSS (HR = 0.4; 95% CI 0.2–1.0; p = 0.047). Conclusions These results suggest differential roles for lamins in PCa progression. Reduced amounts of lamin A/C and B2 increase risk for lymph node metastasis and disease specific death possibly through increased nuclear deformability while high expression of lamin B1 predicts disease recurrence. PMID:26469707

  19. Nuclear heparanase-1 activity suppresses melanoma progression via its DNA-binding affinity.

    PubMed

    Yang, Y; Gorzelanny, C; Bauer, A T; Halter, N; Komljenovic, D; Bäuerle, T; Borsig, L; Roblek, M; Schneider, S W

    2015-11-19

    Heparanase-1 (HPSE) plays a pivotal role in structural remodeling of the ECM and the glycocalyx, thus conferring protumorigenic, proangiogenic and prometastatic properties to many cancer entities. In addition to its extracellular function, recent studies suggest an intracellular activity of HPSE with a largely unknown significance during tumor progression. Therefore, we investigated the relevance of the dual functions of HPSE to malignant melanoma in vitro, as well as in different mouse melanoma models based on the intradermal or intravenous injection of melanoma cells. Consistent with its extracellular action, an HPSE deficiency led to a reduced shedding of the glycocalyx accompanied by a reduced availability of vascular endothelial growth factor, affecting tumor growth and vascularization. In contrast, we measured an elevated expression of the protumorigenic factors pentraxin-3, tissue factor, TNF-? and most prominently, MMP-9, upon HPSE knockdown. In vivo, an HPSE deficiency was related to increased lymph node metastasis. Since the inhibition of its extracellular function with heparin was unable to block the gene regulatory impact of HPSE, we proposed an intracellular mechanism. Immunostaining revealed a counter-staining of HPSE and NF-?B in the nucleus, suggesting a close relationship between both proteins. This finding was further supported by the discovery of a direct charge-driven molecular interaction between HPSE and DNA by using atomic force microscopy and a co-precipitation approach. Our findings are novel and point towards a dual function for HPSE in malignant melanoma with a protumorigenic extracellular activity and a tumor-suppressive nuclear action. The identification of molecular strategies to shuttle extracellular HPSE into the nuclei of cancer cells could provide new therapeutic options. PMID:25745999

  20. Nuclear spectroscopic studies. Progress report, June 1, 1980-May 31, 1981

    SciTech Connect

    Bingham, C.R.; Riedinger, L.L.; Guidry, M.W.

    1981-03-01

    Research in nuclear spectroscopy at University of Tennessee from June 1980 through May 1981 is summarized. Topics covered include: radioactive decay studies; high spin states; inelastic scattering and reactions of heavy ions from deformed nuclei; and nuclear structure theory. (GHT)

  1. The revision of RP 91 on criteria for acceptability of radiological (including radiotherapy) and nuclear medicine installations.

    PubMed

    Faulkner, K; Malone, J F; Christofides, S; Lillicrap, S; Horton, P

    2013-02-01

    In 1997 the European Commission published Radiation Protection 91: 'Criteria for acceptability of radiological (including radiotherapy) and nuclear medicine installations'. This document specified the minimum criteria for acceptability. It has been used to this effect in legislation, codes of practice and by individual professionals. In a single document, it defined a level of performance at which remedial action was required. The document specified a series of parameters which characterised equipment performance and acceptable levels of performance. In its time it proved to be a useful document which was applied in member states to various degrees. Since the publication of Report 91 in 1997, a series of weaknesses emerged over time. Development of new radiological systems and technologies, as well as improvements in traditional technologies, has created circumstances where the acceptability criteria were in need of review. These weaknesses were recognised by the European Commission and a tender for its revision was issued. The criteria were developed by a team drawn from a broad range of backgrounds including hospitals, industry, government bodies, regulators and standardisation organisations. Representatives were mainly from Europe, but individuals from the American Association of Physicists in Medicine and International Atomic Energy Agency were included in the drafting process. This study describes the process employed in developing the revised document and the consultation process involved. One of the major difficulties the revision team encountered was related to an understanding of the actual meaning of the EC Directive. The view taken by the revision team was that Article 8, paragraph 3 places responsibilities on both the holders of radiological equipment and competent authorities. The acceptability criteria have been produced consistent with the European Commission's Medical Exposures Directive, which requires that patient exposures are optimised and justified. PMID:23169813

  2. Index to Nuclear Safety: a technical progress review by chronology, permuted title, and author, Volume 18 (1) through Volume 22 (6)

    SciTech Connect

    Cottrell, W.B.; Passiakos, M.

    1982-06-01

    This index to Nuclear Safety covers articles published in Nuclear Safety, Volume 18, Number 1 (January-February 1977) through Volume 22, Number 6 (November-December 1981). The index is divided into three section: a chronological list of articles (including abstracts), a permuted-title (KWIC) index, and an author index. Nuclear Safety, a bimonthly technical progress review prepared by the Nuclear Safety Information Center, covers all safety aspects of nuclear power reactors and associated facilities. Over 300 technical articles published in Nuclear Safety in the last 5 years are listed in this index.

  3. A traditional herbal medicine enhances bilirubin clearance by activating the nuclear receptor CAR

    PubMed Central

    Huang, Wendong; Zhang, Jun; Moore, David D.

    2004-01-01

    Yin Zhi Huang, a decoction of Yin Chin (Artemisia capillaris) and three other herbs, is widely used in Asia to prevent and treat neonatal jaundice. We recently identified the constitutive androstane receptor (CAR, NR1I3) as a key regulator of bilirubin clearance in the liver. Here we show that treatment of WT and humanized CAR transgenic mice with Yin Zhi Huang for 3 days accelerates the clearance of intravenously infused bilirubin. This effect is absent in CAR knockout animals. Expression of bilirubin glucuronyl transferase and other components of the bilirubin metabolism pathway is induced by Yin Zhi Huang treatment of WT mice or mice expressing only human CAR, but not CAR knockout animals. 6,7-Dimethylesculetin, a compound present in Yin Chin, activates CAR in primary hepatocytes from both WT and humanized CAR mice and accelerates bilirubin clearance in vivo. We conclude that CAR mediates the effects of Yin Zhi Huang on bilirubin clearance and that 6,7-dimethylesculetin is an active component of this herbal medicine. CAR is a potential target for the development of new drugs to treat neonatal, genetic, or acquired forms of jaundice. PMID:14702117

  4. Clinical problems in renovascular disease and the role of nuclear medicine.

    PubMed

    Prigent, Alain; Chaumet-Riffaud, Philippe

    2014-03-01

    Although renovascular disease remains defined as a stenosis of the main renal artery or its proximal branches (renal artery stenosis [RAS]), its clinical overview has changed dramatically over the last 15-20 years and its management is more controversial than ever before. The clinical problems, not only diagnosis and treatment but also the relative contribution of different pathophysiological mechanisms involved in the progression of kidney disease, have shifted dramatically. This presentation aims to emphasize the paradigm change revisiting the (recent) past focused on renovascular hypertension (RVH) to the current context of preservation or recovery of threatened renal function in patients with progressive atherosclerotic renovascular disease until its last stage of irreversible "ischemic nephropathy." In the past, the foreground was occupied by RVH, a very rare disease, where the activation of the renin-angiotensin-aldosterone system (RAAS) was supposed to play the major, if not only, role in RVH issues. The retrospective RVH diagnosis was established either on the improvement or, more rarely, on the cure of hypertension after revascularization by, most often, a percutaneous transluminal renal angioplasty with or without a stent placement. At this time, captoptril radionuclide renography was an efficient diagnostic tool, because it was a functional (angiotensin-converting enzyme inhibition), noninvasive test aiming to evidence both the RAAS activation and the lateralization (or asymmetry) of renin secretion by the kidney affected by a "hemodynamically significant" RAS. At present, even if captoptril radionuclide renography could be looked upon as the most efficient (and cost effective in selected high-risk patients) noninvasive, functional test to predict the improvement of hypertension after RAS correction, its clinical usefulness is questioned as the randomized, prospective trials failed to demonstrate any significant benefits (either on blood pressure control or on renal function protection) of the revascularization over current antihypertensive therapy. Today many patients with RVH remain undetected for years because they are treated successfully and at low expense with these new blockers of RAAS. In addition to its well-known role in hemodynamics, angiotensin II promotes activations of profibrogenic and inflammatory factors and cells and stimulates reactive oxygen species generation. The "atherosclerotic milieu" itself plays a role in the loss of renal microvessels and defective angiogenesis. After an "adaptative" phase, ischemia eventually develops and induces hypoxia, the substratum of ischemic nephropathy. Because blood oxygen level-dependent MRI may provide an index of oxygen content in vivo, it may be useful to predict renal function outcome after percutaneous transluminal renal angioplasty. New PET tracers, dedicated to assess RAAS receptors, inflammatory cell infiltrates, angiogenesis, and apoptose, would be tested in this context of atherosclerotic renovascular disease. PMID:24484748

  5. Progress in space nuclear reactor power systems technology development - The SP-100 program

    NASA Technical Reports Server (NTRS)

    Davis, H. S.

    1984-01-01

    Activities related to the development of high-temperature compact nuclear reactors for space applications had reached a comparatively high level in the U.S. during the mid-1950s and 1960s, although only one U.S. nuclear reactor-powered spacecraft was actually launched. After 1973, very little effort was devoted to space nuclear reactor and propulsion systems. In February 1983, significant activities toward the development of the technology for space nuclear reactor power systems were resumed with the SP-100 Program. Specific SP-100 Program objectives are partly related to the determination of the potential performance limits for space nuclear power systems in 100-kWe and 1- to 100-MW electrical classes. Attention is given to potential missions and applications, regimes of possible space power applicability, safety considerations, conceptual system designs, the establishment of technical feasibility, nuclear technology, materials technology, and prospects for the future.

  6. Chemistry-nuclear chemistry division. Progress report, October 1979-September 1980

    SciTech Connect

    Ryan, R.R.

    1981-05-01

    This report presents the research and development programs pursued by the Chemistry-Nuclear Chemistry Division of the Los Alamos National Laboratory. Topics covered include advanced analytical methods, atmospheric chemistry and transport, biochemistry, biomedical research, element migration and fixation, inorganic chemistry, isotope separation and analysis, atomic and molecular collisions, molecular spectroscopy, muonic x rays, nuclear cosmochemistry, nuclear structure and reactions, radiochemical separations, theoretical chemistry, and unclassified weapons research.

  7. Software development for ACR-approved phantom-based nuclear medicine tomographic image quality control with cross-platform compatibility

    NASA Astrophysics Data System (ADS)

    Oh, Jungsu S.; Choi, Jae Min; Nam, Ki Pyo; Chae, Sun Young; Ryu, Jin-Sook; Moon, Dae Hyuk; Kim, Jae Seung

    2015-07-01

    Quality control and quality assurance (QC/QA) have been two of the most important issues in modern nuclear medicine (NM) imaging for both clinical practices and academic research. Whereas quantitative QC analysis software is common to modern positron emission tomography (PET) scanners, the QC of gamma cameras and/or single-photon-emission computed tomography (SPECT) scanners has not been sufficiently addressed. Although a thorough standard operating process (SOP) for mechanical and software maintenance may help the QC/QA of a gamma camera and SPECT-computed tomography (CT), no previous study has addressed a unified platform or process to decipher or analyze SPECT phantom images acquired from various scanners thus far. In addition, a few approaches have established cross-platform software to enable the technologists and physicists to assess the variety of SPECT scanners from different manufacturers. To resolve these issues, we have developed Interactive Data Language (IDL)-based in-house software for crossplatform (in terms of not only operating systems (OS) but also manufacturers) analyses of the QC data on an ACR SPECT phantom, which is essential for assessing and assuring the tomographical image quality of SPECT. We applied our devised software to our routine quarterly QC of ACR SPECT phantom images acquired from a number of platforms (OS/manufacturers). Based on our experience, we suggest that our devised software can offer a unified platform that allows images acquired from various types of scanners to be analyzed with great precision and accuracy.

  8. Center for Nuclear Medicine Research in Alzheimer`s Disease Health Sciences Center, West Virginia University. Environmental Assessment

    SciTech Connect

    Not Available

    1994-04-01

    The Environmental Assessment (EA) of the Center for Nuclear Medicine Research in Alzheimer`s Disease (CNMR) at the Health Sciences Center, at West Virginia University in Morgantown, West Virginia for the construction and operation was prepared by DOE. The EA documents analysis of the environmental and socioeconomic impacts that might occur as a result of these actions, and characterizes potential impacts on the environment. In the EA, DOE presents its evaluation of potential impacts of construction and operation of the CNMR on health and safety of both workers and the public, as well as on the external environment. Construction impacts include the effects of erosion, waste disposal, air emissions, noise, and construction traffic and parking. Operational impacts include the effects of waste generation (domestic, sanitary, hazardous, medical/biological, radioactive and mixed wastes), radiation exposures, air emissions (radioactive, criteria, and air toxics), noise, and new workers. No sensitive resources (wetlands, special sources of groundwater, protected species) exist in the area of project effect.

  9. Nuclear Safety. Technical Progress Journal, October--December 1991: Volume 32, No. 4

    SciTech Connect

    Not Available

    1991-01-01

    This document is a review journal that covers significant developments in the field of nuclear safety. Its scope includes the analysis and control of hazards associated with nuclear energy, operations involving fissionable materials, and the products of nuclear fission and their effects on the environment. Primary emphasis is on safety in reactor design, construction, and operation; however, the safety aspects of the entire fuel cycle, including fuel fabrication, spent-fuel processing, nuclear waste disposal, handling of radioisotopes, and environmental effects of these operations, are also treated.

  10. Radiation Exposure Levels in Diagnostic Patients Injected with 99mTc, 67Ga and 131I at the Mexican National Institute of Cancerology Nuclear Medicine Department

    SciTech Connect

    Trujillo-Zamudio, F. E.; Gomez-Argumosa, E.; Estrada-Lobato, E.; Medina, L. A.

    2006-09-08

    According to the Mexican Radiation Safety regulations for patients treated in a nuclear medicine service, the exposure rate limit at 1 m from the patients is 5 mR/h before leaving the hospital. Three groups of patients have been monitored after: a) whole body bone studies with 740 MBq of 99mTc-MDP (207 patients); b) infection studies after i.v. administration of 185 MBq of 67Ga (207 patients); and c) thyroid studies with 185 MBq of 131I (142 patients). The results indicated that the average exposure rate levels in each group were: a) 0.57 {+-} 0.17 mR/h, b) 0.47 {+-} 0.20 mR/h, and c) 0.86 {+-} 0.14 mR/h. This study has shown that the Nuclear Medicine Department at INCAN complies with the NOM-013-NUCL-1995 Mexican regulation.

  11. Studies of nuclear processes at the Triangle Universities Nuclear Laboratory. Progress report, 1 September 1995--31 August 1996

    SciTech Connect

    Ludwig, E.J.

    1996-09-01

    The Triangle Universities Nuclear Laboratory (TUNL)--a collaboration of Duke University, North Carolina State University, and the University of North Carolina at Chapel Hill--has had a very productive year. This report covers parts of the second and third year of a three-year grant between the US Department of Energy and the three collaborating universities. The TUNL research program focuses on the following areas: precision test of parity-invariance violation in resonance neutron scattering at LANSCE/LANL; parity violation measurements using charged-particle resonances in A = 20--40 targets and the A = 4 system at TUNL; chaotic behavior in the nuclei {sup 30}P and {sup 34}Cl from studies of eigenvalue fluctuations in nuclear level schemes; search for anomalies in the level density (pairing phase transition) in 1f-2p shell nuclei using GEANIE at LANSCE/LANL; parity-conserving time-reversal noninvariance tests using {sup 166}Ho resonances at Geel, ORELA, or LANSCE/LANL; nuclear astrophysics; few-body nuclear systems; Nuclear Data evaluation for A = 3--20 for which TUNL is now the international center. Developments in technology and instrumentation are vital to the research and training program. Innovative work was continued in: polarized beam development; polarized target development; designing new cryogenic systems; designing new detectors; improving high-resolution beams for the KN and FN accelerators; development of an unpolarized Low-Energy Beam Facility for radiative capture studies of astrophysical interest. Preliminary research summaries are presented.

  12. ORNL nuclear waste programs annual progress report for period ending September 30, 1982

    SciTech Connect

    Not Available

    1983-05-01

    Research progress is reported in 20 activities under the headings: spent fuels, defense waste management, commercial waste management, remedial action, and conventional reactors. Separate entries were prepared for each activity.

  13. Theoretical aspects of electroweak and other interactions in medium energy nuclear physics. Progress report

    SciTech Connect

    Mukhopadhyay, N.C.

    1991-12-04

    In the project under review, progress has been made on the problem of dynamic symmetries exhibited by mesons as color strings. A novel property of the vibrational states of heavy mesons, that of an approximate saturation of a particular spectroscopic interval, has been found as a ``fingerprint`` for linear quark confinement potentials. Progress has been continued in the study of electroweak excitation of the baryon resonances, including the use of Compton scattering.

  14. Advanced Gas Cooled Nuclear Reactor Materials Evaluation and Development Program. Progress report, January 1, 1980-March 31, 1980

    SciTech Connect

    Not Available

    1980-06-25

    Results are presented of work performed on the Advanced Gas-Cooled Nuclear Reactor Materials Evaluation and Development Program. The objectives of this program are to evaluate candidate alloys for Very High Temperature Reactor (VHTR) Nuclear Process Heat (NPH) and Direct Cycle Helium Turbine (DCHT) applications, in terms of the effect of simulated reactor primary coolant (helium containing small amounts of various other gases), high temperatures, and long time exposures, on the mechanical properties and structural and surface stability of selected candidate alloys. A second objective is to select and recommend materials for future test facilities and more extensive qualification programs. Included are the activities associated with the status of the simulated reactor helium supply system, testing equipment and gas chemistry analysis instrumentation and equipment. The progress in the screening test program is described, including screening creep results and metallographic analysis for materials thermally exposed or tested at 750, 850, and 950/sup 0/C.

  15. Theoretical research in intermediate-energy nuclear physics. [Technical progress report, April 1, 1993--March 31, 1994

    SciTech Connect

    Seki, R.

    1994-09-01

    This paper discusses progress that has been made on the following seven problems: (1) (e, e{prime}p) at high momentum transfer; (2) post,acceleration effects in two-nucleon interferometry of heavy-ion collisions; (3) pion-nucleus interactions above 0.5 GeV; (4) chiral symmetry breaking in nuclei and picnic atom anomaly; (5) atomic screening on nuclear astronomical reactions; (6) QCD related work (coherent pion production from skyrmion-antiskyrmion annihilation, QCD in 1 + 1 dimensions, and correlation functions in the QCD vacuum), and (7) kaonic hydrogen atom experiment. The problems deal with various topics mostly in intermediate-energy nuclear physics. We place priority on (1) and (2), and describe them somewhat in detail below. Other problems are our on-going projects, but we are placing lower priority on them in the second and third year.

  16. Investigations of nuclear structure and nuclear reactions induced by complex projectiles. Progress report, September 1, 1991--August 31, 1992

    SciTech Connect

    Sarantites, D.G.

    1992-12-01

    The research program described touches five areas of nuclear physics: nuclear structure studies at high spin (hyperdeformation in the mass A {approx_equal} 182 region, structure of {sup 182}Hg and {sup 182}Au at high spin, a highly deformed band in {sup 136}Pm and the anomalous h{sub 11/2} proton crossing in the A{approximately}135 superdeformed region), studies at the interface between structure and reactions (population of entry states in heavy-ion fusion reactions, nuclear structure effects in proton evaporation spectra, nuclear structure- dependent entry state population by total spectroscopy, entrance channel effects in fusion near the barrier, lifetimes of subbarrier {alpha} particles by the atomic clock method), production and study of hot nuclei (the statistical model evaporation code EVAP, statistical emission of deuterons and tritons from highly excited compound nuclei, heavy-fragment emission as a probe of the thermal properties of highly excited compound nuclei, use of incoming-wave boundary condition transmission coefficients in the statistical model: implications in the particle evaporation spectra, study of transparency in the optical model), reaction mechanism studies (binary character of highly dissipative {sup 209}Bi + {sup 136}Xe collisions at E/A=28.2 MeV), and development and use of novel techniques and instrumentation in these areas of research (including a 4{pi} channel selection device, a novel x-ray detector, and a simple channel-selecting detector).

  17. Development of Career Opportunities for Technicians in the Nuclear Medicine Field, Phase I. Interim Report Number 1: Survey of Job Characteristics, Manpower Needs and Training Resources, July 1969.

    ERIC Educational Resources Information Center

    Technical Education Research Center, Cambridge, MA.

    Phase I of a multiphase research program in progress at the Technical Education Research Center, Inc., was conducted to analyze needs and resources in terms of job performance tasks, career opportunities, and training requirements for nuclear medical technicians. Data were gathered through personal interviews with 203 persons, mostly physicians,…

  18. Study of a new design of p-N semiconductor detector array for nuclear medicine imaging by monte carlo simulation codes.

    PubMed

    Hajizadeh-Safar, M; Ghorbani, M; Khoshkharam, S; Ashrafi, Z

    2014-07-01

    Gamma camera is an important apparatus in nuclear medicine imaging. Its detection part is consists of a scintillation detector with a heavy collimator. Substitution of semiconductor detectors instead of scintillator in these cameras has been effectively studied. In this study, it is aimed to introduce a new design of P-N semiconductor detector array for nuclear medicine imaging. A P-N semiconductor detector composed of N-SnO2 :F, and P-NiO:Li, has been introduced through simulating with MCNPX monte carlo codes. Its sensitivity with different factors such as thickness, dimension, and direction of emission photons were investigated. It is then used to configure a new design of an array in one-dimension and study its spatial resolution for nuclear medicine imaging. One-dimension array with 39 detectors was simulated to measure a predefined linear distribution of Tc(99_m) activity and its spatial resolution. The activity distribution was calculated from detector responses through mathematical linear optimization using LINPROG code on MATLAB software. Three different configurations of one-dimension detector array, horizontal, vertical one sided, and vertical double-sided were simulated. In all of these configurations, the energy windows of the photopeak were ± 1%. The results show that the detector response increases with an increase of dimension and thickness of the detector with the highest sensitivity for emission photons 15-30° above the surface. Horizontal configuration array of detectors is not suitable for imaging of line activity sources. The measured activity distribution with vertical configuration array, double-side detectors, has no similarity with emission sources and hence is not suitable for imaging purposes. Measured activity distribution using vertical configuration array, single side detectors has a good similarity with sources. Therefore, it could be introduced as a suitable configuration for nuclear medicine imaging. It has been shown that using semiconductor P-N detectors such as P-NiO:Li, N-SnO2 :F for gamma detection could be possibly applicable for design of a one dimension array configuration with suitable spatial resolution of 2.7 mm for nuclear medicine imaging. PMID:25298932

  19. Nuclear physics at extreme energy density. Progress report, May 1991--April 1992

    SciTech Connect

    Mueller, B.

    1992-05-15

    This report discusses topics in the following areas: QCD transport theory; minijets in hadronic and nuclear collisions; lattice gauge theory; hadronic matter and other studies; and strong electromagnetic fields. (LSP)

  20. COMPREHENSIVE PROGRESS REPORT FOR FOURIER TRANSFORM NMR (NUCLEAR MAGNETIC RESONANCE) OF METALS OF ENVIRONMENTAL SIGNIFICANCE

    EPA Science Inventory

    Interactions of the metals cadmium and selenium with various biologically important substrates were studied by nuclear magnetic resonance (NMR) spectroscopy. Cadmium-113 NMR was used for a critical examination of three metalloproteins: concanavalin A, bovine superoxide dismutase ...

  1. A Boolean Network Model of Nuclear Receptor Mediated Cell Cycle Progression

    EPA Science Inventory

    Nuclear receptors (NRs) are ligand-activated transcription factors that regulate a broad range of cellular processes. Hormones, lipids and xenobiotics have been shown to activate NRs with a range of consequences on development, metabolism, oxidative stress, apoptosis, and prolif...

  2. A Boolean Network Model of Nuclear Receptor Mediated Cell Cycle Progression (S)

    EPA Science Inventory

    Nuclear receptors (NRs) are ligand-activated transcription factors that regulate a broad range of cellular processes. Hormones, lipids and xenobiotics have been shown to activate NRs with a range of consequences on development, metabolism, oxidative stress, apoptosis, and prolif...

  3. Development of radiohalogenated muscarinic ligands for the in vivo imaging of m-AChR by nuclear medicine techniques

    SciTech Connect

    McPherson, D.W.; Luo, H.; Knapp, F.F. Jr.

    1994-06-01

    Alterations in the density of acetylcholinergic muscarinic receptors (m-AChR) have been observed in various dementias. This has spurred interest in the development of radiohalogenated ligands which can be used for the non-invasive in vivo detection of m-AChR by nuclear medicine techniques. We have developed a new ligand 1-azabicyclo[2.2.2]oct-3-yl ({alpha}-hydroxy-{alpha}-(1-iodo-1-propen-3-yl)-{alpha}-phenylacetate (IQNP,12) which demonstrates high affinity for the muscarinic receptor. When labeled with radioiodine it has been shown to be selective and specific for m-ACHR. Initial studies on the separation and in vivo evaluation of the various isomers of IQNP have shown that the stereochemistry of the chiral centers and the configuration around the double bond play an important role in m-AChR subtype specificity. In vivo evaluation of these stereoisomers demonstrate that E-(R,R)-IQNP has a high affinity for the M{sub 1} muscarinic subtype while Z-(R,R)-IQNP demonstrate a high affinity for M{sub 1} and M{sub 2} receptor subtypes. These data demonstrate IQNP (12) has potential for use in the non-evasive in vivo detection of m-AChR by single photon emission computed tomography (SPECT). A brominated analogue, ``BrQNP,`` in which the iodine has been replaced by a bromine atom, has also been prepared and was shown to block the in vivo uptake of IQNP in the brain and heart and therefore has potential for positron emission tomographic (PET) studies of m-AChR.

  4. The effect of gamma ray penetration on angle-dependent sensitivity for pinhole collimation in nuclear medicine

    SciTech Connect

    Smith, M.F.; Jaszczak, R.J.

    1997-11-01

    The sensitivity of a pinhole collimator for gamma ray imaging in nuclear medicine is dependent on the angle of incidence of the gamma rays. The effect of penetration near the pinhole aperture on angle-dependent sensitivity was investigated using experimental measurements and numerical modeling. Projection data measurements were acquired with Tc-99m and I-131 point sources using tungsten pinhole inserts with 1.0 to 4.0 mm diameter apertures. Curves of the form sin{sup x}{theta}, where {theta} is the angle of the incident ray with the surface of the detector crystal, were fit to sensitivity measurements from the projection data. Experimentally measured x values were between 3.3 and 4.1 for Tc-99m and between 5.1 and 7.2 for I-131. Penetration near the pinhole aperture was modeled using (1) an expression for effective pinhole diameter that is a generalization of Anger{close_quote}s formula for normally incident photons and (2) a photon transport simulation code. Experimentally measured sensitivity exponents x from new and previously reported experimental observations were modeled within 15{percent} by the numerical simulations. For modeling using the generalized expression for effective diameter the average error was 1.4{percent} and the standard deviation was 7.7{percent}. For the photon transport simulation code the average error was 1.5{percent} and the standard deviation also was 7.7{percent}. The effect of pinhole aperture design parameters on angle-dependent sensitivity for high resolution pinhole apertures was modeled using a photon transport simulation code. The sensitivity exponents x were greater for 364 keV photons than for 140 keV photons and were greater for small aperture diameters, small acceptance angles, and large aperture channel heights. (Abstract Truncated)

  5. The effects of radioisotopes used in nuclear medicine on diagnostic radioimmunoassay testing. Is there any significant interference

    SciTech Connect

    Riccio, J.A.; Maturani, D.; Wright, J.; Fleetwood, M.K. )

    1990-11-01

    The administration of radioisotopes for diagnostic nuclear medicine scans and therapeutic procedures is quite prevalent today. A period of interference with the counting of a radioimmunoassay (RIA) test may occur with the serum of a patient receiving an in vivo radionuclide that decays by gamma emission. Because the logistics of precounting all specimens may be cumbersome and prohibitive, it is important to determine the degree of this interference. In this study, the authors evaluate the potential interference of the most commonly used radioisotopes with RIA studies. For two months (March and August 1988) 10,650 patient serum specimens were counted for significant background gamma radiation before RIA testing. Forty-three patients, on whom 105 RIA tests were performed, were identified as having preassay gamma radiation in their serum. With the use of selective energy windows for each different interfering radionuclide, proportional determinations were made as to the amount of interfering gamma radiation spilling into the iodine 125 test marker window. It was shown that initial whole serum pretest gamma counts as high as 111,000 counts/minute did not significantly affect the results of the RIA. Because of the meticulous washing and decanting procedures required in modern RIA and the monoclonal nature of most antibodies used currently, it appears the degree of nonspecific binding of this potentially interfering radiation is minuscule. The energy level of cobalt 57, however, and many of the other commonly used radioisotopes, overlaps so closely that it is difficult to window for this interference. It is possible, therefore, that this distinction cannot be made and folate and vitamin B12 test systems using cobalt 57 markers may have to be routinely prescreened.

  6. Textbook of respiratory medicine

    SciTech Connect

    Murray, J.F.; Nadel, J.

    1987-01-01

    This book presents a clinical reference of respiratory medicine. It also details basic science aspects of pulmonary physiology and describes recently developed, sophisticated diagnostic tools and therapeutic methods. It also covers anatomy, physiology, pharmacology, and pathology; microbiologic, radiologic, nuclear medicine, and biopsy methods for diagnosis.

  7. A program in medium-energy nuclear physics. Progress report, January 1, 1992--March 31, 1995

    SciTech Connect

    Berman, B.L.; Dhuga, K.S.

    1994-08-01

    This renewal proposal requests continued funding for our program in experimental medium-energy nuclear physics. The focus of our program remains the understanding of the short-range part of the strong interaction in the nuclear medium. In the past three years we have focused our attention ever more sharply on experiments with real tagged photons at CEBAF. We are part of the Hall-B Collaboration at CEBAF. We are co-spokespersons on two approved CEBAF experiments, Photoreactions on {sup 3}He and Photoabsorption and Photofission of Nuclei, and we are preparing another, Nondiffractive Photoproduction of the {rho} Meson with Linearly Polarized Photons, for presentation to the next CEBAF PAC. We are part of the team that is instrumenting the Photon Tagger and a high-energy tagged polarized-photon beam for Hall B; some of the instrumentation for these projects is being built at our Nuclear Detector Laboratory, under the auspices of The George Washington University Center for Nuclear Studies. Our recent measurements of pion scattering from {sup 3}H and {sup 3}He at LAMPF and of cluster knockout from few-body nuclei at NIKHEF have yielded very provocative results, showing the importance of the very light nuclei as a laboratory for quantifying important aspects of the nuclear many-body force. We look forward to expanding our studies of short-range forces in nuclei, particularly the very fight nuclei using electromagnetic probes and employing the extraordinary power of CEBAF and the CLAS.

  8. Studies of nuclear processes; Progress report, 1 September 1992--31 August 1993

    SciTech Connect

    Ludwig, E.J.

    1993-09-01

    Results for the period 1 Sep 92 through 31 Aug 93 are presented in nearly a hundred brief papers, some of which present new but preliminary data. Activities reported may be grouped as follows: Fundamental symmetries in the nucleus (parity-mixing measurements, time reversal invariance measurements, signatures of quantum chaos in nuclei), Internucleon reactions (neutron -- proton interactions, the neutron -- neutron scattering length, reactions between deuterons and very light nuclei), Dynamics of very light nuclei (measurements of D states of very light nuclei by transfer reactions, nuclear reactions between very light nuclei, radiative capture reactions with polarized sources), The many-nucleon problem (nuclear astrophysics, high-spin spectroscopy and superdeformation, the nuclear mean field: Dispersive relations and nucleon scattering, configuration mixing in {sup 56}Co and {sup 46}Sc using (d,{alpha}) reactions, radiative capture studies, high energy resolution resonance studies at 100--400 keV, nuclear data evaluation for A=3--20), Nuclear instruments and methods (FN tandem accelerator operation, KN accelerator operation and maintenance, atomic beam polarized ion source, development of techniques for determining the concentration of SF{sub 6} in the accelerator insulating gas mixture, production of beams and targets, detector systems, updating of TeX, Psprint, and associated programs on the VAX cluster), and Educational Activities.

  9. Investigations of nuclear structure and nuclear reactions induced by complex projectiles. Progress report for the period September 1, 1992--August 31, 1993

    SciTech Connect

    Sarantites, D.G.

    1993-09-06

    This is a progress report on activities of the Washington University group in nuclear reaction studies for the period Sept 1, 1992 to Aug 31, 1993. This group has a research program which touches five areas of nuclear physics: nuclear structure studies at high spin; studies at the interface between structure and reactions; production and study of hot nuclei; reaction mechanism studies; development and use of novel techniques and instrumentation in the above areas of research. Specific activities of the group include in part: superdeformation in {sup 82}Sr; structure of and identical bands in {sup 182}Hg and {sup 178}Pt; a highly deformed band in {sup 136}Pm; particle decay of the {sup 164}Yb compound nucleus; fusion reactions; proton evaporation; two-proton decay of {sup 12}O; modeling and theoretical studies; excited {sup 16}O disassembly into four alpha particles; {sup 209}Bi + {sup 136}Xe collisions at 28.2 MeV/amu; and development work on 4{pi} solid angle gamma detectors, and x-ray detectors.

  10. General-purpose heat source project and space nuclear safety fuels program. Progress report, February 1980

    SciTech Connect

    Maraman, W.J.

    1980-05-01

    This formal monthly report covers the studies related to the use of /sup 238/PuO/sub 2/ in radioisotopic power systems carried out for the Advanced Nuclear Systems and Projects Division of the Los Alamos Scientific Laboratory. The two programs involved are: General-Purpose Heat Source Development and Space Nuclear Safety and Fuels. Most of the studies discussed here are of a continuing nature. Results and conclusions described may change as the work continues. Published reference to the results cited in this report should not be made without the explicit permission of the person in charge of the work.

  11. ANNUAL PROGRESS REPORT. IRON PHOSPHATE GLASSES: AN ALTERNATIVE FOR VITRIFYING CERTAIN NUCLEAR WASTES

    EPA Science Inventory

    A high priority has been given to investigating the vitrification of three specific nuclear wastes in iron phosphate glasses (IPG). These wastes, which were recommended by the Tank Focus Area (TFA) group of Hanford, are poorly suited for vitrification in the currently DOE-approve...

  12. Experimental nuclear and radiochemistry. Progress report, February 1, 1980-January 31, 1981

    SciTech Connect

    Karol, P.J.

    1980-11-01

    Deep nuclear spallation reactions induced by high-energy light particles on complex nuclei were investigated. Experimental studies involve activation of various medium to heavy mass targets bombarded by pi-mesons, protons and alpha particles. A prime objective is to deconvolve the cascade and evaporation steps in the reaction mechanism. Emphasis has been placed on spallation products far from yield maxima where the deconvolution is most justifiable. Irradiations have been performed predominantly at the Clinton P. Anderson Los Alamos Meson Physics Facility. Results of cross section determinations from bombardments of /sup 89/Y, /sup 92/Mo, /sup 96/Mo and /sup 100/Mo with 800 MeV protons have nearly been completed, providing comparison of isobaric and mass-yield distributions. Data have also been obtained at 500 MeV. Theoretical efforts are being directed at the evaporative behavior of very high-temperature nuclei as determined by the nuclear equation of state and how such behavior might be observed in very deep spallation processes. In addition, the soft spheres model has been combined with spallation systematics to explore the feasibility of high-intensity beams to incinerate high-level nuclear wastes and also to predict interaction lengths in nuclear emulsion studies of relativistic heavy ions. Data are presented on spallation of /sup 130/Te by 800-MeV protons, decay of /sup 87/Zr, and /sup 84/Zr, spallation-transmutation of /sup 90/Sr, and anomalous relativistic projectile fragments in emulsion detectors. (DLC)

  13. Nuclear Medicine Imaging

    MedlinePLUS

    ... porque registra la radiación que se emite desde el cuerpo del paciente en vez de la radiación ... a órganos, huesos o tejidos espe- cíficos. Cuando el radiofármaco viaja a través del cuerpo, produce emisiones ...

  14. Nuclear research with heavy ions. Annual progress report. January 1, 1980-December 31, 1980

    SciTech Connect

    Kaplan, M.

    1980-10-01

    The program of research is oriented towards experimental studies of the interactions between heavy ions and complex nuclei. These interactions are probed by detailed measurements of light-charged-particle emission using counter telescopes for atomic number and mass number identification. Singles measurements of the charged-particle energy spectra and angular distributions, together with coincidence correlations with heavy nuclear-reaction fragments, provide insight into the contributing reaction mechanisms. The application of the statistical model to the appropriate experimental data allows the determination of parameters necessary to calibrate the theory, and gives indications of dynamical control vs. equilibrium in the several degrees of freedom associated with the nuclear collisions. A large body of data are presented and discussed for /sup 40/Ar reactions with /sup 116/Sn, /sup 154/Sm, /sup 164/Dy, and /sup 197/Au targets. Complete results are also given for twelve reactions which produce /sup 194/Hg compound nuclei at several excitation energies.

  15. Progress toward bridging from atomistic to continuum modeling to predict nuclear waste glass dissolution.

    SciTech Connect

    Zapol, Peter; Bourg, Ian; Criscenti, Louise Jacqueline; Steefel, Carl I.; Schultz, Peter Andrew

    2011-10-01

    This report summarizes research performed for the Nuclear Energy Advanced Modeling and Simulation (NEAMS) Subcontinuum and Upscaling Task. The work conducted focused on developing a roadmap to include molecular scale, mechanistic information in continuum-scale models of nuclear waste glass dissolution. This information is derived from molecular-scale modeling efforts that are validated through comparison with experimental data. In addition to developing a master plan to incorporate a subcontinuum mechanistic understanding of glass dissolution into continuum models, methods were developed to generate constitutive dissolution rate expressions from quantum calculations, force field models were selected to generate multicomponent glass structures and gel layers, classical molecular modeling was used to study diffusion through nanopores analogous to those in the interfacial gel layer, and a micro-continuum model (K{mu}C) was developed to study coupled diffusion and reaction at the glass-gel-solution interface.

  16. Progress in the Development of Compressible, Multiphase Flow Modeling Capability for Nuclear Reactor Flow Applications

    SciTech Connect

    R. A. Berry; R. Saurel; F. Petitpas; E. Daniel; O. Le Metayer; S. Gavrilyuk; N. Dovetta

    2008-10-01

    In nuclear reactor safety and optimization there are key issues that rely on in-depth understanding of basic two-phase flow phenomena with heat and mass transfer. Within the context of multiphase flows, two bubble-dynamic phenomena – boiling (heterogeneous) and flashing or cavitation (homogeneous boiling), with bubble collapse, are technologically very important to nuclear reactor systems. The main difference between boiling and flashing is that bubble growth (and collapse) in boiling is inhibited by limitations on the heat transfer at the interface, whereas bubble growth (and collapse) in flashing is limited primarily by inertial effects in the surrounding liquid. The flashing process tends to be far more explosive (and implosive), and is more violent and damaging (at least in the near term) than the bubble dynamics of boiling. However, other problematic phenomena, such as crud deposition, appear to be intimately connecting with the boiling process. In reality, these two processes share many details.

  17. SRNL CRP progress report [Development of Melt Processed Ceramics for Nuclear Waste Immobilization

    SciTech Connect

    Amoroso, J.; Marra, J.

    2014-10-02

    A multi-phase ceramic waste form is being developed at the Savannah River National Laboratory (SRNL) for treatment of secondary waste streams generated by reprocessing commercial spent nuclear. The envisioned waste stream contains a mixture of transition, alkali, alkaline earth, and lanthanide metals. Ceramic waste forms are tailored (engineered) to incorporate waste components as part of their crystal structure based on knowledge from naturally found minerals containing radioactive and non-radioactive species similar to the radionuclides of concern in wastes from fuel reprocessing. The ability to tailor ceramics to mimic naturally occurring crystals substantiates the long term stability of such crystals (ceramics) over geologic timescales of interest for nuclear waste immobilization [1]. A durable multiphase ceramic waste form tailored to incorporate all the waste components has the potential to broaden the available disposal options and thus minimize the storage and disposal costs associated with aqueous reprocessing.

  18. Prognostic Methods in Medicine Peter Lucas

    E-print Network

    Utrecht, Universiteit

    Prognostic Methods in Medicine Peter Lucas Department of Computer Science, Utrecht University, P Role of prediction and prognosis in medicine Scienti#12;c progress in Medicine is made at an annually to as Evidence-Based Medicine (EBM). Ideas concerning EBM are gradually starting to in uence patient care

  19. Dual adaptive statistical approach for quantitative noise reduction in photon-counting medical imaging: application to nuclear medicine images.

    PubMed

    Hannequin, Pascal Paul

    2015-06-01

    Noise reduction in photon-counting images remains challenging, especially at low count levels. We have developed an original procedure which associates two complementary filters using a Wiener-derived approach. This approach combines two statistically adaptive filters into a dual-weighted (DW) filter. The first one, a statistically weighted adaptive (SWA) filter, replaces the central pixel of a sliding window with a statistically weighted sum of its neighbors. The second one, a statistical and heuristic noise extraction (extended) (SHINE-Ext) filter, performs a discrete cosine transformation (DCT) using sliding blocks. Each block is reconstructed using its significant components which are selected using tests derived from multiple linear regression (MLR). The two filters are weighted according to Wiener theory. This approach has been validated using a numerical phantom and a real planar Jaszczak phantom. It has also been illustrated using planar bone scintigraphy and myocardial single-photon emission computed tomography (SPECT) data. Performances of filters have been tested using mean normalized absolute error (MNAE) between the filtered images and the reference noiseless or high-count images.Results show that the proposed filters quantitatively decrease the MNAE in the images and then increase the signal-to-noise Ratio (SNR). This allows one to work with lower count images. The SHINE-Ext filter is well suited to high-size images and low-variance areas. DW filtering is efficient for low-size images and in high-variance areas. The relative proportion of eliminated noise generally decreases when count level increases. In practice, SHINE filtering alone is recommended when pixel spacing is less than one-quarter of the effective resolution of the system and/or the size of the objects of interest. It can also be used when the practical interest of high frequencies is low. In any case, DW filtering will be preferable.The proposed filters have been applied to nuclear medicine images but can also be used for any other kind of photon-counting images, such as x-ray and fluorescence images. PMID:26009552

  20. Dual adaptive statistical approach for quantitative noise reduction in photon-counting medical imaging: application to nuclear medicine images

    NASA Astrophysics Data System (ADS)

    Hannequin, Pascal Paul

    2015-06-01

    Noise reduction in photon-counting images remains challenging, especially at low count levels. We have developed an original procedure which associates two complementary filters using a Wiener-derived approach. This approach combines two statistically adaptive filters into a dual-weighted (DW) filter. The first one, a statistically weighted adaptive (SWA) filter, replaces the central pixel of a sliding window with a statistically weighted sum of its neighbors. The second one, a statistical and heuristic noise extraction (extended) (SHINE-Ext) filter, performs a discrete cosine transformation (DCT) using sliding blocks. Each block is reconstructed using its significant components which are selected using tests derived from multiple linear regression (MLR). The two filters are weighted according to Wiener theory. This approach has been validated using a numerical phantom and a real planar Jaszczak phantom. It has also been illustrated using planar bone scintigraphy and myocardial single-photon emission computed tomography (SPECT) data. Performances of filters have been tested using mean normalized absolute error (MNAE) between the filtered images and the reference noiseless or high-count images. Results show that the proposed filters quantitatively decrease the MNAE in the images and then increase the signal-to-noise Ratio (SNR). This allows one to work with lower count images. The SHINE-Ext filter is well suited to high-size images and low-variance areas. DW filtering is efficient for low-size images and in high-variance areas. The relative proportion of eliminated noise generally decreases when count level increases. In practice, SHINE filtering alone is recommended when pixel spacing is less than one-quarter of the effective resolution of the system and/or the size of the objects of interest. It can also be used when the practical interest of high frequencies is low. In any case, DW filtering will be preferable. The proposed filters have been applied to nuclear medicine images but can also be used for any other kind of photon-counting images, such as x-ray and fluorescence images.

  1. [Cyclotron based nuclear science]. Progress in research, April 1, 1992--March 31, 1993

    SciTech Connect

    Not Available

    1993-07-01

    The period 1 April 1992--31 March 1993 saw the initial runs of three new spectrometers, which constitute a major portion of the new detection capabilities developed for this facility. These devices are the Proton Spectrometer (PSP) (data from which are shown on the cover of this document), the Mass Achroniat Recoil Mass Spectrometer (MARS), and the Multipole Dipole Multipole (MDM) Particle Spectrometer. The ECR-K500 cyclotron combination operated 5,849 hours. The beam was on target 39% of this time. Studies of nuclear dynamics and nuclear thermodynamics using the neutron ball have come to fruition. A critical re-evaluation of the available data on the giant monopole resonance indicated that the incompressibility is not specified to a range smaller than 200--350 MeV by those data. New systematic experiments using the MDM spectrometer are now underway. The MEGA collaboration obtained the first data on the {mu} {yields} e{gamma} decay rate and determination of the Michel parameter in normal {mu} decay. Experiments appear to confirm the existence of monoenergetic pair peaks even for relatively low Z{sub projectile} -- Z{sub target} combinations. Studies of the ({alpha},2{alpha}) knockout reaction indicate that this reaction may prove to be a valuable tool for determination of reaction rates of astrophysical interest. Theoretical work reported in this document ranges from nuclear structure calculations using the IBM-2 model to calculations of kaon production and the in-medium properties of the rho and phi mesons. Nuclear dynamics and exotic shapes and fragmentation modes of hot nuclei are also addressed. New measurements of x-ray emission from highly ionized ions, of molecular dissociation and of surface interactions are reported. The research is presented in nearly 50 brief summaries usually including data and references.

  2. Fetal imaging by nuclear magnetic resonance: a study in goats: work in progress

    SciTech Connect

    Foster, M.A.; Knight, C.H.; Rimmington, J.E.; Mallard, J.R.

    1983-10-01

    Nuclear magnetic resonance proton imaging was used to obtain images of goat fetuses in utero. The long T1 relaxation time of amniotic fluid makes it appear black on proton density images when examined using the Aberdeen imager, and so allows very good discrimination of the position and structure of the fetus. Some fetal internal tissues can be seen on T1 images. These findings suggest that NMR imaging has great potential in pregnancy studies.

  3. Nucleosynthesis in novae: experimental progress in the determination of nuclear reaction rates

    E-print Network

    Alain Coc

    2008-01-18

    The sources of nuclear uncertainties in nova nucleosynthesis have been identified using hydrodynamical nova models. Experimental efforts have followed and significantly reduced those uncertainties. This is important for the evaluation of nova contribution to galactic chemical evolution, gamma--ray astronomy and possibly presolar grain studies. In particular, estimations of expected gamma-ray fluxes are essential for the planning of observations with existing or future satellites.

  4. Nuclear-structure studies with medium-energy probes. Annual progress report, August 1981-August 1982

    SciTech Connect

    Seth, K. K.

    1982-01-01

    Progress is reported on the following studies: pion induced reactions, proton induced reactions, and electron induced reactions. Pion induced reaction studies include double charge exchange and elastic and inelastic scattering. Proton reaction studies include pion production reactions, p Vector + p ..-->.. d + ..pi../sup +/, p Vector + p Vector ..-->.. d + ..pi../sup +/, p Vector + d ..-->.. t + ..pi../sup +/, d (p Vector, ..pi../sup +/) d*, and proton elastic and inelastic scattering. Electron scattering from /sup 40/Ca and /sup 26/Mg are under study. Lists of publications and papers are included. (WHK)

  5. Use of Rhenium-188 Liquid-Filled Balloons for Inhibition of Coronary Restenosis After PTCA - A New Opportunity for Nuclear Medicine

    SciTech Connect

    Knapp, F.F., Jr.; Spencer, R.H.; Stabin, M.

    1999-05-13

    Although the use of ionizing radiation for the treatment of benign lesions such as keloids has been available for nearly one hundred years, only recently have the cost effective benefits of such technology for the inhibition of arterial restenosis following controlled vessel damage from balloon angioplasty been fully realized. In particular, the use of balloons filled with solutions of beta-emitting radioisotopes for vessel irradiation provide the benefit of uniform vessel irradiation. Use of such contained ("unsealed") sources is expected to represent a new opportunity for nuclear medicine physicians working in conjunction with interventional cardiologists to provide this new approach for restenosis therapy.

  6. Nuclear physics and astrophysics. Progress report, July 15, 1991--June 15, 1992

    SciTech Connect

    Schramm, D.N.; Olinto, A.V.

    1992-09-01

    We have investigated a variety of research topics on the interface of nuclear physics and astrophysics during the past year. We have continued our study of dihyperon states in dense matter and have started to make a connection between their properties in the core of neutron stars with the ongoing experimental searches at Brookhaven National Laboratory. We started to build a scenario for the origin of gamma-ray bursts using the conversion of neutron stars to strange stars close to an active galactic nucleous. We have been reconsidering the constraints due to neutron star cooling rates on the equation of state for high density matter in the light, of recent findings which show that the faster direct Urca cooling process is possible for a range of nuclear compositions. We have developed a model for the formation of primordial magnetic fields due to the dynamics of the quark-hadron phase transition. Encouraged by the most recent observational developments, we have investigated the possible origin of the boron and beryllium abundances. We have greatly improved the calculations of the primordial abundances of these elements I>y augmenting the reaction networks and by updating the most recent experimental nuclear reaction rates. Our calculations have shown that the primordial abundances are much higher than previously thought but that the observed abundances cannot be explained by primordial sources alone. We have also studied the origin of the boron and beryllium abundances due to cosmic ray spallation. Finally, we have continued to address the solar neutrino problem by investigating the impact of astrophysical uncertainties on the MSW solution for a full three-family treatment of MSW mixing.

  7. Nuclear waste criticality analysis. Quarterly progress report, 1 October--31 December 1995

    SciTech Connect

    Culbreth, W.G.

    1996-01-19

    The work to date includes the preparation of a report related to criticality in spent fuel, a report on the Oklo reactors and their relevance to Yucca Mountain, and the creation of a computer program to model the Oklo reactors. The objective of the program includes a computational model of the only known natural analogue to an underground nuclear waste repository and the possible application of the model to predict the long-term behavior of Yucca Mountain. A final summary of all work completed will be presented after the end of the project on February 29, 1996.

  8. Cell cycle regulation of Greatwall kinase nuclear localization facilitates mitotic progression

    PubMed Central

    Wang, Peng; Galan, Jacob A.; Normandin, Karine; Bonneil, Éric; Hickson, Gilles R.; Roux, Philippe P.; Thibault, Pierre

    2013-01-01

    Cell division requires the coordination of critical protein kinases and phosphatases. Greatwall (Gwl) kinase activity inactivates PP2A-B55 at mitotic entry to promote the phosphorylation of cyclin B–Cdk1 substrates, but how Gwl is regulated is poorly understood. We found that the subcellular localization of Gwl changed dramatically during the cell cycle in Drosophila. Gwl translocated from the nucleus to the cytoplasm in prophase. We identified two critical nuclear localization signals in the central, poorly characterized region of Gwl, which are required for its function. The Polo kinase associated with and phosphorylated Gwl in this region, promoting its binding to 14-3-3? and its localization to the cytoplasm in prophase. Our results suggest that cyclin B–Cdk1 phosphorylation of Gwl is also required for its nuclear exclusion by a distinct mechanism. We show that the nucleo-cytoplasmic regulation of Gwl is essential for its functions in vivo and propose that the spatial regulation of Gwl at mitotic entry contributes to the mitotic switch. PMID:23857770

  9. PROGRESS IN REDUCING THE NUCLEAR THREAT: UNITED STATES PLUTONIUM CONSOLIDATION AND DISPOSITION

    SciTech Connect

    Allender, J.; Koenig, R.; Davies, S.

    2009-06-01

    Following the end of the Cold War, the United States identified 61.5 metric tons (MT) of plutonium and larger quantities of enriched uranium that are permanently excess to use in nuclear weapons programs. The Department of Energy (DOE) also began shutting down, stabilizing, and removing inventories from production facilities that were no longer needed to support weapons programs and non-weapons activities. The storage of 'Category I' nuclear materials at Rocky Flats, Sandia National Laboratories, and several smaller sites has been terminated to reduce costs and safeguards risks. De-inventory continues at the Hanford site and the Lawrence Livermore National Laboratory. Consolidation of inventories works in concert with the permanent disposition of excess inventories, including several tonnes of plutonium that have already been disposed to waste repositories and the preparation for transfers to the planned Mixed Oxide (MOX) Fuel Fabrication Facility (for the bulk of the excess plutonium) and alternative disposition methods for material that cannot be used readily in the MOX fuel cycle. This report describes status of plutonium consolidation and disposition activities and their impacts on continuing operations, particularly at the Savannah River Site.

  10. Applied nuclear data research and development. Progress report, January 1-March 31, 1981

    SciTech Connect

    Baxman, C.I.; Young, P.G.

    1981-07-01

    Activities of the Los Alamos Nuclear Data Group for January 1 through March 31, 1981, are described. Topics include: (1) peripheral effects in R-matrix theory; (2) Coulomb corrections in light nuclei; (3) new R-matrix analysis of reactions in the /sup 7/Li system; (4) variance-covariance analysis of n + Li reactions; (5) calculated charged-particle emission in the mass-90 region; (6) determination of deformed optical model parameters for neutron reactions on /sup 235/U and /sup 239/Pu; (7) calculation of excited state cross sections for actinide nuclei; (8) calculation of the prompt neutron spectrum and ..nu../sub p/ for the spontaneous fission of /sup 252/Cf; (9) international nuclear model codes comparison study; (10) an improved calculation of heating and radiation damage from neutron capture; (11) LMFBR cross-section production with MAX; (12) TRANSX development; (13) THOR calculations; (14) covariance processing; (15) analysis of charges for use of central computing facility; (16) S/sub n/ calculations for D/sub 2/O sphere; (17) integral data testing of ENDF/B fission-product data; (18) decay power comparisons using ENDF/B-IV and -V data in CINDER-10; (19) ENDF/B-V data testing and summary data; (20) SPEC5: code to produce multigroup spectra; and (21) calculation of H. B. Robinson-2 fuel isotopics and comparison with measurements. (WHK)

  11. PROGRESS WITH K BASINS SLUDGE RETRIEVAL STABILIZATION & PACKAGING AT THE HANFORD NUCLEAR SITE

    SciTech Connect

    KNOLLMEYER, P.M.; PHILLIPS, C; TOWNSON, P.S.

    2006-01-30

    This paper shows how Fluor Hanford and BNG America have combined nuclear plant skills from the U.S. and the U.K. to devise methods to retrieve and treat the sludge that has accumulated in K Basins at the Hanford Site over many years. Retrieving the sludge is the final stage in removing fuel and sludge from the basins to allow them to be decontaminated and decommissioned, so as to remove the threat of contamination of the Columbia River. A description is given of sludge retrieval using vacuum lances and specially developed nozzles and pumps into Consolidation Containers within the basins. The special attention that had to be paid to the heat generation and potential criticality issues with the irradiated uranium-containing sludge is described. The processes developed to re-mobilize the sludge from the Consolidation Containers and pump it through flexible and transportable hose-in-hose piping to the treatment facility are explained with particular note made of dealing with the abrasive nature of the sludge. The treatment facility, housed in an existing Hanford building, is described, and the uranium-corrosion and grout packaging processes explained. The uranium corrosion process is a robust, tempered process very suitable for dealing with a range of differing sludge compositions. Optimization and simplification of the original sludge corrosion process design is described and the use of transportable and reusable equipment is indicated. The processes and techniques described in the paper are shown to have wide applicability to nuclear cleanup.

  12. [Research in theoretical nuclear physics]. [Annual progress report, July 1992--June 1993

    SciTech Connect

    Kapusta, J.I.

    1993-12-31

    The main subject of research was the physics of matter at energy densities greater than 0.15 GeV/fm{sup 3}. Theory encompasses the relativistic many-body/quantum field theory aspects of QCD and the electroweak interactions at these high energy densities, both in and out of thermal equilibrium. Applications range from neutron stars/pulsars to QCD and electroweak phase transitions in the early universe, from baryon number violation in cosmology to the description of nucleus-nucleus collisions at CERN and at Brookhaven. Recent activity to understand the properties of matter at energy densities where the electroweak W and Z boson degrees of freedom are important is reported. This problem has applications to cosmology and has the potential to explain the baryon asymmetry produced in the big bang at energies where the particle degrees of freedom will soon be experimentally, probed. This problem is interesting for nuclear physics because of the techniques used in many-body, physics of nuclei and the quark-gluon plasma may be extended to this new problem. The was also interested in problems related to multiparticle production. This includes work on production of particles in heavy-ion collisions, the small x part, of the nuclear and hadron wave function, and multiparticle production induced by instantons in weakly coupled theories. These problems have applications in the heavy ion program at RHIC and the deep inelastic scattering experiments at HERA.

  13. Studies of fluctuation processes in nuclear collisions. Progress report, March 1, 1992--February 28, 1993

    SciTech Connect

    Ayik, S.

    1993-02-01

    Investigations of various aspects of heavy-ion collisions were carried out in the framework of the Boltzmann-Langevin Model (BLM). In a previous work, by projection the BLM onto a collective space, a memory-dependent collective transport model was reduced. This model was applied to thermal fission to investigate the influence of the memory effects on the fission dynamics. Some results of the calculations are presented. In addition a reduction of the relativistic BLM to a two-fluid model was carried out, and transport coefficients associated with fluid dynamical variables was carried out. Then this model was applied to investigate equilabration and fluctuation properties in a counter-streaming nuclear fluid.

  14. Theoretical nuclear physics. Progress report, October 1, 1991--August 1, 1992

    SciTech Connect

    Rost, E.; Shephard, J.R.

    1992-08-01

    This report discusses the following topics: Exact 1-loop vacuum polarization effects in 1 + 1 dimensional QHD; exact 1-fermion loop contributions in 1 + 1 dimensional solitons; exact scalar 1-loop contributions in 1 + 3 dimensions; exact vacuum calculations in a hyper-spherical basis; relativistic nuclear matter with self- consistent correlation energy; consistent RHA-RPA for finite nuclei; transverse response functions in the {triangle}-resonance region; hadronic matter in a nontopological soliton model; scalar and vector contributions to {bar p}p {yields} {bar {Lambda} {Lambda}} reaction; 0+ and 2+ strengths in pion double-charge exchange to double giant-dipole resonances; and nucleons in a hybrid sigma model including a quantized pion field.

  15. Nuclear chemistry progress report, Oregon State University. August 1, 1995--August 1, 1996

    SciTech Connect

    Loveland, W.

    1996-12-31

    In this report, the authors summarize the highlights of the work done between August 1, 1995, and August 1, 1996. The work reported herein is the result of a collaborative effort between the nuclear chemists at Oregon State University and many other individuals and research groups. Each project discussed was the result of a joint effort of the groups, interchanging roles in data acquisition and analysis. The work described is part of a project involving the study of low energy (< 10 MeV/nucleon), and intermediate energy (10--100 MeV/nucleon) heavy ion reactions. Their work in the low energy regime included: the first US studies of fusion utilizing radioactive beams. Half of their effort was spent in the study of intermediate energy nuclear collisions. Among the accomplishments were: the establishment of a systematics of angular momentum transfer in peripheral collisions; completion of the first portion of high resolution studies of heavy residue formation in reactions induced by 20 MeV/nucleon {sup 197}Au utilizing the MSU A1200 separator; synthesis of several new neutron-deficient nuclides in reactions of 20 MeV/nucleon {sup 197}Au with heavy targets (Ti, Zr and Au); their participation in exclusive studies of heavy residue formation in the reaction of 35 MeV/nucleon {sup 86}Kr with {sup 197}Au in which it was found that the residues had large associated particle multiplicities indicating their formation in highly dissipative collisions, and that particle emission leading to residue formation relative to fission was favored as the dissipated energy increased.

  16. Nepheline Crystallization in Nuclear Waste Glasses: Progress toward acceptance of high-alumina formulations

    SciTech Connect

    McCloy, John S.; Schweiger, Michael J.; Rodriguez, Carmen P.; Vienna, John D.

    2011-09-01

    We have critically compiled and analyzed historical data for investigating the quantity of nepheline (NaAlSiO4) precipitation as a function of composition in simulated nuclear waste glasses. To understand composition we used two primary methods: 1) investigating the Al2O3-SiO2-Na2O ternary with filtering for different B2O3 levels and 2) creating a quadrant system consisting of compositions reduced to two metric numbers. These metrics are 1) the nepheline discriminator (ND) which depends only on the SiO2 content by weight normalized to the total weight of the Al2O3-SiO2-Na2O sub-mixture and 2) the optical basicity (OB) which contains contributions from all constituents in the glass. Nepheline precipitation is expected to be suppressed at high SiO2 levels (ND >0.62) or at low basicities (OB <0.55 to 0.57). Changes in sodium aluminosilicate glass OB due to additions of CaO and B2O3 correlate with observed effects on nepheline formation. We propose that additional composition space is available for formulating high-waste-loading, high-Al¬2O3 nuclear waste glasses when Na2O levels are less than ~0.125 (normalized by weight on the Al2O3-SiO2-Na2O sub-mixture). However, this compositional space is considerably extended to higher Na2O levels when adding >5 wt% B2O3. The OB concept can help further refine regions of nepheline-free glass formation.

  17. Paralympic medicine.

    PubMed

    Webborn, Nick; Van de Vliet, Peter

    2012-07-01

    Paralympic medicine describes the health-care issues of those 4500 or so athletes who gather every 4 years to compete in 20 sports at the Summer Paralympic Games and in five sports at the Winter Paralympic Games. Paralympic athletes compete within six impairment groups: amputation or limb deficiencies, cerebral palsy, spinal cord-related disability, visual impairment, intellectual impairment, or a range of physically impairing disorders that do not fall into the other classification categories, known as les autres. The variety of impairments, many of which are severe, fluctuating, or progressive disorders (and are sometimes rare), makes maintenance of health in thousands of Paralympians while they undertake elite competition an unusual demand on health-care resources. The increased physical fitness of athletes with disabilities has important implications for cardiovascular risk reduction in a population for whom the prevalence of risk factors can be high. PMID:22770458

  18. Bangladeshi medicinal plant extracts inhibiting molecular interactions between nuclear factors and target DNA sequences mimicking NF-kappaB binding sites.

    PubMed

    Lampronti, I; Khan, M T H; Bianchi, N; Ather, A; Borgatti, M; Vizziello, L; Fabbri, E; Gambari, R

    2005-07-01

    Several medicinal plants can be employed to produce extracts exhibiting biological effects. The aim of this work was to verify the ability of extracts derived from different medicinal plants of Bangladesh in interfering with specific DNA-protein interactions. The rationale for this study is based on the observation that alteration of gene transcription represents a very promising approach to control the expression of selected genes and could be obtained using different molecules acting on the interactions between DNA and transcription factors (TFs). We have analysed the antiproliferative activity of extracts from the medicinal plants Hemidesmus indicus, Polyalthia longifolia, Aphanamixis polystachya, Moringa oleifera, Lagerstroemia speciosa, Paederia foetida, Cassia sophera, Hygrophila auriculata and Ocimum sanctum. Antiproliferative activity was assayed on different human cell lines, including erythroleukemia K562, B-lymphoid Raji, T-lymphoid Jurkat and erythroleukemia HEL cell lines. We employed the electrophoretic mobility shift assay (EMSA) as a suitable technique for the identification of plant extracts altering the binding between transcription factors and the specific DNA elements. We found that low concentrations of Hemidesmus indicus, Polyalthia longifolia, Moringa oleifera and Lagerstroemia speciosa, and very low concentrations of Aphanamixis polystachya extracts inhibit the interactions between nuclear factors and target DNA elements mimicking sequences recognized by the nuclear factor kappaB (NF-kappaB). On the contrary, high amount of extracts from Paederia foetida, Cassia sophera, Hygrophila auriculata or Ocimum sanctum were unable to inhibit NF-kappaB/DNA interactions. Extracts inhibiting both NF-kappaB binding activity and tumor cell growth might be a source for anti-tumor compounds, while extracts inhibiting NF-kappaB/DNA interactions with lower effects on cell growth, could be of interest in the search of compounds active in inflammatory diseases, for which inhibition of NF-kappaB binding activity without toxic effects should be obtained. PMID:16789890

  19. TH-E-9A-01: Medical Physics 1.0 to 2.0, Session 4: Computed Tomography, Ultrasound and Nuclear Medicine

    SciTech Connect

    Samei, E; Nelson, J; Hangiandreou, N

    2014-06-15

    Medical Physics 2.0 is a bold vision for an existential transition of clinical imaging physics in face of the new realities of value-based and evidencebased medicine, comparative effectiveness, and meaningful use. It speaks to how clinical imaging physics can expand beyond traditional insular models of inspection and acceptance testing, oriented toward compliance, towards team-based models of operational engagement, prospective definition and assurance of effective use, and retrospective evaluation of clinical performance. Organized into four sessions of the AAPM, this particular session focuses on three specific modalities as outlined below. CT 2.0: CT has been undergoing a dramatic transition in the last few decades. While the changes in the technology merits discussions of their own, an important question is how clinical medical physicists are expected to effectively engage with the new realities of CT technology and practice. Consistent with the upcoming paradigm of Medical Physics 2.0, this CT presentation aims to provide definitions and demonstration of the components of the new clinical medical physics practice pertaining CT. The topics covered include physics metrics and analytics that aim to provide higher order clinicallyrelevant quantification of system performance as pertains to new (and not so new) technologies. That will include the new radiation and dose metrics (SSDE, organ dose, risk indices), image quality metrology (MTF/NPS/d’), task-based phantoms, and the effect of patient size. That will follow with a discussion of the testing implication of new CT hardware (detectors, tubes), acquisition methods (innovative helical geometries, AEC, wide beam CT, dual energy, inverse geometry, application specialties), and image processing and analysis (iterative reconstructions, quantitative CT, advanced renditions). The presentation will conclude with a discussion of clinical and operational aspects of Medical Physics 2.0 including training and communication, use optimization (dose and technique factors), automated analysis and data management (automated QC methods, protocol tracking, dose monitoring, issue tracking), and meaningful QC considerations. US 2.0: Ultrasound imaging is evolving at a rapid pace, adding new imaging functions and modes that continue to enhance its clinical utility and benefits to patients. The ultrasound talk will look ahead 10–15 years and consider how medical physicists can bring maximal value to the clinical ultrasound practices of the future. The roles of physics in accreditation and regulatory compliance, image quality and exam optimization, clinical innovation, and education of staff and trainees will all be considered. A detailed examination of expected technology evolution and impact on image quality metrics will be presented. Clinical implementation of comprehensive physics services will also be discussed. Nuclear Medicine 2.0: Although the basic science of nuclear imaging has remained relatively unchanged since its inception, advances in instrumentation continue to advance the field into new territories. With a great number of these advances occurring over the past decade, the role and testing strategies of clinical nuclear medicine physicists must evolve in parallel. The Nuclear Medicine 2.0 presentation is designed to highlight some of the recent advances from a clinical medical physicist perspective and provide ideas and motivation for designing better evaluation strategies. Topics include improvement of traditional physics metrics and analytics, testing implications of hybrid imaging and advanced detector technologies, and strategies for effective implementation into the clinic. Learning Objectives: Become familiar with new physics metrics and analytics in nuclear medicine, CT, and ultrasound. To become familiar with the major new developments of clinical physics support. To understand the physics testing implications of new technologies, hardware, software, and applications. Identify approaches for implementing comprehensive medical physics services in future imaging pr

  20. Taking Medicines

    MedlinePLUS

    ... of this page please turn Javascript on. Taking Medicines Drugs in the Body Medicines can enter the body in many different ways, ... many steps happen along the way. Understanding how medicines work in your body can help you learn ...

  1. ADHD Medicines

    MedlinePLUS

    ... System How the Body Works Main Page ADHD Medicines KidsHealth > Kids > Health Problems > Learning & Emotional Problems > ADHD ... doctor can decide if ADHD medicine is needed. Medicine and the Mind There are a lot of ...

  2. Diabetes Medicines

    MedlinePLUS

    ... choices and physical activity, you may need diabetes medicines. The kind of medicine you take depends on your type of diabetes, ... pills. Combination pills contain two kinds of diabetes medicine in one tablet. Some people take pills and ...

  3. Essential Medicines: An Indian Perspective

    PubMed Central

    Maiti, Rituparna; Bhatia, Vikas; Padhy, Biswa Mohan; Hota, Debasish

    2015-01-01

    The concept of defining essential medicines and establishing a list of them was aimed to improve the availability of affordable medicines for the world's poor. Access to essential medicines is a major determinant of health outcomes. Several countries have made substantial progress towards increasing access to essential medicines, but access to essential medicines in developing countries like India is not adequate. In this review we have tried to present the Indian scenario in respect to availability and accessibility of essential medicines over last one decade. To enhance the credibility of Indian healthcare system, procurement and delivery systems of essential medicines have to be strengthened through government commitment, careful selection, adequate public sector financing, efficient distribution systems, control on taxes and duties, and inculcating a culture of rational use of medicines in current and future prescribers. PMID:26435594

  4. Essential Medicines: An Indian Perspective.

    PubMed

    Maiti, Rituparna; Bhatia, Vikas; Padhy, Biswa Mohan; Hota, Debasish

    2015-01-01

    The concept of defining essential medicines and establishing a list of them was aimed to improve the availability of affordable medicines for the world's poor. Access to essential medicines is a major determinant of health outcomes. Several countries have made substantial progress towards increasing access to essential medicines, but access to essential medicines in developing countries like India is not adequate. In this review we have tried to present the Indian scenario in respect to availability and accessibility of essential medicines over last one decade. To enhance the credibility of Indian healthcare system, procurement and delivery systems of essential medicines have to be strengthened through government commitment, careful selection, adequate public sector financing, efficient distribution systems, control on taxes and duties, and inculcating a culture of rational use of medicines in current and future prescribers. PMID:26435594

  5. Further progress for a fast scanning of nuclear emulsions with Large Angle Scanning System

    NASA Astrophysics Data System (ADS)

    Alexandrov, A.; Tioukov, V.; Vladymyrov, M.

    2014-02-01

    The LASSO (Large Angle Scanning System for OPERA) is a scanning system designed in the framework of the OPERA experiment as a result of several R&Ds aimed to improve the performance of the European Scanning System (ESS) by increasing the scanning speed, the angular acceptance and the efficiency in microtrack reconstruction. The novel Continuous Motion (CM) scanning approach allows to double the ESS nominal speed without any changes in the hardware set-up. The LASSO modular design makes the system easily adaptable to new hardware. The novel microtrack reconstruction algorithm has been developed to be efficient in both standard Stop&Go (SG) and CM modes, performing a number of corrections during the processing like corrections for vibrations, optical distortions, field of view curvature. As an intermediate step it reconstructs silver grains positions inside emulsion layer to make a transition from 2D images to real 3D traces of a charged particle. This allows the algorithm to have no internal limits on the slope of microtracks being equally efficient on all angles. The LASSO has been used for about one year for mass production scanning of emulsion films of OPERA, Muon Radiography and also of films employed to study nuclear fragmentation of ion beams used in medical physics. More than 50000 cm2 of the emulsion surface have been analyzed during this period.

  6. Correlation Between Nuclear Factor E2-Related Factor 2 Expression and Gastric Cancer Progression

    PubMed Central

    Zheng, Hongyu; Nong, Zhiwei; Lu, Guohao

    2015-01-01

    Background Nuclear factor E2-related factor 2 (Nrf2) plays an anti-oxidative and phase II detoxification function via its up-regulation on various antioxidant response elements (ARE) genes. Nrf2 can protect both normal and cancer cells from damages of cell stress, thereby exerting a critical role in the development of cancer. The expression and significance of Nrf2 in gastric cancer, however, has not been reported. This study thus aimed to investigate the expression of Nrf2 in gastric cancer tissues via immunohistochemical (IHC) staining. Material/Methods Gastric carcinoma tissues from a total of 175 patients during surgical resection were examined for Nfr2 expression profiles using IHC staining on paraffin-embedded slides. Between-group-comparisons were performed by chi-square, Fisher’s exact, or Mann-Whitney U test. The correlation between Nfr2 expression and clinical indexes was further analyzed by Kaplan-Meier test, univariate/multivariate analysis, and log-rank test. Results Nrf2 is mainly expressed in nuclei of gastric carcinoma tissues, with significant correlation with clinical indexes, including tumor size, invasive depth, lymph node metastasis, and invasion. Patients with Nrf2-positive expression had significantly lower survival rates compared to those in the negative group (p<0.01), with chemo-resistance against 5-fluorouracil (5-FU) (p<0.05). Conclusions Nrf2 expression is positively correlated with invasive gastric cancer, suggesting its utility as a predictive index for unfavorable prognosis. PMID:26410168

  7. Expression of nuclear matrix proteins binding matrix attachment regions in prostate cancer. PARP-1: New player in tumor progression.

    PubMed

    Barboro, Paola; Ferrari, Nicoletta; Capaia, Matteo; Petretto, Andrea; Salvi, Sandra; Boccardo, Simona; Balbi, Cecilia

    2015-10-01

    Prostate cancer (PCa) displays infrequent point mutations, whereas genomic rearrangements are highly prevalent. In eukaryotes, the genome is compartmentalized into chromatin loop domains by the attachment to the nuclear matrix (NM), and it has been demonstrated that several recombination hot spots are situated at the base of loops. Here, we have characterized the binding between NM proteins and matrix attachment regions (MARs) in PCa. Nontumor and 44 PCa tissues were analyzed. More aggressive tumors were characterized by an increase in the complexity of the NM protein patterns that was synchronous with a decrease in the number of proteins binding the MAR sequences. PARP-1 was the protein that showed the most evident changes. The expression of the PARP-1 associated with NM increased and it was dependent on tumor aggressiveness. Immunohistochemical analysis showed that the protein was significantly overexpressed in tumor cells. To explore the role of PARP-1 in PCa progression, PCa cells were treated with the PARP inhibitor, ABT-888. In androgen-independent PC3 cells, PARP inhibition significantly decreased cell viability, migration, invasion, chromatin loop dimensions and histone acetylation. Collectively, our study provides evidence that MAR-binding proteins are involved in the development and progression of PCa. PARP could play a key role in the compartmentalization of chromatin and in the development of the more aggressive phenotype. Thus, PARP can no longer be viewed only as an enzyme involved in DNA repair, but that its role in chromatin modulation could provide the basis for a new therapeutic approach to the treatment of PCa. PMID:25808111

  8. Radiolytic and thermal process relevant to dry storage of spent nuclear fuels. 1998 annual progress report

    SciTech Connect

    Marschman, S.C.; Cowin, J.P.; Orlando, T.M.; Haustein, P.E.; Madey, T.E.

    1998-06-01

    'This project involves basic research in chemistry and physics aimed at providing information pertinent to the safe long-term dry storage of spent nuclear fuel (SNF), thousands of tons of which remain in water storage across the DOE complex. The Hanford Site K-Basins alone hold 2,300 tons of spent fuel, much of it severely corroded, and similar situations exist at Savannah River and Idaho National Engineering and Environmental Laboratory. The DOE plans to remove this fuel and seal it in overpack canisters for dry interim storage for up to 75 years while awaiting permanent disposition. Chemically-bound water will remain in this fuel even following proposed drying steps, leading to possible long-term corrosion of the containers and/or fuel rods themselves, generation of H{sub 2} and O{sub 2} gas via radiolysis (which could lead to deflagration or detonation), and reactions of pyrophoric uranium hydrides. No thoroughly tested model is currently available to predict fuel behavior during pre-processing, processing, or storage. In a collaboration between Rutgers University, Pacific Northwest National Laboratory, and Brookhaven National Laboratory, the authors are studying the radiolytic reaction, drying processes, and corrosion behavior of actual SNF materials, and of pure and mixed-phase samples. The authors propose to determine what is omitted from current models: radiolysis of water adsorbed on or in hydrates or hydroxides, thermodynamics of interfacial phases, and kinetics of drying. A model will be developed and tested against actual fuel rod behavior to insure validity and applicability to the problems associated with developing dry storage strategies for DOE-owned SNF. This report summarizes work after eight months of a three-year project.'

  9. Resveratrol attenuates the progress of liver fibrosis via the Akt/nuclear factor-?B pathways.

    PubMed

    Zhang, Hui; Sun, Qingfeng; Xu, Tingyan; Hong, Liang; Fu, Rongquan; Wu, Jinguo; Ding, Jiguang

    2016-01-01

    Liver fibrosis is a wound-healing response to chronic liver injury that results in the accumulation of extracellular matrix proteins. It eventually leads to cirrhosis of the liver and liver failure, and it is a critical threat to the health and lives of patients with chronic liver diseases. No effective treatment is currently available. Resveratrol is a polyphenol with antioxidant, anti?cancer and anti?inflammatory properties. It has been reported that resveratrol prevents liver fibrosis, possibly by inhibiting NF??B activation. The present study investigated the mechanisms by which resveratrol prevented liver fibrosis, focusing on the possible involvement of the NF??B pathway. Mice with carbon tetrachloride (CCl4)?induced liver fibrosis were treated with various concentrations of resveratrol. Serum levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST) and tumor necrosis factor (TNF)?? were detected by ELISAs. Expression of ??smooth muscle actin (??SMA), collagen I, inhibitor of NF??B (I?B) and NF??B were detected by western blot analysis. In addition, the present study examined the effects of resveratrol on the expression of fibrosis markers in LX?2 cells. Western blot analysis was further used to detect the levels of Akt and phosphorylated Akt, as well as the nuclear levels of I?B, phosphorylated I?B and NF??B p65. The expression of ??SMA in resveratrol?treated LX?2 cells was detected by immunofluorescence and flow cytometry, which demonstrated that resveratrol decreased the expression of ??SMA in LX?2 cells. Resveratrol also decreased CCl4?induced upregulation of serum AST, ALT, TNF??, ??SMA and collagen I. Finally, resveratrol prevented the activation of NF??B and Akt. The results of the present study therefore indicated that resveratrol attenuates liver fibrosis via the Akt/NF-?B pathways. PMID:26530037

  10. Methods of increasing the performance of radionuclide generators used in nuclear medicine: daughter nuclide build-up optimisation, elution-purification-concentration integration, and effective control of radionuclidic purity.

    PubMed

    Le, Van So; Do, Zoe Phuc-Hien; Le, Minh Khoi; Le, Vicki; Le, Natalie Nha-Truc

    2014-01-01

    Methods of increasing the performance of radionuclide generators used in nuclear medicine radiotherapy and SPECT/PET imaging were developed and detailed for 99Mo/99mTc and 68Ge/68Ga radionuclide generators as the cases. Optimisation methods of the daughter nuclide build-up versus stand-by time and/or specific activity using mean progress functions were developed for increasing the performance of radionuclide generators. As a result of this optimisation, the separation of the daughter nuclide from its parent one should be performed at a defined optimal time to avoid the deterioration in specific activity of the daughter nuclide and wasting stand-by time of the generator, while the daughter nuclide yield is maintained to a reasonably high extent. A new characteristic parameter of the formation-decay kinetics of parent/daughter nuclide system was found and effectively used in the practice of the generator production and utilisation. A method of "early elution schedule" was also developed for increasing the daughter nuclide production yield and specific radioactivity, thus saving the cost of the generator and improving the quality of the daughter radionuclide solution. These newly developed optimisation methods in combination with an integrated elution-purification-concentration system of radionuclide generators recently developed is the most suitable way to operate the generator effectively on the basis of economic use and improvement of purposely suitable quality and specific activity of the produced daughter radionuclides. All these features benefit the economic use of the generator, the improved quality of labelling/scan, and the lowered cost of nuclear medicine procedure. Besides, a new method of quality control protocol set-up for post-delivery test of radionuclidic purity has been developed based on the relationship between gamma ray spectrometric detection limit, required limit of impure radionuclide activity and its measurement certainty with respect to optimising decay/measurement time and product sample activity used for QC quality control. The optimisation ensures a certainty of measurement of the specific impure radionuclide and avoids wasting the useful amount of valuable purified/concentrated daughter nuclide product. This process is important for the spectrometric measurement of very low activity of impure radionuclide contamination in the radioisotope products of much higher activity used in medical imaging and targeted radiotherapy. PMID:24918542

  11. Medium energy nuclear physics research. Progress report, July 1, 1987--September 30, 1988

    SciTech Connect

    Peterson, G.A.; Dubach, J.F.; Hicks, R.S.; Miskimen, R.A.

    1988-09-01

    The UMass group has concentrated on using electromagnetic probes, particularly the electron in high-energy scattering experiments at the Stanford Liner Accelerator Center (SLAC). Plans are also being made for high energy work at the Continuous Beam Accelerator Facility (CEBAF). The properties of this accelerator should permit a whole new class of coincidence experiments to be carried out. At SLAC UMass has made major contributions toward the plans for a cluster-jet gas target and detector system at the 16 GeV PEP storage ring. For the future CEBAF accelerator, tests were made of the feasibility of operating wire drift chambers in the vicinity of a continuous electron beam at the University Illinois microtron. At the same time a program of studies of the nuclear structure of more complex nuclei has been continued at the MIT-Bates Linear Accelerator Center and in Amsterdam at the NIKHEF-K laboratory. At the MIT-Bates Accelerator, because of an unforeseen change in beam scheduling as a result of problems with the T{sub 20} experiment, the UMass group was able to complete data acquisition on experiments involving 180{degrees} elastic magnetic scattering on {sup 117}Sn and {sup 41}Ca. A considerable effort has been given to preparations for a future experiment at Bates involving the high-resolution threshold electrodisintegration of the deuteron. The use of these chambers should permit a high degree of discrimination against background events in the measurement of the almost neutrino-like small cross sections that are expected. In Amsterdam at the NIKHEF-K facility, single arm (e,e{prime}) measurements were made in November of 1987 on {sup 10}B in order to better determine the p{sub 3/2} wave function from the transition from the J{sup pi} = 3{sup +} ground state to the O{sup +} excited state at 1.74 MeV. In 1988, (e,e{prime}p) coincidence measurements on {sup 10}B were completed. The objective was to obtain information on the p{sub 3/2} wave function by another means.

  12. Advanced Gas Cooled Nuclear Reactor Materials Evaluation and Development Program. Progress report, April 1, 1980-June 30, 1980

    SciTech Connect

    Not Available

    1980-11-14

    Objectives of this program are to evaluate candidate alloys for Very High Temperature Reactor (VHTR) Nuclear Process Heat (NPH) and Direct Cycle Helium Turbine (DCHT) applications, in terms of the effect of simulated reactor primary coolant (helium containing small amounts of various other gases), high temperatures, and long time exposures, on the mechanical properties and structural and surface stability of selected candidate alloys. A second objective is to select and recommend materials for future test facilities and more extensive qualification programs. Work covered in this report includes the activities associated with the status of the simulated reactor helium supply system, testing equipment and gas chemistry analysis instrumentation and equipment. The progress in the screening test program is described; this includes: screening creep results and metallographic analysis for materials thermally exposed or tested at 750, 850 and 950/sup 0/C. The initiation of air creep-rupture testing in the intensive screening test program is discussed. In addition, the status of the data management system is described.

  13. Beta-Catenin Nuclear Labeling is a Common Feature of Sessile Serrated Adenomas and Correlates with Early Neoplastic Progression Following BRAF Activation

    PubMed Central

    Yachida, Shinichi; Mudali, Shiyama; Martin, Sherri A.; Montgomery, Elizabeth A.; Iacobuzio-Donahue, Christine A.

    2009-01-01

    Recent observations indicate that some sessile serrated adenomas (SSAs) have aberrant ?-catenin nuclear labeling, implicating the Wnt pathway in the molecular progression of SSAs to colorectal carcinoma. We sought to expand upon this finding by characterizing ?-catenin expression in the full spectrum of serrated colorectal polyps, and correlating these findings with the genetic status of BRAF, KRAS and CTNNB1. Immunolabeling for ?-catenin confirmed the presence of abnormal nuclear accumulation in SSAs, with 35/54 (67%) SSAs showing nuclear labeling compared to 0/12 hyperplastic polyps (HPs). Abnormal nuclear labeling was also identified in 4/11 (36%) traditional serrated adenomas (TSAs) (p=0.00001). When SSAs were further analyzed with respect to the presence or absence of conventional epithelial dysplasia, nuclear ?-catenin labeling was seen in 8/27 (29%) SSAs without dysplasia (SSA) but in 27/27 (100%) of SSAs with dysplasia (SSADs) (p=0.000001). Sequencing of genomic DNA extracted from a subset of HPs, SSAs, SSADs, TSAs and tubular adenomas (TAs) failed to identify any CTNNB1 mutations to account for abnormal ?-catenin nuclear labeling. However, abnormal nuclear labeling always occurred in the setting of a BRAF V600E mutation, indicating aberrant nuclear labeling occurs on a background of BRAF activation. Of interest, all six TSAs contained a KRAS mutation confirming that SSAs and TSAs are genetically distinct entities. These findings validate previous reports implicating activation of the Wnt signaling pathway in SSAs, and further indicate that Wnt pathway activation plays a role in the neoplastic progression of SSAs and TSAs to colonic carcinoma by mechanisms independent of CTNNB1 mutation. PMID:19745699

  14. [PCR in forensic medicine].

    PubMed

    Coquoz, R

    1994-05-17

    PCR has brought important progress to forensic medicine. It has provided access to various effective, rapid and simple analytic techniques. It has distinctly increased the range of analyzable samples and comparably improved chances to identify a criminal. This had consequences for laboratories as well as police departments and even physicians that occasionally cooperate with legal agencies. PMID:7911590

  15. Doug Brutlag 2015 Genomics, Bioinformatics & Medicine

    E-print Network

    Brutlag, Doug

    Brutlag Professor Emeritus of Biochemistry & Medicine Stanford University School of Medicine Stem Cell Therapies http://biochem158.stanford.edu/Stem%20Cell%20Therapies.html #12;© Doug Brutlag 2015 California Institute for Regenerative Medicine http://www.cirm.ca.gov/our-progress/stem-cells-therapies #12;© Doug

  16. Evolving trade policy and the Trans-Pacific Partnership Agreement: does it threaten Vietnam's access to medicine and its progress towards scaling up HIV prevention, treatment and care?

    PubMed

    Linh, Nguyen Nhat; Huong, Nguyen Thanh; Thuy, Hua Thanh

    2015-01-01

    The Trans-Pacific Partnership Agreement (TPP) has undergone 18 rounds of secretive negotiation between the USA and 11 Asia-Pacific countries. Aiming at a free trade area, this multilateral trade proposal covers all aspects of commercial relations among the countries involved. Despite some anticipated positive impacts in trade, specific articles in this proposal's intellectual property and transparency chapters might negatively impact access to medicine, in general, and to antiretroviral (ARV) drugs, in particular, in Vietnam. Drawing on a desk review and qualitative in-depth interviews with 20 key informants from government, academia, hospitals and civil society, we analyse various provisions of the proposal being negotiated leaked after the 14th round of negotiations in September 2012. Findings suggest that the TPP could lead to increased monopoly protection and could limit technological advancements within the local pharmaceutical manufacturing industry, resulting in higher medicine prices in Vietnam. This outcome would have a significant impact on Vietnam's ability to achieve goals for HIV prevention, treatment and care, and create barriers to universal health-care coverage. This research provides unique evidence for Vietnam to advocate for more equitable pharmaceutical provisions in and to raise awareness of the implications of the TPP among the pharmaceutical stakeholder community in Vietnam. PMID:25469870

  17. The roles played by mitochondrial DNA and nuclear genes in reversion to fertility in S-Type male-sterile maize. Progress report, April 1, 1985--March 31, 1989

    SciTech Connect

    Laughnan, J.R.

    1995-03-01

    This is a progress report/renewal request for work of the roles played by mitochondrial DNA and nuclear genes in reversion to fertility in s-type male sterile maize. Information is included for the following major catagories of research on this project: molecular basis for nuclear reversion; molecular characterization of cytoplasmic revertants; nuclear control over cytoplasmic reversion and over replication of S1 and S2; developmental studies; transposition of nuclear restorer elements.

  18. COPD Medicine

    MedlinePLUS

    ... 5654 ) You are here: Health Information > Medications > COPD COPD Medicine Your doctor may prescribe medicine to control ... Calendar Read the News View Daily Pollen Count COPD Program This program offers comprehensive, individualized care for ...

  19. Herbal Medicine

    MedlinePLUS

    ... for its scent, flavor, or therapeutic properties. Herbal medicines are one type of dietary supplement. They are ... and fresh or dried plants. People use herbal medicines to try to maintain or improve their health. ...

  20. Alternative Medicine

    MedlinePLUS

    ... News About Us Donate In This Section Alternative Medicine en Español email Send this article to a ... Send Thanks for emailing that article! Tweet Alternative medicine may be defined as non-standard, unconventional treatments ...

  1. Osteopathic Medicine: About Osteopathic Medicine

    MedlinePLUS

    ... Advancing the distinctive philosophy and practice of osteopathic medicine Inside the AOA About the AOA AOA Annual ... DOs Licensed? How Are DOs Certified? About Osteopathic Medicine Page Content You are more than just the ...

  2. Preventing Nuclear War: What Physicians Can Achieve

    PubMed Central

    Bates, Don G.

    1986-01-01

    On its fifth anniversary, the International Physicians for the Prevention of Nuclear War was awarded the Nobel Peace Prize. The organization was conceived by two Boston cardiologists who joined with some Soviet colleagues to create an international forum for considering the medical consequences of and means for preventing nuclear war. This article by the organization's archivist documents its difficult progress yet remarkable growth. Overcoming serious obstacles has added to its strength and credibility: now involving organizations with 145,000 members in 41 countries, IPPNW has become the international voice of medicine's concern about nuclear war. PMID:21274253

  3. Robotics in medicine

    NASA Astrophysics Data System (ADS)

    Kuznetsov, D. N.; Syryamkin, V. I.

    2015-11-01

    Modern technologies play a very important role in our lives. It is hard to imagine how people can get along without personal computers, and companies - without powerful computer centers. Nowadays, many devices make modern medicine more effective. Medicine is developing constantly, so introduction of robots in this sector is a very promising activity. Advances in technology have influenced medicine greatly. Robotic surgery is now actively developing worldwide. Scientists have been carrying out research and practical attempts to create robotic surgeons for more than 20 years, since the mid-80s of the last century. Robotic assistants play an important role in modern medicine. This industry is new enough and is at the early stage of development; despite this, some developments already have worldwide application; they function successfully and bring invaluable help to employees of medical institutions. Today, doctors can perform operations that seemed impossible a few years ago. Such progress in medicine is due to many factors. First, modern operating rooms are equipped with up-to-date equipment, allowing doctors to make operations more accurately and with less risk to the patient. Second, technology has enabled to improve the quality of doctors' training. Various types of robots exist now: assistants, military robots, space, household and medical, of course. Further, we should make a detailed analysis of existing types of robots and their application. The purpose of the article is to illustrate the most popular types of robots used in medicine.

  4. Medicine and Veterinary Medicine Postgraduate Opportunities

    E-print Network

    Maizels, Rick

    Medicine and Veterinary Medicine Imaging Postgraduate Opportunities MSc/Dip/Cert by online distance of students with backgrounds in clinical medicine (Radiology, Radiography, Surgery, Medicine and Veterinary medicine); basic sciences & engineering (Biology, Biomedical Sciences, Physics, Engineering, Chemistry

  5. The Inner Nuclear Membrane Protein Src1 Is Required for Stable Post-Mitotic Progression into G1 in Aspergillus nidulans

    PubMed Central

    Osmani, Aysha H.; Osmani, Stephen A.

    2015-01-01

    How membranes and associated proteins of the nuclear envelope (NE) are assembled specifically and inclusively around segregated genomes during exit from mitosis is incompletely understood. Inner nuclear membrane (INM) proteins play key roles by providing links between DNA and the NE. In this study we have investigated the highly conserved INM protein Src1 in Aspergillus nidulans and have uncovered a novel cell cycle response during post mitotic formation of G1 nuclei. Live cell imaging indicates Src1 could have roles during mitotic exit as it preferentially locates to the NE abscission points during nucleokinesis and to the NE surrounding forming daughter G1 nuclei. Deletion analysis further supported this idea revealing that although Src1 is not required for interphase progression or mitosis it is required for stable post-mitotic G1 nuclear formation. This conclusion is based upon the observation that in the absence of Src1 newly formed G1 nuclei are structurally unstable and immediately undergo architectural modifications typical of mitosis. These changes include NPC modifications that stop nuclear transport as well as disassembly of nucleoli. More intriguingly, the newly generated G1 nuclei then cycle between mitotic- and interphase-like states. The findings indicate that defects in post-mitotic G1 nuclear formation caused by lack of Src1 promote repeated failed attempts to generate stable G1 nuclei. To explain this unexpected phenotype we suggest a type of regulation that promotes repetition of defective cell cycle transitions rather than preventing progression past the defective cell cycle transition. We suggest the term “reboot regulation” to define this mode of cell cycle regulation. The findings are discussed in relationship to recent studies showing the Cdk1 master oscillator can entrain subservient oscillators that when uncoupled cause cell cycle transitions to be repeated. PMID:26147902

  6. SPACE-R Thermionic Space Nuclear Power System: Design and Technology Demonstration Program. Semiannual technical progress report for period ending March 1993

    SciTech Connect

    Not Available

    1993-05-01

    This Semiannual Technical Progress Report summarizes the technical progress and accomplishments for the Thermionic Space Nuclear Power System (TI-SNPS) Design and Technology Demonstration Program of the Prime Contractor, Space Power Incorporated (SPI), its subcontractors and supporting National Laboratories during the first half of the Government Fiscal Year (GFY) 1993. SPI`s subcontractors and supporting National Laboratories include: Babcock & Wilcox for the reactor core and externals; Space Systems/Loral for the spacecraft integration; Thermocore for the radiator heat pipes and the heat exchanger; INERTEK of CIS for the TFE, core elements and nuclear tests; Argonne National Laboratories for nuclear safety, physics and control verification; and Oak Ridge National laboratories for materials testing. Parametric trade studies are near completion. However, technical input from INERTEK has yet to be provided to determine some of the baseline design configurations. The INERTEK subcontract is expected to be initiated soon. The Point Design task has been initiated. The thermionic fuel element (TFE) is undergoing several design iterations. The reactor core vessel analysis and design has also been started.

  7. Progressive multifocal leukoencephalopathy and promyelocytic leukemia nuclear bodies: a review of clinical, neuropathological, and virological aspects of JC virus-induced demyelinating disease

    PubMed Central

    2010-01-01

    Progressive multifocal leukoencephalopathy is a fatal viral-induced demyelinating disease that was once rare but has become more prevalent today. Over the past decades, much has been learned about the disease from molecular study of the etiological agent of the disease, JC virus. Recently, promyelocytic leukemia nuclear bodies (PML-NBs), punctuate structures for important nuclear functions in eukaryotic cells, were identified as an intranuclear target of JC virus infection. Neuropathologically, JC virus-infected glial cells display diffuse amphophilic viral inclusions by hematoxylin–eosin staining (full inclusions), a diagnostic hallmark of this disease. Recent results using immunohistochemistry, however, revealed the presence of punctate viral inclusions preferentially located along the inner nuclear periphery (dot-shaped inclusions). Dot-shaped inclusions reflect the accumulation of viral progeny at PML-NBs, which may be disrupted after viral replication. Structural changes to PML-NBs have been reported for a variety of human diseases, including cancers and neurodegenerative disorders. Thus, PML-NBs may provide clues to the further pathogenesis of JC virus-induced demyelinating disease. Here, we review what we have learned since the disease entity establishment, including a look at recent progress in understanding the relationship between JC virus, etiology and PML-NBs. PMID:20464404

  8. NUCLEAR ENERGY RESEARCH INITIATIVE (NERI) PROGRAM GRANT NUMBER DE-FG03-00SF22168 TECHNICAL PROGRESS REPORT (Nov. 15, 2001 - Feb. 15,2002) ''Design and Layout Concepts for Compact, Factory-Produced, Transportable, Generation IV Reactor Systems''

    SciTech Connect

    Fred R. Mynatt; Andy Kadak; Marc Berte; Larry Miller; Mohammed Khan; Joe McConn; Lawrence Townsend; Wesley Williams; Martin Williamson

    2002-03-15

    The objectives of this project are to develop and evaluate nuclear power plant designs and layout concepts to maximize the benefits of compact modular Generation IV reactor concepts including factory fabrication and packaging for optimal transportation and siting. Three nuclear power plant concepts are being studied representing water, helium and lead-bismuth coolants. This is the sixth quarterly progress report.

  9. Evaluation of the geologic relations and seismotectonic stability of the Yucca Mountain area Nevada Nuclear Waste site investigation (NNWSI). Progress report, October 1, 1992--September 30, 1993

    SciTech Connect

    1993-09-30

    This report provides a summary of progress for the project {open_quotes}Evaluation of the Geologic Relations and Seismotectonic Stability of the Yucca Mountain Area, Nevada Nuclear Waste Site Investigation (NNWSI).{close_quotes} A similar report was previously provided for the period of 1 October 1991 to 30 September 1992. The report initially covers the activities of the General Task and is followed by sections that describe the progress of the other ongoing Tasks. This report summarizes the geologic and seismotectonic studies conducted at Yucca Mountain during the contract period including Quaternary tectonics, an evaluation of mineral resource potential of the area, caldera geology, and volcano-tectonic activity at and near the site. A report of basinal studies conducted during the contract period is also included. Selected papers are indexed separately for inclusion in the Energy Science and Technology Database.

  10. Development of more efficacious Tc-99m organ imaging agents for use in nuclear medicine by analytical characterization of radiopharmaceutical mixtures

    SciTech Connect

    Heineman, W.R.

    1992-01-24

    The long-range objective of this research program is the development of more efficacious technetium-99m radiopharmaceuticals for use as imaging agents in diagnostic nuclear medicine. We seek to isolate and develop distinct site imaging agents, each of which has properties optimized to provide diagnostic information concerning a given pathological condition. The specific objectives during the period (9/1/89 to 8/31/92) include: (1) Development of strategies for improving yields of specific Tc-diphosphonate complexes with optimum imaging properties; (2) Development of electrodes for rapid in situ electrochemical generation of skeletal imaging agents; (3) Development of electrochemical sensors for {Tc} and Re imaging agents; (4) Characterization of stable {Tc}- and Re-diphosphonate complexes obtainable in high yield by structural studies with techniques such as NMR, EXAFS, and Raman spectroscopy; (5) Development of improved separation techniques for the characterization of diphosphonate skeletal imaging agents; (6) Evaluation of the effect of the biological milieu on {Tc}-diphosphonate complexes; and (7) Electrochemical studies of technetium and rhenium complexes synthesized by Professor Deutsch's research group for heart and brain imaging.

  11. Quantitative in vivo cell-surface receptor imaging in oncology: kinetic modeling and paired-agent principles from nuclear medicine and optical imaging

    NASA Astrophysics Data System (ADS)

    Tichauer, Kenneth M.; Wang, Yu; Pogue, Brian W.; Liu, Jonathan T. C.

    2015-07-01

    The development of methods to accurately quantify cell-surface receptors in living tissues would have a seminal impact in oncology. For example, accurate measures of receptor density in vivo could enhance early detection or surgical resection of tumors via protein-based contrast, allowing removal of cancer with high phenotype specificity. Alternatively, accurate receptor expression estimation could be used as a biomarker to guide patient-specific clinical oncology targeting of the same molecular pathway. Unfortunately, conventional molecular contrast-based imaging approaches are not well adapted to accurately estimating the nanomolar-level cell-surface receptor concentrations in tumors, as most images are dominated by nonspecific sources of contrast such as high vascular permeability and lymphatic inhibition. This article reviews approaches for overcoming these limitations based upon tracer kinetic modeling and the use of emerging protocols to estimate binding potential and the related receptor concentration. Methods such as using single time point imaging or a reference-tissue approach tend to have low accuracy in tumors, whereas paired-agent methods or advanced kinetic analyses are more promising to eliminate the dominance of interstitial space in the signals. Nuclear medicine and optical molecular imaging are the primary modalities used, as they have the nanomolar level sensitivity needed to quantify cell-surface receptor concentrations present in tissue, although each likely has a different clinical niche.

  12. Site characterization progress report: Yucca Mountain, Nevada, April 1, 1990--September 30, 1990, Number 3; Nuclear Waste Policy Act (Section 113)

    SciTech Connect

    1991-03-01

    In accordance with the requirements of Section 113(b)(3) of the Nuclear Waste Policy Act of 1982 (NWPA), as amended, the US Department of Energy has prepared this report on the progress of site characterization activities at Yucca Mountain, Nevada, for the period April 1 through September 30, 1990. This report is the third of a series of reports that are issued at intervals of approximately six months during site characterization. The report covers a number of new initiatives to improve the effectiveness of the site characterization program and covers continued efforts related to preparatory activities, study plans, and performance assessment. 85 refs., 2 figs., 3 tabs.

  13. Molecular imaging with optics: primer and case for near-infrared fluorescence techniques in personalized medicine

    PubMed Central

    Sevick-Muraca, Eva M.; Rasmussen, John C.

    2010-01-01

    We compare and contrast the development of optical molecular imaging techniques with nuclear medicine with a didactic emphasis for initiating readers into the field of molecular imaging. The nuclear imaging techniques of gamma scintigraphy, single-photon emission computed tomography, and positron emission tomography are first briefly reviewed. The molecular optical imaging techniques of bioluminescence and fluorescence using gene reporter/probes and gene reporters are described prior to introducing the governing factors of autofluorescence and excitation light leakage. The use of dual-labeled, near-infrared excitable and radio-labeled agents are described with comparative measurements between planar fluorescence and nuclear molecular imaging. The concept of time-independent and -dependent measurements is described with emphasis on integrating time-dependent measurements made in the frequency domain for 3-D tomography. Finally, we comment on the challenges and progress for translating near-infrared (NIR) molecular imaging agents for personalized medicine. PMID:19021311

  14. Use Medicines Safely

    MedlinePLUS

    ... Medicines Safely Print This Topic En español Use Medicines Safely Browse Sections The Basics Overview Prescription Medicines ... Medicines 1 of 8 sections The Basics: Prescription Medicines There are different types of medicine. The 2 ...

  15. Nuclear chemistry research and spectroscopy with radioactive sources. Twenty-first annual progress report, February 1, 1985-January 31, 1986

    SciTech Connect

    Fink, R.W.

    1985-08-31

    The nuclear chemistry group in the School of Chemistry continues investigating the radioactive decay of nuclei far from stability under this DOE contract. These nuclei are produced with heavy ions from the Holifield Heavy Ion Research Facility (HHIRF) and studied on-line with the University Isotope Separator at Oak Ridge (UNISOR). Radioactive decay represents a unique method for the population of low-energy, low-spin structures in nuclei, and new phenomena which do not occur near stability can be explored. Our research encompasses three aspects of nuclear structure: (1) nuclear spectroscopy with detailed elelt, e elt, Xelt, etc., multiparameter coincidence spectrometry; (2) on-line laser hyperfine structure (hfs) and isotope shift measurements for the determination of nuclear quadrupole moments, nuclear spins, and changes in mean nuclear charge radii as a means of revealing systematic shape changes in nuclei; and (3) theoretical calculations of predictions of nuclear models for comparison with experimental level structures in nuclei studied at UNISOR. 20 refs., 9 figs., 2 tabs.

  16. Nuclear chemistry research and spectroscopy with radioactive sources. Twentieth annual progress report, September 1, 1983-August 31, 1984

    SciTech Connect

    Fink, R.W.

    1984-08-31

    Research under this continuing DOE contract centers on radioactive decay studies of nuclei far from stability produced with heavy ions from the Holifield Heavy Ion Research Facility (HHIRF) and studied on-line with the University Isotope Separator at Oak Ridge (UNISOR). These investigations encompass three aspects of nuclear structure research: nuclear spectroscopic measurements involving detailed ..gamma gamma..t, ..gamma..e/sup -/t, and X..gamma..t three-parameter coincidence spectrometry; on-line laser hyperfine structure (hfs) and isotope shift spectroscopy for determining quadrupole moments, nuclear spins, and mean nuclear charge radii; and computer calculations of nuclear model predictions for comparison with the experimental level schemes. The focus of this research program is on odd-mass nuclei in which the odd nucleon probes the core, making possible observation of such phenomena as the onset of abrupt shape changes, the occurrence of shape coexistence, and shell-model intruder states. These phenomena are critical tests of concepts fundamental to an understanding of low-energy nuclear structure, such as nuclear deformations, shell models, collective models, and particle-core couplings.

  17. Faculty of Medicine Graduate School of Medicine

    E-print Network

    Miyashita, Yasushi

    2007--2008 Faculty of Medicine Graduate School of Medicine PROSPECTUS The University of Tokyo #12;#12;Welcome to Faculty of Medicine, Graduate School of Medicine The University of Tokyo Takao Shimizu Dean, Faculty of Medicine, Graduate School of Medicine The University of Tokyo The Faculty of Medicine

  18. Contributions of Ibn Al-Nafis (1210-1288 AD) to the progress of medicine and urology. A study and translations from his medical works.

    PubMed

    Abdel-Halim, Rabie E

    2008-01-01

    This primary-source study of 4 medical works of the 13th century Muslim scholar Ibn Al-Nafis confirmed that his Kitab Al-Mujaz Fi Al-Tibb was authored as an independent book meant to be a handbook for medical students and practitioners not as an epitome of Kitab Al-Qanun of Ibn Sina as thought by recent historians. His huge medical encyclopedia, Al-Shamil, represents a wave of intense scientific activity that spread among the scholars of Cairo and Damascus following the massive destruction of books by Hulako's Army during the devastation of Baghdad in 1258. Like his predecessors in the Islamic Era, Ibn Al-Nafis critically appraised the views of scholars before him in the light of his own experimentation and direct observations. Accordingly, in his books Sharh Tashreeh Al-Qanun, Risalat al-Aadaa and Al-Risalah Al-Kameleyyah, we find the first description of the coronary vessels and the true concept of the blood supply of the heart as well as the correct description of the pulmonary circulation and the beginnings of the proper understanding of the systemic circulation. Those discoveries of Ibn Al-Nafis, translated to Latin by Andreas Alpagus printed in Venice in 1547, appeared, 6 years later, in the Christianismi Restituto of Servetus and, in 1555, in the De Fabrica Humani Corporis of Vesalius 2nd edition then in the works of Valvarde 1554, Columbus 1559, Cesalpino 1571, and finally Harvey in 1628. Furthermore, this study documented several other contributions of Ibn Al-Nafis to the progress of human functional anatomy and to advances in medical and surgical practice. PMID:18176669

  19. Vulnerable Medicine

    ERIC Educational Resources Information Center

    Bochner, Arthur P.

    2009-01-01

    In "Narrative Medicine: Honoring the Stories of Illness," Rita Charon paints an original and humane portrait of what it can mean to be a doctor, to live a life immersed in sickness and dedicated to wellness. Charon drops the veil, inviting readers to look at the secret, subjective, emotional face of medicine, a zone of self-censored feelings and…

  20. Aerospace Medicine

    NASA Technical Reports Server (NTRS)

    Davis, Jeffrey R.

    2006-01-01

    This abstract describes the content of a presentation for ground rounds at Mt. Sinai School of Medicine. The presentation contains three sections. The first describes the history of aerospace medicine beginning with early flights with animals. The second section of the presentation describes current programs and planning for future missions. The third section describes the medical challenges of exploration missions.

  1. Final Progress Report to the Department of Energy's Office of Science on the Committee on Nuclear Physics

    SciTech Connect

    Board on Physics and Astronomy

    2001-01-01

    The Committee on Nuclear Physics (CNP), under the National Research Council's Board on Physics and Astronomy (BPA), conducted an assessment of the field as part of the BPA's survey of physics in the last decade, titled ''Physics in a New Era.'' The CNP report was published by the National Academy Press in early 1999 under the title ''Nuclear Physics: The Core of Matter, The Fuel of Stars.''

  2. Theoretical studies in medium-energy nuclear and hadronic physics. Annual technical progress report, April 1, 1991--March 31, 1992

    SciTech Connect

    Horowitz, C.J.; Macfarlane, M.H.; Matsui, Tetsuo; Serot, B.D.

    1991-12-03

    In the period covered by this report (April 1, 1991 to March 31, 1992), work focused on six main areas: (1) Relativistic Theories of Nuclear Structure and Saturation, (2) Relativistic Descriptions of Proton-Nucleus and Electron-Nucleus Scattering, (3) Nonrelativistic Theory of Nucleon-Nucleus Reactions, (4) Relativistic Many-Body Theory at Finite Temperature and Density, (5) Neutrino Interactions in Dense Matter, (6) Quark Models of Nuclear and Quark Matter.

  3. Nuclear chemistry research and spectroscopy with radioactive sources. Twenty-second annual progress report, February 1, 1986-January 31, 1987

    SciTech Connect

    Fink, R.W.

    1986-08-31

    The nuclear chemistry group in the School of Chemistry continues investigations of radioactive decay of nuclei far from stability under this DOE contract. These nuclei are produced with heavy ions from the Holifield Heavy Ion Research Facility (HHIRF) and studied on-line with the University Isotope Separator at Oak Ridge (UNISOR). Radioactive decay represents a unique method for the population of low-energy, low-spin structures in nuclei, and new phenomena which do not occur near stability can be explored. Our research interest encompasses three aspects of nuclear structure: (1) nuclear spectroscopy with detailed ..gamma gamma..t, e/sup -/..gamma..t, X..gamma..t, ..cap alpha gamma..t multiparameter coincidence spectrometry; (2) measurements of single ..gamma..-ray angular distributions and magnetic moments of mass separated low-temperature oriented nuclei, using the helium dilution refrigerator ''ORIENT'' being installed on-line to the isotope separator; and (3) on-line laser hyperfine structure (hfs) and isotope shift measurements for determination of nuclear quadrupole moments, nuclear spins, and changes in mean nuclear charge radii as a means of revealing systematic shape changes in nuclei. 35 refs., 8 figs., 1 tab.

  4. Will regenerative medicine replace transplantation?

    PubMed

    Orlando, Giuseppe; Soker, Shay; Stratta, Robert J; Atala, Anthony

    2013-08-01

    Recent groundbreaking advances in organ bioengineering and regeneration have provided evidence that regenerative medicine holds promise to dramatically improve the approach to organ transplantation. The two fields, however, share a common heritage. Alexis Carrel can be considered the father of both regenerative medicine and organ transplantation, and it is now clear that his legacy is equally applicable for the present and future generations of transplant and regenerative medicine investigators. In this review, we will briefly illustrate the interplay that should be established between these two complementary disciplines of health sciences. Although regenerative medicine has shown to the transplant field its potential, transplantation is destined to align with regenerative medicine and foster further progress probably more than either discipline alone. Organ bioengineering and regeneration technologies hold the promise to meet at the same time the two most urgent needs in organ transplantation, namely, the identification of a new, potentially inexhaustible source of organs and immunosuppression-free transplantation of tissues and organs. PMID:23906883

  5. Will Regenerative Medicine Replace Transplantation?

    PubMed Central

    Orlando, Giuseppe; Soker, Shay; Stratta, Robert J.; Atala, Anthony

    2013-01-01

    Recent groundbreaking advances in organ bioengineering and regeneration have provided evidence that regenerative medicine holds promise to dramatically improve the approach to organ transplantation. The two fields, however, share a common heritage. Alexis Carrel can be considered the father of both regenerative medicine and organ transplantation, and it is now clear that his legacy is equally applicable for the present and future generations of transplant and regenerative medicine investigators. In this review, we will briefly illustrate the interplay that should be established between these two complementary disciplines of health sciences. Although regenerative medicine has shown to the transplant field its potential, transplantation is destined to align with regenerative medicine and foster further progress probably more than either discipline alone. Organ bioengineering and regeneration technologies hold the promise to meet at the same time the two most urgent needs in organ transplantation, namely, the identification of a new, potentially inexhaustible source of organs and immunosuppression-free transplantation of tissues and organs. PMID:23906883

  6. Uranium recovery research sponsored by the Nuclear Regulatory Commission at Pacific Northwest Laboratory. Quarterly progress report, June-September 1983

    SciTech Connect

    Foley, M.G.; Deutsch, W.J.; Gee, G.W.; Hartley, J.N.; Kalkwarf, D.R.; Mayer, D.W.; Nelson, R.W.; Opitz, B.E.; Peterson, S.R.; Serne, R.J.

    1983-11-01

    This report documents progress for the following major research projects: stabilization, engineering, and monitoring alternatives assessment for improving regulation of uranium recovery operations and waste management; attenuation of radon emission from uranium tailings; assessment of leachate movement from uranium mill tailings; and methods of minimizing ground-water contaminants from in-situ leach uranium mining.

  7. Wilderness medicine

    PubMed Central

    Sward, Douglas G.; Bennett, Brad L.

    2014-01-01

    BACKGROUND: Human activity in wilderness areas has increased globally in recent decades, leading to increased risk of injury and illness. Wilderness medicine has developed in response to both need and interest. METHODS: The field of wilderness medicine encompasses many areas of interest. Some focus on special circumstances (such as avalanches) while others have a broader scope (such as trauma care). Several core areas of key interest within wilderness medicine are discussed in this study. RESULTS: Wilderness medicine is characterized by remote and improvised care of patients with routine or exotic illnesses or trauma, limited resources and manpower, and delayed evacuation to definitive care. Wilderness medicine is developing rapidly and draws from the breadth of medical and surgical subspecialties as well as the technical fields of mountaineering, climbing, and diving. Research, epidemiology, and evidence-based guidelines are evolving. A hallmark of this field is injury prevention and risk mitigation. The range of topics encompasses high-altitude cerebral edema, decompression sickness, snake envenomation, lightning injury, extremity trauma, and gastroenteritis. Several professional societies, academic fellowships, and training organizations offer education and resources for laypeople and health care professionals. CONCLUSIONS: The future of wilderness medicine is unfolding on multiple fronts: education, research, training, technology, communications, and environment. Although wilderness medicine research is technically difficult to perform, it is essential to deepening our understanding of the contribution of specific techniques in achieving improvements in clinical outcomes. PMID:25215140

  8. Progress and goals for INMM ASC N15 consensus standard ""Administrative practices for the determination and reporting of results of non-destructive assay measurements of nuclear material in situ for safeguards nuclear criticality safety and other purposes

    SciTech Connect

    Bracken, David S; Lamb, Frank W

    2009-01-01

    This paper will discuss the goals and progress to date on the development of INMM Accredited Standard Committee (ASC) N15 consensus standard Administrative Practices for the Determination and Reporting of Results of Non-Destructive Assay Measurements of Nuclear Material in situ for Safeguards, Nuclear Criticality Safety, and Other Purposes. This standard will define administrative practices in the areas of data generation and reporting of NDA assay of holdup deposits with consideration of the stakeholders of the reported results. These stakeholders may include nuclear material accounting and safeguards, nuclear criticality safety, waste management, health physics, facility characterization, authorization basis, radiation safety, and site licensing authorities. Stakeholder input will be solicited from interested parties and incorporated during the development of the document. Currently only one consensus standard exists that explicitly deals with NDA holdup measurements: ASTM C1455 Standard Test Method for Nondestructive Assay of Special Nuclear Material Holdup Using Gamma-Ray Spectroscopic Methods. The ASTM International standard emphasizes the activities involved in actually making measurements, and was developed by safeguards and NDA experts. This new INMM ASC N15 standard will complement the existing ASTM international standard. One of the largest driving factors for writing this new standard was the recent emphasis on in situ NDA measurements by the safeguards community due to the Defense Nuclear Facility Safety Board (DNFSB) recommendation 2007-1 on in situ NDA measurements. Specifically, DNFSB recommendation 2007-1 referenced the lack of programmatic requirements for accurate in situ measurements and the use of measurement results for compliance with safety based requirements. That being the case, this paper will also discuss the progress made on the Implementation Plan for Defense Nuclear Facilities Safety Board Recommendation 2007-1 Safety-Related In Situ Nondestructive Assay of Radioactive Materials. Some of the information that will be presented includes observations made during site visits, how information useful to all facilities using nondestructive assay to determine holdup material quantities will be disseminated, and preliminary results of a gap analysis performed on current in situ nondestructive assay holdup measurements.

  9. Challenges of flow-cytometric estimation of nuclear genome size in orchids, a plant group with both whole-genome and progressively partial endoreplication.

    PubMed

    Trávní?ek, Pavel; Ponert, Jan; Urfus, Tomáš; Jersáková, Jana; Vrána, Jan; H?ibová, Eva; Doležel, Jaroslav; Suda, Jan

    2015-10-01

    Nuclear genome size is an inherited quantitative trait of eukaryotic organisms with both practical and biological consequences. A detailed analysis of major families is a promising approach to fully understand the biological meaning of the extensive variation in genome size in plants. Although Orchidaceae accounts for ?10% of the angiosperm diversity, the knowledge of patterns and dynamics of their genome size is limited, in part due to difficulties in flow cytometric analyses. Cells in various somatic tissues of orchids undergo extensive endoreplication, either whole-genome or partial, and the G1-phase nuclei with 2C DNA amounts may be lacking, resulting in overestimated genome size values. Interpretation of DNA content histograms is particularly challenging in species with progressively partial endoreplication, in which the ratios between the positions of two neighboring DNA peaks are lower than two. In order to assess distributions of nuclear DNA amounts and identify tissue suitable for reliable estimation of nuclear DNA content, we analyzed six different tissue types in 48 orchid species belonging to all recognized subfamilies. Although traditionally used leaves may provide incorrect C-values, particularly in species with progressively partial endoreplication, young ovaries and pollinaria consistently yield 2C and 1C peaks of their G1-phase nuclei, respectively, and are, therefore, the most suitable parts for genome size studies in orchids. We also provide new DNA C-values for 22 orchid genera and 42 species. Adhering to the proposed methodology would allow for reliable genome size estimates in this largest plant family. Although our research was limited to orchids, the need to find a suitable tissue with dominant 2C peak of G1-phase nuclei applies to all endopolyploid species. PMID:25929591

  10. WE-A-17A-07: Evaluation of a Grid-Based Boltzmann Solver for Nuclear Medicine Voxel-Based Dose Calculations

    SciTech Connect

    Mikell, J; Kappadath, S; Wareing, T; Mourtada, F

    2014-06-15

    Purpose: Grid-based Boltzmann solvers (GBBS) have been successfully implemented in radiation oncology clinics as dose calculations for e×ternal photon beams and 192Ir sealed-source brachytherapy. We report on the evaluation of a GBBS for nuclear medicine vo×el-based absorbed doses. Methods: Vo×el-S-values were calculated for monoenergetic betas and photons (1, 0.1, 0.01 MeV), 90Y, and 131I for 3 mm vo×el sizes using Monte Carlo (DOS×YZnrc) and GBBS (Attila 8.1-beta5, Transpire). The source distribution was uniform throughout a single vo×el. The material was an infinite 1.04 g/cc soft tissue slab. To e×plore convergence properties of the GBBS 3 tetrahedral meshes, 3 energy group structures, 3 different square Chebyschev-Legendre quadrature set orders (Sn), and 4×2013;7 spherical harmonic e×pansion terms (Pn) were investigated for a total of 168 discretizations per source. The mesh, energy group, and quadrature sets are 8×, 3×, and 16×, respectively, finer than the corresponding coarse discretization. GBBS cross sections were generated with full electronphoton-coupling using the vendors e×tended CEP×S code. For accuracy, percent differences (%?) in source vo×el absorbed doses between MC and GBBS are reported for the coarsest and finest discretization. For convergence, ratios of the two finest discretization solutions are reported along each variable. Results: For 1 MeV, 0.1 MeV, 0.01 MeV, Y90, and I-131 beta sources the %? in the source vo×el for (coarsest,finest) discretization were (+2.0,?6.4), (?8.0, ?7.5), (?13.8, ?13.4), (+0.9,?5.5), and (? 10.1,?9.0) respectively. The corresponding %? for photons were (+33.7,?7.1), (?9.4, ?9.8), (?17.4, ?15.2), and (?1.7,?7.7), respectively. For betas, the convergence ratio of mesh, energy, Sn, and Pn ranged from 0.991–1.000. For gammas, the convergence ratio of mesh, Sn, and Pn ranged from 0.998–1.003 while the ratio for energy ranged from 0.964–1.001. Conclusions: GBBS is promising for nuclear medicine vo×el-based dose calculations. Ongoing work includes evaluating GBBS in bone, lung, and realistic clinical PET/SPECT-based activity distributions. Research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health under Award Number R01CA138986. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

  11. SU-C-9A-02: Structured Noise Index as An Automated Quality Control for Nuclear Medicine: A Two Year Experience

    SciTech Connect

    Nelson, J; Christianson, O; Samei, E

    2014-06-01

    Purpose: Flood-field uniformity evaluation is an essential element in the assessment of nuclear medicine (NM) gamma cameras. It serves as the central element of the quality control (QC) program, acquired and analyzed on a daily basis prior to clinical imaging. Uniformity images are traditionally analyzed using pixel value-based metrics which often fail to capture subtle structure and patterns caused by changes in gamma camera performance requiring additional visual inspection which is subjective and time demanding. The goal of this project was to develop and implement a robust QC metrology for NM that is effective in identifying non-uniformity issues, reporting issues in a timely manner for efficient correction prior to clinical involvement, all incorporated into an automated effortless workflow, and to characterize the program over a two year period. Methods: A new quantitative uniformity analysis metric was developed based on 2D noise power spectrum metrology and confirmed based on expert observer visual analysis. The metric, termed Structured Noise Index (SNI) was then integrated into an automated program to analyze, archive, and report on daily NM QC uniformity images. The effectiveness of the program was evaluated over a period of 2 years. Results: The SNI metric successfully identified visually apparent non-uniformities overlooked by the pixel valuebased analysis methods. Implementation of the program has resulted in nonuniformity identification in about 12% of daily flood images. In addition, due to the vigilance of staff response, the percentage of days exceeding trigger value shows a decline over time. Conclusion: The SNI provides a robust quantification of the NM performance of gamma camera uniformity. It operates seamlessly across a fleet of multiple camera models. The automated process provides effective workflow within the NM spectra between physicist, technologist, and clinical engineer. The reliability of this process has made it the preferred platform for NM uniformity analysis.

  12. Effective radiation dose to the patient and to the general population from nuclear medicine procedures: variations in the last twenty-year period.

    PubMed

    Garancini, S; Bianchi, L; Conte, L; Monciardini, M; Roncari, G

    1995-06-01

    We have evaluated how changes in nuclear medicine (NM) techniques over the last twenty-year period have modified radiation exposure to the patient and population. For this purpose, we estimated the variations in the mean effective dose to the patient, and both the collective and the per capita effective dose to the population of the province of Varese, derived from radioisotope examinations carried out in the four NM Centers of this province in the years 1972, 1981, and 1991. Dosimetric calculations were based on ICRP Publication 53 for most of the radiopharmaceuticals used, and tissue weighting factors were based on ICRP Publication 60. The total number of NM exams carried out was 19,744 in 1972, 31,973 in 1981, and 23,623 in 1991. Between 1972 and 1991 there has been a substantial decrease in the effective irradiation to the patient and to the general population (mean effective dose to the patient: from 21.2 to 6 mSv; per capita mean effective dose: from 0.58 to 0.18 mSv), and in the per capita equivalent dose to some target organs, such as the thyroid (9.6-->1.5 mSv) and liver (0.51-->0.07 mSv). At the same time, there has been a significant increase in the per capita equivalent dose to the bladder (0.05-->0.48 mSv), skeleton (0.08-->0.36 mSv), and testes (0.02-->0.15 mSv), and a less marked increase to the ovaries (0.03-->0.06 mSv). The per capita equivalent dose to red marrow (0.13-->0.1 mSv) and to the large intestine (0.1-->0.12 mSv) did not change significantly. PMID:8574811

  13. General-purpose heat source project and space nuclear safety and fuels program. Progress reportt, January 1980

    SciTech Connect

    Maraman, W.J.

    1980-04-01

    This formal monthly report covers the studies related to the use of /sup 238/PuO/sub 2/ in radioisotopic power systems carried out for the Advanced Nuclear Systems and Projects Division of the Los Alamos Scientific Laboratory. The two programs involved are the general-purpose heat source development and space nuclear safety and fuels. Most of the studies discussed here are of a continuing nature. Results and conclusions described may change as the work continues. Published reference to the results cited in this report should not be made without the explicit permission of the person in charge of the work.

  14. Faculty of Medicine Graduate School of Medicine

    E-print Network

    Miyashita, Yasushi

    2005--2006 Faculty of Medicine Graduate School of Medicine PROSPECTUS The University of Tokyo #12;#12;Welcome to Faculty of Medicine, Graduate School of Medicine The University of Tokyo Nobutaka Hirokawa Dean, Faculty of Medicine, Graduate School of Medicine The University of Tokyo The University of Tokyo Graduate

  15. Quantum chromodynamics and nuclear physics at extreme energy density. Progress report, May 15, 1994--May 14, 1995

    SciTech Connect

    Mueller, B.; Springer, R.P.

    1995-05-15

    A brief summary of the progress made for the year is given for each of the following areas: (1) quark-gluon plasma and relativistic heavy ion collisions (nine contributions); (2) effective theories for hadrons and nuclei (four contributions); (4) renormalization group approach to field theory at finite temperature; (5) symmetry-preserving regularization; and (6) an effective field theory approach to the cosmological constant problem.

  16. Uranium recovery research sponsored by the Nuclear Regulatory Commission at Pacific Northwest Laboratory. Quarterly progress report, January-March 1984

    SciTech Connect

    Foley, M.G.; Opitz, B.E.; Deutsch, W.J.; Peterson, S.R.; Gee, G.W.; Serne, R.J.; Hartley, J.N.; Thomas, V.W.; Kalkwarf, D.R.; Walters, W.H.; Fayer, M.J.; Wogman, N.A.; Nelson, R.W.

    1984-05-01

    Progress is reported on the following studies dealing with mill tailings: long-term stabilizaton; interim stabilization of mill tailings piles; tailings dewatering techniques; tailings neutralization and other alternatives in immobilizing toxic materials in tailings; evaluation of seepage and leachate transport from tailings disposal facilities; effluent and environmental monitoring methods and equipment and instrument testing; attenuation of radon emissions; assessment of leachate movement from uranium mill tailings; and methods of minimizing ground water contamination in in-situ leach uranium mining.

  17. Uranium recovery research sponsored by the Nuclear Regulatory Commission at Pacific Northwest Laboratory. Quarterly progress report, April-June 1984

    SciTech Connect

    Foley, M.G.; Deutsch, W.J.; Gee, G.W.; Hartley, J.N.; Kalkwarf, D.R.; Fayer, M.J.; Nelson, R.W.; Opitz, B.E.; Peterson, S.R.; Serne, R.J.; thomas, V.W.; Walters, W.H.; Wogman, N.A.

    1984-08-01

    Progress is reported on the following studies dealing with mill tailings: long-term stabilization; interim stabilization of mill tailings piles; tailings dewatering techniques; tailings neutralization and other alternatives in immobilizing toxic materials in tailings; evaluation of seepage and leachate transport from tailings disposal facilities; effluent and environmental monitoring methods and equipment and instrument testing; attenuation of radon emissions; assessment of leachate movement from uranium mill tailings; and methods of minimizing ground water contamination in in-situ leach uranium mining. 1 figure.

  18. Engineering and Physics Optimization of Breed and Burn Fast Reactor Systems; NUCLEAR ENERGY RESEARCH INITIATIVE (NERI) QUARTERLY PROGRESS REPORT

    SciTech Connect

    ERROR,; Hejzlar, Pavel; Yarsky, Peter; Driscoll, Mike; Wachs, Dan; Weaver, Kevan; Czerwinski, Ken; Pope, Mike; Parry, James; Marshall, Theron D.; Davis, Cliff B.; Crawford, Dustin; Hartmann, Thomas; Saha, Pradip

    2005-01-31

    This project is organized under four major tasks (each of which has two or more subtasks) with contributions among the three collaborating organizations (MIT, INEEL and ANL-West): Task A: Core Physics and Fuel Cycle; Task B: Core Thermal Hydraulics; Task C: Plant Design; Task D: Fuel Design The lead PI, Michael J. Driscoll, has consolidated and summarized the technical progress submissions provided by the contributing investigators from all sites, under the above principal task headings.

  19. Research and development related to the Nevada Nuclear Waste Storage Investigations: Progress report, October 1--December 31, 1984

    SciTech Connect

    Thomas, K.W.

    1988-11-01

    This report summarizes some of the technical contributions by the Los Alamos National Laboratory to the Nevada Nuclear Waste Storage Investigations (NNWSI) Project from October 1 through December 31, 1984. The report is not a detailed technical document but does indicate the status of the investigations being performed at Los Alamos.

  20. www.elsevier.com/locate/pnucene Progress in Nuclear Energy, Vol. 43, No. I-4, pp. 35-41,2003

    E-print Network

    Pázsit, Imre

    in real measurements, and many of them have been used routinely afterwards. In this paper two particular;36 7: Andersson et al. Ringhals is the largest nuclear power site in Sweden, with one BWR and 3 PWR), (Pfizsit et al, 1999). This paper gives a detailed account of the last two items above. 2. DETERMINATION